Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Bladder Cancer, January 2020

Free Subscription


Retrieve all available abstracts of the following 2253 articles:
HTML format


Single Articles

  1. NAITO T, Higuchi T, Shimada Y, Kakinuma C, et al
    An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer.
    Oncol Lett. 2020;19:833-839.
    Abstract     Related articles   

  2. LU J, Xue Y, Shen F, Gu H, et al
    Transurethral holmium laser resection and transurethral electrocision combined with intravesical epirubicin within 24 hours postoperatively for treatment of bladder cancer.
    J Int Med Res. 2019 Dec 29:300060519887267. doi: 10.1177/0300060519887267.
    Abstract     Related articles   

  3. XIONG Y, Yuan L, Xiong J, Xu H, et al
    An outcome model for human bladder cancer: A comprehensive study based on weighted gene co-expression network analysis.
    J Cell Mol Med. 2019 Dec 28. doi: 10.1111/jcmm.14918.
    Abstract     Related articles   

  4. KUROKI H, Anraku T, Kazama A, Bilim V, et al
    9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer.
    Sci Rep. 2019;9:19977.
    Abstract     Related articles   

  5. WANG J, Wang C
    Dietary fat intake and risk of bladder cancer: Evidence from a meta-analysis of observational studies.
    Cell Mol Biol (Noisy-le-grand). 2019;65:5-9.
    Abstract     Related articles   

  6. TATUM JL, Kalen JD, Jacobs PM, Ileva LV, et al
    A spontaneously metastatic model of bladder cancer: imaging characterization.
    J Transl Med. 2019;17:425.
    Abstract     Related articles   

  7. GIROUARD J, Belgorosky D, Hamelin-Morrissette J, Boulanger V, et al
    Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFalpha/NFKappaB and iNOS/NO pathways.
    Biochem Pharmacol. 2019 Dec 23:113778. doi: 10.1016/j.bcp.2019.113778.
    Abstract     Related articles   

  8. PU K, Huang J, Jiang Y, Li J, et al
    Renal-clearable Macromolecular Reporter for Near-infrared Fluorescence Imaging of Bladder Cancer.
    Angew Chem Int Ed Engl. 2019 Dec 25. doi: 10.1002/anie.201911859.
    Abstract     Related articles   

  9. AMOUROUX M, Salleron J, Huin-Schohn C, Ali S, et al
    Clinical evaluation of a device providing simultaneous white-light and fluorescence video streams as well as panoramic imaging during fluorescence assisted-transurethral resection of bladder cancer.
    J Opt Soc Am A Opt Image Sci Vis. 2019;36:C62-C68.
    Abstract     Related articles   

  10. YIN X, Zheng X, Liu M, Wang D, et al
    Exosomal miR-663b targets Ets2-repressor factor to promote proliferation and the epithelial-mesenchymal transition of bladder cancer cells.
    Cell Biol Int. 2019 Dec 24. doi: 10.1002/cbin.11292.
    Abstract     Related articles   

  11. WU G, Wang F, Li K, Li S, et al
    Significance of TP53 mutation in bladder cancer disease progression and drug selection.
    PeerJ. 2019;7:e8261.
    Abstract     Related articles   

    Comment on "Bladder Cancer-Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection".
    Dis Markers. 2019;2019:6432596.
    Abstract     Related articles   

  13. LYNCH KE, Viernes B, Khader K, DuVall SL, et al
    Sex and the Diagnostic Pathway to Bladder Cancer among Veterans: No Evidence of Disparity.
    Womens Health Issues. 2019 Dec 21. pii: S1049-3867(19)30497.
    Abstract     Related articles   

  14. DOBOSZ P, Stempor PA, Roszik J, Herman A, et al
    Checkpoint Genes at the Cancer Side of the Immunological Synapse in Bladder Cancer.
    Transl Oncol. 2019;13:193-200.
    Abstract     Related articles   

  15. MANCINI M, Righetto M, Baggio G
    Spotlight on gender-specific disparities in bladder cancer.
    Urologia. 2019 Dec 23:391560319887327. doi: 10.1177/0391560319887327.
    Abstract     Related articles   

  16. YU Q, Liu P, Han G, Xue X, et al
    CircRNA circPDSS1 promotes bladder cancer by downregulating miR-16.
    Biosci Rep. 2019 Dec 23. pii: 221714. doi: 10.1042/BSR20191961.
    Abstract     Related articles   

  17. ZHANG Z, Yang L, Xie D, Wang Y, et al
    Illness perceptions are a potential predictor of psychological distress in patients with non-muscle-invasive bladder cancer: a 12-month prospective, longitudinal, observational study.
    Psychol Health Med. 2019 Dec 22:1-11. doi: 10.1080/13548506.2019.1707242.
    Abstract     Related articles   

  18. PLACZEK F, Cordero Bautista E, Kretschmer S, Wurster LM, et al
    Morpho-molecular ex vivo detection and grading of non-muscle-invasive bladder cancer using forward imaging probe based multimodal optical coherence tomography and Raman spectroscopy.
    Analyst. 2019 Dec 23. doi: 10.1039/c9an01911.
    Abstract     Related articles   

  19. GUO Y, Jie X, Zhang A, Zhang W, et al
    Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer.
    Front Oncol. 2019;9:1315.
    Abstract     Related articles   

  20. ZHANG PB, Huang ZL, Xu YH, Huang J, et al
    Systematic analysis of gene expression profiles reveals prognostic stratification and underlying mechanisms for muscle-invasive bladder cancer.
    Cancer Cell Int. 2019;19:337.
    Abstract     Related articles   

  21. WORTEL K, Hovius MC, van Andel G, de Reijke TM, et al
    The feasibility and utility of cystoscopy-guided hydrogel marker placement in patients with muscle invasive bladder cancer.
    Pract Radiat Oncol. 2019 Dec 19. pii: S1879-8500(19)30370.
    Abstract     Related articles   

  22. BRUINS HM, Veskimae E, Hernandez V, Neuzillet Y, et al
    The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic B
    Eur Urol Oncol. 2019 Dec 19. pii: S2588-9311(19)30164.
    Abstract     Related articles   

  23. JERECZEK-FOSSA BA, Marvaso G
    Palliative radiation therapy in bladder cancer: a matter of dose, techniques and patients' selection.
    Ann Palliat Med. 2019;8:786-789.
    Abstract     Related articles   

  24. HERR H
    Urologic Principles Define the Standards for Successful Bladder Preservation in Muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2019 Dec 18. pii: S2405-4569(19)30381.
    Abstract     Related articles   

  25. WANG YC, Wu J, Dai B, Shen YJ, et al
    Extended versus non-extended lymphadenectomy during radical cystectomy for patients with bladder cancer: a meta-analysis of the effect on long-term and short-term outcomes.
    World J Surg Oncol. 2019;17:225.
    Abstract     Related articles   

  26. KOUTROS S, Kogevinas M, Friesen MC, Stewart PA, et al
    Diesel exhaust and bladder cancer risk by pathologic stage and grade subtypes.
    Environ Int. 2019;135:105346.
    Abstract     Related articles   

  27. BOUBAKER NS, Spagnuolo M, Trabelsi N, Said R, et al
    miR-143 expression profiles in urinary bladder cancer: correlation with clinical and epidemiological parameters.
    Mol Biol Rep. 2019 Dec 20. pii: 10.1007/s11033-019-05228.
    Abstract     Related articles   

  28. LIN YH, Tsui KH, Chang KS, Hou CP, et al
    Maspin is a PTEN-Upregulated and p53-Upregulated Tumor Suppressor Gene and Acts as an HDAC1 Inhibitor in Human Bladder Cancer.
    Cancers (Basel). 2019;12.
    Abstract     Related articles   

  29. LI X, Ma H, Shu K, Wang L, et al
    Efficacy and safety of intra-arterial chemotherapy combined with intravesical chemotherapy for high-risk non-muscle invasive bladder cancer: A protocol for a systematic review and meta-analysis.
    Medicine (Baltimore). 2019;98:e18516.
    Abstract     Related articles   

  30. PATEL A, Elzweig J
    Mycobacterium bovis prosthetic joint infection following intravesical instillation of BCG for bladder cancer.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  31. ERICSON KJ, Murthy PB, Bryk DJ, Ramkumar RR, et al
    Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer.
    Clin Adv Hematol Oncol. 2019;17:697-707.
    Abstract     Related articles   

  32. HUANG Y, Luan T, Bao X, Fu S, et al
    A Novel Long Non-Coding RNA KMU15 Promotes Growth and Chemoresistance of Bladder Cancer.
    Clin Lab. 2019;65.
    Abstract     Related articles   

  33. GE L, Chen Y, Yan C, Zhao P, et al
    Study Progress of Radiomics With Machine Learning for Precision Medicine in Bladder Cancer Management.
    Front Oncol. 2019;9:1296.
    Abstract     Related articles   

  34. GUO J, Zhao P, Liu Z, Li Z, et al
    MiR-204-3p Inhibited the Proliferation of Bladder Cancer Cells via Modulating Lactate Dehydrogenase-Mediated Glycolysis.
    Front Oncol. 2019;9:1242.
    Abstract     Related articles   

  35. MARTINEZ VG, Munera-Maravilla E, Bernardini A, Rubio C, et al
    Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet.
    Front Genet. 2019;10:1125.
    Abstract     Related articles   

  36. CHEN M, Gao X, Huang D, Wang S, et al
    Knockdown of SLC35F2 Inhibits the Proliferation and Metastasis of Bladder Cancer Cells.
    Onco Targets Ther. 2019;12:10771-10786.
    Abstract     Related articles   

  37. LU JJ, Yang WM, Li F, Zhu W, et al
    Tunneling Nanotubes Mediated microRNA-155 Intercellular Transportation Promotes Bladder Cancer Cells' Invasive and Proliferative Capacity.
    Int J Nanomedicine. 2019;14:9731-9743.
    Abstract     Related articles   

  38. WU D, Zhang T, Wang J, Zhou J, et al
    Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression.
    Aging (Albany NY). 2019;11.
    Abstract     Related articles   

  39. LIU SB, Zhou LB, Wang HF, Li G, et al
    Loss of IGF2R indicates a poor prognosis and promotes cell proliferation and tumorigenesis in bladder cancer via AKT signaling pathway.
    Neoplasma. 2019 Dec 17. pii: 190206N108. doi: 10.4149/neo_2019_190206.
    Abstract     Related articles   

  40. WANG J, Xing H, Nikzad AA, Liu B, et al
    LncRNA MNX1-AS1 exerts oncogenic functions in bladder cancer by regulating miR-218-5p/RAB1A axis.
    J Pharmacol Exp Ther. 2019 Dec 16. pii: jpet.119.262949.
    Abstract     Related articles   

  41. RIBEIRO L, Rajendran S, Stenson K, Loftus I, et al
    Rare case of a proximal descending thoracic aorta mycotic aneurysm following intravesical BCG injections for the treatment of bladder cancer.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  42. YANG Z, Chen J, Xie H, Liu T, et al
    Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.
    Cancer Lett. 2019 Dec 13. pii: S0304-3835(19)30624.
    Abstract     Related articles   

  43. PICHLER R, Lindner AK, Comperat E, Obrist P, et al
    Amplification of 7p12 Is Associated with Pathologic Nonresponse to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
    Am J Pathol. 2019 Dec 13. pii: S0002-9440(19)30855.
    Abstract     Related articles   

  44. WOJTCZYK-MIASKOWSKA A, Schlichtholz B
    Tobacco carcinogens and the methionine metabolism in human bladder cancer.
    Mutat Res. 2019;782:108281.
    Abstract     Related articles   

  45. LEI Q, Zhao L, Ye S, Sun Y, et al
    Rapid and quantitative detection of urinary Cyfra21-1 using fluorescent nanosphere-based immunochromatographic test strip for diagnosis and prognostic monitoring of bladder cancer.
    Artif Cells Nanomed Biotechnol. 2019;47:4266-4272.
    Abstract     Related articles   

  46. YE ZY, Xu N, Chen SH, Lin YZ, et al
    [Analysis of influencing factors of ureteral anastomotic stenosis following urinary diversion after laparoscopic radical cystectomy].
    Zhonghua Yi Xue Za Zhi. 2019;99:3612-3616.
    Abstract     Related articles   

  47. ZHOU YJ, Wangyi YBN, Song Y, Yan YZ, et al
    [Study on the disease burden of cancer attributed to the dietary inorganic arsenic exposure in Chinese population in 2013].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53:1247-1252.
    Abstract     Related articles   

  48. WU K, Fan J, Liang H, Yao Y, et al
    Rapid testicular metastasis from bladder transitional urothelial carcinoma after radical cystoprostatectomy: A case report.
    Medicine (Baltimore). 2019;98:e18000.
    Abstract     Related articles   

    Commentary: The shift to intra-arterial chemotherapy - Relevance in Indian context.
    Indian J Ophthalmol. 2019;67:2011-2012.
    Abstract     Related articles   

  50. DE LUCA R, Profita G, Vella M, Cicero G, et al
    Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen.
    Oncology. 2019;97:341-347.
    Abstract     Related articles   

    Cervical Cancer Staging in Saudi Arabia Clinicoradiological Correlation.
    Biomed Res Int. 2019;2019:8745828.
    Abstract     Related articles   

  52. YADAV D, Singh M, Gupta K, Kaur M, et al
    A report of orbital metastasis from a urinary bladder adenocarcinoma.
    Indian J Ophthalmol. 2019;67:1377-1380.
    Abstract     Related articles   

  53. KUO KL, Liu SH, Lin WC, Hsu FS, et al
    Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  54. YANG HY, Yang CC, Wu CY, Wang LJ, et al
    Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  55. ULLEN A
    Outside the box of immunotherapy - new hope for patients with advanced urothelial cancer.
    Acta Oncol. 2019;58:951-952.
    Abstract     Related articles   

    Overexpression of SIRT1 in urothelial carcinoma of the urinary bladder is associated with local recurrence and poor survival.
    Saudi Med J. 2019;40:541-547.
    Abstract     Related articles   

  57. BLACKMUR JP, Melquiot N, Robertson KE, Teahan S, et al
    Comparison of two patients presenting with the clear cell variant of urothelial cell carcinoma of the urinary bladder: laser-assisted partial cystectomy for local disease versus chemotherapy for locally advanced disease.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  58. MANDELKOW T, Blessin NC, Lueerss E, Pott L, et al
    Immune Exclusion Is Frequent in Small-Cell Carcinoma of the Bladder.
    Dis Markers. 2019;2019:2532518.
    Abstract     Related articles   

  59. AKHTAR M, Al-Bozom IA, Ben Gashir M, Taha NM, et al
    Intrinsic Molecular Subclassification of Urothelial Carcinoma of the Bladder: Are We Finally there?
    Adv Anat Pathol. 2019;26:251-256.
    Abstract     Related articles   

  60. AL-MAGHRABI B, Gomaa W, Abdelwahed M, Al-Maghrabi J, et al
    Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis.
    Anal Cell Pathol (Amst). 2019;2019:5026939.
    Abstract     Related articles   

  61. DE BROT S, Grau-Roma L, Stirling-Stainsby C, Dettwiler M, et al
    A Fibromyxoid Stromal Response is Associated with Muscle Invasion in Canine Urothelial Carcinoma.
    J Comp Pathol. 2019;169:35-46.
    Abstract     Related articles   

  62. NAGAI T, Okamura T, Tanaka Y, Moritoki Y, et al
    Evaluation of the Dwell-Time and Dose Difference in Intravesical Bacillus Calmette-Guerin Therapy
    Asian Pac J Cancer Prev. 2019;20:1389-1392.
    Abstract     Related articles   

  63. ARSHAD Z, Zaidi SZ
    Urothelial carcinoma in children, case report with review of literature.
    J Pak Med Assoc. 2019;69:720-721.
    Abstract     Related articles   

  64. GONDKAR K, Patel K, Krishnappa S, Patil A, et al
    E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma.
    Cancer Biomark. 2019;25:223-232.
    Abstract     Related articles   

  65. MAURIZI P, Capozza MA, Triarico S, Perrotta ML, et al
    Relapsed papillary urothelial neoplasm of low malignant potential (PUNLMP) of the young age: a case report and a review of the literature.
    BMC Urol. 2019;19:36.
    Abstract     Related articles   

  66. KUANG S, Li H, Feng J, Xu S, et al
    Correlation of BRCA2 gene mutation and prognosis as well as variant genes in invasive urothelial carcinoma of the bladder.
    Cancer Biomark. 2019;25:203-212.
    Abstract     Related articles   

  67. HUANG H, Yan B, Shang M, Liu L, et al
    Is hysterectomy beneficial in radical cystectomy for female patient with urothelial carcinoma of bladder? A retrospective analysis of consecutive 112 cases from a single institution.
    BMC Urol. 2019;19:28.
    Abstract     Related articles   

  68. OEDORF K, Skaaheim Haug E, Liedberg F, Jarvinen R, et al
    Perioperative management of radical cystectomy in the Nordic countries.
    Scand J Urol. 2019;53:51-55.
    Abstract     Related articles   

  69. ZHAO P
    Urine cytology of metastatic breast lobular carcinoma.
    Diagn Cytopathol. 2019;47:738-739.
    Abstract     Related articles   

  70. BARCHETTI G, Simone G, Ceravolo I, Salvo V, et al
    Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Eur Radiol. 2019;29:5498-5506.
    Abstract     Related articles   

  71. ADAMS EJ, Amerine LB
    Process improvement strategy to prepare and administer bacillus Calmette-Guerin vaccine in compliance with United States Pharmacopeia chapter 800 standards.
    Am J Health Syst Pharm. 2019;76:613-616.
    Abstract     Related articles   

  72. DE PALMA G, Di Lorenzo VF, Krol S, Paradiso AV, et al
    Urinary exosomal shuttle RNA: Promising cancer diagnosis biomarkers of lower urinary tract.
    Int J Biol Markers. 2019;34:101-107.
    Abstract     Related articles   

  73. SHELEKHOVA KV, Krykow KA, Mescherjakov IA, Mitin NP, et al
    Molecular Pathologic Subtyping of Urothelial Bladder Carcinoma in Young Patients.
    Int J Surg Pathol. 2019;27:483-491.
    Abstract     Related articles   

  74. DEGBOE A, Ivanescu C, Rohay JM, Turner RR, et al
    Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients.
    Support Care Cancer. 2019;27:4189-4198.
    Abstract     Related articles   

  75. MIYAKE M, Furuya H, Onishi S, Hokutan K, et al
    Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth.
    Theranostics. 2019;9:853-867.
    Abstract     Related articles   

  76. CIMADAMORE A, Palagonia E, Piccinni P, Misericordia M, et al
    Inguinal bladder hernia with lipomatosis of the bladder wall: A potential clinical pitfall for cancer.
    Urologia. 2019;86:35-38.
    Abstract     Related articles   

  77. UGATA K, Imamachi N, Hashimoto A, Saito Y, et al
    Anesthetic Management in an Adult Patient With Costello Syndrome: A Case Report.
    A A Pract. 2019;13:41-43.
    Abstract     Related articles   

  78. KADHIM A, McKenzie LK, Bryant HE, Twyman LJ, et al
    Synthesis and Aggregation of a Porphyrin-Cored Hyperbranched Polyglycidol and Its Application as a Macromolecular Photosensitizer for Photodynamic Therapy.
    Mol Pharm. 2019;16:1132-1139.
    Abstract     Related articles   

  79. ANAGNOSTOPOULOS I, Lagou S, Papatheodoridi M, Marinos L, et al
    A rare case of bone marrow BCG-itis responding to second-line anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2019;23:119-120.
    Abstract     Related articles   

  80. MALMSTROM PU, Skaaheim Haug E, Bostrom PJ, Gudjonsson S, et al
    Progress towards a Nordic standard for the investigation of hematuria: 2019.
    Scand J Urol. 2019;53:1-6.
    Abstract     Related articles   

  81. LIANG X, Hu X, Hu Y, Zeng W, et al
    Recovery and functionality of cryopreserved peripheral blood mononuclear cells using five different xeno-free cryoprotective solutions.
    Cryobiology. 2019;86:25-32.
    Abstract     Related articles   

  82. ZHOU Z, Zhao S, Lu Y, Wu J, et al
    Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors.
    World J Urol. 2019;37:1075-1084.
    Abstract     Related articles   

  83. WANG D, Sule N
    Mucinous Cystadenoma of the Urachus and Review of Current Classification of Urachal Mucinous Cystic Neoplasms.
    Arch Pathol Lab Med. 2019;143:258-263.
    Abstract     Related articles   

  84. SHIM JS, Seo HK, Ku JH, Jeong BC, et al
    Oncologic, Perioperative Outcomes of Female Radical Cystectomy: Results from a Multicenter Study in Korea.
    Cancer Res Treat. 2019;51:1064-1072.
    Abstract     Related articles   

  85. TAN X, Broses LJ, Zhou M, Day KC, et al
    Multiparameter urine analysis for quantitative bladder cancer surveillance of orthotopic xenografted mice.
    Lab Chip. 2020 Jan 10. doi: 10.1039/c9lc01006.
    Abstract     Related articles   

  86. AKAND M, Muilwijk T, Cornelissen J, Van Bruwaene S, et al
    Development of a Prospective Data Registry System for Non-muscle-Invasive Bladder Cancer Patients Incorporated in the Electronic Patient File System.
    Front Oncol. 2019;9:1402.
    Abstract     Related articles   

  87. BATISTA R, Vinagre J, Prazeres H, Sampaio C, et al
    Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study.
    Front Genet. 2019;10:1237.
    Abstract     Related articles   

  88. WANG K, Lu H, Qu H, Xie Q, et al
    miR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer.
    Onco Targets Ther. 2019;12:11453-11464.
    Abstract     Related articles   

  89. LIU W, Tian J, Zhang S, Yang E, et al
    The utilization status of neoadjuvant chemotherapy in muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Minerva Urol Nefrol. 2020 Jan 7. pii: S0393-2249.19.03648.
    Abstract     Related articles   

  90. GAO X, Zhang S
    [Research progress in mechanisms for drug-resistance and recurrence in bladder cancer].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019;44:1287-1293.
    Abstract     Related articles   

  91. WANG Y, Zhu W, Chen X, Wei G, et al
    Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer.
    J Transl Med. 2020;18:17.
    Abstract     Related articles   

  92. WEI S, Gao J, Zhang M, Dou Z, et al
    Dual delivery nanoscale device for miR-451 and adriamycin co-delivery to combat multidrug resistant in bladder cancer.
    Biomed Pharmacother. 2020;122:109473.
    Abstract     Related articles   

  93. DANFORTH KN, Luong TQ, Yi DK, Yamamoto A, et al
    Disparities in Stage at Diagnosis in an Equal-access Integrated Delivery System: A Retrospective Cohort Study of 7244 Patients With Bladder Cancer.
    Clin Genitourin Cancer. 2019 Sep 12. pii: S1558-7673(19)30271.
    Abstract     Related articles   

  94. MACLEOD LC, Fam MM, Yabes JG, Hale NE, et al
    Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2019 Dec 14. pii: S1558-7673(19)30384.
    Abstract     Related articles   

  95. SHEN Y, Lu Q, Ye H, Deng Z, et al
    Genetic variant of MAML2 in the NOTCH signaling pathway and the risk of bladder cancer: A STROBE-compliant study.
    Medicine (Baltimore). 2020;99:e18725.
    Abstract     Related articles   

  96. SCHMIDT S, Kunath F, Coles B, Draeger DL, et al
    Intravesical Bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
    Cochrane Database Syst Rev. 2020;1:CD011935.
    Abstract     Related articles   

  97. LEI T, Zhou S, Meng Q, Zhang M, et al
    STAT3 signaling pathway in drug-resistant bladder cancer cell line.
    J Biol Regul Homeost Agents. 2019;33:1347-1357.
    Abstract     Related articles   

  98. AGREDA CASTANEDA F, Raventos Busquets CX, Morote Robles J
    Assessing the Clinical Benefit of UBC Rapid in the Surveillance and Initial Diagnosis of Bladder Cancer.
    Clin Genitourin Cancer. 2019 Dec 4. pii: S1558-7673(19)30352.
    Abstract     Related articles   

  99. LIPUNOVA N, Wesselius A, Cheng KK, van Schooten FJ, et al
    Systematic Review: Genetic Associations for Prognostic Factors of Urinary Bladder Cancer.
    Biomark Cancer. 2019;11:1179299X19897255.
    Abstract     Related articles   

  100. FURUYA H, Chan OTM, Hokutan K, Tsukikawa Y, et al
    Prognostic Significance of Lymphocyte Infiltration and a Stromal Immunostaining of a Bladder Cancer Associated Diagnostic Panel in Urothelial Carcinoma.
    Diagnostics (Basel). 2019;10.
    Abstract     Related articles   

  101. DILER SB, Polat F, Bingol G
    The MNS16A VNTR polymorphism of the TERT gene in bladder cancer.
    Turk J Urol. 2019;46:44-49.
    Abstract     Related articles   

  102. FERNANDEZ-CONEJO G, de la Pena E, Hernandez V, Guijarro A, et al
    The value of tumour weight as a predictive factor for recurrence and progression in non-muscle invasive bladder cancer.
    Scand J Urol. 2020 Jan 6:1-6. doi: 10.1080/21681805.2019.1708968.
    Abstract     Related articles   

  103. TANG Z, Gillatt D, Rowe E, Koupparis A, et al
    IGFBP-2 acts as a tumour suppressor and plays a role in determining chemosensitivity in bladder cancer cells.
    Oncotarget. 2019;10:7043-7057.
    Abstract     Related articles   

  104. ZHANG D, Yao L, Yu S, Cheng Y, et al
    Safety and efficacy of en bloc transurethral resection versus conventional transurethral resection for primary nonmuscle-invasive bladder cancer: a meta-analysis.
    World J Surg Oncol. 2020;18:4.
    Abstract     Related articles   

  105. CHEN Y, Zhang W, Kadier A, Zhang H, et al
    MicroRNA-769-5p suppresses cell growth and migration via targeting NUSAP1 in bladder cancer.
    J Clin Lab Anal. 2020 Jan 3:e23193. doi: 10.1002/jcla.23193.
    Abstract     Related articles   

  106. AYDIN AM, Baydar DE, Hazir B, Babaoglu B, et al
    Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy.
    World J Urol. 2020 Jan 3. pii: 10.1007/s00345-019-03065.
    Abstract     Related articles   

  107. DAI R, Zhou Y, Chen Z, Zou Z, et al
    Lnc-MUC20-9 binds to ROCK1 and functions as a tumor suppressor in bladder cancer.
    J Cell Biochem. 2020 Jan 3. doi: 10.1002/jcb.29626.
    Abstract     Related articles   

  108. LIU Y, Lin F, Chen Y, Wang R, et al
    Cryptotanshinone Inhibites Bladder Cancer Cell Proliferation and Promotes Apoptosis via the PTEN/PI3K/AKT Pathway.
    J Cancer. 2020;11:488-499.
    Abstract     Related articles   

  109. ZHANG Z, Mao W, Wang L, Liu M, et al
    Depletion of CDC5L inhibits bladder cancer tumorigenesis.
    J Cancer. 2020;11:353-363.
    Abstract     Related articles   

  110. TIAN J, Fan J, Xu J, Ren T, et al
    circ-FNTA accelerates proliferation and invasion of bladder cancer.
    Oncol Lett. 2020;19:1017-1023.
    Abstract     Related articles   

  111. GUSZCZ T, Szymanska B, Kozlowski R, Lukaszewski Z, et al
    Plasma aromatase as a sensitive and selective potential biomarker of bladder cancer and its role in tumorigenesis.
    Oncol Lett. 2020;19:562-568.
    Abstract     Related articles   

  112. PIAO XM, Jeong P, Yan C, Kim YH, et al
    A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer.
    Oncol Lett. 2020;19:476-486.
    Abstract     Related articles   

  113. GAN D, He W, Yin H, Gou X, et al
    beta-elemene enhances cisplatin-induced apoptosis in bladder cancer cells through the ROS-AMPK signaling pathway.
    Oncol Lett. 2020;19:291-300.
    Abstract     Related articles   

  114. ZHANG R, Wang J, Jia E, Zhang J, et al
    lncRNA BCAR4 sponges miR3703p to promote bladder cancer progression via Wnt signaling.
    Int J Mol Med. 2019 Dec 27. doi: 10.3892/ijmm.2019.4444.
    Abstract     Related articles   

  115. CHEN MK, Chen ZJ, Xiao KH, Qin ZK, et al
    Predictive value of cadherin-11 for subsequent recurrence and progression in non-muscle invasive bladder cancer.
    Jpn J Clin Oncol. 2020 Jan 2. pii: 5688862. doi: 10.1093.
    Abstract     Related articles   

  116. ZHAO D, Peng Q, Wang L, Li C, et al
    Identification of a six-lncRNA signature based on a competing endogenous RNA network for predicting the risk of tumour recurrence in bladder cancer patients.
    J Cancer. 2020;11:108-120.
    Abstract     Related articles   

  117. LIAO C, Long Z, Zhang X, Cheng J, et al
    LncARSR sponges miR-129-5p to promote proliferation and metastasis of bladder cancer cells through increasing SOX4 expression.
    Int J Biol Sci. 2020;16:1-11.
    Abstract     Related articles   

  118. FAN J, Liu Y, Liu L, Huang Y, et al
    A Multifunction Lipid-Based CRISPR-Cas13a Genetic Circuit Delivery System for Bladder Cancer Gene Therapy.
    ACS Synth Biol. 2020 Jan 10. doi: 10.1021/acssynbio.9b00349.
    Abstract     Related articles   

  119. KIMURA S, Iwata T, Abufaraj M, Janisch F, et al
    Impact of Gender on Chemotherapeutic Response and Oncologic Outcomes in Patients Treated With Radical Cystectomy and Perioperative Chemotherapy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    Clin Genitourin Cancer. 2019 Dec 5. pii: S1558-7673(19)30358.
    Abstract     Related articles   

  120. REIS H, Mairinger F, Ting S, Nagy N, et al
    [Urachal Cancer: an update of current molecular findings].
    Pathologe. 2019;40.
    Abstract     Related articles   

  121. LEE D, Zimmern P
    Management of Pelvic Organ Prolapse After Radical Cystectomy.
    Curr Urol Rep. 2019;20:71.
    Abstract     Related articles   

  122. ROPERTO S, De Falco F, Perillo A, Catoi C, et al
    Mitophagy mediated by BNIP3 and BNIP3L/NIX in urothelial cells of the urinary bladder of cattle harbouring bovine papillomavirus infection.
    Vet Microbiol. 2019;236:108396.
    Abstract     Related articles   

  123. KAUR S, Gupta A, Gulwani HV
    A clinicopathological and immunohistochemical study of non-urothelial bladder tumours.
    Indian J Cancer. 2019;56:254-260.
    Abstract     Related articles   

    Special Issue on Molecular Research Efforts in Urothelial Carcinoma: Summary of Included Topics.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  125. KANEHIRA K, Yano Y, Hasumi H, Fukuhara H, et al
    Fluorescence Enhancement Effect of TiO2 Nanoparticles and Application for Photodynamic Diagnosis.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  126. RAZAFIMAHEFA J, Gosset C, Mongiat-Artus P, Andriamampionona TF, et al
    Stromal osseous metaplasia in urothelial carcinoma of the bladder: a rare case report and literature review.
    Diagn Pathol. 2019;14:75.
    Abstract     Related articles   

  127. KRATIRAS Z, Spapis V, Koniaris E, Kozyrakis D, et al
    Malignant solitary fibrous tumor of urinary bladder: A rare clinical entity.
    Arch Ital Urol Androl. 2019;91.
    Abstract     Related articles   

  128. PARMAR KM, Sharma G, Rai T
    Urinary bladder mass with emphysematous cystitis: double whammy.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  129. FA'AK F, Vanegas D, Osei KM
    A Case Report of Atezolizumab Induced Tumor Lysis Syndrome.
    Am J Case Rep. 2019;20:785-789.
    Abstract     Related articles   

  130. HAMLIN AN, Chadwick LE, Fox-Alvarez SA, Hostnik ET, et al
    Ultrasound characteristics of feline urinary bladder transitional cell carcinoma are similar to canine urinary bladder transitional cell carcinoma.
    Vet Radiol Ultrasound. 2019;60:552-559.
    Abstract     Related articles   

  131. KUMARI K, Pradeep I, Kakkar A, Dinda AK, et al
    BK polyomavirus and urothelial carcinoma: Experience at a tertiary care centre in India with review of literature.
    Ann Diagn Pathol. 2019;40:77-80.
    Abstract     Related articles   

  132. HOSSEINI A, Ebbing J, Collins J
    Clinical outcomes of robot-assisted radical cystectomy and continent urinary diversion.
    Scand J Urol. 2019;53.
    Abstract     Related articles   

  133. SANGUEDOLCE F, Russo D, Calo B, Cindolo L, et al
    Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review.
    Pathol Res Pract. 2019;215:152413.
    Abstract     Related articles   

  134. ZHU D, Singh S, Chen X, Zheng Z, et al
    The landscape of chimeric RNAs in bladder urothelial carcinoma.
    Int J Biochem Cell Biol. 2019;110:50-58.
    Abstract     Related articles   

  135. PALANGI A, Shakhssalim N, Parvin M, Bayat S, et al
    Differential expression of S1P receptor subtypes in human bladder transitional cell carcinoma.
    Clin Transl Oncol. 2019;21:1240-1249.
    Abstract     Related articles   

  136. LIN G, Ye H, Wang J, Chen S, et al
    Immune Checkpoint Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 is Upregulated and Independently Predicts Unfavorable Prognosis in Bladder Urothelial Carcinoma.
    Nephron. 2019;141:256-264.
    Abstract     Related articles   

  137. WANG G, McKenney JK
    Urinary Bladder Pathology: World Health Organization Classification and American Joint Committee on Cancer Staging Update.
    Arch Pathol Lab Med. 2019;143:571-577.
    Abstract     Related articles   

  138. HELLMAN JB, Traynis I, Lin LK
    Pembrolizumab and epacadostat induced fatal myocarditis and myositis presenting as a case of ptosis and ophthalmoplegia.
    Orbit. 2019;38:244-247.
    Abstract     Related articles   

  139. KONG VC, Taylor A, Chung P, Craig T, et al
    Comparison of 3 image-guided adaptive strategies for bladder locoregional radiotherapy.
    Med Dosim. 2019;44:111-116.
    Abstract     Related articles   

  140. JAWORSKI D, Szylberg L, Gzil A, Stawinski P, et al
    Diagnostic difficulties in cases of papillary urothelial neoplasm of low malignant potential, urothelial proliferation of uncertain malignant potential, urothelial dysplasia and urothelial papilloma: A review of current literature.
    Ann Diagn Pathol. 2019;40:182-188.
    Abstract     Related articles   

  141. SOLIMAN MM, Cornman-Homonoff J, Schiffman MH
    Incidental sonographic detection of bladder cancer in a woman with large uterine fibroids: significance and lessons learned.
    Clin Imaging. 2020;61:1-3.
    Abstract     Related articles   

  142. SIRACUSANO S, Rizzetto R, Porcaro AB
    Bladder cancer genomics.
    Urologia. 2020 Jan 16:391560319899011. doi: 10.1177/0391560319899011.
    Abstract     Related articles   

  143. WALKER AK, Na J, Browning L, Humayun-Zakaria N, et al
    MRE11A Isoform Expression Associated with Outcome Following Radiotherapy in Muscle-Invasive Bladder Cancer does not Alter Cell Survival and DNA Double-Strand Break Repair Following Ionising Radiation.
    Bladder Cancer. 2019;5:147-157.
    Abstract     Related articles   

  144. BATISTA R, Vinagre N, Meireles S, Vinagre J, et al
    Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review.
    Diagnostics (Basel). 2020;10.
    Abstract     Related articles   

  145. CAO Y, Tian T, Li W, Xu H, et al
    Long non-coding RNA in bladder cancer.
    Clin Chim Acta. 2020 Jan 12. pii: S0009-8981(20)30017.
    Abstract     Related articles   

  146. BERMUDEZ-ORIA A, Rodriguez-Gutierrez G, Rubio-Senent F, Sanchez-Carbayo M, et al
    Antiproliferative Activity of the Olive Extract Rich in Polyphenols and Modified Pectin on Bladder Cancer Cells.
    J Med Food. 2020 Jan 15. doi: 10.1089/jmf.2019.0136.
    Abstract     Related articles   

  147. EVLAMPIDOU I, Font-Ribera L, Rojas-Rueda D, Gracia-Lavedan E, et al
    Trihalomethanes in Drinking Water and Bladder Cancer Burden in the European Union.
    Environ Health Perspect. 2020;128:17001.
    Abstract     Related articles   

  148. OU Z, Li K, Yang T, Dai Y, et al
    Detection of bladder cancer using urinary cell-free DNA and cellular DNA.
    Clin Transl Med. 2020;9:4.
    Abstract     Related articles   

  149. MEZHEYEUSKI A, Segersten U, Leiss LW, Malmstrom PU, et al
    Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome.
    Sci Rep. 2020;10:281.
    Abstract     Related articles   

  150. MOUSTAKAS G, Kampantais S, Nikolaidou A, Vakalopoulos I, et al
    HER-2 overexpression is a negative predictive factor for recurrence in patients with non-muscle-invasive bladder cancer on intravesical therapy.
    J Int Med Res. 2020;48:300060519895847.
    Abstract     Related articles   

  151. CHEN M, Zhang S, Wen X, Cao H, et al
    Prognostic value of CLIC3 mRNA overexpression in bladder cancer.
    PeerJ. 2020;8:e8348.
    Abstract     Related articles   

  152. AL-MAGHRABI JA, Qureshi IA, Khabaz MN
    Immunhistochemical expression of GLUT1 is associated with low grade and low stage of urinary bladder cancer.
    Int J Clin Exp Pathol. 2019;12:3049-3057.
    Abstract     Related articles   

  153. PAN J, Xie X, Li H, Li Z, et al
    Detection of serum long non-coding RNA UCA1 and circular RNAs for the diagnosis of bladder cancer and prediction of recurrence.
    Int J Clin Exp Pathol. 2019;12:2951-2958.
    Abstract     Related articles   

  154. CHEN X, Li S, Yu Z, Tan W, et al
    Yes-associated protein 1 promotes bladder cancer invasion by regulating epithelial-mesenchymal transition.
    Int J Clin Exp Pathol. 2019;12:1070-1077.
    Abstract     Related articles   

  155. YANG K, Tang H, Ding M, Guo Y, et al
    Expression of miR-195 and MEK1 in patients with bladder cancer and their relationship to prognosis.
    Int J Clin Exp Pathol. 2019;12:843-850.
    Abstract     Related articles   

  156. ZHAO W, Li W, Jin X, Niu T, et al
    Silencing long non-coding RNA NEAT1 enhances the suppression of cell growth, invasion, and apoptosis of bladder cancer cells under cisplatin chemotherapy.
    Int J Clin Exp Pathol. 2019;12:549-558.
    Abstract     Related articles   

  157. CHEN H, Xu L, Wang L
    Expression of miR-182 and Foxo3a in patients with bladder cancer correlate with prognosis.
    Int J Clin Exp Pathol. 2019;12:4193-4203.
    Abstract     Related articles   

  158. SOGA N, Furusawa J, Ogura Y
    Long-Term Management of Incidental Bladder Cancer Detected in Patients Undergoing Prostatectomy for Prostate Cancer.
    Curr Urol. 2019;13:145-149.
    Abstract     Related articles   

  159. MITA K, Kobatake K, Ohara S, Kato M, et al
    [Second Transurethral Resection (TUR) for Bladder Cancer Diagnosed with High Grade pT1 by Initial TUR Under Narrow Band Imaging].
    Hinyokika Kiyo. 2019;65:501-506.
    Abstract     Related articles   

  160. BOTHIG R, Tiburtius C, Fiebag K, Kowald B, et al
    Traumatic spinal cord injury confers bladder cancer risk to patients managed without permanent urinary catheterization: lessons from a comparison of clinical data with the national database.
    World J Urol. 2020 Jan 13. pii: 10.1007/s00345-020-03077.
    Abstract     Related articles   

  161. WOOLBRIGHT BL, Pilbeam CC, Taylor JA 3rd
    Prostaglandin E2 as a Therapeutic Target in Bladder Cancer: From Basic Science to Clinical Trials.
    Prostaglandins Other Lipid Mediat. 2020 Jan 10:106409.
    Abstract     Related articles   

  162. WU Z, Wang M, Liu Q, Liu Y, et al
    Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer.
    Int J Med Sci. 2020;17:89-96.
    Abstract     Related articles   

  163. PICH J
    Perioperative nutrition for the treatment of bladder cancer by radical cystectomy: A Cochrane review summary.
    Int J Nurs Stud. 2019 Dec 19:103505. doi: 10.1016/j.ijnurstu.2019.103505.
    Abstract     Related articles   

  164. MATSUOKA Y, Taoka R, Xia Z, Sugimoto M, et al
    Hyperthermic therapy using warm sterile water enhances cytocidal effects on bladder cancer cells.
    Scand J Urol. 2020 Jan 13:1-5. doi: 10.1080/21681805.2019.1708967.
    Abstract     Related articles   

  165. YU EYW, Dai Y, Wesselius A, van Osch F, et al
    Coffee consumption and risk of bladder cancer: a pooled analysis of 501,604 participants from 12 cohort studies in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study.
    Eur J Epidemiol. 2020 Jan 11. pii: 10.1007/s10654-019-00597.
    Abstract     Related articles   

  166. MURAKAMI Y, Kobayashi T, Naruse Y, Goto T, et al
    [Metastatic Brain Tumor from Urachal Cancer:A Case Report].
    No Shinkei Geka. 2019;47:1269-1274.
    Abstract     Related articles   

  167. KHOO ACH, Tang WH
    Renal Pelvis Urothelial Carcinoma With Bowel Metastases.
    Clin Nucl Med. 2019;44:983-984.
    Abstract     Related articles   

  168. LIU C, Tate T, Batourina E, Truschel ST, et al
    Pparg promotes differentiation and regulates mitochondrial gene expression in bladder epithelial cells.
    Nat Commun. 2019;10:4589.
    Abstract     Related articles   

  169. MUNOZ MOYA JE, Alfaro Aguirre MO, Leiva Silva M, Kakarieka Weisskopf E, et al
    [Inflammatory myofibroblastic tumor: Variable presentation of the same pathology].
    Rev Chil Pediatr. 2019;90:328-335.
    Abstract     Related articles   

  170. SEKIGUCHI K, Hashimoto R, Noda Y, Tachibana H, et al
    Diaphragm involvement in immune checkpoint inhibitor-related myositis.
    Muscle Nerve. 2019;60:E23-E25.
    Abstract     Related articles   

  171. WANG T, Ding Y, Yang Y, Wang Z, et al
    Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
    Biomed Pharmacother. 2019;115:108899.
    Abstract     Related articles   

  172. TRANKENSCHUH W, Biesdorf AS, Papadimas N, Samara S, et al
    Mixed Adenocarcinomatous and Neuroendocrine Tumor of the Urinary Bladder With Concomitant Carcinoma In Situ: A Case Report With a Comprehensive Immunohistochemical Analysis and Review of the Literature.
    Int J Surg Pathol. 2019;27:684-692.
    Abstract     Related articles   

  173. HAN L, Gallan A, Paner GP
    Patterns of Urachal Remnant Involvement by Urothelial Carcinoma: Intraluminal Noninvasive Spread Can Mimic a Deep-seated Bladder Invasion.
    Am J Surg Pathol. 2019;43:475-479.
    Abstract     Related articles   

  174. DUNCAN C, Joon DL, Lawrentschuk N, Jenkins T, et al
    Fiducial markers: can the urologist do better?
    World J Urol. 2019;37:1281-1287.
    Abstract     Related articles   

  175. AYATI M, Amini E, Shahrokhi Damavand R, Nowroozi MR, et al
    Second Transurethral Resection of Bladder Tumor: Is it Necessary in All T1 and/or High-Grade Tumors?
    Urol J. 2019;16:152-156.
    Abstract     Related articles   

  176. LIU Z, Yan H, Yang Y, Wei L, et al
    Down-regulation of CIT can inhibit the growth of human bladder cancer cells.
    Biomed Pharmacother. 2020;124:109830.
    Abstract     Related articles   

  177. YING Y, Li J, Xie H, Yan H, et al
    CCND1, NOP14 and DNMT3B are involved in miR-502-5p-mediated inhibition of cell migration and proliferation in bladder cancer.
    Cell Prolif. 2020 Jan 23:e12751. doi: 10.1111/cpr.12751.
    Abstract     Related articles   

  178. XU S, Tan S, Wu T, Gu J, et al
    The value of transurethral thulium laser en bloc resection combined with a single immediate postoperative intravesical instillation of pirarubicin in primary non-muscle-invasive bladder cancer.
    Lasers Med Sci. 2020 Jan 22. pii: 10.1007/s10103-020-02960.
    Abstract     Related articles   

  179. LIU T, Lu Q, Liu J, Xie S, et al
    Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating NP63 by sponging miR-762.
    Cell Death Dis. 2020;11:47.
    Abstract     Related articles   

  180. XIE Y, Xu P, Wang M, Zheng Y, et al
    Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  181. LI T, Jiang D, Wu K
    p62 promotes bladder cancer cell growth by activating KEAP1/NRF2-dependent antioxidative response.
    Cancer Sci. 2020 Jan 22. doi: 10.1111/cas.14321.
    Abstract     Related articles   

  182. HUDOLIN T, Kastelan Z, El-Saleh A, Bakula M, et al
    Bone morphogenic proteins-2, -4, -6 and 7 in non-muscle invasive bladder cancer.
    Oncol Lett. 2020;19:1291-1297.
    Abstract     Related articles   

  183. FU L, Zhang J, Li L, Yang Y, et al
    Diagnostic accuracy of urinary survivin mRNA expression detected by RT-PCR compared with urine cytology in the detection of bladder cancer: A meta-analysis of diagnostic test accuracy in head-to-head studies.
    Oncol Lett. 2020;19:1165-1174.
    Abstract     Related articles   

  184. ABUFARAJ M, Shariat S, Moschini M, Rohrer F, et al
    The impact of hormones and reproductive factors on the risk of bladder cancer in women: results from the Nurses' Health Study and Nurses' Health Study II.
    Int J Epidemiol. 2020 Jan 21. pii: 5713010. doi: 10.1093.
    Abstract     Related articles   

  185. ABUGOMAA A, Elbadawy M, Yamawaki H, Usui T, et al
    Emerging Roles of Cancer Stem Cells in Bladder Cancer Progression, Tumorigenesis, and Resistance to Chemotherapy: A Potential Therapeutic Target for Bladder Cancer.
    Cells. 2020;9.
    Abstract     Related articles   

  186. GUERRERO ORRIACH JL, Raigon Ponferrada A, Malo Manso A, Herrera Imbroda B, et al
    Anesthesia in Combination with Propofol Increases Disease-Free Survival in Bladder Cancer Patients Who Undergo Radical Tumor Cystectomy as Compared to Inhalational Anesthetics and Opiate-Based Analgesia.
    Oncology. 2020 Jan 21:1-7. doi: 10.1159/000504807.
    Abstract     Related articles   

  187. HAMAD J, McCloskey H, Milowsky MI, Royce T, et al
    Bladder preservation in muscle-invasive bladder cancer: a comprehensive review.
    Int Braz J Urol. 2020;46.
    Abstract     Related articles   

  188. ROSENBLATT R, Lorentzi G, Bahar M, Asad D, et al
    Blood transfusions during neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer may have a negative impact on overall survival.
    Scand J Urol. 2020 Jan 21:1-6. doi: 10.1080/21681805.2020.1716067.
    Abstract     Related articles   

  189. ZHANG L, Xia HB, Zhao CY, Shi L, et al
    Cyclic RNA hsa_circ_0091017 inhibits proliferation, migration and invasiveness of bladder cancer cells by binding to microRNA-589-5p.
    Eur Rev Med Pharmacol Sci. 2020;24:86-96.
    Abstract     Related articles   

  190. WANG F, Wu H, Fan M, Yu R, et al
    Sodium butyrate inhibits migration and induces AMPK-mTOR pathway-dependent autophagy and ROS-mediated apoptosis via the miR-139-5p/Bmi-1 axis in human bladder cancer cells.
    FASEB J. 2020 Jan 19. doi: 10.1096/fj.201902626.
    Abstract     Related articles   

  191. WANG T, Luo R, Li W, Yan H, et al
    Dihydroartemisinin suppresses bladder cancer cell invasion and migration by regulating KDM3A and p21.
    J Cancer. 2020;11:1115-1124.
    Abstract     Related articles   

  192. CHEN C, Huang H, Zhao Y, Liu H, et al
    Diagnostic accuracy of photodynamic diagnosis with 5-aminolevulinic acid, hexaminolevulinate and narrow band imaging for non-muscle invasive bladder cancer.
    J Cancer. 2020;11:1082-1093.
    Abstract     Related articles   

  193. CAJIPE M, Wang H, Elshabrawy A, Kaushik D, et al
    Pathological downstaging following radical cystectomy for muscle-invasive bladder cancer: Survival outcomes in the setting of neoadjuvant chemotherapy versus transurethral resection only.
    Urol Oncol. 2020 Jan 16. pii: S1078-1439(19)30506.
    Abstract     Related articles   

  194. SCHULZ GB, Grimm T, Buchner A, Jokisch F, et al
    Bladder Cancer Stage Development, 2004-2014 in Europe Compared With the United States: Analysis of European Population-based Cancer Registries, the United States SEER Database, and a Large Tertiary Institutional Cohort.
    Clin Genitourin Cancer. 2019 Oct 16. pii: S1558-7673(19)30312.
    Abstract     Related articles   

  195. MIYATA H, Osawa T, Abe T, Kikuchi H, et al
    The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer.
    Jpn J Clin Oncol. 2020 Jan 19. pii: 5709020. doi: 10.1093.
    Abstract     Related articles   

  196. AFONSO J, Santos LL, Longatto-Filho A, Baltazar F, et al
    Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.
    Nat Rev Urol. 2020 Jan 17. pii: 10.1038/s41585-019-0263.
    Abstract     Related articles   

  197. MATULEWICZ RS, Rademaker A, Meeks JJ
    A simplified nomogram to assess risk of bladder cancer in patients with a new diagnosis of microscopic hematuria.
    Urol Oncol. 2020 Jan 14. pii: S1078-1439(19)30497.
    Abstract     Related articles   

  198. OZAYDIN S, Atas E, Karadurmus N, Emirzeoglu L, et al
    Outcomes of bladder preservation therapy on survival in patients with muscle-invasive bladder cancer.
    Arch Esp Urol. 2020;73:41-46.
    Abstract     Related articles   

  199. YU X, Wang R, Han C, Wang Z, et al
    A Panel of Urinary Long Non-coding RNAs Differentiate Bladder Cancer from Urocystitis.
    J Cancer. 2020;11:781-787.
    Abstract     Related articles   

  200. HIRABAYASHI N, Nishizawa O, Kobayashi N, Ikeyama M, et al
    [Inverted Variant of Urothelial Carcinoma of the Urinary Bladder : A Case Report].
    Hinyokika Kiyo. 2019;65:463-467.
    Abstract     Related articles   

  201. KANNO T, Inoue T, Ito K, Kono Y, et al
    [The Safety of Laparoscopic Radical Cystectomy during Initial Phases in a Japanese Multicenter Cohort].
    Hinyokika Kiyo. 2019;65:439-444.
    Abstract     Related articles   

  202. SIKIC D, Richterstetter M, Wullich B, Apel H, et al
    [Renal transplantation in urinary diversions].
    Urologe A. 2020;59:27-31.
    Abstract     Related articles   

  203. GARRIDO-ABAD P, Martin LG, Zarra KV, Menendez AD, et al
    Metastatic non-muscle invasive bladder can-cer with cervical lymph node metastasis.
    Int Braz J Urol. 2019;45:1270-1274.
    Abstract     Related articles   

  204. KORKES F, Palou J
    High mortality rates after radical cystectomy: we must have acceptable protocols and consider the rationale of cutaneous ureterostomy for high-risk patients.
    Int Braz J Urol. 2019;45:1090-1093.
    Abstract     Related articles   

  205. THOMA C
    PD-L1 and BCG response prediction.
    Nat Rev Urol. 2020;17:8.
    Abstract     Related articles   

  206. MORALES J, Malles A, Kimble M, Rodriguez de la Vega P, et al
    Does Health Insurance Modify the Association Between Race and Cancer-Specific Survival in Patients with Urinary Bladder Malignancy in the U.S.?
    Int J Environ Res Public Health. 2019;16.
    Abstract     Related articles   

  207. PIERANTONI F, Maruzzo M, Gardi M, Bezzon E, et al
    Immunotherapy and urothelial carcinoma: An overview and future prospectives.
    Crit Rev Oncol Hematol. 2019;143:46-55.
    Abstract     Related articles   

  208. EL HUSSEIN S, Colanta A, Khader SN
    Revisiting cercariform cells: Small cell carcinoma masquerading as cercariform cells.
    Diagn Cytopathol. 2019;47:1072-1075.
    Abstract     Related articles   

  209. FINOTELLO R, Schiavo L, Ressel L, Frohmader A, et al
    Lipoxygenase-5 Expression in Canine Urinary Bladder: Normal Urothelium, Cystitis and Transitional Cell Carcinoma.
    J Comp Pathol. 2019;170:1-9.
    Abstract     Related articles   

  210. AKHTAR M, Al-Bozom IA, Ben Gashir M, Taha NM, et al
    Urothelial Carcinoma In Situ (CIS): New Insights.
    Adv Anat Pathol. 2019;26:313-319.
    Abstract     Related articles   

  211. YORITA K
    Clinical evaluation of ureteral pseudodiverticulosis.
    Abdom Radiol (NY). 2019;44:2676.
    Abstract     Related articles   

  212. MORGAN MA, Zafar HM, Papanicolaou N, Ramchandani P, et al
    Reply to letter to the editor: "clinical evaluation of ureteral pseudodiverticulosis".
    Abdom Radiol (NY). 2019;44:2677.
    Abstract     Related articles   

  213. PROSKOKOV AA, Darenkov SP, Agabekian AA, Trofimchuk AD, et al
    [Current trends in the method used for urine derivation after radical cystectomy for muscle-invasive bladder cancer].
    Urologiia. 2020;:120-124.
    Abstract     Related articles   

  214. RIPAMONTI E, Azoulay L, Abrahamowicz M, Platt RW, et al
    Pioglitazone and bladder cancer: improving research methods.
    Diabet Med. 2020 Jan 29. doi: 10.1111/dme.14248.
    Abstract     Related articles   

  215. IIDA K, Naiki T, Naiki-Ito A, Suzuki S, et al
    Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin (mTOR) pathway.
    Cancer Sci. 2020 Jan 29. doi: 10.1111/cas.14334.
    Abstract     Related articles   

  216. ELAMIN AA, Klunkelfuss S, Kampfer S, Oehlmann W, et al
    A Specific Blood Signature Reveals Higher Levels of S100A12: A Potential Bladder Cancer Diagnostic Biomarker Along With Urinary Engrailed-2 Protein Detection.
    Front Oncol. 2020;9:1484.
    Abstract     Related articles   

  217. ALAVI A, Izadpanahi MH, Haghshenas L, Faridizad R, et al
    Comparing urine levels of BLCA-4 nuclear matrix protein in patients with bladder cancer and non-bladder cancer.
    Int J Physiol Pathophysiol Pharmacol. 2019;11:289-292.
    Abstract     Related articles   

  218. HOURIGAN SK, Zhu W, S W Wong W, Clemency NC, et al
    Studying the urine microbiome in superficial bladder cancer: samples obtained by midstream voiding versus cystoscopy.
    BMC Urol. 2020;20:5.
    Abstract     Related articles   

  219. WU W, Jing Y, Xu Q, Hao J, et al
    MiR-9 promotes proliferation and inhibits apoptosis of bladder cancer cells via notch signaling pathway.
    Panminerva Med. 2020 Jan 24. pii: S0031-0808.19.03818.
    Abstract     Related articles   

  220. MANDELLI GE, Missale F, Bresciani D, Gatta LB, et al
    Tumor Infiltrating Neutrophils Are Enriched in Basal-Type Urothelial Bladder Cancer.
    Cells. 2020;9.
    Abstract     Related articles   

  221. ZHANG C, Berndt-Paetz M, Neuhaus J
    Identification of Key Biomarkers in Bladder Cancer: Evidence from a Bioinformatics Analysis.
    Diagnostics (Basel). 2020;10.
    Abstract     Related articles   

  222. MAINWARING A, Bullock N, Ellul T, Hughes O, et al
    Int J Surg. 2020 Jan 25. pii: S1743-9191(20)30138.
    Abstract     Related articles   

  223. JORGENSEN KR, Jensen JB
    Human papillomavirus and urinary bladder cancer revisited.
    APMIS. 2020 Jan 28. doi: 10.1111/apm.13016.
    Abstract     Related articles   

  224. FUKUSHIMA H, Moriyama S, Waseda Y, Fukuda S, et al
    Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non-muscle-invasive Bladder Cancer.
    Eur Urol Focus. 2020 Jan 24. pii: S2405-4569(20)30022.
    Abstract     Related articles   

  225. GAKIS G
    Management of Muscle-invasive Bladder Cancer in the 2020s: Challenges and Perspectives.
    Eur Urol Focus. 2020 Jan 24. pii: S2405-4569(20)30023.
    Abstract     Related articles   

  226. HORWICH A, Babjuk M, Bellmunt J, Bruins HM, et al
    EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees.
    Ann Oncol. 2019;30:1697-1727.
    Abstract     Related articles   

  227. MURTHY V
    International consensus for advanced bladder cancer: an opportunity between the lines.
    Ann Oncol. 2019;30:1688-1690.
    Abstract     Related articles   

  228. HAN YH, Sun GL, Wan Y, Xiong H, et al
    Structural maintenance of chromosomes 2 is identified as an oncogene in bladder cancer in vitro and in vivo.
    Neoplasma. 2020 Jan 27. pii: 190510N419. doi: 10.4149/neo_2020_190510.
    Abstract     Related articles   

  229. KAPOOR K, Datta C, Pal DK
    Immunocytochemical detection of minichromosome maintenance protein 2 as a potential urinary-based marker of bladder cancer: A prospective observational study.
    Indian J Urol. 2020;36:32-36.
    Abstract     Related articles   

  230. AWADALLA A, Abol-Enein H, Gabr MM, Hamam ET, et al
    Prediction of recurrence and progression in patients with T1G3 bladder cancer by gene expression of circulating tumor cells.
    Urol Oncol. 2020 Jan 23. pii: S1078-1439(19)30489.
    Abstract     Related articles   

  231. AU S, Keyes M, Black P, Villamil CF, et al
    Clinical and pathological characteristics of bladder cancer in post brachytherapy patients.
    Pathol Res Pract. 2020 Jan 10:152822. doi: 10.1016/j.prp.2020.152822.
    Abstract     Related articles   

  232. LORENCIN I, Andelic N, Spanjol J, Car Z, et al
    Using multi-layer perceptron with Laplacian edge detector for bladder cancer diagnosis.
    Artif Intell Med. 2020;102:101746.
    Abstract     Related articles   

  233. LOFFEL LM, Furrer MA, Favre A, Engel D, et al
    Intra-operative norepinephrine administration and cancer-related outcomes following radical cystectomy for bladder cancer: A cohort study.
    Eur J Anaesthesiol. 2020 Jan 23. doi: 10.1097/EJA.0000000000001155.
    Abstract     Related articles   

  234. CHEHROUDI AC, Black P
    Emerging intravesical therapies for the management of bacillus Calmette-Guerin (BCG)-unresponsive non-muscle-invasive bladder cancer: Charting a path forward.
    Can Urol Assoc J. 2020 Jan 20. pii: cuaj.6101. doi: 10.5489/cuaj.6101.
    Abstract     Related articles   

  235. TRENTI E, Pycha S, Mian C, Schwienbacher C, et al
    Comparison of 2 new real-time polymerase chain reaction-based urinary markers in the follow-up of patients with non-muscle-invasive bladder cancer.
    Cancer Cytopathol. 2020 Jan 24. doi: 10.1002/cncy.22246.
    Abstract     Related articles   

  236. D'ANDREA D, Soria F, Zehetmayer S, Stangl-Kremser J, et al
    Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer.
    Scand J Urol. 2020 Jan 24:1-6. doi: 10.1080/21681805.2019.1711160.
    Abstract     Related articles   

  237. TAARNHOJ GA, Johansen C, Pappot H
    Correction to: Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature.
    Health Qual Life Outcomes. 2020;18:15.
    Abstract     Related articles   

  238. YAMADA S, Osawa T, Abe T, Takada N, et al
    [The Development of the Preoperative Nomogram Predicting Major Perioperative Complications after Radical Cystectomy with Ileal Conduit or Orthotopic Neobladder].
    Hinyokika Kiyo. 2019;65:495-499.
    Abstract     Related articles   

  239. SCHROEDER SR, Albuquerque K
    Clear Cell Conundrum.
    Int J Radiat Oncol Biol Phys. 2019;105:690-691.
    Abstract     Related articles   

  240. LANG K, Kahveci S, Bonberg N, Wichert K, et al
    TGFBI Protein Is Increased in the Urine of Patients with High-Grade Urothelial Carcinomas, and Promotes Cell Proliferation and Migration.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  241. MINNULLINA L, Pudova D, Shagimardanova E, Shigapova L, et al
    Comparative Genome Analysis of Uropathogenic Morganella morganii Strains.
    Front Cell Infect Microbiol. 2019;9:167.
    Abstract     Related articles   

  242. FLIPPOT R, Beinse G, Boileve A, Vibert J, et al
    Long non-coding RNAs in genitourinary malignancies: a whole new world.
    Nat Rev Urol. 2019;16:484-504.
    Abstract     Related articles   

  243. ALLISON DB, VandenBussche CJ
    A Review of Urine Ancillary Tests in the Era of the Paris System.
    Acta Cytol. 2020;64.
    Abstract     Related articles   

  244. SALTAOURAS G, Lightowler H, Coe S, Brett J, et al
    Availability and quality assessment of online nutrition information materials for pelvic cancer patients in the UK.
    Eur J Cancer Care (Engl). 2019;28:e13039.
    Abstract     Related articles   

  245. LYON TD, Boorjian SA, Shah PH, Tarrell R, et al
    Comprehensive characterization of perioperative reoperation following radical cystectomy.
    Urol Oncol. 2019;37:292.
    Abstract     Related articles   

  246. HIZLI F, Argun G, Guney I, Guven O, et al
    Retraction Note: Obturator nerve block transurethral surgery for bladder cancer: comparison of inguinal and intravesical approaches: prospective randomized trial.
    Ir J Med Sci. 2020 Feb 7. pii: 10.1007/s11845-020-02194.
    Abstract     Related articles   

  247. WANG C, Hamacher A, Petzsch P, Kohrer K, et al
    Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  248. JUE JS, Koru-Sengul T, Miao F, Velasquez MC, et al
    Neoadjuvant vs adjuvant chemotherapy for muscle-invasive bladder cancer: a propensity matched analysis.
    Minerva Urol Nefrol. 2020 Jan 30. pii: S0393-2249.19.03657.
    Abstract     Related articles   

  249. CLAPS F, Pavan N, Umari P, Rizzo M, et al
    Incidence, predictive factors and survival outcomes of incidental prostate cancer in patients who underwent radical cystectomy for bladder cancer.
    Minerva Urol Nefrol. 2020 Jan 30. pii: S0393-2249.20.03646.
    Abstract     Related articles   

  250. FURUYA H, Hayashi K, Shimizu Y, Kim N, et al
    Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model.
    J Transl Med. 2020;18:57.
    Abstract     Related articles   

  251. BATISTA R, Lima L, Vinagre J, Pinto V, et al
    TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  252. TIMOTEO F, Korkes F, Baccaglini W, Glina S, et al
    Bladder cancer trends and mortality in the brazilian public health system.
    Int Braz J Urol. 2020;46:224-233.
    Abstract     Related articles   

    Bladder Cancer highlighted.
    Int Braz J Urol. 2020;46:150-151.
    Abstract     Related articles   

  254. ZHOU L, Liang X, Zhang K
    Assessment of the clinical efficacy of simultaneous transurethral resection of both bladder cancer and the prostate: a systematic review and meta-analysis.
    Aging Male. 2020 Feb 5:1-12. doi: 10.1080/13685538.2020.1718637.
    Abstract     Related articles   

  255. BOTHIG R, Schops W, Zellner M, Fiebag K, et al
    [Urinary bladder cancer as a late sequela of spinal cord injury : Decision-making aids for assessment of this causal association].
    Urologe A. 2020 Feb 4. pii: 10.1007/s00120-020-01124.
    Abstract     Related articles   

  256. SU Y, Feng W, Shi J, Chen L, et al
    circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-beta2/smad3 pathway.
    Mol Cancer. 2020;19:23.
    Abstract     Related articles   

  257. ZHAN Y, Chen Z, He S, Gong Y, et al
    Long non-coding RNA SOX2OT promotes the stemness phenotype of bladder cancer cells by modulating SOX2.
    Mol Cancer. 2020;19:25.
    Abstract     Related articles   

  258. HAO L, Pang K, Pang H, Zhang J, et al
    Knockdown of P3H4 inhibits proliferation and invasion of bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  259. DENG M, Cao X, Guo L, Cao H, et al
    Graphene quantum dots: efficient mechanosynthesis, white-light and broad linear excitation-dependent photoluminescence and growth inhibition of bladder cancer cells.
    Dalton Trans. 2020 Feb 4. doi: 10.1039/c9dt04575.
    Abstract     Related articles   

  260. ROLEVICH A, Minich A, Vasilevich V, Zhegalik A, et al
    Efficacy of fluorescent cystoscopy-assisted transurethral resection in patients with non-muscle invasive bladder cancer and quality of surgery: post-hoc analysis of small a, Cyrillic prospective randomized study.
    Cent European J Urol. 2019;72:351-356.
    Abstract     Related articles   

  261. LU HC, Yao JQ, Yang X, Han J, et al
    Identification of a potentially functional circRNA-miRNA-mRNA regulatory network for investigating pathogenesis and providing possible biomarkers of bladder cancer.
    Cancer Cell Int. 2020;20:31.
    Abstract     Related articles   

  262. YUCETAS U, Aglamis E, Ates HA, Behzatoglu K, et al
    Is cystoscopy follow-up protocol safe for low-risk bladder cancer without muscle invasion?
    Urol Ann. 2020;12:25-30.
    Abstract     Related articles   

  263. ASHRAFIZADEH M, Yaribeygi H, Sahebkar A
    Therapeutic Effects of Curcumin against Bladder Cancer: A Review of Possible Molecular Pathways.
    Anticancer Agents Med Chem. 2020 Feb 3. pii: ACAMC-EPUB-104182.
    Abstract     Related articles   

  264. MASTUO T, Miyata Y, Yuno T, Mukae Y, et al
    Molecular Mechanisms of the Anti-Cancer Effects of Isothiocyanates from Cruciferous Vegetables in Bladder Cancer.
    Molecules. 2020;25.
    Abstract     Related articles   

  265. IM SW, Sung CO, Kim KS, Cho NH, et al
    Genomic Landscape of Young-Onset Bladder Cancer and Its Prognostic Implications on Adult Bladder Cancer.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  266. VAN HENSBERGEN M, van Osch FHM, Jochems S, James ND, et al
    Fluid intake and clinicopathological characteristics of bladder cancer: the West Midlands Bladder Cancer Prognosis Programme.
    Eur J Cancer Prev. 2020;29:110-118.
    Abstract     Related articles   

  267. ZHU G, Pei L, Li Y, Gou X, et al
    EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  268. LI G, Wang S, Deng D, Xiao Z, et al
    Fluorinated Chitosan To Enhance Transmucosal Delivery of Sonosensitizer-Conjugated Catalase for Sonodynamic Bladder Cancer Treatment Post-intravesical Instillation.
    ACS Nano. 2020 Feb 7. doi: 10.1021/acsnano.9b06689.
    Abstract     Related articles   

  269. JIANG DM, Chung P, Kulkarni GS, Sridhar SS, et al
    Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions.
    Curr Oncol Rep. 2020;22:14.
    Abstract     Related articles   

  270. WANG G, Huang Y, Yang F, Tian X, et al
    High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  271. LI C, Gao L, Zhang J, Yang X, et al
    The effect of holmium laser resection versus standard transurethral resection on non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Lasers Med Sci. 2020 Jan 31. pii: 10.1007/s10103-020-02972.
    Abstract     Related articles   

  272. PEREIRA PMR, Roberts S, Figueira F, Tome JPC, et al
    PET/CT imaging with a (18)F-labeled galactodendritic unit in a galectin-1 overexpressing orthotopic bladder cancer model.
    J Nucl Med. 2020 Jan 31. pii: jnumed.119.236430. doi: 10.2967/jnumed.119.236430.
    Abstract     Related articles   

  273. MAO S, Wu Y, Wang R, Guo Y, et al
    Intraoperative use of single dose of nonsteroidal anti-inflammatory drugs was not associated with cancer recurrence and mortality after bladder cancer surgery: a retrospective study.
    Ann Palliat Med. 2020;9:8-18.
    Abstract     Related articles   

  274. ROFI E, Del Re M, Arrigoni E, Rizzo M, et al
    Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers.
    Crit Rev Oncol Hematol. 2019;144:102812.
    Abstract     Related articles   

  275. AN HW, Li LL, Wang Y, Wang Z, et al
    A tumour-selective cascade activatable self-detained system for drug delivery and cancer imaging.
    Nat Commun. 2019;10:4861.
    Abstract     Related articles   

  276. IDE H, Inoue S, Mizushima T, Kashiwagi E, et al
    Role of glucocorticoid signaling in urothelial tumorigenesis: Inhibition by prednisone presumably through inducing glucocorticoid receptor transrepression.
    Mol Carcinog. 2019;58:2297-2305.
    Abstract     Related articles   

  277. SOMA O, Hatakeyama S, Okamoto T, Fujita N, et al
    Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.
    Med Oncol. 2019;36:88.
    Abstract     Related articles   

  278. SAHU KK, Pandey D, Mishra AK, O'Shea J, et al
    Mystery of neck lump: an uncommon presentation of urachal cancer.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  279. GLASER AP, Procissi D, Yu Y, Meeks JJ, et al
    Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors.
    J Vis Exp. 2019;.
    Abstract     Related articles   

  280. SWAMI U, Grivas P, Agarwal N
    The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma.
    Oncologist. 2019;24:580-583.
    Abstract     Related articles   

  281. PANAHI MH
    Letter to the Editor regarding the article "Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors".
    World J Urol. 2020;38:513.
    Abstract     Related articles   

    Large-scale genomic comparison of UTUC and bladder tumours.
    Nat Rev Urol. 2019;16:149-150.
    Abstract     Related articles   

  283. FURRER MA, Huesler J, Fellmann A, Burkhard FC, et al
    The Comprehensive Complication Index CCI: A proposed modification to optimize short-term complication reporting after cystectomy and urinary diversion.
    Urol Oncol. 2019;37:291.
    Abstract     Related articles   

  284. TSAY MD, Hsieh MJ, Wang SS, Wang WC, et al
    Impact of endothelial nitric oxide synthase polymorphisms on urothelial cell carcinoma development.
    Urol Oncol. 2019;37:293.
    Abstract     Related articles   

  285. LEVI LI, Schlemmer F, de Castro N, Brun O, et al
    Bacillus Calmette-Guerin infection following intravesical instillation: Does the strain matter?
    Med Mal Infect. 2019;49:350-355.
    Abstract     Related articles   

  286. KADAM PD, Han HC, Kwok JL
    An uncommon case of mucosa-associated lymphoid tissue (MALT) tumor of the bladder.
    Int Urogynecol J. 2019;30:1017-1018.
    Abstract     Related articles   

  287. PHAM TM, Kubo T, Fujino Y, Fujimoto N, et al
    Premature Mortality Due to Malignancies of the Kidney and Bladder in Japan, 1980-2010.
    J Epidemiol. 2019;29:464-470.
    Abstract     Related articles   

  288. PAVLIC K, Pohar Perme M
    Using pseudo-observations for estimation in relative survival.
    Biostatistics. 2019;20:384-399.
    Abstract     Related articles   

  289. MOTTET N, Ribal MJ, Boyle H, De Santis M, et al
    Management of bladder cancer in older patients: Position paper of a SIOG Task Force.
    J Geriatr Oncol. 2020 Feb 10. pii: S1879-4068(19)30481.
    Abstract     Related articles   

  290. D'ANDREA D, Black PC, Zargar H, Zargar-Shoshtari K, et al
    Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer.
    Urol Oncol. 2020 Feb 11. pii: S1078-1439(20)30011.
    Abstract     Related articles   

  291. EFILOGLU O, Basok BI, Turan T, Toprak T, et al
    Role of serum and urine transforming growth factor beta 1, matrix metallopeptidase 9, tissue inhibitor of metalloproteinase 2, and nerve growth factor beta levels and serum neutrophil-to-lymphocyte ratio in predicting recurrence and progression risks
    Turk J Urol. 2020 Feb 7:1-7. doi: 10.5152/tud.2020.19186.
    Abstract     Related articles   

  292. CELEN S, Kaygisiz O, Vuruskan H, Yavascaoglu I, et al
    Laparoscopic versus open radical cystectomy in the treatment of locally advanced T3 and T4 bladder cancer: Perioperative and Mid-term oncological outcomes.
    Turk J Urol. 2020 Jan 17:1-6. doi: 10.5152/tud.2020.19077.
    Abstract     Related articles   

  293. CHEN J, Li Y, Li Z, Cao L, et al
    LncRNA MST1P2/miR-133b axis affects the chemoresistance of bladder cancer to cisplatin-based therapy via Sirt1/p53 signaling.
    J Biochem Mol Toxicol. 2020 Feb 13:e22452. doi: 10.1002/jbt.22452.
    Abstract     Related articles   

  294. CHEN J, Sun Y, Ou Z, Yeh S, et al
    Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion.
    EMBO Rep. 2020 Feb 13:e48467. doi: 10.15252/embr.201948467.
    Abstract     Related articles   

  295. XU Y, Wu G, Li J, Li J, et al
    Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data.
    Biomed Res Int. 2020;2020:8283401.
    Abstract     Related articles   

  296. WANG K, Ma L, Tang J, Yu Q, et al
    LncRNA00518 promotes cell proliferation through regulating miR-101 in bladder cancer.
    J Cancer. 2020;11:1468-1477.
    Abstract     Related articles   

  297. WANG X, Ding Y, Wang J, Wu Y, et al
    Identification of the Key Factors Related to Bladder Cancer by lncRNA-miRNA-mRNA Three-Layer Network.
    Front Genet. 2020;10:1398.
    Abstract     Related articles   

  298. WANG Y, Du L, Yang X, Li J, et al
    A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  299. KOYA M, Osborne S, Chemasle C, Porten S, et al
    An evaluation of the real world use and clinical utility of the Cxbladder Monitor assay in the follow-up of patients previously treated for bladder cancer.
    BMC Urol. 2020;20:12.
    Abstract     Related articles   

  300. ROSE M, Bringezu S, Godfrey L, Fiedler D, et al
    ITIH5 and ECRG4 DNA Methylation Biomarker Test (EI-BLA) for Urine-Based Non-Invasive Detection of Bladder Cancer.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  301. HINDUPUR SV, Schmid SC, Koch JA, Youssef A, et al
    STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  302. BALLAS L, Wei O, Daneshmand S, Schuckman A, et al
    Chemoradiation for Management of Locally Recurrent or Residual Bladder Cancer: A Case Series and Review of the Literature.
    Clin Genitourin Cancer. 2020 Jan 7. pii: S1558-7673(19)30389.
    Abstract     Related articles   

  303. PLOUVIER SD, Bonnal JL, Machuron F, Colin P, et al
    Impact of age on bladder cancer management practices: a general population study.
    Acta Oncol. 2020 Feb 11:1-5. doi: 10.1080/0284186X.2020.1723164.
    Abstract     Related articles   

  304. WONG R, Rosser CJ
    UroSEEK gene panel for bladder cancer surveillance.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  305. CLINTON TN, Wiseman M, Walasek A, Pietzak E, et al
    Commentary: underutilization of curative-intent therapy for patients with muscle-invasive bladder cancer in Sweden mimics the United States.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  306. SOLANKI AA, Liauw SL
    The perils of using registry data to compare the survival and cost of radical cystectomy and trimodality therapy in bladder cancer.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

    Bacillus Calmette Guerin in bladder cancer: is more immune stimulation better?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  308. DESAI NB, Bagrodia A
    The challenge of matching assays to biology in DNA damage response biomarkers for response to radiotherapy in bladder cancer.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  309. BOTTERO M, Ali E, Demofonti C, Lancia A, et al
    High-resolution microultrasound imaging for bladder cancer: the birth of a new diagnostic tool?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  310. FANKHAUSER CD, Mostafid H
    The inflammatory potential of diet and bladder cancer risk: results from a prospective cohort study.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  311. NASELLI A, Guarneri A
    Bladder cancer under staging: still unavoidable?
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  312. MOTTERLE G, Karnes RJ
    Neoadjuvant chemotherapy in bladder cancer: not a matter on how much but on who it is effective.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  313. REIS LO
    Non-muscle invasive bladder cancer cystoscopic surveillance: from overuse to underuse and non-adherence impact.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  314. MAGEE DE, Kulkarni GS
    Editorial comment: understanding the cost of bladder preservation in muscle invasive bladder cancer-an evaluation of radical cystectomy versus trimodal therapy costs.
    Transl Androl Urol. 2019;8.
    Abstract     Related articles   

  315. KNAPP DW, Dhawan D, Ramos-Vara JA, Ratliff TL, et al
    Naturally-Occurring Invasive Urothelial Carcinoma in Dogs, a Unique Model to Drive Advances in Managing Muscle Invasive Bladder Cancer in Humans.
    Front Oncol. 2020;9:1493.
    Abstract     Related articles   

  316. SCHULZ A, Gorodetska I, Behrendt R, Fuessel S, et al
    Linking NRP2 With EMT and Chemoradioresistance in Bladder Cancer.
    Front Oncol. 2020;9:1461.
    Abstract     Related articles   

  317. BOU KHEIR G, Aoun F, Roumeguere T
    CD47 targeted near-infrared photo-immunotherapy: a promising tool combining monoclonal antibodies and photodynamics for treating human bladder cancer.
    Transl Androl Urol. 2019;8:779-780.
    Abstract     Related articles   

  318. LI X, Gheinani AH, Adam RM
    A multi-omics approach to understanding the field effect in bladder cancer.
    Transl Androl Urol. 2019;8:775-778.
    Abstract     Related articles   

    Expeditious Radical Cystectomy in Patients with High-risk Bladder Cancer Remains an Important Part of Patient Care.
    Eur Urol Oncol. 2020 Feb 6. pii: S2588-9311(20)30011.
    Abstract     Related articles   

  320. SOOD R, Sharma H, Sharma B, Parekh S, et al
    A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer.
    Urol Oncol. 2020 Feb 6. pii: S1078-1439(20)30003.
    Abstract     Related articles   

  321. GADZINSKI AJ, Psutka SP
    Risk stratification metrics for bladder cancer: Comprehensive Geriatric Assessments.
    Urol Oncol. 2020 Feb 6. pii: S1078-1439(20)30004.
    Abstract     Related articles   

  322. LUZZAGO S, Palumbo C, Rosiello G, Knipper S, et al
    Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study.
    Clin Genitourin Cancer. 2019 Oct 16. pii: S1558-7673(19)30320.
    Abstract     Related articles   

  323. KOTOV SV, Khachatryan AL, Kotova DP, Guspanov RI, et al
    [Analysis of the results of ERAS protocol in real-life clinical practice AFTER radical cystectomy (the first prospective multicenter study in Russia)].
    Urologiia. 2019;:60-66.
    Abstract     Related articles   

  324. PERLIN DV, Alexandrov IV, Zippunnikov VP, Shmanev AO, et al
    [Laparoscopic radical cystectomy: novel technique with late dividing of the ureters].
    Urologiia. 2019;:54-59.
    Abstract     Related articles   

  325. BORGNA V, Vidal I, Castillo OA
    [Open vs Laparoscopic Radical Cystectomy: Comparison of perioperative and Mid-term oncological outcomes.]
    Arch Esp Urol. 2020;73:32-40.
    Abstract     Related articles   

  326. FERREIRA JT, Pina J, Ribeiro CAF, Fernandes R, et al
    Highly Efficient Singlet Oxygen Generators Based on Ruthenium Phthalocyanines: Synthesis, Characterization and in vitro Evaluation for Photodynamic Therapy.
    Chemistry. 2020;26:1697.
    Abstract     Related articles   

  327. TSUI KH, Lin YH, Chang KS, Hou CP, et al
    Transgelin, a p53 and PTEN-Upregulated Gene, Inhibits the Cell Proliferation and Invasion of Human Bladder Carcinoma Cells in Vitro and in Vivo.
    Int J Mol Sci. 2019;20.
    Abstract     Related articles   

  328. QIN QP, Wang ZF, Huang XL, Tan MX, et al
    Two telomerase-targeting Pt(ii) complexes of jatrorrhizine and berberine derivatives induce apoptosis in human bladder tumor cells.
    Dalton Trans. 2019;48:15247-15254.
    Abstract     Related articles   

  329. LIU W, Sun L, Guan F, Wang F, et al
    Prognostic Value of Lymphovascular Invasion in Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy: A Systematic Review and Meta-Analysis.
    Dis Markers. 2019;2019:7386140.
    Abstract     Related articles   

  330. HSU WC, Lee YC, Liang PI, Chang LL, et al
    CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas.
    Dis Markers. 2019;2019:2724948.
    Abstract     Related articles   

  331. YUK HD, Jeong CW, Kwak C, Kim HH, et al
    De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study.
    Dis Markers. 2019;2019:6702964.
    Abstract     Related articles   

  332. REDKNAP C, Kaitiff D
    Delirium superimposed on dementia precipitated by an unexpected bladder tumour.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  333. ZAJAC M, Scott M, Ratcliffe M, Scorer P, et al
    Concordance among four commercially available, validated programmed cell death ligand-1 assays in urothelial carcinoma.
    Diagn Pathol. 2019;14:99.
    Abstract     Related articles   

  334. ALSTON ELJ, Zynger DL
    Does the addition of AMACR to CK20 help to diagnose challenging cases of urothelial carcinoma in situ?
    Diagn Pathol. 2019;14:91.
    Abstract     Related articles   

  335. WANG X, Wang L, Zong S, Qiu R, et al
    Use of multifunctional composite nanofibers for photothermalchemotherapy to treat cervical cancer in mice.
    Biomater Sci. 2019 Jul 10. doi: 10.1039/c9bm00756.
    Abstract     Related articles   

  336. MISTRETTA FA, Mazzone E, Knipper S, Palumbo C, et al
    Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients.
    Cancer Epidemiol. 2019;59:135-142.
    Abstract     Related articles   

  337. RENSHAW AA, Gould EW
    Adequacy criteria for voided urine cytology using cytospin preparations.
    Cancer Cytopathol. 2019;127:116-119.
    Abstract     Related articles   

  338. CRISS SD, Weaver DT, Sheehan DF, Lee RJ, et al
    Effect of PD-L1 testing on the cost-effectiveness and budget impact of pembrolizumab for advanced urothelial carcinoma of the bladder in the United States.
    Urol Oncol. 2019;37:180.
    Abstract     Related articles   

  339. MOSCHINI M, Soria F, Mathieu R, Xylinas E, et al
    Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy.
    Urol Oncol. 2019;37:179.
    Abstract     Related articles   

  340. BARROS TMB, Lima APB, Almeida TC, da Silva GN, et al
    Inhibition of urinary bladder cancer cell proliferation by silibinin.
    Environ Mol Mutagen. 2020 Feb 20. doi: 10.1002/em.22363.
    Abstract     Related articles   

  341. STACHOWIAK M, Szymanski M, Ornoch A, Jancewicz I, et al
    SWI/SNF chromatin remodeling complex and glucose metabolism are deregulated in advanced bladder cancer.
    IUBMB Life. 2020 Feb 19. doi: 10.1002/iub.2254.
    Abstract     Related articles   

  342. KRAJEWSKI W, Rodriguez Faba O, Breda A, Pisano F, et al
    Analysis of age influence on oncological results and toxicity of BCG immunotherapy in non-muscle invasive bladder cancer.
    World J Urol. 2020 Feb 18. pii: 10.1007/s00345-020-03130.
    Abstract     Related articles   

  343. HE Q, Yan D, Dong W, Bi J, et al
    circRNA circFUT8 Upregulates Krupple-like Factor 10 to Inhibit the Metastasis of Bladder Cancer via Sponging miR-570-3p.
    Mol Ther Oncolytics. 2020;16:172-187.
    Abstract     Related articles   

    Complexities of Contemporary Bladder Cancer Care: NYU Case of the Month, September 2019.
    Rev Urol. 2019;21:172-174.
    Abstract     Related articles   

  345. GOLLA V, Lenis AT, Faiena I, Chamie K, et al
    Intravesical Therapy for Non-muscle Invasive Bladder Cancer-Current and Future Options in the Age of Bacillus Calmette-Guerin Shortage.
    Rev Urol. 2019;21:145-153.
    Abstract     Related articles   

  346. GUPTA A, Bansal N, Mitash N, Kumar D, et al
    NMR-derived targeted serum metabolic biomarkers appraisal of bladder cancer: A pre- and post-operative evaluation.
    J Pharm Biomed Anal. 2020;183:113134.
    Abstract     Related articles   

  347. WANG B, Zhang K, Wang J, Zhao R, et al
    Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy.
    Colloids Surf B Biointerfaces. 2020;189:110832.
    Abstract     Related articles   

  348. CHEN D, Guo Y, Chen Y, Guo Q, et al
    LncRNA growth arrest-specific transcript 5 targets miR-21 gene and regulates bladder cancer cell proliferation and apoptosis through PTEN.
    Cancer Med. 2020 Feb 18. doi: 10.1002/cam4.2664.
    Abstract     Related articles   

  349. TAO T, Yuan S, Liu J, Shi D, et al
    Cancer stem cell-specific expression profiles reveal emerging bladder cancer biomarkers and identify circRNA_103809 as an important regulator in bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  350. CALO B, Falagario U, Sanguedolce F, Veccia A, et al
    Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette-Guerin.
    World J Urol. 2020 Feb 15. pii: 10.1007/s00345-020-03108.
    Abstract     Related articles   

  351. OH H, Lee DH, Giovannucci EL, Keum N, et al
    Gastric and duodenal ulcers, periodontal disease, and risk of bladder cancer in the Health Professionals Follow-up Study.
    Cancer Causes Control. 2020 Feb 14. pii: 10.1007/s10552-020-01274.
    Abstract     Related articles   

  352. SUN Y, Zhu D, Xing H, Hou Y, et al
    Screening of characteristic biomolecules related to bladder cancer based on construction of ceRNA regulation network.
    World J Urol. 2020 Feb 14. pii: 10.1007/s00345-020-03086.
    Abstract     Related articles   

  353. DE KRUIJFF IE, Beije N, Martens JWM, de Wit R, et al
    Liquid Biopsies to Select Patients for Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: A Systematic Review.
    Eur Urol Oncol. 2020 Feb 11. pii: S2588-9311(20)30010.
    Abstract     Related articles   

  354. SCHREIBER H, Hanze J, Nimphius W, Verburg FA, et al
    Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and staging.
    J Cancer Res Clin Oncol. 2020;146:305-313.
    Abstract     Related articles   

  355. YIP W, Ashrafi A, Daneshmand S
    High-grade T1 Urothelial Carcinoma: Where Do We Stand?
    Curr Urol Rep. 2019;20:79.
    Abstract     Related articles   

  356. KALAMPOKIS N, Grivas N, Olschlager M, Hassan FN, et al
    Radical Cystectomy in Female Patients - Improving Outcomes.
    Curr Urol Rep. 2019;20:83.
    Abstract     Related articles   

  357. ROHRA P, Yan L, Mir F, Farrell MR, et al
    Follicular cystitis in urine cytology: A clinical and cytopathologic study.
    Diagn Cytopathol. 2019;47:1223-1228.
    Abstract     Related articles   

  358. KVIKSTAD V, Mangrud OM, Gudlaugsson E, Dalen I, et al
    Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas.
    Diagn Pathol. 2019;14:90.
    Abstract     Related articles   

  359. MARTIN C, West JM, Palermo S, Patel DP, et al
    Elderly patients undergoing cystectomy, comparing preoperative American Society of Anesthesiology and Eastern Cooperative Oncology Group scores and operative approaches.
    Urologia. 2019;86:183-188.
    Abstract     Related articles   

  360. MCINTIRE P, Khan R, Kilic I, Wojcik EM, et al
    Immunohistochemistry in the workup of bladder biopsies: Frequency, variation and utility of use at an academic center.
    Ann Diagn Pathol. 2019;41:124-128.
    Abstract     Related articles   

  361. IWAMOTO H, Morizane S, Koie T, Shiroki R, et al
    Peri-operative efficacy and long-term survival benefit of robotic-assisted radical cystectomy in septuagenarian patients compared with younger patients: a nationwide multi-institutional study in Japan.
    Int J Clin Oncol. 2019;24:1588-1595.
    Abstract     Related articles   

  362. AKAMATSU H, Nakamura K, Ebara T, Inaba K, et al
    Organ-preserving approach via radiotherapy for small cell carcinoma of the bladder: an analysis based on the Japanese Radiation Oncology Study Group (JROSG) survey.
    J Radiat Res. 2019;60:509-516.
    Abstract     Related articles   

  363. IWATA T, Kimura S, Foerster B, Fossati N, et al
    Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis.
    World J Urol. 2019;37:1557-1570.
    Abstract     Related articles   

  364. HUNTER L, Moser J, Sturge C, Barraza G, et al
    First-line pembrolizumab therapy in a cisplatin-ineligible patient with plasmacytoid urothelial carcinoma: A case report.
    J Oncol Pharm Pract. 2020;26:216-219.
    Abstract     Related articles   

  365. WANG B, Xie S, Bi J, Liu Z, et al
    Elevated pre-existing lymphocytic infiltrates in tumour stroma predict poor prognosis in resectable urothelial carcinoma of the bladder.
    Histopathology. 2019;75:354-364.
    Abstract     Related articles   

  366. TEOH JY, Cho CL, Wei Y, Isotani S, et al
    A newly developed porcine training model for transurethral piecemeal and en bloc resection of bladder tumour.
    World J Urol. 2019;37:1879-1887.
    Abstract     Related articles   

  367. GERGELIS KR, Kreofsky CR, Choo CS, Viehman J, et al
    Outcomes and profiles of elderly patients receiving definitive radiotherapy for muscle-invasive bladder cancer at a tertiary medical center.
    Pract Radiat Oncol. 2020 Feb 25. pii: S1879-8500(20)30045.
    Abstract     Related articles   

  368. LI WQ, Zhao WC, Xin J, Niu TL, et al
    MicroRNA-142-3p suppresses cell proliferation and migration in bladder cancer via Rac1.
    J Biol Regul Homeost Agents. 2020;34.
    Abstract     Related articles   

  369. JIANG F, Li C, Han J, Wang L, et al
    Diagnostic Value of Combination of MicroRNA-192 in Urinary Sediment and B-Ultrasound for Bladder Cancer.
    Technol Cancer Res Treat. 2020;19:1533033819894573.
    Abstract     Related articles   

  370. FAURE WALKER NA, Nair R
    Commentary on "The Top 100 most cited Manuscripts in Bladder cancer: A bibliometric analysis".
    Int J Surg. 2020 Feb 24. pii: S1743-9191(20)30195.
    Abstract     Related articles   

  371. GUALLAR-GARRIDO S, Julian E
    Bacillus Calmette-Guerin (BCG) Therapy for Bladder Cancer: An Update.
    Immunotargets Ther. 2020;9:1-11.
    Abstract     Related articles   

  372. WANG C, Liu Q, Huang M, Zhou Q, et al
    Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer.
    FASEB J. 2020 Feb 26. doi: 10.1096/fj.201903176.
    Abstract     Related articles   

  373. ABOUSHOUSHA T, Hammam O, Aref A, Kamel A, et al
    Tissue Profile of CDK4 and STAT3 as Possible Innovative Therapeutic Targets in Urinary Bladder Cancer.
    Asian Pac J Cancer Prev. 2020;21:547-554.
    Abstract     Related articles   

  374. MONTEIRO-REIS S, Blanca A, Tedim-Moreira J, Carneiro I, et al
    A Multiplex Test Assessing MiR663ame and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions.
    J Clin Med. 2020;9.
    Abstract     Related articles   

  375. CUCCI MA, Grattarola M, Dianzani C, Damia G, et al
    Ailanthone increases oxidative stress in CDDP-resistant ovarian and bladder cancer cells by inhibiting of Nrf2 and YAP expression through a post-translational mechanism.
    Free Radic Biol Med. 2020 Feb 23. pii: S0891-5849(20)30046.
    Abstract     Related articles   

  376. WANG C, Yang S, Jin L, Dai G, et al
    Biological and Clinical Significance of GATA3 Detected from TCGA Database and FFPE Sample in Bladder Cancer Patients.
    Onco Targets Ther. 2020;13:945-958.
    Abstract     Related articles   

  377. GAO S, Yin H, Tong H, Zhan K, et al
    Nucleolar and Spindle Associated Protein 1 (NUSAP1) Promotes Bladder Cancer Progression Through the TGF-beta Signaling Pathway.
    Onco Targets Ther. 2020;13:813-825.
    Abstract     Related articles   

  378. CAI Z, Zhang F, Chen W, Zhang J, et al
    miRNAs: A Promising Target in the Chemoresistance of Bladder Cancer.
    Onco Targets Ther. 2019;12:11805-11816.
    Abstract     Related articles   

  379. LIN H, Zhou Q, Wu W, Ma Y, et al
    Midkine Is a Potential Urinary Biomarker for Non-Invasive Detection of Bladder Cancer with Microscopic Hematuria.
    Onco Targets Ther. 2019;12:11765-11775.
    Abstract     Related articles   

  380. HANSON HA, Leiser CL, O'Neil B, Martin C, et al
    Harnessing Population Pedigree Data and Machine Learning Methods to Identify Patterns of Familial Bladder Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2020 Feb 25. pii: 1055-9965.EPI-19-0681.
    Abstract     Related articles   

  381. TERAUCHI T, Nakada S, Takenaka M, Mizuguchi S, et al
    Intracytoplasmic Lumen in Urine Cytology Predicts Worse Prognosis in Non-Muscle-Invasive Bladder Cancers.
    Acta Cytol. 2020 Feb 25:1-8. doi: 10.1159/000505955.
    Abstract     Related articles   

  382. ZAVALISHINA LE, Andreeva YY, Olyushina EM, Frank GA, et al
    [Immunohistochemical study of the MSI phenotype of urothelial bladder cancer].
    Arkh Patol. 2020;82:5-14.
    Abstract     Related articles   

  383. JIANG W, Zhu D, Wang C, Zhu Y, et al
    An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle-invasive bladder cancer (MIBC).
    Cancer Med. 2020 Feb 25. doi: 10.1002/cam4.2942.
    Abstract     Related articles   

  384. HAN CT, Bao QY, Cheng SJ, Liu M, et al
    Circular RNA hsa_circ_0017247 acts as an oncogene in bladder cancer by inducing Wnt/beta-catenin signaling pathway.
    Eur Rev Med Pharmacol Sci. 2020;24:1081-1087.
    Abstract     Related articles   

  385. MORTADA WI, Awadalla A, Khater S, Ahmed A, et al
    Copper and zinc levels in plasma and cancerous tissues and their relation with expression of VEGF and HIF-1 in the pathogenesis of muscle invasive urothelial bladder cancer: a case-controlled clinical study.
    Environ Sci Pollut Res Int. 2020 Feb 24. pii: 10.1007/s11356-020-08113.
    Abstract     Related articles   

  386. FUMAROLA S, Cecati M, Sartini D, Ferretti G, et al
    Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression.
    Antioxidants (Basel). 2020;9.
    Abstract     Related articles   

  387. WARRICK JI, Knowles MA, Yves A, van der Kwast T, et al
    Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges.
    Am J Surg Pathol. 2020 Feb 19. doi: 10.1097/PAS.0000000000001453.
    Abstract     Related articles   

  388. ZHANG N, Li F, Gao J, Zhang S, et al
    Osteopontin accelerates the development and metastasis of bladder cancer via activating JAK1/STAT1 pathway.
    Genes Genomics. 2020 Feb 22. pii: 10.1007/s13258-019-00907.
    Abstract     Related articles   

  389. NAKA M, Shuto S, Konishi C, Maekawa K, et al
    High prevalence of airway obstruction and pulmonary emphysema in urothelial (renal pelvis, ureter, and bladder) cancer patients.
    Respir Investig. 2020 Feb 19. pii: S2212-5345(20)30004.
    Abstract     Related articles   

  390. JOHN JB, Varughese MA, Cooper N, Wong K, et al
    Treatment Allocation and Survival in Patients Diagnosed with Nonmetastatic Muscle-invasive Bladder Cancer: An Analysis of a National Patient Cohort in England.
    Eur Urol Focus. 2020 Feb 19. pii: S2405-4569(20)30032.
    Abstract     Related articles   

  391. LUO H, Yang L, Liu C, Wang X, et al
    TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer.
    Int J Biochem Cell Biol. 2020 Feb 19:105702. doi: 10.1016/j.biocel.2020.105702.
    Abstract     Related articles   

  392. ABDELKADER EL HAKIM B, Caid N, Braneci F, Boudjemaa M, et al
    Epidemiological study of gall bladder cancer.
    Ann Oncol. 2019;30 Suppl 4:iv66.
    Abstract     Related articles   

  393. HAROON N
    An invited commentary on: "The top 100 most cited manuscripts in bladder cancer: A bibliometric analysis" [Int. J. surg. 2020; Epub ahead of print].
    Int J Surg. 2020;76:4.
    Abstract     Related articles   

  394. FENG D, Li A, Hu X, Lin T, et al
    Comparative effectiveness of open, laparoscopic and robot-assisted radical cystectomy for bladder cancer: a systematic review and network meta-analysis.
    Minerva Urol Nefrol. 2020 Feb 19. pii: S0393-2249.20.03680.
    Abstract     Related articles   

  395. REGNIER P, De Luca V, Brunelle S, Sfumato P, et al
    Impact of sarcopenia status of muscle-invasive bladder cancer patients on kidney function after neoadjuvant chemotherapy and post cystectomy complications.
    Minerva Urol Nefrol. 2020 Feb 19. pii: S0393-2249.20.03616.
    Abstract     Related articles   

  396. PANG K, Hao L, Shi Z, Chen B, et al
    Comprehensive gene expression analysis after ERH gene knockdown in human bladder cancer T24 cell lines.
    Gene. 2020 Feb 17:144475. doi: 10.1016/j.gene.2020.144475.
    Abstract     Related articles   

  397. HOSEN MI, Sheikh M, Zvereva M, Scelo G, et al
    Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study.
    EBioMedicine. 2020 Feb 12:102643. doi: 10.1016/j.ebiom.2020.102643.
    Abstract     Related articles   

  398. HERMANNS T, Savio AJ, Olkhov-Mitsel E, Mari A, et al
    A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
    Urol Oncol. 2020 Feb 18. pii: S1078-1439(20)30008.
    Abstract     Related articles   

  399. MURAMATSU-MAEKAWA Y, Taniguchi T, Ito H, Nakane K, et al
    Pembrolizumab Treatment and Pathologic Therapeutic Evaluation for Granulocyte Colony-stimulating Factor-producing Bladder Cancer: A Case Report and Literature Review.
    J Immunother. 2020 Feb 19. doi: 10.1097/CJI.0000000000000311.
    Abstract     Related articles   

  400. KUDELSKI J, Mlynarczyk G, Darewicz B, Bruczko-Goralewska M, et al
    Dominative role of MMP-14 over MMP-15 in human urinary bladder carcinoma on the basis of its enhanced specific activity.
    Medicine (Baltimore). 2020;99:e19224.
    Abstract     Related articles   

  401. QAYOOM S, Chakrabarti D, Khan F, Goel MM, et al
    Primary small cell carcinoma of the urinary bladder.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  402. DING Y, Cao Q, Wang C, Duan H, et al
    LGALS4 as a Prognostic Factor in Urothelial Carcinoma of Bladder Affects Cell Functions.
    Technol Cancer Res Treat. 2019;18:1533033819876601.
    Abstract     Related articles   

  403. LUO X, Lin J, Du L, Wu R, et al
    Ultrasound findings of urachal anomalies. A series of interesting cases.
    Med Ultrason. 2019;21:294-298.
    Abstract     Related articles   

  404. BUSZEK SM, Ludmir EB, Grosshans DR, McAleer MF, et al
    Patterns of failure and toxicity profile following proton beam therapy for pediatric bladder and prostate rhabdomyosarcoma.
    Pediatr Blood Cancer. 2019;66:e27952.
    Abstract     Related articles   

  405. RASMUSSEN LA, Jensen H, Virgilsen LF, Falborg AZ, et al
    Time from incident primary cancer until recurrence or second primary cancer: Risk factors and impact in general practice.
    Eur J Cancer Care (Engl). 2019;28:e13123.
    Abstract     Related articles   

  406. SHAFIEI S, Kalantari E, Saeednejad Zanjani L, Abolhasani M, et al
    Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas.
    Exp Mol Pathol. 2019;108:164-172.
    Abstract     Related articles   

  407. HASHEMIAN M, Sinha R, Murphy G, Weinstein SJ, et al
    Coffee and tea drinking and risk of cancer of the urinary tract in male smokers.
    Ann Epidemiol. 2019;34:33-39.
    Abstract     Related articles   

  408. LIU J, Li J
    PKCalpha and Netrin-1/UNC5B positive feedback control in relation with chemical therapy in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2020;24:1712-1717.
    Abstract     Related articles   

  409. SU Y, Feng W, Zhong G, Ya Y, et al
    Correction for: ciRs-6 upregulates March1 to suppress bladder cancer growth by sponging miR-653.
    Aging (Albany NY). 2020 Mar 2. pii: 102885. doi: 10.18632/aging.102885.
    Abstract     Related articles   

  410. STEINBACH D, Kaufmann M, Hippe J, Gajda M, et al
    High Detection Rate for Non-Muscle-Invasive Bladder Cancer Using an Approved DNA Methylation Signature Test.
    Clin Genitourin Cancer. 2019 Oct 17. pii: S1558-7673(19)30311.
    Abstract     Related articles   

  411. ESAWY MM, Abdel-Samd KM
    The diagnostic and prognostic roles of serum irisin in bladder cancer.
    Curr Probl Cancer. 2019 Nov 20:100529.
    Abstract     Related articles   

  412. LUO Y, Fu X, Ru R, Han B, et al
    CpG Oligodeoxynucleotides Induces Apoptosis of Human Bladder Cancer Cells via Caspase-3-Bax/Bcl-2-p53 Axis.
    Arch Med Res. 2020 Mar 3. pii: S0188-4409(19)30676.
    Abstract     Related articles   

  413. FLAIG TW, Spiess PE, Agarwal N, Bangs R, et al
    Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
    J Natl Compr Canc Netw. 2020;18:329-354.
    Abstract     Related articles   

  414. ANNELS NE, Simpson GR, Pandha H
    Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response.
    Front Oncol. 2020;10:175.
    Abstract     Related articles   

  415. ZHU S, Huang Z, Nabi G
    Fluorometric optical sensor arrays for the detection of urinary bladder cancer specific volatile organic compounds in the urine of patients with frank hematuria: a prospective case-control study.
    Biomed Opt Express. 2020;11:1175-1185.
    Abstract     Related articles   

  416. OH SS, Lee KW, Madhi H, Jeong JW, et al
    Cordycepin Resensitizes T24R2 Cisplatin-Resistant Human Bladder Cancer Cells to Cisplatin by Inactivating Ets-1 Dependent MDR1 Transcription.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  417. MITIN T, Dengina N, Chernykh M, Usychkin S, et al
    Management of Muscle Invasive Bladder Cancer with Bladder Preservation in Russia: a Survey-Based Analysis of Current Practice and the Impact of an Educational Workshop on Clinical Expertise.
    J Cancer Educ. 2020 Mar 4. pii: 10.1007/s13187-020-01728.
    Abstract     Related articles   

  418. YANG Y, Yang X, Liu C, Li J, et al
    Preliminary study on the application of en bloc resection combined with near-infrared molecular imaging technique in the diagnosis and treatment of bladder cancer.
    World J Urol. 2020 Mar 4. pii: 10.1007/s00345-020-03143.
    Abstract     Related articles   

  419. NAGARAJAN G, Kundalia K
    Should every cholecystectomy specimen be sent for histopathology to identify incidental gall bladder cancer?
    Indian J Cancer. 2020;57:2-3.
    Abstract     Related articles   

  420. NASON GJ, Khaled A, Tan GH, Kulkarni GS, et al
    Bladder-sparing treatment options in localized muscle-invasive bladder cancer.
    Expert Rev Anticancer Ther. 2020 Mar 4. doi: 10.1080/14737140.2020.1736565.
    Abstract     Related articles   

  421. LOH-DOYLE JC, Han J, Ghodoussipour S
    Factors Associated With Patient-Reported Penile Length Loss After Radical Cystoprostatectomy in Male Patients With Bladder Cancer.
    J Sex Med. 2020 Feb 29. pii: S1743-6095(20)30063.
    Abstract     Related articles   

  422. CHOI SJ, Park KJ, Lee G, Kim MH, et al
    Urothelial phase CT for assessment of pathologic complete response after neoadjuvant chemotherapy in muscle-invasive bladder cancer.
    Eur J Radiol. 2020;126:108902.
    Abstract     Related articles   

  423. XIE H, Li J, Ying Y, Yan H, et al
    METTL3/YTHDF2 m(6) A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer.
    J Cell Mol Med. 2020 Mar 3. doi: 10.1111/jcmm.15063.
    Abstract     Related articles   

  424. IKEDA A, Kojima T, Kawai K, Hinotsu S, et al
    Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan.
    Int J Clin Oncol. 2020 Mar 3. pii: 10.1007/s10147-020-01634.
    Abstract     Related articles   

  425. SU Y, Du Z, Zhong G, Ya Y, et al
    Correction for: circ5912 suppresses cancer progression via inducing MET in bladder cancer.
    Aging (Albany NY). 2020 Feb 27. pii: 102886. doi: 10.18632/aging.102886.
    Abstract     Related articles   

  426. KARSIYAKALI N, Karabay E, Yucetas U
    Predictive value of prognostic nutritional index on tumor stage in patients with primary bladder cancer.
    Arch Esp Urol. 2020;73:132-139.
    Abstract     Related articles   

  427. NAUSEEF JT, Villamar DM, Lebenthal J, Vlachostergios PJ, et al
    An evaluation of the efficacy and safety of erdafitinib for the treatment of bladder cancer.
    Expert Opin Pharmacother. 2020 Mar 3:1-8. doi: 10.1080/14656566.2020.1736036.
    Abstract     Related articles   

  428. HUANG Z, Wang X, Ma L, Guo Z, et al
    Genetic variations in Hippo pathway genes influence bladder cancer risk in a Chinese population.
    Arch Toxicol. 2020 Mar 2. pii: 10.1007/s00204-020-02663.
    Abstract     Related articles   

  429. SHIOTA M, Fujimoto N, Yamamoto Y, Takeuchi A, et al
    Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Guerin therapy for non-muscle invasive bladder cancer.
    Cancer Immunol Immunother. 2020 Mar 2. pii: 10.1007/s00262-020-02533.
    Abstract     Related articles   

  430. ABDELHAKAM D, Young PR, Jain MK, Nassar A, et al
    Complete remission with immunotherapy: Case report of a patient with metastatic bladder cancer to the humerus.
    Urol Case Rep. 2020;30:101130.
    Abstract     Related articles   

  431. MOKKAPATI S, Porten SP, Narayan VM, Lim AH, et al
    TCF21 promotes luminal-like differentiation and suppresses metastasis in bladder cancer.
    Mol Cancer Res. 2020 Mar 2. pii: 1541-7786.MCR-19-0766.
    Abstract     Related articles   

  432. COOLEY LF, Glaser AP, Meeks JJ
    Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancer.
    Urol Oncol. 2020 Feb 28. pii: S1078-1439(20)30041.
    Abstract     Related articles   

  433. ECKE TH, Otto T
    Illumination of a Vision 2020-Urinary Based Biomarkers for Bladder Cancer on the Way to Clinical Decisions-Dream or Nightmare?
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  434. LIU N, Leng M, Yue T, Dong L, et al
    Simultaneously Quantifying Both Young's Modulus and Specific Membrane Capacitance of Bladder Cancer Cells with Different Metastatic Potential.
    Micromachines (Basel). 2020;11.
    Abstract     Related articles   

  435. GOONEWARDENA SAS, Jayarajah U, de Silva MVC, Kuruppu SN, et al
    Bladder cancer in women: a Sri Lankan study
    Ceylon Med J. 2019;64:98-102.
    Abstract     Related articles   

  436. SCHROECK FR, St Ivany A, Lowrance W, Makarov DV, et al
    Patient Perspectives on the Implementation of Risk-Aligned Bladder Cancer Surveillance: Systematic Evaluation Using the Tailored Implementation for Chronic Diseases Framework.
    JCO Oncol Pract. 2020 Mar 2:JOP1900576. doi: 10.1200/JOP.19.00576.
    Abstract     Related articles   

  437. WU J, Wang M, Chen H, Xu J, et al
    The Rare Variant rs35356162 in UHRF1BP1 Increases Bladder Cancer Risk in Han Chinese Population.
    Front Oncol. 2020;10:134.
    Abstract     Related articles   

  438. ZHU S, Yu W, Yang X, Wu C, et al
    Traditional Classification and Novel Subtyping Systems for Bladder Cancer.
    Front Oncol. 2020;10:102.
    Abstract     Related articles   

  439. LIU K, Zhu J, Song YX, Wang X, et al
    Thermal Intravesical Chemotherapy Reduce Recurrence Rate for Non-muscle Invasive Bladder Cancer Patients: A Meta-Analysis.
    Front Oncol. 2020;10:29.
    Abstract     Related articles   

  440. QIU H, Hu X, He C, Yu B, et al
    Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes.
    Front Genet. 2020;11:12.
    Abstract     Related articles   

  441. JIN H, Ma J, Xu J, Li H, et al
    Oncogenic role of MIR516A in human bladder cancer was mediated by its attenuating PHLPP2 expression and BECN1-dependent autophagy.
    Autophagy. 2020 Mar 1:1-15. doi: 10.1080/15548627.2020.1733262.
    Abstract     Related articles   

  442. ZHANG M, Du H, Wang L, Yue Y, et al
    Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt/beta-catenin signaling pathway.
    Chem Biol Interact. 2020;320:109022.
    Abstract     Related articles   

  443. CAGLIC I, Panebianco V, Vargas HA, Bura V, et al
    MRI of Bladder Cancer: Local and Nodal Staging.
    J Magn Reson Imaging. 2020 Feb 29. doi: 10.1002/jmri.27090.
    Abstract     Related articles   

    Bladder Cancer: Advances and Innovations.
    Eur Urol Focus. 2020 Feb 25. pii: S2405-4569(20)30069.
    Abstract     Related articles   

  445. DAZA J, Charap A, Wiklund PN, Sfakianos JP, et al
    Role of the Innate Immune System in the Development, Progression, and Therapeutic Response of Bladder Cancer.
    Eur Urol Focus. 2020 Feb 25. pii: S2405-4569(20)30070.
    Abstract     Related articles   

  446. WANG Y, Li Q, Wang J, Tong M, et al
    Small cell carcinoma of the bladder: the characteristics of molecular alterations, treatment, and follow-up.
    Med Oncol. 2019;36:98.
    Abstract     Related articles   

  447. JENA R, Sureka SK, Ruidas S, Lal H, et al
    Spontaneous renoalimentary fistula as a complication of upper tract urothelial carcinoma: unknown complication of a rare disease.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  448. SUN J, Wang C, Wang D, Wu J, et al
    Follicular dendritic cell sarcoma (FDCS) of urinary bladder with coexisting urothelial carcinoma-a case report.
    BMC Urol. 2019;19:83.
    Abstract     Related articles   

  449. MOLDAN MM, Stewart TM, Kor TM, Brown MJ, et al
    Bilateral Cavernous Sinus Syndrome, Pituitary Macroadenoma, and Postoperative Loss of Vision: A Case Report.
    A A Pract. 2019;13:350-351.
    Abstract     Related articles   

  450. SHARMA A, Frohlich H, Zhang R, Ebert AK, et al
    Classic bladder exstrophy and adenocarcinoma of the bladder: Methylome analysis provide no evidence for underlying disease-mechanisms of this association.
    Cancer Genet. 2019;235-236:18-20.
    Abstract     Related articles   

  451. CULIG Z
    Centrosomal Proteins in Urothelial Tumors: New Pathways in Disease Pathogenesis.
    Am J Pathol. 2019;189:1178-1179.
    Abstract     Related articles   

  452. AUDENET F, Attalla K, Giordano M, Pfail J, et al
    Prospective implementation of a nonopioid protocol for patients undergoing robot-assisted radical cystectomy with extracorporeal urinary diversion.
    Urol Oncol. 2019;37:300.
    Abstract     Related articles   

  453. MATULEWICZ RS, Demzik AL, DeLancey JO, Popescu O, et al
    Disparities in the diagnostic evaluation of microhematuriaand implications for the detection of urologic malignancy.
    Urol Oncol. 2019;37:300.
    Abstract     Related articles   

  454. LEE YE, Chan TC, Tian YF, Liang PI, et al
    High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
    Urol Oncol. 2019;37:299.
    Abstract     Related articles   

  455. BURGESS EF, Livasy C, Hartman A, Robinson MM, et al
    Discordance of high PD-L1 expression in primary and metastatic urothelial carcinoma lesions.
    Urol Oncol. 2019;37:299.
    Abstract     Related articles   

  456. MAISH WN, Nguyen LK, Ngu C, Bennett G, et al
    Metastatic Urachus Neoplasia: A Case Report and Review of the Current Literature.
    Clin Genitourin Cancer. 2019;17:e377-e382.
    Abstract     Related articles   

  457. JALANKO T, de Jong JJ, Gibb EA, Seiler R, et al
    Genomic Subtyping in Bladder Cancer.
    Curr Urol Rep. 2020;21:9.
    Abstract     Related articles   

  458. AMIN HAA, Kobaisi MH, Samir RM
    Schistosomiasis and Bladder Cancer in Egypt: Truths and Myths.
    Open Access Maced J Med Sci. 2019;7:4023-4029.
    Abstract     Related articles   

  459. FAHMY UA, Fahmy O
    In vitro evaluation of cytotoxic properties of 5-Aminolevulinic acid (5-ALA) on bladder cancer cells.
    Photodiagnosis Photodyn Ther. 2020 Mar 9:101714.
    Abstract     Related articles   

  460. MIRON B, Hoffman-Censits JH, Anari F, O'Neill J, et al
    Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2020 Mar 10. pii: S2588-9311(20)30028.
    Abstract     Related articles   

  461. ZHOU X, Zhai Y, Liu C, Yang G, et al
    Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin alpha5beta1 interaction and Akt signaling pathway.
    Cell Commun Signal. 2020;18:44.
    Abstract     Related articles   

  462. ILIOU A, Panagiotakis A, Giannopoulou AF, Benaki D, et al
    Malignancy Grade-Dependent Mapping of Metabolic Landscapes in Human Urothelial Bladder Cancer: Identification of Novel, Diagnostic, and Druggable Biomarkers.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  463. WETTSTEIN MS, Naimark D, Hermanns T, Herrera-Caceres JO, et al
    Required efficacy for novel therapies in BCG-unresponsive non-muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes?
    Cancer Med. 2020 Mar 12. doi: 10.1002/cam4.2980.
    Abstract     Related articles   

  464. FRAGKOULIS C, Glykas I, Papadopoulos G, Ntoumas K, et al
    Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Br J Radiol. 2020 Mar 11:20200025. doi: 10.1259/bjr.20200025.
    Abstract     Related articles   

  465. ISHIDA M, Ohno N, Sato H, Kitajima T, et al
    [Neoadjuvant Proton Beam Chemoradiotherapy for Locally Advanced Gall Bladder Cancer-A Case Report].
    Gan To Kagaku Ryoho. 2019;46:1975-1977.
    Abstract     Related articles   

  466. EL-GAMAL R, Mokhtar N, Ali-El-Dein B, Baiomy AA, et al
    Netrin-1: A new promising diagnostic marker for muscle invasion in bladder cancer.
    Urol Oncol. 2020 Mar 7. pii: S1078-1439(20)30047.
    Abstract     Related articles   

  467. GEAVLETE BF, Ene CV, Balan GX, Bulai CA, et al
    Bipolar en Bloc Resection - Is it the Future in Non-Muscle Invasive Bladder Cancer?
    Chirurgia (Bucur). 2020;115:89-94.
    Abstract     Related articles   

  468. TAARNHOJ GA, Johansen C, Lindberg H, Basch E, et al
    Patient reported symptoms associated with quality of life during chemo- or immunotherapy for bladder cancer patients with advanced disease.
    Cancer Med. 2020 Mar 10. doi: 10.1002/cam4.2958.
    Abstract     Related articles   

  469. YANG Y, Wang X, Bai Y, Feng D, et al
    Programmed death-ligand 2 (PD-L2) expression in bladder cancer.
    Urol Oncol. 2020 Mar 6. pii: S1078-1439(20)30002.
    Abstract     Related articles   

  470. KUMAR R, Kumar R, Tanwar P, Rath GK, et al
    Deciphering the impact of missense mutations on structure and dynamics of SMAD4 protein involved in pathogenesis of gall bladder cancer.
    J Biomol Struct Dyn. 2020 Mar 10:1-27. doi: 10.1080/07391102.2020.1740789.
    Abstract     Related articles   

  471. PENG J, Jiang H, Guo J, Huang J, et al
    CD147 Expression Is Associated with Tumor Proliferation in Bladder Cancer via GSDMD.
    Biomed Res Int. 2020;2020:7638975.
    Abstract     Related articles   

  472. ZHANG Z, Chen D, Li Z, Liu Z, et al
    Bioinformatics Analysis to Screen the Key Prognostic Genes in Tumor Microenvironment of Bladder Cancer.
    Biomed Res Int. 2020;2020:6034670.
    Abstract     Related articles   

  473. SHI C, Sun L, Liu S, Zhang E, et al
    Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway.
    Med Sci Monit. 2020;26:e921087.
    Abstract     Related articles   

  474. LANGLE YV, Balarino NP, Belgorosky D, Cresta Morgado PD, et al
    Effect of nitric oxide inhibition in Bacillus Calmette-Guerin bladder cancer treatment.
    Nitric Oxide. 2020 Mar 5. pii: S1089-8603(20)30004.
    Abstract     Related articles   

  475. EULITT PJ, Altun E, Sheikh A, Wong TZ, et al
    Pilot Study of [(18)F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC).
    Clin Genitourin Cancer. 2020 Mar 5. pii: S1558-7673(20)30042.
    Abstract     Related articles   

  476. XU QH, Yuan Q, Zhang YQ, Li B, et al
    Ocular Metastasis in Elderly Male Bladder Cancer Patients: Potential Risk Factors.
    Am J Mens Health. 2020;14:1557988320908998.
    Abstract     Related articles   

  477. HECK MM, Koll FJ, Retz M, Autenrieth M, et al
    Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection.
    Urol Oncol. 2020 Mar 4. pii: S1078-1439(20)30040.
    Abstract     Related articles   

  478. MAHENDRA I, Hanaoka H, Yamaguchi A, Amartuvshin T, et al
    Diagnosis of bladder cancer using (18)F-labeled alpha-methyl-phenylalanine tracers in a mouse model.
    Ann Nucl Med. 2020 Mar 6. pii: 10.1007/s12149-020-01452.
    Abstract     Related articles   

  479. BANDINI M, Pederzoli F, Madison R, Briganti A, et al
    Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study.
    Clin Genitourin Cancer. 2020 Feb 8. pii: S1558-7673(20)30033.
    Abstract     Related articles   

  480. COX E, Saramago P, Kelly J, Porta N, et al
    Effects of Bladder Cancer on UK Healthcare Costs and Patient Health-Related Quality of Life: Evidence From the BOXIT Trial.
    Clin Genitourin Cancer. 2019 Dec 14. pii: S1558-7673(19)30377.
    Abstract     Related articles   

  481. MARTIN JW, Jefferson FA, Huang M, Sung JM, et al
    A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival.
    Clin Genitourin Cancer. 2020 Jan 16. pii: S1558-7673(20)30011.
    Abstract     Related articles   

  482. OSSICK MV, Ferrari KL, Nunes-Silva I, Denardi F, et al
    Chorioallantoic urothelial tumor avatar. A clinical tool for phenotype-based therapy.
    Acta Cir Bras. 2020;34:e201901207.
    Abstract     Related articles   

  483. DE JONG JJ, Zwarthoff EC
    Molecular and clinical heterogeneity within the luminal subtype.
    Nat Rev Urol. 2020;17:69-70.
    Abstract     Related articles   

  484. WEN Y, Chen Y, Duan X, Zhu W, et al
    The clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis.
    Clin Exp Med. 2019;19:407-416.
    Abstract     Related articles   

  485. LI X, Dong P, Wei W, Jiang L, et al
    Overexpression of CEP72 Promotes Bladder Urothelial Carcinoma Cell Aggressiveness via Epigenetic CREB-Mediated Induction of SERPINE1.
    Am J Pathol. 2019;189:1284-1297.
    Abstract     Related articles   

  486. TAKAI M, Kato D, Iinuma K, Maekawa YM, et al
    Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report.
    Urol Case Rep. 2020;31:101145.
    Abstract     Related articles   

  487. LIU D, Qiu X, Xiong X, Chen X, et al
    Current updates on the role of reactive oxygen species in bladder cancer pathogenesis and therapeutics.
    Clin Transl Oncol. 2020 Mar 18. pii: 10.1007/s12094-020-02330.
    Abstract     Related articles   

  488. ZHOU W, Wang W, Wu W, Yan T, et al
    Can a second resection be avoided after initial thulium laser endoscopic en bloc resection for non-muscle invasive bladder cancer? A retrospective single-center study of 251 patients.
    BMC Urol. 2020;20:30.
    Abstract     Related articles   

  489. KALAN FARMANFARMA K, Mahdavifar N, Salehiniya H
    Bladder Cancer in Iran: An Epidemiological Review.
    Res Rep Urol. 2020;12:91-103.
    Abstract     Related articles   

  490. QIAO Z, Dai H, Zhang Y, Li Q, et al
    LncRNA NCK1-AS1 Promotes Cancer Cell Proliferation and Increase Cell Stemness in Urinary Bladder Cancer Patients by Downregulating miR-143.
    Cancer Manag Res. 2020;12:1661-1668.
    Abstract     Related articles   

  491. ZHANG T, Du E, Liu Y, Cheng J, et al
    Anticancer Effects of Zinc Oxide Nanoparticles Through Altering the Methylation Status of Histone on Bladder Cancer Cells.
    Int J Nanomedicine. 2020;15:1457-1468.
    Abstract     Related articles   

  492. FUKUOKAYA W, Kimura T, Miki J, Kimura S, et al
    Red cell distribution width predicts time to recurrence in patients with primary non-muscle-invasive bladder cancer and improves the accuracy of the EORTC scoring system.
    Urol Oncol. 2020 Mar 14. pii: S1078-1439(20)30036.
    Abstract     Related articles   

  493. SAGINALA K, Barsouk A, Aluru JS, Rawla P, et al
    Epidemiology of Bladder Cancer.
    Med Sci (Basel). 2020;8.
    Abstract     Related articles   

  494. LIANG H, Huang H, Li Y, Lu Y, et al
    CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486-3p/FOXP4 axis.
    Biosci Rep. 2020 Mar 17. pii: 222397. doi: 10.1042/BSR20193484.
    Abstract     Related articles   

  495. NAZARI A, Ahmadi Z, Hassanshahi G, Abbasifard M, et al
    Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review.
    Oman Med J. 2020;35:e103.
    Abstract     Related articles   

  496. HU C, Jiang D, Wu M, Wang J, et al
    Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of VEGFR2-targeted CD-TK-loaded cationic nanobubbles in the treatment of bladder cancer.
    J Cancer Res Clin Oncol. 2020 Mar 16. pii: 10.1007/s00432-020-03160.
    Abstract     Related articles   

  497. MATSUMOTO K, Murakami Y, Shimizu Y, Hirayama T, et al
    Electronic nose to distinguish bladder cancer by urinary odour feature: A pilot study.
    Cancer Biomark. 2020 Feb 28. pii: CBM190466. doi: 10.3233/CBM-190466.
    Abstract     Related articles   

  498. JIN L, Yuan F, Dai G, Yao Q, et al
    Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells.
    Cell Mol Biol Lett. 2020;25:17.
    Abstract     Related articles   

  499. FERRO M, Katalin MO, Buonerba C, Marian R, et al
    Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guerin after transurethral resection of the bladder tumor.
    Urol Oncol. 2020 Mar 12. pii: S1078-1439(20)30057.
    Abstract     Related articles   

  500. YIN L, Liu Y, Jing H, Yu H, et al
    Corrigendum to "TIS11D can affect bladder cancer cells by regulating epithelial-mesenchymal transition" [Life Sci. 235 (2019) 116832].
    Life Sci. 2020 Mar 12:117516. doi: 10.1016/j.lfs.2020.117516.
    Abstract     Related articles   

  501. SEIDL C
    Targets for Therapy of Bladder Cancer.
    Semin Nucl Med. 2020;50:162-170.
    Abstract     Related articles   

  502. LI X, Shang D, Shen H, Song J, et al
    ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes.
    Biomed Pharmacother. 2020;126:110066.
    Abstract     Related articles   

  503. KRAJEWSKI W, Poletajew S, Zdrojowy R, Kolodziej A, et al
    Complications after BCG immunotherapy - neither a mountain nor a molehill.
    Scand J Urol. 2019;53:265-266.
    Abstract     Related articles   

  504. KHANDELWAL M, Anand V, Appunni S, Seth A, et al
    RASSF1A-Hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic target.
    Mol Cell Biochem. 2020;464.
    Abstract     Related articles   

  505. YANG Y, Bai Y, Wang X, Tang Y, et al
    Internal double-J stent was associated with a lower incidence of ureteroileal anastomosis stricture than external ureteral catheter for patients undergoing radical cystectomy and orthotopic neobladder: A systematic review and meta-analysis.
    Int J Surg. 2019;72:80-84.
    Abstract     Related articles   

  506. KUMAR L, Narwal A, Kumar M, Kaushal S, et al
    Primary clear-cell urothelial carcinoma of urinary bladder: a not-so-clear entity with review of literature.
    BMJ Case Rep. 2019;12.
    Abstract     Related articles   

  507. STABILE A, Muttin F, Zamboni S, Moschini M, et al
    Therapeutic approaches for lymph node involvement in prostate, bladder and kidney cancer.
    Expert Rev Anticancer Ther. 2019;19:739-755.
    Abstract     Related articles   

  508. VICUNA L, Fernandez MI, Vial C, Valdebenito P, et al
    Adaptation to Extreme Environments in an Admixed Human Population from the Atacama Desert.
    Genome Biol Evol. 2019;11:2468-2479.
    Abstract     Related articles   

  509. BOCCI F, Tripathi SC, Vilchez Mercedes SA, George JT, et al
    NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype.
    Integr Biol (Camb). 2019;11:251-263.
    Abstract     Related articles   

  510. HAREMZA C, Baert M, Pascual C, Biet-Hornstein A, et al
    Head and neck squamous cell carcinoma and metachronous second primaries.
    Eur Ann Otorhinolaryngol Head Neck Dis. 2019;136:367-372.
    Abstract     Related articles   

  511. FERRERO VT, Oset MM, Masferrer JP, Pardo EH, et al
    Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy.
    Clin Transl Oncol. 2019;21:1707-1711.
    Abstract     Related articles   

  512. LU H, Male M, Jiang K, Ye Z, et al
    Clinical significance of functional and anatomical classifications in paraganglioma of the urinary bladder.
    Urol Oncol. 2019;37:354.
    Abstract     Related articles   

  513. FEUERSTEIN MA, Goldstein L, Reaves B, Sun A, et al
    Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy.
    World J Urol. 2019;37:2401-2407.
    Abstract     Related articles   

  514. JANISCH F, D'Andrea D, Iwata T, Kimura S, et al
    The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC).
    Urol Oncol. 2020 Mar 21. pii: S1078-1439(20)30043.
    Abstract     Related articles   

  515. GONG P, Xu R, Zhuang Q, He X, et al
    A novel circular RNA (hsa_circRNA_102336), a plausible biomarker, promotes the tumorigenesis by sponging miR-515-5p in human bladder cancer.
    Biomed Pharmacother. 2020;126:110059.
    Abstract     Related articles   

  516. GOTO T, Miyamoto H
    Why has the prognosis for muscle-invasive bladder cancer not significantly improved after decades of therapeutic advancements?
    Expert Rev Anticancer Ther. 2020 Mar 24:1-3. doi: 10.1080/14737140.2020.1744437.
    Abstract     Related articles   

  517. ADAMCZYK P, Juszczak K, Kadlubowski M, Ostrowski A, et al
    Can laparoscopic cystectomy become the method of choice in the treatment of invasive urothelial urinary bladder cancer?
    Adv Clin Exp Med. 2020 Mar 24. doi: 10.17219/acem/115084.
    Abstract     Related articles   

  518. CHEN W, Jiang T, Mao H, Gao R, et al
    SNHG16 regulates invasion and migration of bladder cancer through induction of epithelial-to-mesenchymal transition.
    Hum Cell. 2020 Mar 24. pii: 10.1007/s13577-020-00343.
    Abstract     Related articles   

  519. DE JONG JJ, Boormans JL, van Rhijn BWG, Seiler R, et al
    Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences.
    Eur Urol Oncol. 2020 Mar 20. pii: S2588-9311(20)30035.
    Abstract     Related articles   

  520. ALBAN L, Monteiro WF, Diz FM, Miranda GM, et al
    New quercetin-coated titanate nanotubes and their radiosensitization effect on human bladder cancer.
    Mater Sci Eng C Mater Biol Appl. 2020;110:110662.
    Abstract     Related articles   

  521. MORALES-BARRERA R, Suarez C, Gonzalez M, Valverde C, et al
    The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor.
    Cancer Treat Rev. 2020;86:102000.
    Abstract     Related articles   

  522. LUO J, Shivappa N, Hebert JR, Xu X, et al
    Dietary inflammatory index and bladder cancer risk: a prospective study.
    Eur J Clin Nutr. 2020 Mar 19. pii: 10.1038/s41430-020-0602.
    Abstract     Related articles   

  523. WU H, Zhang X, Han D, Cao J, et al
    Tumour-associated macrophages mediate the invasion and metastasis of bladder cancer cells through CXCL8.
    PeerJ. 2020;8:e8721.
    Abstract     Related articles   

  524. FU G, Xu Z, Chen X, Pan H, et al
    CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation.
    J Cancer. 2020;11:2408-2420.
    Abstract     Related articles   

  525. KAMAT AM, Lerner SP, O'Donnell M, Georgieva MV, et al
    Evidence-based Assessment of Current and Emerging Bladder-sparing Therapies for Non-muscle-invasive Bladder Cancer After Bacillus Calmette-Guerin Therapy: A Systematic Review and Meta-analysis.
    Eur Urol Oncol. 2020 Mar 19. pii: S2588-9311(20)30031.
    Abstract     Related articles   

  526. RUPLIN AT, Spengler AMZ, Montgomery RB, Wright JL, et al
    Downstaging of Muscle-Invasive Bladder Cancer Using Neoadjuvant Gemcitabine and Cisplatin or Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin as Single Regimens or as Switch Therapy Modalities.
    Clin Genitourin Cancer. 2020 Feb 22. pii: S1558-7673(20)30044.
    Abstract     Related articles   

  527. FUJITA N, Hatakeyama S, Momota M, Tobisawa Y, et al
    Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
    Urol Oncol. 2020 Mar 20. pii: S1078-1439(20)30042.
    Abstract     Related articles   

  528. TAKEYAMA Y, Kato M, Tamada S, Azuma Y, et al
    Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer.
    Cancer Lett. 2020 Mar 18. pii: S0304-3835(20)30132.
    Abstract     Related articles   

  529. WOO S, Panebianco V, Narumi Y, Del Giudice F, et al
    Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Eur Urol Oncol. 2020 Mar 18. pii: S2588-9311(20)30032.
    Abstract     Related articles   

  530. BENDERSKA-SODER N, Hovanec J, Pesch B, Goebell PJ, et al
    Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial.
    Urol Oncol. 2020 Mar 18. pii: S1078-1439(20)30007.
    Abstract     Related articles   

  531. WANG Y, Ma DL, Yu CH, Sha KF, et al
    MicroRNA-370 suppresses SOX12 transcription and acts as a tumor suppressor in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2020;24:2303-2312.
    Abstract     Related articles   

  532. XIE F, Zhao N, Zhang H, Xie D, et al
    Circular RNA CircHIPK3 Promotes Gemcitabine Sensitivity in Bladder Cancer.
    J Cancer. 2020;11:1907-1912.
    Abstract     Related articles   

  533. BORGNA V, Lobos-Gonzalez L, Guevara F, Landerer E, et al
    Targeting antisense mitochondrial noncoding RNAs induces bladder cancer cell death and inhibition of tumor growth through reduction of survival and invasion factors.
    J Cancer. 2020;11:1780-1791.
    Abstract     Related articles   

  534. YAN X, Fu X, Guo ZX, Liu XP, et al
    Construction and validation of an eight-gene signature with great prognostic value in bladder cancer.
    J Cancer. 2020;11:1768-1779.
    Abstract     Related articles   

  535. XIONG T, Huang C, Li J, Yu S, et al
    LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer.
    J Cancer. 2020;11:1751-1760.
    Abstract     Related articles   

  536. WANG Z, Gao W, Li J, Wang T, et al
    Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-Muscle Invasive Bladder Cancer in the Han Chinese Population.
    J Cancer. 2020;11:1668-1678.
    Abstract     Related articles   

  537. YUAN S, Luan X, Chen H, Shi X, et al
    Long non-coding RNA EGFR-AS1 sponges micorRNA-381 to upregulate ROCK2 in bladder cancer.
    Oncol Lett. 2020;19:1899-1905.
    Abstract     Related articles   

  538. WANG X, Meng R, Hu QM
    LINC00319-Mediated miR-3127 Repression Enhances Bladder Cancer Progression Through Upregulation of RAP2A.
    Front Genet. 2020;11:180.
    Abstract     Related articles   

  539. WEI X, Wang B, Wang Q, Yang X, et al
    MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI.
    Front Pharmacol. 2020;11:164.
    Abstract     Related articles   

  540. LI Y, Hendryx MS, Xun P, He K, et al
    The association between type 2 diabetes mellitus and bladder cancer risk among postmenopausal women.
    Cancer Causes Control. 2020 Mar 19. pii: 10.1007/s10552-020-01294.
    Abstract     Related articles   

  541. BJURLIN MA, Matulewicz RS, Roberts TR, Dearing BA, et al
    Carcinogen Biomarkers in the Urine of Electronic Cigarette Users and Implications for the Development of Bladder Cancer: A Systematic Review.
    Eur Urol Oncol. 2020 Mar 7. pii: S2588-9311(20)30029.
    Abstract     Related articles   

  542. OZCAN Y, Caglar F, Celik S, Demir AB, et al
    The role of cancer stem cells in immunotherapy for bladder cancer: An in vitro study.
    Urol Oncol. 2020 Mar 16. pii: S1078-1439(20)30062.
    Abstract     Related articles   

  543. MICHEL C, Robertson HL, Camargo J, Hamilton-Reeves JM, et al
    Nutrition risk and assessment process in patients with bladder cancer undergoing radical cystectomy.
    Urol Oncol. 2020 Mar 16. pii: S1078-1439(20)30060.
    Abstract     Related articles   

  544. ZHANG J, Zhou X, Ding H, Wang L, et al
    The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer.
    BMC Urol. 2020;20:31.
    Abstract     Related articles   

  545. YANAGIHARA Y, Nishida K, Watanabe R, Koyama K, et al
    Feasibility of Laparoscopic Radical Cystectomy in Elderly Patients: A Comparative Analysis of Clinical Outcomes in a Single Institution.
    Acta Med Okayama. 2019;73:417-418.
    Abstract     Related articles   

  546. BRASSETTI A, Tuderti G, Anceschi U, Ferriero M, et al
    Combined reporting of surgical quality, cancer control and functional outcomes of robot-assisted radical cystectomy with intracorporeal orthotopic neobladder into a novel trifecta.
    Minerva Urol Nefrol. 2019;71:590-596.
    Abstract     Related articles   

  547. ALBISINNI S, Veccia A, Aoun F, Diamand R, et al
    A systematic review and meta-analysis comparing the outcomes of open and robotic assisted radical cystectomy.
    Minerva Urol Nefrol. 2019;71:553-568.
    Abstract     Related articles   

  548. BOUHAJJA L, Farah F, Garbouj N, Rammeh S, et al
    Primary signet-ring cell carcinoma of the urinary bladder: A report of two cases.
    Tunis Med. 2019;97:167-169.
    Abstract     Related articles   

  549. COOK T, Ma Y, Gamagedara S
    Evaluation of statistical techniques to normalize mass spectrometry-based urinary metabolomics data.
    J Pharm Biomed Anal. 2020;177:112854.
    Abstract     Related articles   

  550. LIN P, Wen DY, Chen L, Li X, et al
    A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma.
    Eur Radiol. 2020;30:547-557.
    Abstract     Related articles   

  551. TOLWIN Y, Gillis R, Agmon IN, Shrem NS, et al
    Increased Incidence of Lung Cancer Among Patients With Superficial Transitional Cell Carcinoma: A Potential Risk Cohort for Lung Cancer Screening.
    Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30152.
    Abstract     Related articles   

  552. GELWAN E, Zhang ML, Allison DB, Cowan ML, et al
    Variability among observers utilizing the CellSolutions BestCyte Cell Sorter imaging system for the assessment of urinary tract cytology specimens.
    J Am Soc Cytopathol. 2019;8:18-26.
    Abstract     Related articles   

  553. XU X, Liu K, Jiao B, Luo K, et al
    Mucoadhesive nanoparticles based on ROS activated gambogic acid prodrug for safe and efficient intravesical instillation chemotherapy of bladder cancer.
    J Control Release. 2020 Mar 31. pii: S0168-3659(20)30180.
    Abstract     Related articles   

  554. LUO C, Huang B, Wu Y, Chen J, et al
    Use of Vesical Imaging-Reporting and Data System (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis.
    Eur Radiol. 2020 Apr 2. pii: 10.1007/s00330-020-06802.
    Abstract     Related articles   

  555. SCHULZ WA, Hoffmann MJ, Niegisch G, Fussel S, et al
    [Report from the 9th symposium of the German Association for Bladder Cancer Research].
    Urologe A. 2020 Apr 2. pii: 10.1007/s00120-020-01181.
    Abstract     Related articles   

  556. PEREIRA GLDC, Almeida TC, Seibert JB, Amparo TR, et al
    Antitumor effect of Cymbopogon densiflorus (Linneu) essential oil in bladder cancer cells.
    Nat Prod Res. 2020 Apr 2:1-5. doi: 10.1080/14786419.2020.1747453.
    Abstract     Related articles   

  557. PENG Y, Chen Y, Chen S, Wang J, et al
    JUND-dependent upregulation of HMOX1 is associated with cisplatin resistance in muscle-invasive bladder cancer.
    J Biochem. 2020 Apr 2. pii: 5815268. doi: 10.1093.
    Abstract     Related articles   

  558. SEMENIUK-WOJTAS A, Lubas A, Cierniak S, Brzoskowska U, et al
    Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer.
    J Cancer Res Clin Oncol. 2020 Apr 1. pii: 10.1007/s00432-020-03202.
    Abstract     Related articles   

  559. LV J, Zhu Y, Ji A, Zhang Q, et al
    Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.
    Biosci Rep. 2020 Apr 2. pii: 222532. doi: 10.1042/BSR20194337.
    Abstract     Related articles   

  560. MEEKS JJ, Al-Ahmadie H, Faltas BM, Taylor JA 3rd, et al
    Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.
    Nat Rev Urol. 2020 Mar 31. pii: 10.1038/s41585-020-0304.
    Abstract     Related articles   

  561. JIANG J, Bi Y, Liu XP, Yu D, et al
    To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
    J Cell Mol Med. 2020 Mar 31. doi: 10.1111/jcmm.15193.
    Abstract     Related articles   

  562. MIYAKE M, Matsuyama H, Teramukai S, Kinoshita F, et al
    A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables.
    Int J Clin Oncol. 2020 Mar 30. pii: 10.1007/s10147-020-01654.
    Abstract     Related articles   

  563. ABBASTABAR M, Sarfi M, Golestani A, Karimi A, et al
    Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer.
    EXCLI J. 2020;19:301-310.
    Abstract     Related articles   

  564. FANG W, Yang ZY, Chen TY, Shen XF, et al
    Ethnicity and survival in bladder cancer: a population-based study based on the SEER database.
    J Transl Med. 2020;18:145.
    Abstract     Related articles   

  565. WEI X, Bian F, Cai X, Wang Y, et al
    Multiplexed Detection Strategy for Bladder Cancer MicroRNAs Based on Photonic Crystal Barcodes.
    Anal Chem. 2020 Mar 31. doi: 10.1021/acs.analchem.0c00630.
    Abstract     Related articles   

  566. HARSHA BS, Manikandan R, Sreerag KS, Dorairajan LN, et al
    Eosinophilic Leukemoid Reaction with Eosinophilic Tumor Tissue Infiltration as an Extermely Poor Prognostic Factor in Urinary Bladder Cancer- a Known Entity Revisited.
    Pathol Oncol Res. 2020 Mar 29. pii: 10.1007/s12253-020-00807.
    Abstract     Related articles   

  567. TAO W, Sun C, Yao Q, Fu K, et al
    The clinical study of en Bloc transurethral resection with 980 nm Laser for treatment of primary non-muscle invasive bladder cancer.
    J Xray Sci Technol. 2020 Mar 21. pii: XST190616. doi: 10.3233/XST-190616.
    Abstract     Related articles   

  568. CHO JM, Moon KT, Lee HJ, Shin SC, et al
    Nucleobindin 2 expression is an independent prognostic factor for bladder cancer.
    Medicine (Baltimore). 2020;99:e19597.
    Abstract     Related articles   

  569. YANG Y, Jain RK, Glenn ST, Xu B, et al
    Complete response to anti-PD-L1 antibody in a metastatic bladder cancer associated with novel MSH4 mutation and microsatellite instability.
    J Immunother Cancer. 2020;8.
    Abstract     Related articles   

  570. HONG SB, Lee NK, Kim S, Son IW, et al
    Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer.
    J Magn Reson Imaging. 2020 Mar 27. doi: 10.1002/jmri.27141.
    Abstract     Related articles   

  571. TESCH ME, Pater JA, Vandekerkhove G, Wang G, et al
    Concurrent germline and somatic pathogenic BAP1 variants in a patient with metastatic bladder cancer.
    NPJ Genom Med. 2020;5:12.
    Abstract     Related articles   

  572. ZHU Z, Chang F, Liu J, Wang J, et al
    Comprehensive circular RNA profiling reveals the regulatory role of circ_100242/miR-145 pathway in bladder cancer.
    Oncol Lett. 2020;19:2971-2978.
    Abstract     Related articles   

  573. WU Z, Zhu K, Liu Q, Liu Y, et al
    Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis.
    Int J Med Sci. 2020;17:762-772.
    Abstract     Related articles   

  574. JOBCZYK M, Stawiski K, Fendler W, Rozanski W, et al
    Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non-muscle-invasive bladder cancer (NMIBC): A cohort analysis.
    Cancer Med. 2020 Mar 26. doi: 10.1002/cam4.3007.
    Abstract     Related articles   

  575. ZIARAN S, Harsanyi S, Bevizova K, Varchulova Novakova Z, et al
    Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence.
    Eur J Histochem. 2020;64.
    Abstract     Related articles   

  576. RKMAN D, Likic R, Bebek M, Gnjidic M, et al
    Skin autoimmunity might be associated with increased efficacy of atezolizumab in metastatic urothelial carcinoma: a case report.
    Croat Med J. 2019;60:552-555.
    Abstract     Related articles   

  577. SAMADDAR S, Mazur J, Boehm D, Thompson DH, et al
    Development And In Vitro Characterization Of Bladder Tumor Cell Targeted Lipid-Coated Polyplex For Dual Delivery Of Plasmids And Small Molecules.
    Int J Nanomedicine. 2019;14:9547-9561.
    Abstract     Related articles   

  578. GRIVAS P, DerSarkissian M, Shenolikar R, Laliberte F, et al
    Healthcare resource utilization and costs of adverse events among patients with metastatic urothelial cancer in USA.
    Future Oncol. 2019;15:3809-3818.
    Abstract     Related articles   

  579. NAGUMO Y, Kojima T, Shiga M, Kandori S, et al
    A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma.
    Int J Clin Oncol. 2020;25:354-361.
    Abstract     Related articles   

  580. LIU Y, Huang J, Urbanowicz RJ, Chen K, et al
    Embracing study heterogeneity for finding genetic interactions in large-scale research consortia.
    Genet Epidemiol. 2020;44:52-66.
    Abstract     Related articles   

  581. LIU L, Zhao Y, Cui J, Chen S, et al
    Evaluation of platelet distribution width as a diagnostic and prognostic biomarker in bladder neoplasm.
    Future Oncol. 2019;15:3797-3807.
    Abstract     Related articles   

  582. RODRIGUEZ PENA MDC, Springer SU, Taheri D, Li L, et al
    Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology.
    Virchows Arch. 2020;476:423-429.
    Abstract     Related articles   

  583. MORET R, Hellmers L, Zhang X, Gills J, et al
    Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.
    J Vis Exp. 2019;.
    Abstract     Related articles   

  584. AKGUL M, MacLennan GT, Cheng L
    Distinct mutational landscape of inverted urothelial papilloma.
    J Pathol. 2019;249:3-5.
    Abstract     Related articles   

  585. KAO C, McNamara M, Alley C, Spector N, et al
    A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder.
    Clin Genitourin Cancer. 2019;17:e672-e677.
    Abstract     Related articles   

  586. MAKBOUL R, Hassan HM, Refaiy A, Abdelkawi IF, et al
    A Simple Immunohistochemical Panel Could Predict and Correlate to Clinicopathologic and Molecular Subgroups of Urinary Bladder Urothelial Carcinoma.
    Clin Genitourin Cancer. 2019;17:e712-e719.
    Abstract     Related articles   

  587. KOHADA Y, Goriki A, Yukihiro K, Ohara S, et al
    The risk factors of urinary tract infection after transurethral resection of bladder tumors.
    World J Urol. 2019 Mar 26. pii: 10.1007/s00345-019-02737.
    Abstract     Related articles   

  588. ZAMBONI S, Moschini M, Gallina A, Colombo R, et al
    The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy.
    World J Urol. 2019;37:2707-2714.
    Abstract     Related articles   

  589. YANG G, Zhang L, Liu M, Liu Q, et al
    CD163+ macrophages predict a poor prognosis in patients with primary T1 high-grade urothelial carcinoma of the bladder.
    World J Urol. 2019;37:2721-2726.
    Abstract     Related articles   

  590. LI R, Kukreja JEB, Seif MA, Petros FG, et al
    The role of metastatic burden in cytoreductive/consolidative radical cystectomy.
    World J Urol. 2019;37:2691-2698.
    Abstract     Related articles   

  591. LORA V, Haneke E, Scarabello A, Morrone A, et al
    Subungual metastasis: expanding the spectrum.
    J Eur Acad Dermatol Venereol. 2019;33:e282-e284.
    Abstract     Related articles   

  592. ALHALABI O, Rafei H, Shah A, Siefker-Radtke A, et al
    Targeting advanced urothelial carcinoma-developing strategies.
    Curr Opin Oncol. 2019;31:207-215.
    Abstract     Related articles   

  593. THAKER H, Ghodoussipour S, Saffarian M, Ashrafi A, et al
    Extended hospital stay after radical cystectomy with enhanced recovery protocol.
    Can J Urol. 2019;26:9654-9659.
    Abstract     Related articles   

  594. GRIMM T, Grimm J, Buchner A, Schulz G, et al
    Health-related quality of life after radical cystectomy and ileal orthotopic neobladder: effect of detailed continence outcomes.
    World J Urol. 2019;37:2385-2392.
    Abstract     Related articles   

  595. YUEN C, Reid P, Zhang Z, Soliven B, et al
    Facial Palsy Induced by Checkpoint Blockade: A Single Center Retrospective Study.
    J Immunother. 2019;42:94-96.
    Abstract     Related articles   

  596. STANGL-KREMSER J, D'Andrea D, Vartolomei M, Abufaraj M, et al
    Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder.
    Urol Oncol. 2019;37:372-379.
    Abstract     Related articles   

  597. QIU JG, Shi DY, Liu X, Zheng XX, et al
    Chromatin-regulatory genes served as potential therapeutic targets for patients with urothelial bladder carcinoma.
    J Cell Physiol. 2019;234:6976-6982.
    Abstract     Related articles   

  598. DIAO X, Cai J, Zheng J, Kong J, et al
    Association of chromosome 7 aneuploidy measured by fluorescence in situ hybridization assay with muscular invasion in bladder cancer.
    Cancer Commun (Lond). 2020 Apr 12. doi: 10.1002/cac2.12017.
    Abstract     Related articles   

  599. FUJITA N, Hatakeyama S, Momota M, Kido K, et al
    Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guerin in patients with high-risk non-muscle-invasive bladder cancer.
    Urol Oncol. 2020 Apr 9. pii: S1078-1439(20)30093.
    Abstract     Related articles   

  600. LIN YZ, Wu YP, Ke ZB, Cai H, et al
    Bioinformatics Analysis of the Expression of Key Long Intergenic Non-Protein Coding RNA Genes in Bladder Cancer.
    Med Sci Monit. 2020;26:e920504.
    Abstract     Related articles   

  601. CELIK S, Sari H, Ugur Mungan M, Yorukoglu K, et al
    Assessment of ex-vivo efficacy (oncogram) of immunotherapeutic and chemotherapeutic agents in bladder cancer: A pilot study of personalized treatment.
    J BUON. 2020;25:295-301.
    Abstract     Related articles   

  602. YE Z, Liang Z, Mi Q, Guo Y, et al
    Limonene terpenoid obstructs human bladder cancer cell (T24 cell line) growth by inducing cellular apoptosis, caspase activation, G2/M phase cell cycle arrest and stops cancer metastasis.
    J BUON. 2020;25:280-285.
    Abstract     Related articles   

  603. XU A, Yang GG, Zhang Y, Zhao ST, et al
    Heptaphylline suppresses the proliferation and migration of human bladder cancer cells via induction of intrinsic apoptosis, autophagy and inhibition of beta-catenin signalling pathway.
    J BUON. 2020;25:274-279.
    Abstract     Related articles   

  604. WANG Y, Liu Q, Men T, Liang Y, et al
    A microfluidic system based on the monoclonal antibody BCMab1 specifically captures circulating tumor cells from bladder cancer patients.
    J Biomater Sci Polym Ed. 2020 Apr 10:1-12. doi: 10.1080/09205063.2020.1748332.
    Abstract     Related articles   

  605. SALEH AA, Gohar SF, Hemida AS, Elgharbawy M, et al
    Evaluation of ASPM and TEF Gene Expressions as Potential Biomarkers for Bladder Cancer.
    Biochem Genet. 2020 Apr 9. pii: 10.1007/s10528-020-09962.
    Abstract     Related articles   

  606. WANG X, He H, Rui W, Xie X, et al
    Long Non-Coding RNA BCAR4 Binds to miR-644a and Targets TLX1 to Promote the Progression of Bladder Cancer.
    Onco Targets Ther. 2020;13:2483-2490.
    Abstract     Related articles   

  607. TSAI TF, Chen PC, Lin YC, Chou KY, et al
    Miconazole Contributes to NRF2 Activation by Noncanonical P62-KEAP1 Pathway in Bladder Cancer Cells.
    Drug Des Devel Ther. 2020;14:1209-1218.
    Abstract     Related articles   

  608. IYER G, Tully CM, Zabor EC, Bochner BH, et al
    Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience.
    Clin Genitourin Cancer. 2020 Mar 6. pii: S1558-7673(20)30048.
    Abstract     Related articles   

  609. ZHONG XL, Wang L, Yan X, Yang XK, et al
    MiR-20a acted as a ceRNA of lncRNA PTENPL and promoted bladder cancer cell proliferation and migration by regulating PDCD4.
    Eur Rev Med Pharmacol Sci. 2020;24:2955-2964.
    Abstract     Related articles   

  610. CUI YP, Xie M, Pan WX, Zhang ZY, et al
    HOXA10 promotes the development of bladder cancer through regulating FOSL1.
    Eur Rev Med Pharmacol Sci. 2020;24:2945-2954.
    Abstract     Related articles   

  611. KUNATH F
    [Robotic versus open radical cystectomy for adults with bladder cancer].
    Urologe A. 2020 Apr 8. pii: 10.1007/s00120-020-01185.
    Abstract     Related articles   

  612. GUO J, Zhang J, Yang T, Zhang W, et al
    MiR-22 suppresses the growth and metastasis of bladder cancer cells by targeting E2F3.
    Int J Clin Exp Pathol. 2020;13:587-596.
    Abstract     Related articles   

  613. [Consensus on standardized handling of specimen and pathological diagnosis of bladder cancer].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:305-310.
    Abstract     Related articles   

  614. MARIAPPAN P, Fineron P, O'Donnell M, Gailer RM, et al
    Combining two grading systems: the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-up.
    World J Urol. 2020 Apr 7. pii: 10.1007/s00345-020-03180.
    Abstract     Related articles   

  615. VAGO R, Ravelli A, Bettiga A, Casati S, et al
    Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  616. AGHAALIKHANI N, Zamani M, Allameh A, Mashayekhi A, et al
    Involvement of haptoglobin phenotypes and genotypes in non-muscle invasive bladder cancer: A possible prognostic marker for risk stratification.
    EXCLI J. 2020;19:351-359.
    Abstract     Related articles   

  617. CAPECE M, Spirito L, La Rocca R, Napolitano L, et al
    Hexaminolevulinate blue light cystoscopy (Hal) assisted transurethral resection of the bladder tumour vs white light transurethral resection of the bladder tumour in non-muscle invasive bladder cancer (NMIBC) : a retrospective analysis.
    Arch Ital Urol Androl. 2020;92:17-20.
    Abstract     Related articles   

  618. MOJARRAD M, Moghbeli M
    Genetic and molecular biology of bladder cancer among Iranian patients.
    Mol Genet Genomic Med. 2020 Apr 6:e1233. doi: 10.1002/mgg3.1233.
    Abstract     Related articles   

  619. SROUGI V, Reis ST, Viana N, Gallucci FP, et al
    Prospective evaluation of a urinary biomarker panel to detect and predict recurrence of non-muscle-invasive bladder cancer.
    World J Urol. 2020 Apr 6. pii: 10.1007/s00345-020-03188.
    Abstract     Related articles   

  620. HWANG MJ, Kamat AM, Dinney CP, Czerniak B, et al
    Bladder Cancer Involving Smooth Muscle of Indeterminate Type or Muscularis Mucosae in Transurethral Biopsy Specimens.
    Am J Clin Pathol. 2020 Apr 7. pii: 5816797. doi: 10.1093.
    Abstract     Related articles   

  621. WANG Z, Shang Y, Luan T, Duan Y, et al
    Evaluation of the value of the VI-RADS scoring system in assessing muscle infiltration by bladder cancer.
    Cancer Imaging. 2020;20:26.
    Abstract     Related articles   

  622. KURMAN Y, Kiliccioglu I, Dikmen AU, Esendagli G, et al
    Cucurbitacin B and cisplatin induce the cell death pathways in MB49 mouse bladder cancer model.
    Exp Biol Med (Maywood). 2020 Apr 6:1535370220917367.
    Abstract     Related articles   

  623. BHASIN A, Sanders EC, Ziegler JM, Briggs JS, et al
    A Virus BioResistor (VBR) for the Detection of the Bladder Cancer Marker DJ-1 in Urine at 10 pM in One Minute.
    Anal Chem. 2020 Apr 6. doi: 10.1021/acs.analchem.0c00534.
    Abstract     Related articles   

  624. SIKIC D, Eckstein M, Wirtz RM, Jarczyk J, et al
    FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy.
    J Clin Med. 2020;9.
    Abstract     Related articles   

  625. HENTSCHEL AE, Nieuwenhuijzen JA, Bosschieter J, Splunter APV, et al
    Comparative Analysis of Urine Fractions for Optimal Bladder Cancer Detection Using DNA Methylation Markers.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  626. SHEN C, Wu Z, Wang Y, Gao S, et al
    Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients.
    Cancer Med. 2020 Apr 6. doi: 10.1002/cam4.3006.
    Abstract     Related articles   

  627. HILTBRUNNER S, Mints M, Eldh M, Rosenblatt R, et al
    Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging.
    Sci Rep. 2020;10:5960.
    Abstract     Related articles   

  628. PAGUIO JA, Yao JS, Reyes MSGL, Lee G, et al
    Bladder Cancer and Google Trends: Associations Between US Search Patterns and Disease Outcomes May Show Need for Improved Awareness Strategies.
    J Cancer Educ. 2020 Apr 5. pii: 10.1007/s13187-020-01739.
    Abstract     Related articles   

  629. POHAR KS
    Blue Light Cystoscopy: Indications and Outcomes.
    Curr Urol Rep. 2020;21:19.
    Abstract     Related articles   

  630. GOMES ATPC, Fernandes R, Ribeiro CF, Tome JPC, et al
    Synthesis, Characterization and Photodynamic Activity against Bladder Cancer Cells of Novel Triazole-Porphyrin Derivatives.
    Molecules. 2020;25.
    Abstract     Related articles   

  631. PISAPIA L, Terreri S, Barba P, Mastroianni M, et al
    Role of PA2G4P4 pseudogene in bladder cancer tumorigenesis.
    Biology (Basel). 2020;9.
    Abstract     Related articles   

  632. YANG C, Li Q, Chen X, Zhang Z, et al
    Circular RNA circRGNEF promotes bladder cancer progression via miR-548/KIF2C axis regulation.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  633. JIN L, Lu MH, Dai GC, Yao Q, et al
    O-GlcNAcylation promotes malignant phenotypes of bladder cancer cells.
    Neoplasma. 2020 Apr 16. pii: 191006N1009. doi: 10.4149/neo_2020_191006N1009.
    Abstract     Related articles   

  634. VAN DER HEIJDEN AG, Witjes JA
    Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnostics: The Replacement for Surgery?
    Eur Urol Oncol. 2020 Apr 14. pii: S2588-9311(20)30043.
    Abstract     Related articles   

  635. KRAJEWSKI W, Nowak L, Poletajew S
    A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer.
    Urol Oncol. 2020 Apr 14. pii: S1078-1439(20)30133.
    Abstract     Related articles   

  636. SPAGNUOLO M, Costantini M, Ferriero M, Varmi M, et al
    Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study.
    J Exp Clin Cancer Res. 2020;39:68.
    Abstract     Related articles   

  637. WEN L, Pan X, Yu Y, Yang B, et al
    Down-regulation of FTO promotes proliferation and migration, and protects bladder cancer cells from cisplatin-induced cytotoxicity.
    BMC Urol. 2020;20:39.
    Abstract     Related articles   

  638. AFFERI L, Moschini M, Cumberbatch MG, Catto JW, et al
    Biomarkers predicting oncological outcomes of high-risk non-muscle-invasive bladder cancer.
    Minerva Urol Nefrol. 2020 Apr 16. pii: S0393-2249.20.03786.
    Abstract     Related articles   

  639. RASPOLLINI MR, Montironi R, Mazzucchelli R, Cimadamore A, et al
    pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging.
    Virchows Arch. 2020 Apr 15. pii: 10.1007/s00428-020-02808.
    Abstract     Related articles   

  640. KIM JW, Ahn ST, Oh MM, Moon DG, et al
    Increased incidence of bladder cancer with metabolically unhealthy status: analysis from the National Health Checkup database in Korea.
    Sci Rep. 2020;10:6476.
    Abstract     Related articles   

  641. ZHOU Z, Cui D, Sun MH, Huang JL, et al
    CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling.
    FASEB J. 2020 Apr 15. doi: 10.1096/fj.201902659.
    Abstract     Related articles   

  642. MENCUCCI MV, Lapyckyj L, Rosso M, Besso MJ, et al
    Ephrin-B1 Is a Novel Biomarker of Bladder Cancer Aggressiveness. Studies in Murine Models and in Human Samples.
    Front Oncol. 2020;10:283.
    Abstract     Related articles   

  643. PECORARO M, Takeuchi M, Vargas HA, Muglia VF, et al
    Overview of VI-RADS in Bladder Cancer.
    AJR Am J Roentgenol. 2020 Apr 14:1-10. doi: 10.2214/AJR.20.22763.
    Abstract     Related articles   

  644. NING JZ, Yu WM, Cheng F, Rao T, et al
    MiR-425 Promotes Migration and Invasion in Bladder Cancer by Targeting Dickkopf 3.
    J Cancer. 2020;11:3424-3432.
    Abstract     Related articles   

  645. LIN YC, Chen MC, Hsieh TH, Liou JP, et al
    CK1delta as a potential therapeutic target to treat bladder cancer.
    Aging (Albany NY). 2020;12:5764-5780.
    Abstract     Related articles   

  646. SHEN J, Lv X, Zhang L
    GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process.
    Onco Targets Ther. 2020;13:2511-2522.
    Abstract     Related articles   

  647. WEI JG, Wang C, Teng XD
    [Pathological diagnosis and differential diagnosis of non-urothelial carcinoma of the bladder].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:386-392.
    Abstract     Related articles   

  648. YIN XN, Zhang Q, He XL, Zhao M, et al
    [Large nested variant of urothelial carcinoma of urinary bladder: a clinicopathological analysis of five cases].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:317-323.
    Abstract     Related articles   

  649. FAN DG, Wu CL, Huang HJ, Wu L, et al
    [Paraganglioma of urinary bladder: a clinicopathological features analysis of 23 cases].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:311-316.
    Abstract     Related articles   

  650. QIN J, Zhou G, Chen X
    Imaging manifestations of bladder paraganglioma.
    Ann Palliat Med. 2020;9:346-351.
    Abstract     Related articles   

  651. TULLY KH, Roghmann F, Noldus J, Chen X, et al
    Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer.
    Clin Genitourin Cancer. 2020 Mar 31. pii: S1558-7673(20)30075.
    Abstract     Related articles   

  652. LI J, Ma W, Cheng X, Zhang X, et al
    Activation of FOXO3 pathway is involved in polyphyllin I-induced apoptosis and cell cycle arrest in human bladder cancer cells.
    Arch Biochem Biophys. 2020 Apr 23:108363. doi: 10.1016/j.abb.2020.108363.
    Abstract     Related articles   

  653. GOEL S, Aggarwal A, Iqbal A, Gupta M, et al
    18-FDG PET-CT should be included in preoperative staging of gall bladder cancer.
    Eur J Surg Oncol. 2020 Apr 15. pii: S0748-7983(20)30412.
    Abstract     Related articles   

  654. HARMON SA, Sanford TH, Brown GT, Yang C, et al
    Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer.
    JCO Clin Cancer Inform. 2020;4:367-382.
    Abstract     Related articles   

  655. LONGDON E, Mistry H, Pratt O, Donnelly A, et al
    Variables associated with survival in patients with invasive bladder cancer with and without surgery.
    Anaesthesia. 2020 Apr 24. doi: 10.1111/anae.15034.
    Abstract     Related articles   

  656. PENG T, Wang G, Cheng S, Xiong Y, et al
    The role and function of PPARgamma in bladder cancer.
    J Cancer. 2020;11:3965-3975.
    Abstract     Related articles   

  657. KIM H, Lee SJ, Lee IK, Min SC, et al
    Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  658. MATSUSHITA Y, Watanabe K, Watanabe H, Tamura K, et al
    Second transurethral resection for high-risk non-muscle invasive bladder cancer patients: a propensity score matched analysis.
    Jpn J Clin Oncol. 2020 Apr 23. pii: 5823898. doi: 10.1093.
    Abstract     Related articles   

  659. MACLENNAN SJ, MacLennan S
    How Do We Meet the Supportive Care and Information Needs of Those Living With and Beyond Bladder Cancer?
    Front Oncol. 2020;10:465.
    Abstract     Related articles   

  660. BALOGLU IH, Albayrak AT, Gunay KC, Yavuzsan AH, et al
    Regression of the Sweet's syndrome after Bacillus Calmette-Guerin therapy: A bladder cancer case report.
    Urol Case Rep. 2020;31:101202.
    Abstract     Related articles   

  661. BHAKTA PS, Harris EA, Connolly MM
    A patient with history of bladder cancer presenting with an axillary mass: A rare case of supradiaphragmatic cutaneous bladder cancer metastasis.
    Urol Case Rep. 2020;31:101157.
    Abstract     Related articles   

  662. YU EYW, Wesselius A, Sinhart C, Wolk A, et al
    A Data Mining Approach to Investigate Food Groups related to Incidence of Bladder Cancer in the BLadder cancer Epidemiology and Nutritional Determinants International Study.
    Br J Nutr. 2020 Apr 23:1-28. doi: 10.1017/S0007114520001439.
    Abstract     Related articles   

  663. LUO J, Zhou L, Lin S, Yan W, et al
    Beneficial effect of fluid warming in elderly patients with bladder cancer undergoing Da Vinci robotic-assisted laparoscopic radical cystectomy.
    Clinics (Sao Paulo). 2020;75:e1639.
    Abstract     Related articles   

  664. TAN QL, Zhou CY, Cheng L, Luo M, et al
    Immunotherapy of Bacillus CalmetteGuerin by targeting macrophages against bladder cancer in a NOD/scid IL2Rg/ mouse model.
    Mol Med Rep. 2020 Apr 22. doi: 10.3892/mmr.2020.11090.
    Abstract     Related articles   

  665. HEKTOEN HH, Robsahm TE, Andreassen BK, Stenehjem JS, et al
    Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway.
    Cancer Med. 2020 Apr 21. doi: 10.1002/cam4.3060.
    Abstract     Related articles   

  666. YAO Z, Jiang Y, Zhu X, Wu B, et al
    Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study.
    Int J Clin Oncol. 2020 Apr 21. pii: 10.1007/s10147-020-01679.
    Abstract     Related articles   

  667. WANG H, Xu X, Zhang X, Liu Y, et al
    Elaboration of a multisequence MRI-based radiomics signature for the preoperative prediction of the muscle-invasive status of bladder cancer: a double-center study.
    Eur Radiol. 2020 Apr 21. pii: 10.1007/s00330-020-06796.
    Abstract     Related articles   

  668. MANI J, Neuberth MT, Fettel J, Senf B, et al
    Quality of Patient Information by Urologists Is Associated with Mental Distress in Bladder Cancer Patients.
    Oncol Res Treat. 2020 Apr 21:1-8. doi: 10.1159/000507094.
    Abstract     Related articles   

  669. YAO K, He L, Gan Y, Liu J, et al
    HMGN5 promotes IL-6-induced epithelial-mesenchymal transition of bladder cancer by interacting with Hsp27.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  670. GUO Y, Wang J, Zhou K, Lv J, et al
    Cytotoxic necrotizing factor 1 promotes bladder cancer angiogenesis through activating RhoC.
    FASEB J. 2020 Apr 21. doi: 10.1096/fj.201903266.
    Abstract     Related articles   

  671. LI W, Zeng J, Luo B, Mao Y, et al
    [High expression of activated CD4(+) memory T cells and CD8(+) T cells and low expression of M0 macrophage are associated with better clinical prognosis in bladder cancer patients].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020;36:97-103.
    Abstract     Related articles   

  672. MALANGONE-MONACO E, Wilson K, Diakun D, Tayama D, et al
    Cost of cystectomy-related complications in patients with bladder cancer in the United States.
    Curr Med Res Opin. 2020 Apr 21:1. doi: 10.1080/03007995.2020.1758927.
    Abstract     Related articles   

  673. WANG Z, Zhou Q, Zeng H, Zhang H, et al
    Tumor-infiltrating IL-17A(+) cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer.
    Oncoimmunology. 2020;9:1747332.
    Abstract     Related articles   

  674. SANCHEZ A, Kissel S, Coletta A, Scott J, et al
    Impact of body size and body composition on bladder cancer outcomes: Risk stratification and opportunity for novel interventions.
    Urol Oncol. 2020 Apr 18. pii: S1078-1439(20)30104.
    Abstract     Related articles   

  675. BENLIER N, Solakhan M, Yildirim Z, Kaya V, et al
    A novel diagnostic tool for the detection of bladder cancer: Measurement of urinary high mobility group box-1.
    Urol Oncol. 2020 Apr 17. pii: S1078-1439(20)30131.
    Abstract     Related articles   

  676. WANG J, Wu Y, He W, Yang B, et al
    Nomogram for predicting overall survival of patients with bladder cancer: A population-based study.
    Int J Biol Markers. 2020 Apr 20:1724600820907605. doi: 10.1177/1724600820907605.
    Abstract     Related articles   

  677. ALBERTO BANDEIRA FERREIRA L, Garcia-Fossa F, Radaic A, Duran N, et al
    Biogenic silver nanoparticles: in vitro and in vivo antitumor activity in bladder cancer.
    Eur J Pharm Biopharm. 2020 Apr 17. pii: S0939-6411(20)30106.
    Abstract     Related articles   

  678. BAHRAMI S, Gheysarzadeh A, Sotoudeh M, Bandehpour M, et al
    The Association Between Gelsolin-like Actin-capping Protein (CapG) Overexpression and Bladder Cancer Prognosis.
    Urol J. 2020 Apr 20. pii: 5664/1466. doi: 10.22037/uj.v0i0.5664.
    Abstract     Related articles   

  679. XUE M, Liu L, Du G, Fu Z, et al
    Diagnostic Evaluation of 18F-FDG PET/CT Imaging in Recurrent or Residual Urinary Bladder Cancer: A Meta-Analysis.
    Urol J. 2020 Apr 20. pii: 5538/1462. doi: 10.22037/uj.v0i0.5538.
    Abstract     Related articles   

  680. NISHIYAMA H, Yamamoto Y, Sassa N, Nishimura K, et al
    Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial.
    Int J Clin Oncol. 2020;25:165-174.
    Abstract     Related articles   

  681. TURKBEY B, Czarniecki M, Shih JH, Harmon SA, et al
    Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study.
    AJR Am J Roentgenol. 2020;214:105-113.
    Abstract     Related articles   

  682. MANOCHA U, Kardos J, Selitsky S, Zhou M, et al
    RNA Expression Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder Reveals a Basal-Like Molecular Subtype.
    Am J Pathol. 2020;190:134-144.
    Abstract     Related articles   

  683. AFFERI L, Zamboni S, Karnes RJ, Roghmann F, et al
    The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration.
    World J Urol. 2020 Apr 30. pii: 10.1007/s00345-020-03205.
    Abstract     Related articles   

  684. TEOH JYC, Roupret M, Shariat SF, Herrmann T, et al
    Intravesical therapy for bladder cancer in the pandemic of Covid-19.
    World J Urol. 2020 Apr 30. pii: 10.1007/s00345-020-03218.
    Abstract     Related articles   

  685. RADES D, Nguyen T, Schild SE
    The Results of Whole-brain Radiotherapy for Elderly Patients With Brain Metastases from Urinary Bladder Cancer.
    In Vivo. 2020;34:1317-1320.
    Abstract     Related articles   

  686. TAMURA K, Watanabe K, Matsushita Y, Watanabe H, et al
    Enhanced Sensitivity to NVP-BEZ235 by Inhibition of p62/SQSTM1 in Human Bladder Cancer KoTCC-1 Cells Both In Vitro and In Vivo.
    In Vivo. 2020;34:1001-1008.
    Abstract     Related articles   

  687. JAZZAR U, Shan Y, Klaassen Z, Freedland SJ, et al
    Impact of Alzheimer's disease and related dementia diagnosis following treatment for bladder cancer.
    J Geriatr Oncol. 2020 Apr 27. pii: S1879-4068(20)30061.
    Abstract     Related articles   

  688. HEYES SM, Bond MJ
    Pathways to psychological wellbeing for patients with bladder cancer and their partners-in-care.
    Eur J Oncol Nurs. 2020;46:101757.
    Abstract     Related articles   

  689. GAO L, Meng J, Zhang M, Fan S, et al
    Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer.
    DNA Cell Biol. 2020 Apr 29. doi: 10.1089/dna.2019.5224.
    Abstract     Related articles   

  690. THAM SM, Mahendran R, Chiong E, Wu QH, et al
    Gmcsf and Ifnalpha gene therapy improves the response to BCG immunotherapy in a murine model of bladder cancer.
    Future Oncol. 2020 Apr 30. doi: 10.2217/fon-2020-0137.
    Abstract     Related articles   

  691. LIU S, Chen L, Zhao H, Li Q, et al
    Integrin beta8 facilitates tumor growth and drug resistance via a YBX1 dependent signaling pathway in bladder cancer.
    Cancer Sci. 2020 Apr 29. doi: 10.1111/cas.14439.
    Abstract     Related articles   

  692. SANDOUGHDARAN S, Razzaghdoust A, Tabibi A, Basiri A, et al
    Randomized, Double-blind Pilot Study of Nanocurcumin in Bladder Cancer Patients Receiving Induction Chemotherapy.
    Urol J. 2020 Apr 30. pii: 5719/1477. doi: 10.22037/uj.v0i0.5719.
    Abstract     Related articles   

  693. JAZAYERI MH, Aghaie T, Nedaeinia R, Manian M, et al
    Rapid noninvasive detection of bladder cancer using survivin antibody-conjugated gold nanoparticles (GNPs) based on localized surface plasmon resonance (LSPR).
    Cancer Immunol Immunother. 2020 Apr 30. pii: 10.1007/s00262-020-02559.
    Abstract     Related articles   

  694. CUI Y, Xie M, Zhang Z
    LINC00958 Involves in Bladder Cancer Through Sponging miR-378a-3p to Elevate IGF1R.
    Cancer Biother Radiopharm. 2020 Apr 28. doi: 10.1089/cbr.2019.3300.
    Abstract     Related articles   

  695. LIU Q, Zhou Q, Zhong P
    circ_0067934 increases bladder cancer cell proliferation, migration and invasion through suppressing miR-1304 expression and increasing Myc expression levels.
    Exp Ther Med. 2020;19:3751-3759.
    Abstract     Related articles   

  696. PEDERZOLI F, Ferrarese R, Amato V, Locatelli I, et al
    Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naive Urothelial Bladder Cancer Patients.
    Eur Urol Oncol. 2020 Apr 25. pii: S2588-9311(20)30050.
    Abstract     Related articles   

  697. MONTEIRO-REIS S, Lameirinhas A, Miranda-Goncalves V, Felizardo D, et al
    Sirtuins' Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  698. STEFAN-VAN STADEN RI, Gheorghe DC, Jinga V, Sima CS, et al
    Fast Screening of Whole Blood and Tumor Tissue for Bladder Cancer Biomarkers Using Stochastic Needle Sensors.
    Sensors (Basel). 2020;20.
    Abstract     Related articles   

  699. XIANG H, Liu Z, Zhou YB, Yao Q, et al
    [Effects of long non-coding RNA FLJ37505 on the proliferation and migration of bladder cancer cells].
    Zhonghua Yi Xue Za Zhi. 2020;100:1249-1254.
    Abstract     Related articles   

  700. DUNST J
    [Organ-preserving treatment of bladder cancer].
    Strahlenther Onkol. 2020 Apr 27. pii: 10.1007/s00066-020-01608.
    Abstract     Related articles   

    Commentary on characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study.
    Urol Oncol. 2020 Apr 24. pii: S1078-1439(20)30137.
    Abstract     Related articles   

  702. MASUDA N, Murakami K, Kita Y, Hamada A, et al
    Trp53 mutation in Krt5-expressing basal cells facilitates the development of basal squamous-like invasive bladder cancer in the chemical carcinogenesis of mouse bladder.
    Am J Pathol. 2020 Apr 24. pii: S0002-9440(20)30202.
    Abstract     Related articles   

  703. PEREIRA PMR, Parada B, Ribeiro-Rodrigues TM, Fontes-Ribeiro CA, et al
    Caveolin-1 modulation increases efficacy of a galacto-conjugated phthalocyanine in bladder cancer cells resistant to photodynamic therapy.
    Mol Pharm. 2020 Apr 27. doi: 10.1021/acs.molpharmaceut.0c00298.
    Abstract     Related articles   

  704. GUO Z, Zhu H, Xu W, Wang X, et al
    Alternative splicing related genetic variants contribute to bladder cancer risk.
    Mol Carcinog. 2020 Apr 27. doi: 10.1002/mc.23207.
    Abstract     Related articles   

  705. QUAN X, Qin Q, Chen Y, Wei Y, et al
    Independent risk factors and the potential predictors of bladder cancer-related ischemic stroke.
    J Int Med Res. 2020;48:300060520919227.
    Abstract     Related articles   

  706. KRAJEWSKI W, Nowak L, Poletajew S, Tukiendorf A, et al
    The Impact of Restaging Transurethral Resection of Bladder Tumour on Survival Parameters in T1 Non-Muscle Invasive Bladder Cancer - Systematic Review and Meta-analysis.
    J Endourol. 2020 Apr 25. doi: 10.1089/end.2020.0301.
    Abstract     Related articles   

    Molecular Subtyping Bladder Cancer: Is it ready for clinical practice?
    Turk J Med Sci. 2020 Apr 27. doi: 10.3906/sag-2004.
    Abstract     Related articles   

  708. LESHNO A, Vishnevskia-Dai V, Barak A, Zur D, et al
    Retina. 2017 Dec 15. doi: 10.1097/IAE.0000000000001998.
    Abstract     Related articles   

  709. XU C, Lin X, Qian W, Na R, et al
    Genetic risk scores based on risk-associated single nucleotide polymorphisms can reveal inherited risk of bladder cancer in Chinese population.
    Medicine (Baltimore). 2020;99:e19980.
    Abstract     Related articles   

  710. ZHOU M, Zhang Z, Bao S, Hou P, et al
    Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer.
    Brief Bioinform. 2020 May 8. pii: 5831478. doi: 10.1093.
    Abstract     Related articles   

  711. WANG C, He H, Fang W
    Oncogenic roles of the cholesterol metabolite 25-hydroxycholesterol in bladder cancer.
    Oncol Lett. 2020;19:3671-3676.
    Abstract     Related articles   

  712. DUAN F, Mei C, Yang L, Zheng J, et al
    Vitamin K2 promotes PI3K/AKT/HIF-1alpha-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells.
    Sci Rep. 2020;10:7714.
    Abstract     Related articles   

  713. KIMURA T, Nishiyama H
    [.Topics of Bladder Cancer Treatment of New "Reiwa" Era].
    Gan To Kagaku Ryoho. 2020;47:30-37.
    Abstract     Related articles   

  714. AQUINA CT, Truong M, Justiniano CF, Kaur R, et al
    Variation in Adequate Lymph Node Yield for Gastric, Lung, and Bladder Cancer: Attributable to the Surgeon, Pathologist, or Hospital?
    Ann Surg Oncol. 2020 May 6. pii: 10.1245/s10434-020-08509.
    Abstract     Related articles   

  715. YIP W, Cacciamani G, Bhanvadia SK
    Disparities in Bladder Cancer Outcomes Based on Key Sociodemographic Characteristics.
    Curr Urol Rep. 2020;21:24.
    Abstract     Related articles   

  716. GAO X, Wen X, He H, Zheng L, et al
    Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells.
    PeerJ. 2020;8:e9078.
    Abstract     Related articles   

  717. OTTLEY EC, Pell R, Brazier B, Hollidge J, et al
    Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer.
    J Pathol Clin Res. 2020 May 6. doi: 10.1002.
    Abstract     Related articles   

  718. TASKOVSKA M, Kreft ME, Smrkolj T
    Current and innovative approaches in the treatment of non-muscle invasive bladder cancer: the role of transurethral resection of bladder tumor and organoids.
    Radiol Oncol. 2020.
    Abstract     Related articles   

  719. HUANG Y, Zhu Y, Zhang Z, Li Z, et al
    UNC5B mediates G2/M phase arrest of bladder cancer cells by binding to CDC14A and P53.
    Cancer Gene Ther. 2020 May 6. pii: 10.1038/s41417-020-0175.
    Abstract     Related articles   

  720. SHI R, Bao X, Rogowski P, Schafer C, et al
    Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  721. SHOU J, Yu C, Zhang D, Zhang Q, et al
    Overexpression of Citron Rho-Interacting Serine/Threonine Kinase Associated with Poor Outcome in Bladder Cancer.
    J Cancer. 2020;11:4173-4180.
    Abstract     Related articles   

  722. LIU X, Ke J, Gu L, Tang H, et al
    Long non-coding RNA LINC00675 is associated with bladder cancer metastasis and patient survival.
    J Gene Med. 2020 May 4:e3210. doi: 10.1002/jgm.3210.
    Abstract     Related articles   

  723. WANG T, Zhou Q, Zeng H, Zhang H, et al
    CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.
    Cancer Immunol Immunother. 2020 May 4. pii: 10.1007/s00262-020-02583.
    Abstract     Related articles   

  724. LI S, Zhao K, Jin Y, Ma Z, et al
    Relapse and Prognosis of Non-Muscle Invasive Bladder Cancer After Combined HOLRBT with Sunitinib and TGC Perfusion Chemotherapy.
    Cancer Biother Radiopharm. 2020 May 1. doi: 10.1089/cbr.2019.3455.
    Abstract     Related articles   

  725. LEPARA Z, Lepara O, Fajkic A, Rebic D, et al
    Serum malondialdehyde (MDA) level as a potential biomarker of cancer progression for patients with bladder cancer.
    Rom J Intern Med. 2020.
    Abstract     Related articles   

  726. MAO F, Niu XB, Gu S, Ji L, et al
    Investigation of Leptin G19A polymorphism with bladder cancer risk: A case-control study.
    J Clin Lab Anal. 2020 May 3:e23351. doi: 10.1002/jcla.23351.
    Abstract     Related articles   

  727. RENTSCH CA, Bosshard P, Mayor G, Rieken M, et al
    Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guerin (BCG), in patients with non-muscle invasive bladder cancer and previous failur
    Oncoimmunology. 2020;9:1748981.
    Abstract     Related articles   

  728. CHEN CH, Ho CH, Kuan-Hua Huang S, Shen CH, et al
    Association between VEGF gene promoter polymorphisms and bladder cancer: An updated meta-analysis.
    Cytokine. 2020;131:155112.
    Abstract     Related articles   

    The current situation of 5-aminolevulinic acid mediated photodynamic therapy in bladder cancer.
    Photodiagnosis Photodyn Ther. 2020 Apr 29:101794.
    Abstract     Related articles   

  730. SHI Z, Pang K, Yang W, Zhou J, et al
    Antitumor mechanism of MAP30 in bladder cancer T24 cells, and its potential toxic effects in mice.
    Cell Mol Biol (Noisy-le-grand). 2020;66:42-48.
    Abstract     Related articles   

  731. LUO Y, Fu X, Han B, Zhang F, et al
    The Apoptosis Mechanism of Epirubicin Combined with BCG on Human Bladder Cancer Cells.
    Anticancer Agents Med Chem. 2020 May 1. pii: ACAMC-EPUB-106277.
    Abstract     Related articles   

  732. GRIGNOUX J, Lodde B, Dewitte JD, Larabi L, et al
    [Better screening for work-related cancers: The experience of Brest University Hospital Occupational Disease Center inpatient service].
    Bull Cancer. 2020;107:428-437.
    Abstract     Related articles   

  733. GARCZYK S, Ortiz-Bruchle N, Schneider U, Lurje I, et al
    Next-Generation Sequencing Reveals Potential Predictive Biomarkers and Targets of Therapy for Urothelial Carcinoma in Situ of the Urinary Bladder.
    Am J Pathol. 2020;190:323-332.
    Abstract     Related articles   

  734. CHEN D, Chen J, Gao J, Zhang Y, et al
    LncRNA DDX11-AS1 Promotes Bladder Cancer Occurrence Via Protecting LAMB3 from Downregulation by Sponging miR-2355-5p.
    Cancer Biother Radiopharm. 2020 May 15. doi: 10.1089/cbr.2019.3021.
    Abstract     Related articles   

  735. LAM CJK, Warren JL, Nielsen M, Smith A, et al
    Using the SEER-Medicare Data to Assess Incident Chronic Myeloid Leukemia and Bladder Cancer Cases Missed by Cancer Registries.
    J Natl Cancer Inst Monogr. 2020;2020:31-38.
    Abstract     Related articles   

  736. LUO C, Lei T, Zhao M, Meng Q, et al
    CD40 is Positively Correlated with the Expression of Nucleophosmin in Cisplatin-Resistant Bladder Cancer.
    J Oncol. 2020;2020:3676751.
    Abstract     Related articles   

  737. JALANKO T, de Jong JJ, Gibb EA, Seiler R, et al
    Correction to: Genomic Subtyping in Bladder Cancer.
    Curr Urol Rep. 2020;21:25.
    Abstract     Related articles   

  738. XIONG Q, Liu A, Ren Q, Xue Y, et al
    Cuprous oxide nanoparticles trigger reactive oxygen species-induced apoptosis through activation of erk-dependent autophagy in bladder cancer.
    Cell Death Dis. 2020;11:366.
    Abstract     Related articles   

  739. GARG T, Young AJ, O'Keeffe-Rosetti M, McMullen CK, et al
    Association between metabolic syndrome and recurrence of nonmuscle-invasive bladder cancer in older adults.
    Urol Oncol. 2020 May 11. pii: S1078-1439(20)30150.
    Abstract     Related articles   

  740. MA J, Qi J, Li S, Zhang C, et al
    Desloratadine, a Novel Antigrowth Reagent for Bladder Cancer.
    Technol Cancer Res Treat. 2020;19:1533033820926591.
    Abstract     Related articles   

  741. HAN H, Yu F, Wu C, Dai L, et al
    Trends and Utilization of Inpatient Palliative Care Among Patients With Metastatic Bladder Cancer.
    J Palliat Care. 2020 May 14:825859720924936. doi: 10.1177/0825859720924936.
    Abstract     Related articles   

  742. LUO HL, Chen YT, Cheng YT
    Reply to: High-grade urothelial carcinoma in a kidney transplant recipient after JC virus nephropathy: The first evidence of JC virus as a potential oncovirus in bladder cancer.
    Am J Transplant. 2020 May 14. doi: 10.1111/ajt.16006.
    Abstract     Related articles   

  743. KUTLUHAN MA, Ozsoy E, Baskak F, Urkmez A, et al
    How reliable are imaging techniques in aging males with bladder cancer?
    Aging Male. 2020 May 13:1-7. doi: 10.1080/13685538.2020.1766014.
    Abstract     Related articles   

  744. VOSKAMP MJH, Vermeer M, Molijn GJ, Cornel EB, et al
    The Usefulness of the Modified Frailty Index for Muscle-Invasive Bladder Cancer Patients Treated with Radical Cystectomy.
    Curr Urol. 2020;14:32-37.
    Abstract     Related articles   

  745. CHEN Q, Yin Q, Mao Y, Zhang Z, et al
    Hsa_circ_0068307 mediates bladder cancer stem cell-like properties via miR-147/c-Myc axis regulation.
    Cancer Cell Int. 2020;20:151.
    Abstract     Related articles   

  746. ZHANG J, Duan H, Feng Z, Han X, et al
    Acetyl-CoA synthetase 3 promotes bladder cancer cell growth under metabolic stress.
    Oncogenesis. 2020;9:46.
    Abstract     Related articles   

  747. MATUSZCZAK M, Salagierski M
    Diagnostic and Prognostic Potential of Biomarkers CYFRA 21.1, ERCC1, p53, FGFR3 and TATI in Bladder Cancers.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  748. Correction: High LINC01605 expression predicts poor prognosis and promotes tumor progression via upregulation of MMP9 in bladder cancer.
    Biosci Rep. 2020;40.
    Abstract     Related articles   

  749. ZHEGALIK AG, Polyakov SL, Rolevich AI, Volkov AN, et al
    Long-term results of a single-center prospective randomized trial assessing efficacy of a shortened course of adjuvant chemotherapy after radical cystectomy in patients with locally advanced bladder cancer.
    Cent European J Urol. 2020;73:26-32.
    Abstract     Related articles   

  750. GRONOSTAJ K, Czech AK, Fronczek J, Wiatr T, et al
    Changes in neoadjuvant chemotherapy utilization in muscle invasive bladder cancer treatment: a tertiary center retrospective study.
    Cent European J Urol. 2020;73:13-18.
    Abstract     Related articles   

  751. LIU YC, Chen VC, Lu ML, Lee MJ, et al
    The Association between Selective Serotonin Reuptake Inhibitors (SSRIs) Use and the Risk of Bladder Cancer: A Nationwide Population-Based Cohort Study.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  752. WOLACEWICZ M, Hrynkiewicz R, Grywalska E, Suchojad T, et al
    Immunotherapy in Bladder Cancer: Current Methods and Future Perspectives.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  753. TAN L, Xiao K, Ye Y, Liang H, et al
    High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  754. CAO H, Cheng L, Yu J, Zhang Z, et al
    Identifying the mRNAs associated with Bladder cancer recurrence.
    Cancer Biomark. 2020 Apr 30. pii: CBM190617. doi: 10.3233/CBM-190617.
    Abstract     Related articles   

  755. GUAN H, Li X, Lu J, Meng L, et al
    Aberrant Methylation of Suppressor of Cytokine Signaling 1 (SOCS1) Gene as a Biomarker for Early Prediction and Diagnosis of Bladder Cancer.
    Clin Lab. 2020;66.
    Abstract     Related articles   

  756. SHARMA M, Nagata Y, Yang Z, Miyamoto H, et al
    The impact of routine frozen section analysis during partial cystectomy for bladder cancer on surgical margin status and long-term oncologic outcome.
    Urol Oncol. 2020 May 8. pii: S1078-1439(20)30140.
    Abstract     Related articles   

  757. WU T, Duan X, Hu T, Mu X, et al
    Effect of endostatin on Wnt pathway of stem-like cells in bladder cancer in tumor microenvironment.
    Mol Biol Rep. 2020 May 9. pii: 10.1007/s11033-020-05487.
    Abstract     Related articles   

  758. QI Y, Toyooka T, Nie J, Ohta H, et al
    Comparative gamma-H2AX analysis for assessment of the genotoxicity of six aromatic amines implicated in bladder cancer in human urothelial cell line.
    Toxicol In Vitro. 2020;66:104880.
    Abstract     Related articles   

  759. STAKHOVSKYI OE, Pikul MV, Semko SL, Vitruk IV, et al
    Transperitoneal uretercutaneostomy with use of mesosigmoid colon peritoneum in patients with bladder cancer after radical cystectomy.
    Wiad Lek. 2020;73:988-993.
    Abstract     Related articles   

  760. YOSHINO H, Enokida H, Osako Y, Nohata N, et al
    Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.
    Mol Oncol. 2020 May 9. doi: 10.1002/1878-0261.12697.
    Abstract     Related articles   

  761. WANG F, Qin CP, Yang WB, Liu SJ, et al
    [Advances in Pelvic Lymph Node Dissection for Bladder Cancer].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2020;42:263-269.
    Abstract     Related articles   

  762. HAEDICKE K, Agemy L, Omar M, Berezhnoi A, et al
    High-resolution optoacoustic imaging of tissue responses to vascular-targeted therapies.
    Nat Biomed Eng. 2020;4:286-297.
    Abstract     Related articles   

  763. LI Y, Li G, Guo X, Yao H, et al
    Non-coding RNA in bladder cancer.
    Cancer Lett. 2020 May 10. pii: S0304-3835(20)30225.
    Abstract     Related articles   

  764. JONES P, Eldakhakhny M, Hawary A
    Haematuria caused by bladder cancer in the paediatric setting.
    Ann R Coll Surg Engl. 2020 May 21:e1-e2. doi: 10.1308/rcsann.2020.0108.
    Abstract     Related articles   

  765. HU Y, Zhang Y, Gao J, Lian X, et al
    The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data.
    Bioengineered. 2020;11:572-581.
    Abstract     Related articles   

  766. RINK M
    Electronic cigarettes and bladder cancer - a game-changer?
    Nat Rev Urol. 2020 May 20. pii: 10.1038/s41585-020-0337.
    Abstract     Related articles   

  767. WU JP, Zhang GY, Sun XZ
    LncRNA ZNFX1-AS1 targeting miR-193a-3p/SDC1 regulates cell proliferation, migration and invasion of bladder cancer cells.
    Eur Rev Med Pharmacol Sci. 2020;24:4719-4728.
    Abstract     Related articles   

  768. WATT J, Maguire DG, Reid CN, Lamont JV, et al
    Thrombomodulin Expression in Bladder Cancer Tissue and Its Association with Prognosis and Patient Survival.
    Res Rep Urol. 2020;12:157-165.
    Abstract     Related articles   

  769. VENA F, Bayle S, Nieto A, Quereda V, et al
    Targeting casein kinase 1 delta sensitizes pancreatic and bladder cancer cells to gemcitabine treatment by upregulating deoxycytidine kinase.
    Mol Cancer Ther. 2020 May 19. pii: 1535-7163.MCT-19-0997.
    Abstract     Related articles   

  770. MATULAY JT, Tabayoyong W, Duplisea JJ, Chang C, et al
    Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members.
    Urol Oncol. 2020 May 16. pii: S1078-1439(20)30181.
    Abstract     Related articles   

  771. SORENSEN KK, Jensen BW, Thomas PE, Madsen K, et al
    Early life body size and its associations with adult bladder cancer.
    Ann Hum Biol. 2020;47:166-172.
    Abstract     Related articles   

  772. ECKSTEIN M, Epple E, Jung R, Weigelt K, et al
    CCL2 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Shows Divergent Prognostic Potential for Bladder Cancer Patients Depending on Lymph Node Stage.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  773. GHASEMI H, Mousavibahar SH, Hashemnia M, Karimi J, et al
    Tissue stiffness contributes to YAP activation in bladder cancer patients undergoing transurethral resection.
    Ann N Y Acad Sci. 2020 May 19. doi: 10.1111/nyas.14358.
    Abstract     Related articles   

  774. CHIU YF, Wu CC, Kuo MH, Miao CC, et al
    Critical role of SOX2-IGF2 signaling in aggressiveness of bladder cancer.
    Sci Rep. 2020;10:8261.
    Abstract     Related articles   

  775. KRAJEWSKI W, Karabon L, Partyka A, Tomkiewicz A, et al
    Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy.
    Cent Eur J Immunol. 2020;45:37-47.
    Abstract     Related articles   

  776. LI Q, Wang S, Wu Z, Liu Y, et al
    DDX11-AS1exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p.
    Biomed Pharmacother. 2020;127:110164.
    Abstract     Related articles   

  777. TACHIBANA I, Kaimakliotis HZ
    Tumor downstaging in muscle invasive bladder cancer with neoadjuvant systemic therapy-does it lead to prolonged survival?
    Transl Androl Urol. 2020;9:831-833.
    Abstract     Related articles   

  778. LIU S, Xu F, Xu T, Yan Y, et al
    Evaluation of Vesical Imaging-Reporting and Data System (VI-RADS) scoring system in predicting muscle invasion of bladder cancer.
    Transl Androl Urol. 2020;9:445-451.
    Abstract     Related articles   

  779. MA W, Mao S, Bao M, Wu Y, et al
    Prognostic significance of red cell distribution width in bladder cancer.
    Transl Androl Urol. 2020;9:295-302.
    Abstract     Related articles   

  780. CAI Q, Chen Y, Xin S, Zhang D, et al
    Temporal trends of bladder cancer incidence and mortality from 1990 to 2016 and projections to 2030.
    Transl Androl Urol. 2020;9:153-165.
    Abstract     Related articles   

  781. CAO H, Huang D, Guo L, Gao Y, et al
    Effects of Different Chemical Groups on Behaviors of Bladder Cancer Cells.
    J Biomed Mater Res A. 2020 May 17. doi: 10.1002/jbm.a.36999.
    Abstract     Related articles   

  782. BURASCHI S, Neill T, Xu SQ, Palladino C, et al
    Progranulin/EphA2 axis: A novel oncogenic mechanism in bladder cancer.
    Matrix Biol. 2020 May 14. pii: S0945-053X(20)30038.
    Abstract     Related articles   

  783. NECCHI A, Raggi D, Giannatempo P, Marandino L, et al
    Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study.
    Eur Urol Oncol. 2020 May 13. pii: S2588-9311(20)30053.
    Abstract     Related articles   

  784. FUJITA N, Hatakeyama S, Momota M, Tobisawa Y, et al
    Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
    Urol Oncol. 2020 May 14. pii: S1078-1439(20)30178.
    Abstract     Related articles   

  785. CHIPOLLINI J, Wright JR, Nwanosike H, Kepler CY, et al
    Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study.
    Urol Oncol. 2020 May 12. pii: S1078-1439(20)30139.
    Abstract     Related articles   

  786. WU Q, Wong JPC, Kwok HF
    Putting the Brakes on Tumorigenesis with Natural Products of Plant Origin: Insights into the Molecular Mechanisms of Actions and Immune Targets for Bladder Cancer Treatment.
    Cells. 2020;9.
    Abstract     Related articles   

  787. LI S, Li P, Ge M, Wang H, et al
    Elucidation of leak-resistance DNA hybridization chain reaction with universality and extensibility.
    Nucleic Acids Res. 2020;48:2220-2231.
    Abstract     Related articles   

  788. LI F, Guo H, Wang Y, Liu B, et al
    Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer.
    Int Immunopharmacol. 2020;85:106641.
    Abstract     Related articles   

  789. TODENHOFER T, Boegemann M
    [Immunotherapy in bladder cancer-quo vadis? Update on current trials and developments].
    Urologe A. 2020 May 28. pii: 10.1007/s00120-020-01237.
    Abstract     Related articles   

  790. KRAMER MW, Gakis G
    [Immuno-oncological therapeutic options in high-risk non-muscle invasive bladder cancer].
    Urologe A. 2020 May 28. pii: 10.1007/s00120-020-01233.
    Abstract     Related articles   

  791. ZHANG C, Gou X, He W, Yang H, et al
    A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer.
    Cancer Cell Int. 2020;20:177.
    Abstract     Related articles   

  792. RUTZ J, Janicova A, Woidacki K, Chun FK, et al
    Curcumin-A Viable Agent for Better Bladder Cancer Treatment.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  793. DE RIDDER M, Gerbrandy LC, de Reijke TM, Hinnen KA, et al
    BioXmark(R) liquid fiducial markers for image guided radiotherapy in muscle invasive bladder cancer, a safety and performance trial.
    Br J Radiol. 2020 May 28:20200241. doi: 10.1259/bjr.20200241.
    Abstract     Related articles   

  794. PFISTER D, Niegisch G
    [Bladder cancer - complications related to urinary diversion].
    Aktuelle Urol. 2020 May 27. doi: 10.1055/a-1134-6642.
    Abstract     Related articles   

  795. XIE K, Cao D, Wei Q, Ren Z, et al
    Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials.
    World J Urol. 2020 May 27. pii: 10.1007/s00345-020-03271.
    Abstract     Related articles   

  796. BHUNIA S, Barbhuiya MA, Gupta S, Shrivastava BR, et al
    Epigenetic downregulation of desmin in gall bladder cancer reveals its potential role in disease progression.
    Indian J Med Res. 2020;151:311-318.
    Abstract     Related articles   

  797. MITTAL B
    Desmin dysregulation in gall bladder cancer.
    Indian J Med Res. 2020;151:273-274.
    Abstract     Related articles   

  798. CHEN L, Yang X, Zhao J, Xiong M, et al
    Circ_0008532 promotes bladder cancer progression by regulation of the miR-155-5p/miR-330-5p/MTGR1 axis.
    J Exp Clin Cancer Res. 2020;39:94.
    Abstract     Related articles   

  799. LEE HW, Chung W, Lee HO, Jeong DE, et al
    Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient.
    Genome Med. 2020;12:47.
    Abstract     Related articles   

  800. WANG J, Gao Y, Wang X, Gao Y, et al
    Circulating lncRNAs as noninvasive biomarkers in bladder cancer: A diagnostic meta-analysis based on 15 published articles.
    Int J Biol Markers. 2020 May 28:1724600820926685. doi: 10.1177/1724600820926685.
    Abstract     Related articles   

  801. WILSON JL JR, Antoniassi MP, Lopes PI, Azevedo H, et al
    Proteomic research and diagnosis in bladder cancer: state of the art review.
    Int Braz J Urol. 2020;46.
    Abstract     Related articles   

  802. SHI YR, Wu Z, Xiong K, Liao QJ, et al
    Circular RNA circKIF4A Sponges miR-375/1231 to Promote Bladder Cancer Progression by Upregulating NOTCH2 Expression.
    Front Pharmacol. 2020;11:605.
    Abstract     Related articles   

  803. WANG T, Liu S, Joseph T, Lyou Y, et al
    Managing Bladder Cancer Care during the COVID-19 Pandemic Using a Team-Based Approach.
    J Clin Med. 2020;9.
    Abstract     Related articles   

  804. BLINOVA E, Enikeev D, Roshchin D, Samyshina E, et al
    Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  805. RESZKA E, Lesicka M, Wieczorek E, Jablonska E, et al
    Dysregulation of Redox Status in Urinary Bladder Cancer Patients.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  806. SHEN C, Liu J, Wang J, Yang X, et al
    The Analysis of PTPN6 for Bladder Cancer: An Exploratory Study Based on TCGA.
    Dis Markers. 2020;2020:4312629.
    Abstract     Related articles   

  807. YAO J, Qian K, Chen C, Liu X, et al
    ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  808. NATALE C, Leinwand G, Zeineddine F, Silberstein JL, et al
    Does muscle invasive bladder cancer following pelvic radiotherapy portend worse prognosis? A seer-based study.
    Cancer Treat Res Commun. 2020;24:100177.
    Abstract     Related articles   

  809. KASSOUF W, Aprikian A, Saad F, Fleshner N, et al
    Continuing towards optimization of bladder cancer care in Canada: Summary of the third Bladder Cancer Canada-Canadian Urological Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care consensus meeting.
    Can Urol Assoc J. 2020;14:E115-E125.
    Abstract     Related articles   

  810. DANESHMAND S, Nazemi A
    Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence.
    Eur Urol Focus. 2020 May 22. pii: S2405-4569(20)30110.
    Abstract     Related articles   

  811. GRIMBERG DC, Shah A, Molinger J, Whittle J, et al
    Assessments of frailty in bladder cancer.
    Urol Oncol. 2020 May 22. pii: S1078-1439(20)30195.
    Abstract     Related articles   

  812. WANG M, Hiraki R, Nakamura N, Hayama T, et al
    Determination of Gemcitabine in Plasma of Bladder Cancer Patients by Hydrophilic Interaction Chromatography with Ultraviolet Detection.
    J Chromatogr Sci. 2020 May 25. pii: 5842359. doi: 10.1093.
    Abstract     Related articles   

  813. ECKSTEIN M, Strissel P, Strick R, Weyerer V, et al
    Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy.
    J Immunother Cancer. 2020;8.
    Abstract     Related articles   

  814. CHIANG CL, Huang HH, Huang TY, Shih YL, et al
    Nonalcoholic Fatty Liver Disease Associated With Bladder Cancer.
    Am J Med Sci. 2020 May 4. pii: S0002-9629(20)30164.
    Abstract     Related articles   

  815. ROPERCH JP, Hennion C
    A novel ultra-sensitive method for the detection of FGFR3 mutations in urine of bladder cancer patients - Design of the Urodiag(R) PCR kit for surveillance of patients with non-muscle-invasive bladder cancer (NMIBC).
    BMC Med Genet. 2020;21:112.
    Abstract     Related articles   

  816. LENIS AT, Lec PM, Michel J, Brisbane W, et al
    Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival.
    Urol Oncol. 2020 May 20. pii: S1078-1439(20)30182.
    Abstract     Related articles   

  817. NARAIN TA, Gautam G, Seth A, Panwar VK, et al
    Uro-oncology in times of COVID-19: The available evidence and recommendations in the Indian scenario.
    Indian J Cancer. 2020;57:129-138.
    Abstract     Related articles   

  818. SCHNITZLER T, Ortiz-Bruchle N, Schneider U, Lurje I, et al
    Pure high-grade papillary urothelial bladder cancer: a luminal-like subgroup with potential for targeted therapy.
    Cell Oncol (Dordr). 2020 May 22. pii: 10.1007/s13402-020-00524.
    Abstract     Related articles   

  819. PRADERE B, Shariat SF
    Exploring the molecular basis of sexual dimorphism in bladder cancer.
    Nat Rev Urol. 2020 May 22. pii: 10.1038/s41585-020-0339.
    Abstract     Related articles   

  820. TANG H, Kan L, Ou T, Chen D, et al
    Development of a Novel Prognostic Signature for Predicting the Overall Survival of Bladder Cancer Patients.
    Biosci Rep. 2020 May 22. pii: 224923. doi: 10.1042/BSR20194432.
    Abstract     Related articles   

  821. SFAKIANOS JP, Daza J, Hu Y, Anastos H, et al
    Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers.
    Nat Commun. 2020;11:2540.
    Abstract     Related articles   

  822. CHEN Y, Fu D, Zhao H, Cheng W, et al
    GSG2 (Haspin) promotes development and progression of bladder cancer through targeting KIF15 (Kinase-12).
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  823. KOVACS PT, Juhasz D, Modos O, Kocsmar I, et al
    Characteristics of bladder recurrence after radical nephroureterectomy in upper urinary tract cancer
    Orv Hetil. 2020;161:881-888.
    Abstract     Related articles   

  824. WANG Z, He Y, Wang N, Zhang T, et al
    Clinical value of texture analysis in differentiation of urothelial carcinoma based on multiphase computed tomography images.
    Medicine (Baltimore). 2020;99:e20093.
    Abstract     Related articles   

  825. TOBIAS-MACHADO M, Pazeto CL, Borges RC
    Robot-assisted transvesical partial cystectomy for leiomyoma of bladder trigone.
    Int Braz J Urol. 2020;46:300.
    Abstract     Related articles   

  826. PARRA LA, Swanson SK, Salomao MA, Yang M, et al
    Multifocal Urinary Bladder Paragangliomas With Negative 68Ga-DOTATATE Uptake and Positive 123I-MIBG Uptake.
    Clin Nucl Med. 2020;45:e156-e157.
    Abstract     Related articles   

  827. YOSHIDA T, Shida D
    ASO Author Reflections: Partial versus Total Cystectomy in Bladder-Involving Colorectal Cancer.
    Ann Surg Oncol. 2019 Aug 9. pii: 10.1245/s10434-019-07716.
    Abstract     Related articles   

  828. OH DY, Kwek SS, Raju SS, Li T, et al
    Intratumoral CD4(+) T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer.
    Cell. 2020 Jun 3. pii: S0092-8674(20)30612-7. doi: 10.1016/j.cell.2020.
    Abstract     Related articles   

  829. ZHANG L, Liu B, Deng QH, Li JX, et al
    LncRNA BRE-AS1 acts as a tumor suppressor factor in bladder cancer via mediating STAT3.
    Eur Rev Med Pharmacol Sci. 2020;24:5320-5328.
    Abstract     Related articles   

  830. FENG F, Chen AP, Wang XL, Wu GL, et al
    Circ_0061140 promotes metastasis of bladder cancer through adsorbing microRNA-1236.
    Eur Rev Med Pharmacol Sci. 2020;24:5310-5319.
    Abstract     Related articles   

  831. GRIVAS N, van den Bergh RCN, Brouwer OR, KleinJan GH, et al
    Pelvic lymph node distribution and metastases of prostate and bladder cancer: a systematic literature review and template proposal.
    World J Urol. 2020 Jun 3. pii: 10.1007/s00345-020-03281.
    Abstract     Related articles   

  832. ZHOU N, Zhu X, Man L
    LINC00963 Functions as an Oncogene in Bladder Cancer by Regulating the miR-766-3p/MTA1 Axis.
    Cancer Manag Res. 2020;12:3353-3361.
    Abstract     Related articles   

  833. BESSA A, Martin R, Haggstrom C, Enting D, et al
    Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidence.
    BMC Urol. 2020;20:64.
    Abstract     Related articles   

  834. SUAREZ-IBARROLA R, Kriegmair M, Waldbillig F, Grune B, et al
    A novel endoimaging system for endoscopic 3D reconstruction in bladder cancer patients.
    Minim Invasive Ther Allied Technol. 2020.
    Abstract     Related articles   

  835. ZHOU S, Zhao N, Wang J
    Gambogenic Acid Suppresses Bladder Cancer Cells Growth And Metastasis By Regulating NF-kappaB Signaling.
    Chem Biol Drug Des. 2020 Jun 3. doi: 10.1111/cbdd.13737.
    Abstract     Related articles   

  836. SUKAPIRIYA C, Bandidwattanawong C
    Case of renal cell carcinoma associated with synchronous contralateral renal pelvic cancer and bladder cancer.
    Urol Case Rep. 2020;32:101267.
    Abstract     Related articles   

  837. CHEN S, Yang Y, Luo Z, Deng H, et al
    Establishing a prediction model of infection during the intravesical instillation of bladder cancer: a multicenter retrospective study.
    J Cancer. 2020;11:4324-4331.
    Abstract     Related articles   

  838. KIEHL IGA, Riccetto E, Salustiano ACC, Ossick MV, et al
    Boosting bladder cancer treatment by intravesical nitazoxanide and bacillus calmette-guerin association.
    World J Urol. 2020 Jun 2. pii: 10.1007/s00345-020-03294.
    Abstract     Related articles   

  839. ROH YG, Mun JY, Kim SK, Park W, et al
    Fanconi Anemia Pathway Activation by FOXM1 Is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  840. OLIVEIRA MC, Caires HR, Oliveira MJ, Fraga A, et al
    Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  841. ASHRAFIZADEH M, Zarrabi A, Samarghandian S, Najafi M, et al
    PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer?
    Eur J Pharmacol. 2020 May 30:173226. doi: 10.1016/j.ejphar.2020.173226.
    Abstract     Related articles   

  842. HARSANYI S, Ziaran S, Bevizova K, Varchulova Novakova Z, et al
    The prognostic value of E-cadherin and Ki-67 compared to standard histopathologic examination in non-muscle invasive bladder cancer.
    Bratisl Lek Listy. 2020;121:444-449.
    Abstract     Related articles   

  843. LI J, Wang AS, Wang S, Wang CY, et al
    Death-inducer obliterator 1 (DIDO1) silencing suppresses growth of bladder cancer cells through decreasing SAPK/JNK signaling cascades.
    Neoplasma. 2020 Jun 2. pii: 191115N1171. doi: 10.4149/neo_2020_191115N01171.
    Abstract     Related articles   

  844. NABAVIZADEH R, Bobrek K, Master VA
    Risk stratification for bladder cancer: Biomarkers of inflammation and immune activation.
    Urol Oncol. 2020 May 20. pii: S1078-1439(20)30146.
    Abstract     Related articles   

  845. EDEFONTI V, La Vecchia C, Di Maso M, Crispo A, et al
    Association between Nutrient-Based Dietary Patterns and Bladder Cancer in Italy.
    Nutrients. 2020;12.
    Abstract     Related articles   

  846. SUN R, Liu X, Li G, Wang H, et al
    A Photo-Activated H2 Nanogenerator for Enhanced Chemotherapy of Bladder Cancer.
    ACS Nano. 2020 Jun 1. doi: 10.1021/acsnano.0c01300.
    Abstract     Related articles   

  847. LIU Y, Zhu DY, Xing HJ, Hou Y, et al
    A potential prognostic model based on miRNA expression profile in The Cancer Genome Atlas for bladder cancer patients.
    J Biol Res (Thessalon). 2020;27:6.
    Abstract     Related articles   

  848. LIU X, Zhou Z, Wang Y, Zhu K, et al
    Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis.
    Front Oncol. 2020;10:589.
    Abstract     Related articles   

  849. SONG Q, Seigne JD, Schned AR, Kelsey KT, et al
    A Machine Learning Approach for Long-Term Prognosis of Bladder Cancer based on Clinical and Molecular Features.
    AMIA Jt Summits Transl Sci Proc. 2020;2020:607-616.
    Abstract     Related articles   

  850. SCHMID SC, Koll FJ, Beckert F, Seitz AK, et al
    [Immuno-oncological approaches in the perioperative therapy of muscle invasive bladder cancer].
    Urologe A. 2020 May 29. pii: 10.1007/s00120-020-01234.
    Abstract     Related articles   

  851. ERDMANN K, Salomo K, Klimova A, Heberling U, et al
    Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder Cancer.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  852. TATSUMI Y, Miyake M, Shimada K, Fujii T, et al
    Inhibition of Heparanase Expression Results in Suppression of Invasion, Migration and Adhesion Abilities of Bladder Cancer Cells.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  853. MAIMAITI M, Sakamoto S, Yamada Y, Sugiura M, et al
    Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma.
    Sci Rep. 2020;10:1292.
    Abstract     Related articles   

  854. CLAPS M, Stellato M, Zattarin E, Mennitto A, et al
    Current Understanding of Urachal Adenocarcinoma and Management Strategy.
    Curr Oncol Rep. 2020;22:9.
    Abstract     Related articles   

  855. KHOI PN, Li S, Thuan UT, Sah DK, et al
    Lysophosphatidic Acid Upregulates Recepteur D'origine Nantais Expression and Cell Invasion via Egr-1, AP-1, and NF-kappaB Signaling in Bladder Carcinoma Cells.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  856. JOKISCH F, Buchner A, Schulz GB, Grimm T, et al
    Prospective evaluation of 4-D contrast-enhanced-ultrasound (CEUS) imaging in bladder tumors.
    Clin Hemorheol Microcirc. 2020;74:1-12.
    Abstract     Related articles   

  857. SHAN G, Tang T, Xia Y, Qian HJ, et al
    Long non-coding RNA NEAT1 promotes bladder progression through regulating miR-410 mediated HMGB1.
    Biomed Pharmacother. 2020;121:109248.
    Abstract     Related articles   

  858. MANZI M, Riquelme G, Zabalegui N, Monge ME, et al
    Improving diagnosis of genitourinary cancers: Biomarker discovery strategies through mass spectrometry-based metabolomics.
    J Pharm Biomed Anal. 2020;178:112905.
    Abstract     Related articles   

  859. STRACCIA P, Martini M, Sacco E, Bassi PF, et al
    Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma.
    Diagn Cytopathol. 2020;48:111-117.
    Abstract     Related articles   

  860. CORNEJO KM, Cosar EF, Paner GP, Yang P, et al
    Mutational Profile Using Next-Generation Sequencing May Aid in the Diagnosis and Treatment of Urachal Adenocarcinoma.
    Int J Surg Pathol. 2020;28:51-59.
    Abstract     Related articles   

  861. MITRA S, Ayyanar P, Kaur G
    Villous Morphology in Urinary Bladder Biopsy: An Approach to Diagnosis.
    Int J Surg Pathol. 2020;28:4-12.
    Abstract     Related articles   

  862. JIANG Q, Han T, Ren H, Aziz AUR, et al
    Bladder cancer hunting: a microfluidic paper-based analytical device.
    Electrophoresis. 2020 Jun 12. doi: 10.1002/elps.202000080.
    Abstract     Related articles   

  863. LILGE L, Wu J, Xu Y, Manalac A, et al
    Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer.
    J Biomed Opt. 2020;25:1-13.
    Abstract     Related articles   

  864. YAN YL, Huang ZN, Zhu Z, Cui YY, et al
    Downregulation of TET1 Promotes Bladder Cancer Cell Proliferation and Invasion by Reducing DNA Hydroxymethylation of AJAP1.
    Front Oncol. 2020;10:667.
    Abstract     Related articles   

  865. SALIMIAN J, Baradaran B, Azimzadeh Jamalkandi S, Moridikia A, et al
    MiR-486-5p enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by induction of apoptosis and down-regulation of metastatic genes.
    Urol Oncol. 2020 Jun 8. pii: S1078-1439(20)30212.
    Abstract     Related articles   

  866. SABO AA, Birolo G, Naccarati A, Dragomir MP, et al
    Small Non-Coding RNA Profiling in Plasma Extracellular Vesicles of Bladder Cancer Patients by Next-Generation Sequencing: Expression Levels of miR-126-3p and piR-5936 Increase with Higher Histologic Grades.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  867. SHARMA G, Tyagi S
    Comment on "Bipolar versus monopolar transurethral resection of non-muscle-invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trials".
    World J Urol. 2020 Jun 10. pii: 10.1007/s00345-020-03292.
    Abstract     Related articles   

  868. BARLOW LJ
    Non-muscle-invasive Bladder Cancer Management During BCG Shortages: NYU Case of the Month, February 2020.
    Rev Urol. 2020;22:35-36.
    Abstract     Related articles   

  869. ABUGOMAA A, Elbadawy M, Yamanaka M, Goto Y, et al
    Establishment of 2.5D organoid culture model using 3D bladder cancer organoid culture.
    Sci Rep. 2020;10:9393.
    Abstract     Related articles   

  870. Correction to "Identifying the ErbB/MAPK Signaling Cascade as a Therapeutic Target in Canine Bladder Cancer".
    Mol Pharmacol. 2020;98:23.
    Abstract     Related articles   

  871. YU M, Ozaki T, Sun D, Xing H, et al
    HIF-1alpha-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
    J Exp Clin Cancer Res. 2020;39:108.
    Abstract     Related articles   

  872. XIE H, Zhang T, Yang N, Li Z, et al
    Anticancer effects of Mahanimbine alkaloid on the human bladder cancer cells are due to the induction of G0/G1 cell cycle arrest, apoptosis and autophagy.
    J BUON. 2020;25:1166-1171.
    Abstract     Related articles   

  873. CHAN KM, Gleadle J, Li J, Vasilev K, et al
    Shedding Light on Bladder Cancer Diagnosis in Urine.
    Diagnostics (Basel). 2020;10.
    Abstract     Related articles   

  874. YANG G, Bondaruk J, Cogdell D, Wang Z, et al
    Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer.
    iScience. 2020;23:101201.
    Abstract     Related articles   

  875. ELIE-CAILLE C, Lascombe I, Pechery A, Bittard H, et al
    Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure.
    Mol Cell Biochem. 2020 Jun 9. pii: 10.1007/s11010-020-03771.
    Abstract     Related articles   

  876. ORNAGHI PI, Afferi L, Antonelli A, Cerruto MA, et al
    The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature.
    World J Urol. 2020 Jun 9. pii: 10.1007/s00345-020-03291.
    Abstract     Related articles   

  877. HUANG CS, Ho JY, Chiang JH, Yu CP, et al
    Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells.
    Cells. 2020;9.
    Abstract     Related articles   

  878. JURI H, Narumi Y, Panebianco V, Osuga K, et al
    Staging of bladder cancer with multiparametric MRI.
    Br J Radiol. 2020 Jun 9:20200116. doi: 10.1259/bjr.20200116.
    Abstract     Related articles   

  879. BANDINI M, Ross JS, Raggi D, Gallina A, et al
    Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer.
    J Natl Cancer Inst. 2020 Jun 9. pii: 5855139. doi: 10.1093.
    Abstract     Related articles   

  880. BOSTROM PJ, Jensen JB, Jerlstrom T, Arum CJ, et al
    Clinical markers of morbidity, mortality and survival in bladder cancer patients treated with radical cystectomy. A systematic review.
    Scand J Urol. 2020 Jun 9:1-10. doi: 10.1080/21681805.2020.1773527.
    Abstract     Related articles   

  881. PAL DK, Agrawal A, Ghosh S, Ghosh A, et al
    Association of arsenic with recurrence of urinary bladder cancer.
    Trop Doct. 2020 Jun 9:49475520930155. doi: 10.1177/0049475520930155.
    Abstract     Related articles   

  882. JUSTIN S, Rutz J, Maxeiner S, Chun FK, et al
    Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  883. SUN S, Liu F, Xian S, Cai D, et al
    miR-325-3p Overexpression Inhibits Proliferation and Metastasis of Bladder Cancer Cells by Regulating MT3.
    Med Sci Monit. 2020;26:e920331.
    Abstract     Related articles   

  884. ARIAFAR A, Ghaedi M, Rezaeifard S, Shahriari S, et al
    Clinical relevance and prognostic significance of PD-1/PD-Ls in non-metastatic bladder cancer: A role for PD-L2.
    Mol Immunol. 2020;124:35-41.
    Abstract     Related articles   

  885. HAYASHI Y, Fujita K, Matsuzaki K, Eich ML, et al
    Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer.
    Front Oncol. 2020;10:755.
    Abstract     Related articles   

  886. BERNARDO C, Santos J, Costa C, Tavares A, et al
    Estrogen receptors in urogenital schistosomiasis and bladder cancer: Estrogen receptor alpha-mediated cell proliferation.
    Urol Oncol. 2020 Jun 2. pii: S1078-1439(20)30158.
    Abstract     Related articles   

  887. LONG Q, Ma AH, Zhang H, Cao Z, et al
    Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.
    Cancer Immunol Immunother. 2020 Jun 6. pii: 10.1007/s00262-020-02609.
    Abstract     Related articles   

  888. RAMMANT E, Van Wilder L, Van Hemelrijck M, Pauwels NS, et al
    Health-related quality of life overview after different curative treatment options in muscle-invasive bladder cancer: an umbrella review.
    Qual Life Res. 2020 Jun 6. pii: 10.1007/s11136-020-02544.
    Abstract     Related articles   

  889. KESSLER ER, Kukreja JB, Geiger CL, Fischer SM, et al
    Treating Elderly Patients With Muscle-Invasive Bladder Cancer.
    J Natl Compr Canc Netw. 2020;18:783-790.
    Abstract     Related articles   

  890. CHEN DY, Cheng L, Dong LX, He WJ, et al
    Efficacy of pirarubicin for nonmuscle invasive bladder cancer: A protocol of systematic review and meta-analysis.
    Medicine (Baltimore). 2020;99:e20415.
    Abstract     Related articles   

  891. TANG Q, Wang L, Jiang X, Li R, et al
    MIR22HG regulates miR-486/PTEN axis in bladder cancer to promote cell proliferation.
    Biosci Rep. 2020 Jun 5. pii: 225167. doi: 10.1042/BSR20193991.
    Abstract     Related articles   

  892. GAKIS G, Hassan FN, Schmid MA, Olschlager M, et al
    Prognostic significance of previous tonsillectomy after radical cystectomy for bladder cancer.
    Scand J Urol. 2020 Jun 5:1-7. doi: 10.1080/21681805.2020.1773530.
    Abstract     Related articles   

  893. LIU X, Zhang M, Cheng X, Liu X, et al
    LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma.
    Front Oncol. 2020;10:717.
    Abstract     Related articles   

  894. BURKE B, Eden C, Perez C, Belshoff A, et al
    Inhibition of Histone Deacetylase (HDAC) Enhances Checkpoint Blockade Efficacy by Rendering Bladder Cancer Cells Visible for T Cell-Mediated Destruction.
    Front Oncol. 2020;10:699.
    Abstract     Related articles   

  895. JIN D, Qiu S, Jin K, Zhou X, et al
    Signet-Ring Cell Carcinoma as an Independent Prognostic Factor for Patients With Urinary Bladder Cancer: A Population-Based Study.
    Front Oncol. 2020;10:653.
    Abstract     Related articles   

  896. ROSIELLO G, Knipper S, Palumbo C, Pecoraro A, et al
    Rates of other-cause mortality after radical cystectomy are decreasing over time-A population-based analysis over two decades.
    J Surg Oncol. 2020;121:1329-1336.
    Abstract     Related articles   

  897. PENG L, Li J, Cao D, Ren Z, et al
    Can robotic-assisted radical cystectomy provide patients with a smaller trauma and faster recovery period? A systematic review and meta-analysis of comparative trials.
    J Cancer Res Clin Oncol. 2020;146:1591-1601.
    Abstract     Related articles   

  898. ESPERTO F, Pang KH, Albisinni S, Papalia R, et al
    Bladder Cancer at the time of COVID-19 Outbreak.
    Int Braz J Urol. 2020;46.
    Abstract     Related articles   

  899. HADJIISKI LM, Cha KH, Cohan RH, Chan HP, et al
    Intraobserver Variability in Bladder Cancer Treatment Response Assessment With and Without Computerized Decision Support.
    Tomography. 2020;6:194-202.
    Abstract     Related articles   

  900. LI C, Fu X, He H, Chen C, et al
    The Biogenesis, Functions, and Roles of circRNAs in Bladder Cancer.
    Cancer Manag Res. 2020;12:3673-3689.
    Abstract     Related articles   

  901. MAO S, Wu Y, Wang R, Guo Y, et al
    Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway.
    Onco Targets Ther. 2020;13:4813-4824.
    Abstract     Related articles   

  902. YU C, Wang Y, Liu T, Sha K, et al
    The microRNA miR-3174 Suppresses the Expression of ADAM15 and Inhibits the Proliferation of Patient-Derived Bladder Cancer Cells.
    Onco Targets Ther. 2020;13:4157-4168.
    Abstract     Related articles   

  903. CHENG L, Wang H, Wang Z, Huang H, et al
    Leflunomide Inhibits Proliferation and Induces Apoptosis via Suppressing Autophagy and PI3K/Akt Signaling Pathway in Human Bladder Cancer Cells.
    Drug Des Devel Ther. 2020;14:1897-1908.
    Abstract     Related articles   

  904. GUO CC, Bondaruk J, Yao H, Wang Z, et al
    Assessment of Luminal and Basal Phenotypes in Bladder Cancer.
    Sci Rep. 2020;10:9743.
    Abstract     Related articles   

  905. JAIN RK, Sonpavde G
    Neoadjuvant therapy for muscle-invasive bladder cancer.
    Expert Rev Anticancer Ther. 2020 Jun 16. doi: 10.1080/14737140.2020.1784011.
    Abstract     Related articles   

  906. SILIQUINI N, Viola R, Giura MT, Fierro MT, et al
    Case of bladder cancer during Dupilumab therapy: just an incidental event?
    Dermatol Ther. 2020 Jun 16:e13854. doi: 10.1111/dth.13854.
    Abstract     Related articles   

  907. ZENG H, Zhou Q, Wang Z, Zhang H, et al
    Stromal LAG-3(+) cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contexture.
    J Immunother Cancer. 2020;8.
    Abstract     Related articles   

  908. SONG Y, Jin D, Chen J, Liang W, et al
    Effects of Arsenic (+3 oxidation state) Methyltransferase Gene Polymorphisms and Expression on Bladder Cancer: Evidence From A Systematic Review, Meta-analysis and TCGA dataset.
    Toxicol Sci. 2020 Jun 15. pii: 5857619. doi: 10.1093.
    Abstract     Related articles   

  909. DE LA PENA E, Hernandez V, Guijarro A, Castro A, et al
    [Recommendations on bladder cancer Management during COVID-19 pandemia: lessons learned and future plans.]
    Arch Esp Urol. 2020;73:374-383.
    Abstract     Related articles   

  910. LI XG, Zhang WS, Yan XP
    Piceatannol inhibits proliferation and induces apoptosis of bladder cancer cells through regulation of the PTEN/AKT signal pathway.
    Cell Mol Biol (Noisy-le-grand). 2020;66:181-184.
    Abstract     Related articles   

  911. OOI EH, Popov V, Alfano M, Cheong JKK, et al
    Influence of natural convection on gold nanorods-assisted photothermal treatment of bladder cancer in mice.
    Int J Hyperthermia. 2020;37:634-650.
    Abstract     Related articles   

  912. GLYKAS I, Fragkoulis C, Kapogiannis F, Ntoumas K, et al
    Re: Sungmin Woo, Valeria Panebianco, Yoshifumi Narumi, Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. Eur Urol Oncol. In press. https://d
    Eur Urol Oncol. 2020 Jun 11. pii: S2588-9311(20)30059.
    Abstract     Related articles   

  913. MAO W, Ma B, Wang K, Wu J, et al
    Sarcopenia predicts prognosis of bladder cancer patients after radical cystectomy: A study based on the Chinese population.
    Clin Transl Med. 2020 Jun 14. doi: 10.1002.
    Abstract     Related articles   

  914. PRAYER GALETTI T, Soligo M, Morlacco A, Lami V, et al
    Morbidity, mortality, and quality assessment following open radical cystectomy in elderly patients with bladder cancer.
    Aging Clin Exp Res. 2020 Jun 13. pii: 10.1007/s40520-020-01613.
    Abstract     Related articles   

  915. HSIEH JJ
    The 2020 Bladder Cancer Discrepancy Issue.
    Clin Genitourin Cancer. 2020;18:161.
    Abstract     Related articles   

  916. JIN D, Zhang R, Chen H, Li C, et al
    Aberrantly glycosylated integrin alpha3beta1 is a unique urinary biomarker for the diagnosis of bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  917. HAYASHI Y, Fujita K, Nojima S, Tomiyama E, et al
    TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer.
    Mol Oncol. 2020 Jun 13. doi: 10.1002/1878-0261.12746.
    Abstract     Related articles   

  918. SORIA F, D'Andrea D, Abufaraj M, Moschini M, et al
    Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies.
    Eur Urol Focus. 2020 Jun 9. pii: S2405-4569(20)30115.
    Abstract     Related articles   

  919. HAROON UM, Galvin DJ
    Letter to the Editor regarding the article "Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors".
    World J Urol. 2020;38:1343.
    Abstract     Related articles   

  920. HASEGAWA M, Hasegawa G, Ikeda Y, Hara N, et al
    Emergence of undifferentiated urothelial carcinoma after pembrolizumab treatment for patient with invasive urothelial bladder cancer: A case report.
    SAGE Open Med Case Rep. 2020;8:2050313X20932694.
    Abstract     Related articles   

  921. ROUDNICKY F, Poyet C, Buser L, Saba K, et al
    Characterization of tumor blood vasculature expression of human invasive bladder cancer by laser capture microdissection and transcriptional profiling.
    Am J Pathol. 2020 Jun 22. pii: S0002-9440(20)30296.
    Abstract     Related articles   

  922. ERIKSON MS, Petersen AC, Andersen KK, Jacobsen FK, et al
    Do repeated transurethral procedures under general anesthesia influence mortality in patients with non-invasive urothelial bladder cancer? A Danish national cohort study.
    Scand J Urol. 2020 Jun 25:1-9. doi: 10.1080/21681805.2020.1782978.
    Abstract     Related articles   

  923. FUKUSHIMA H, Nakanishi Y, Kataoka M, Tobisu KI, et al
    Clinically node-positive micropapillary bladder cancer in a young female desiring to spare functional bladder and fertility.
    Int Cancer Conf J. 2020;9:151-154.
    Abstract     Related articles   

  924. SONG Y, Jin D, Chen J, Luo Z, et al
    Identification of an immune-relatedlLong non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  925. TORAB P, Yan Y, Yamashita H, Warrick JI, et al
    Three-Dimensional Microtumors for Probing Heterogeneity of Invasive Bladder Cancer.
    Anal Chem. 2020 Jun 24. doi: 10.1021/acs.analchem.0c00057.
    Abstract     Related articles   

  926. XU X, Shivappa N
    Dietary glycemic index, glycemic load and risk of bladder cancer: a prospective study.
    Eur J Nutr. 2020 Jun 23. pii: 10.1007/s00394-020-02313.
    Abstract     Related articles   

  927. BAJRAMOVIC S, Alic J, Skopljak E, Chikha A, et al
    Renal Tuberculosis Following Intravesical Bacillus Calmette-Guerin (BCG) Immunotherapy for the Treatment of Bladder Cancer.
    Med Arch. 2020;74:146-150.
    Abstract     Related articles   

  928. OKAJIMA E, Tomizawa M, Shimada K, Negishi T, et al
    D2-40/podoplanin expression in cancer stroma by immunohistochemical staining is associated with poor prognosis in bladder cancer patients after radical cystectomy.
    Urol Oncol. 2020 Jun 20. pii: S1078-1439(20)30247.
    Abstract     Related articles   

  929. HUO W, Tan D, Chen Q
    CASC9 Facilitates Cell Proliferation in Bladder Cancer by Regulating CBX2 Expression.
    Nephron. 2020 Jun 22:1-12. doi: 10.1159/000507828.
    Abstract     Related articles   

  930. LIU L, Hu J, Wang Y, Sun T, et al
    Establishment of a novel risk score model by comprehensively analyzing the immunogen database of bladder cancer to indicate clinical significance and predict prognosis.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  931. AJIB K, Tjong MC, Tan GH, Nason G, et al
    Canadian experience of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy for muscle-invasive bladder cancer.
    Can Urol Assoc J. 2020 Jun 16. pii: cuaj.6459. doi: 10.5489/cuaj.6459.
    Abstract     Related articles   

  932. JANG JH, Sung EG, Song IH, Lee TJ, et al
    Metformin induces caspase-dependent and caspase-independent apoptosis in human bladder cancer T24 cells.
    Anticancer Drugs. 2020 Jun 19. doi: 10.1097/CAD.0000000000000966.
    Abstract     Related articles   

  933. KIKUCHI K, Nakamura R, Segawa T, Oikawa H, et al
    Modified Glasgow prognostic score can predict survival of muscle invasive bladder cancer patients after radiotherapy.
    J Radiat Res. 2020 Jun 22. pii: 5860602. doi: 10.1093.
    Abstract     Related articles   

  934. TYAGI A, Kolluru V, Chandrasekaran B, Saran U, et al
    ASR488, a novel small molecule, activates an mRNA binding protein, CPEB1, and inhibits the growth of bladder cancer.
    Oncol Lett. 2020;20:850-860.
    Abstract     Related articles   

  935. OUYANG S, Liu JH, Ni Z, Ding GF, et al
    Downregulation of ST3GAL5 is associated with muscle invasion, high grade and a poor prognosis in patients with bladder cancer.
    Oncol Lett. 2020;20:828-840.
    Abstract     Related articles   

  936. MUKAE Y, Miyata Y, Nakamura Y, Araki K, et al
    Pathological roles of c-Met in bladder cancer: Association with cyclooxygenase-2, heme oxygenase-1, vascular endothelial growth factor-A and programmed death ligand 1.
    Oncol Lett. 2020;20:135-144.
    Abstract     Related articles   

  937. JALLOH M, Cassell A, Diallo T, Gaye O, et al
    Is Schistosomiasis a Risk Factor for Bladder Cancer? Evidence-Based Facts.
    J Trop Med. 2020;2020:8270810.
    Abstract     Related articles   

  938. TIAN Z, Meng L, Long X, Diao T, et al
    DNA methylation-based classification and identification of bladder cancer prognosis-associated subgroups.
    Cancer Cell Int. 2020;20:255.
    Abstract     Related articles   

  939. GUPTA NK, Sarkar D, Pal DK
    Monthly maintenance protocol Bacillus Calmette-Guerin as a viable alternative to Southwest Oncology Group maintenance protocol in nonmuscle-invasive bladder cancer: A prospective randomized study.
    Urol Ann. 2020;12:116-121.
    Abstract     Related articles   

  940. ANASTASI E, Maggi M, Tartaglione S, Angeloni A, et al
    Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: A comparative prospective study.
    Diagn Cytopathol. 2020 Jun 20. doi: 10.1002/dc.24530.
    Abstract     Related articles   

  941. HAN J, Gu X, Li Y, Wu Q, et al
    Mechanisms of BCG in the treatment of bladder cancer-current understanding and the prospect.
    Biomed Pharmacother. 2020;129:110393.
    Abstract     Related articles   

  942. KIM TJ, Yu YD, Hwang SI, Lee HJ, et al
    Analysis of risk factors for post-bacillus Calmette-Guerin-induced prostatitis in patients with non-muscle invasive bladder cancer.
    Sci Rep. 2020;10:9763.
    Abstract     Related articles   

  943. WANG Y, Sun Q, Ji L, Wang G, et al
    lncRNA MORT Regulates Bladder Cancer Behaviors by Downregulating MicroRNA-146a-5p.
    Nephron. 2020;144:351-357.
    Abstract     Related articles   

  944. VETTERLEIN MW, Witjes JA, Loriot Y, Giannarini G, et al
    Cutting-edge Management of Muscle-invasive Bladder Cancer in 2020 and a Glimpse into the Future.
    Eur Urol Oncol. 2020 Jun 15. pii: S2588-9311(20)30078.
    Abstract     Related articles   

  945. MASTERSON AN, Liyanage T, Berman C, Kaimakliotis H, et al
    A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses.
    Analyst. 2020;145:4173-4180.
    Abstract     Related articles   

  946. DIRIX P, Strijbos M, Van den Mooter T, Vandeursen H, et al
    Palliative bladder radiotherapy: caveats in a changing landscape.
    Ann Palliat Med. 2020;9:1269-1271.
    Abstract     Related articles   

  947. LEVY DR, Cheng L
    The expanding molecular and mutational landscape of nested variant of urothelial carcinoma.
    Histopathology. 2020;76:638-639.
    Abstract     Related articles   

  948. HANNA KS
    Clinical Overview of Enfortumab Vedotin in the Management of Locally Advanced or Metastatic Urothelial Carcinoma.
    Drugs. 2020;80:1-7.
    Abstract     Related articles   

  949. LI Y, Qiao L, Zang Y, Ni W, et al
    Circular RNA FOXO3 Suppresses Bladder Cancer Progression and Metastasis by Regulating MiR-9-5p/TGFBR2.
    Cancer Manag Res. 2020;12:5049-5056.
    Abstract     Related articles   

  950. KIM HJ, Gong MK, Yoon CY, Kang J, et al
    Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells.
    Yonsei Med J. 2020;61:587-596.
    Abstract     Related articles   

  951. SHAIKH MO, Huang TC, Wu TF, Chuang CH, et al
    Label free Impedimetric Immunosensor for effective bladder Cancer detection in clinical urine samples.
    Biomed Microdevices. 2020;22:45.
    Abstract     Related articles   

  952. CAO R, Yuan L, Ma B, Wang G, et al
    Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA).
    Cancer Cell Int. 2020;20:276.
    Abstract     Related articles   

  953. BANDINI M, Calareso G, Raggi D, Marandino L, et al
    The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2020 Jun 27. pii: S2588-9311(20)30082.
    Abstract     Related articles   

  954. ZHANG G, Xu L, Zhao L, Mao L, et al
    CT-based radiomics to predict the pathological grade of bladder cancer.
    Eur Radiol. 2020 Jun 29. pii: 10.1007/s00330-020-06893.
    Abstract     Related articles   

  955. BOTHIG R, Golka K, Tiburtius C, Balzer O, et al
    Incidental bladder cancer at initial urological workup of spinal cord injury patients.
    Spinal Cord Ser Cases. 2020;6:55.
    Abstract     Related articles   

  956. PSUTKA SP
    Introduction: Personalizing risk stratification in bladder cancer: Moving away from "the eyeball test" and embracing objective quantification of risk.
    Urol Oncol. 2020 Jun 27. pii: S1078-1439(20)30257.
    Abstract     Related articles   

  957. FERRAN-CARPINTERO A, Dominguez-Garcia A, Munoz-Rodriguez J, Barquero-Lopez M, et al
    Impact of anemia on the survival of patients undergoing radical cystectomy for bladder cancer.
    Actas Urol Esp. 2020 Jun 26. pii: S0210-4806(20)30097.
    Abstract     Related articles   

  958. BILSKI K, Dobruch J, Kozikowski M, Skrzypczyk MA, et al
    Urobiome in Gender-Related Diversities of Bladder Cancer.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  959. ARORA A, Pugliesi FG, Zugail AS, Moschini M, et al
    Comparing peri-operative complications between laparoscopic and robotic radical cystectomy for bladder cancer.
    J Endourol. 2020 Jun 27. doi: 10.1089/end.2020.0112.
    Abstract     Related articles   

  960. DAI G, Huang C, Yang J, Jin L, et al
    LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.
    J Cell Mol Med. 2020 Jun 28. doi: 10.1111/jcmm.15564.
    Abstract     Related articles   

  961. WANG T, Yang Y, Wang Z, Zhang X, et al
    A SNP of miR-146a is involved in bladder cancer relapse by affecting the function of bladder cancer stem cells via the miR-146a signallings.
    J Cell Mol Med. 2020 Jun 28. doi: 10.1111/jcmm.15480.
    Abstract     Related articles   

  962. JIAN Y, Xu Z, Xu C, Zhang L, et al
    The Roles of Glycans in Bladder Cancer.
    Front Oncol. 2020;10:957.
    Abstract     Related articles   

  963. BHAMBHVANI HP, Zamora A, Shkolyar E, Prado K, et al
    Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer.
    Urol Oncol. 2020 Jun 24. pii: S1078-1439(20)30213.
    Abstract     Related articles   

  964. NAKAYAMA T, Nozawa N, Kawada C, Yamamoto S, et al
    Mitomycin C-induced cell cycle arrest enhances 5-aminolevulinic acid-based photodynamic therapy for bladder cancer.
    Photodiagnosis Photodyn Ther. 2020 Jun 24:101893.
    Abstract     Related articles   

  965. LILGE L, Wu J, Xu Y, Manalac A, et al
    Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer (Erratum).
    J Biomed Opt. 2020;25:1.
    Abstract     Related articles   

  966. ERDEM GU, Dogan M, Aytekin A, Sahin S, et al
    Clinical outcomes of patients with pure small cell carcinoma of the urinary bladder.
    Ir J Med Sci. 2020;189:431-438.
    Abstract     Related articles   

  967. DOWNES MR, Slodkowska E, Katabi N, Jungbluth AA, et al
    Interobserver and Intraobserver agreement of PD-L1 scoring in Head and Neck Squamous Cell Carcinoma (HSCC), Urothelial Carcinoma (UC), and Breast Carcinoma (BC).
    Histopathology. 2019 Jun 27. doi: 10.1111/his.13946.
    Abstract     Related articles   

  968. ZHANG Z, Ao P, Han H, Zhang Q, et al
    LncRNA PLAC2 upregulates miR-663 to downregulate TGF-beta1 and suppress bladder cancer cell migration and invasion.
    BMC Urol. 2020;20:94.
    Abstract     Related articles   

  969. PUTTAMALLESH VN, Deb B, Gondkar K, Jain A, et al
    Quantitative Proteomics of Urinary Bladder Cancer Cell Lines Identify UAP1 as a Potential Therapeutic Target.
    Genes (Basel). 2020;11.
    Abstract     Related articles   

  970. XU J, Yang R, Hua X, Huang M, et al
    lncRNA SNHG1 Promotes Basal Bladder Cancer Invasion via Interaction with PP2A Catalytic Subunit and Induction of Autophagy.
    Mol Ther Nucleic Acids. 2020;21:354-366.
    Abstract     Related articles   

  971. YILMAZ A, Yilmaz H, Tekin SB, Bilici M, et al
    The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer.
    Biomark Med. 2020 Jul 10. doi: 10.2217/bmm-2020-0045.
    Abstract     Related articles   

  972. CHO EJ, Kwon Bang C, Kim H, Kyung Lee H, et al
    An ensemble approach of urine sediment image analysis and NMP22 test for detection of bladder cancer cells.
    J Clin Lab Anal. 2020 Jul 10:e23345. doi: 10.1002/jcla.23345.
    Abstract     Related articles   

  973. SAMPOGNA G, Maltagliati M, Galfano A, Bocciardi A, et al
    Experience of a tertiary referral center in managing bladder cancer in conjunction with neurogenic bladder.
    Spinal Cord Ser Cases. 2020;6:61.
    Abstract     Related articles   

  974. ZHANG X, Zhang M, Zhang X, Zhu X, et al
    A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
    BMC Med Inform Decis Mak. 2020;20.
    Abstract     Related articles   

  975. TELFAH M, Parikh RA, Zhang D, Kasi A, et al
    Metastatic Plasmacytoid Bladder Cancer Harboring a CDH-1 Mutation and Producing High Levels of CA 19-9. A Case Report and Literature Review.
    Am J Case Rep. 2020;21:e923130.
    Abstract     Related articles   

  976. JENSEN JB
    Comment on: Cystoscopic surveillance of patients with non-muscle-invasive bladder cancer revisited.
    Scand J Urol. 2020 Jul 9:1. doi: 10.1080/21681805.2020.1790653.
    Abstract     Related articles   

  977. HERRERA JC, Ibilibor C, Wang H, Klein GT, et al
    National Trends and Impact of Regionalization of Radical Cystectomy on Survival Outcomes in Patients with Muscle Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2020 May 22. pii: S1558-7673(20)30120.
    Abstract     Related articles   

  978. HSU CW, Chiu YC, Hu HY, Fan YH, et al
    Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study.
    BMC Urol. 2020;20:91.
    Abstract     Related articles   

  979. YANG JL, Wang CCN, Cai JH, Chou CY, et al
    Identification of GSN and LAMC2 as Key Prognostic Genes of Bladder Cancer by Integrated Bioinformatics Analysis.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  980. PIWOWARCZYK L, Stawny M, Mlynarczyk DT, Muszalska-Kolos I, et al
    Role of Curcumin and (-)-Epigallocatechin-3-O-Gallate in Bladder Cancer Treatment: A Review.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  981. FONT A, Domenech M, Benitez R, Rava M, et al
    Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  982. WANG JF, Gong YQ, He YH, Ying WW, et al
    High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer.
    Eur Rev Med Pharmacol Sci. 2020;24:6605-6615.
    Abstract     Related articles   

  983. CHARALAMPOS F, Ioannis G, Athanasios P, Georgios P, et al
    [Plasmacytoid variant of urothelial bladder cancer. A single center experience.]
    Arch Esp Urol. 2020;73:564-567.
    Abstract     Related articles   

    Cystoscopic surveillance of patients with non-muscle-invasive bladder cancer revisited.
    Scand J Urol. 2020 Jul 7:1-3. doi: 10.1080/21681805.2020.1788635.
    Abstract     Related articles   

  985. MUHLBAUER J, Stein R, Younsi N
    Bladder cancer in patients with spina bifida: a serious risk.
    World J Urol. 2020 Jul 6. pii: 10.1007/s00345-020-03338.
    Abstract     Related articles   

  986. MANSOUR B, Monyok A, Makra N, Gajdacs M, et al
    Bladder cancer-related microbiota: examining differences in urine and tissue samples.
    Sci Rep. 2020;10:11042.
    Abstract     Related articles   

  987. XU X, Mo Q, Shen H, Wang S, et al
    Reproductive and hormonal factors and bladder cancer risk: a prospective study and meta-analysis.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  988. CAI X, Qu L, Yang J, Xu J, et al
    Exosome-transmitted microRNA-133b inhibited bladder cancer proliferation by upregulating dual-specificity protein phosphatase 1.
    Cancer Med. 2020 Jul 6. doi: 10.1002/cam4.3263.
    Abstract     Related articles   

  989. YANG Z, Wang H, Zhang N, Xing T, et al
    Chaetocin Abrogates the Self-Renewal of Bladder Cancer Stem Cells via the Suppression of the KMT1A-GATA3-STAT3 Circuit.
    Front Cell Dev Biol. 2020;8:424.
    Abstract     Related articles   

  990. SU S, Liu L, Sun C, Yang L, et al
    Prognostic significance of serum lactate dehydrogenase in patients undergoing radical cystectomy for bladder cancer.
    Urol Oncol. 2020 Jul 2. pii: S1078-1439(20)30262.
    Abstract     Related articles   

  991. SHEE K, Seigne JD, Karagas MR, Marsit CJ, et al
    Identification of let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancer.
    Cancer Biomark. 2020 Jun 28. pii: CBM191322. doi: 10.3233/CBM-191322.
    Abstract     Related articles   

  992. SONG Y, Qi X, Liu X
    N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: An updated meta-analysis based on 54 case-control studies.
    Gene. 2020;757:144924.
    Abstract     Related articles   

  993. GRILO I, Rodrigues C, Soares A, Grande E, et al
    Facing treatment of non-urothelial bladder cancers in the immunotherapy era.
    Crit Rev Oncol Hematol. 2020;153:103034.
    Abstract     Related articles   

  994. NEDJADI T, Benabdelkamal H, Albarakati N, Masood A, et al
    Circulating proteomic signature for detection of biomarkers in bladder cancer patients.
    Sci Rep. 2020;10:10999.
    Abstract     Related articles   

  995. LORIOT Y, Roupret M
    [Immunotherapies in non-muscle invasive bladder cancer: immunotherapies and NMIBC].
    Bull Cancer. 2020;107.
    Abstract     Related articles   

  996. CAO R, Yuan L, Ma B, Wang G, et al
    Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC).
    Cancer Immunol Immunother. 2020 Jul 2. pii: 10.1007/s00262-020-02649.
    Abstract     Related articles   

  997. VAN DER VOS KE, Vis DJ, Nevedomskaya E, Kim Y, et al
    Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer.
    Sci Rep. 2020;10:10952.
    Abstract     Related articles   

  998. ZACHARIS A, Grullich C
    [First-line treatment of metastatic urothelial carcinoma : Update immuno-oncology].
    Urologe A. 2020;59:797-803.
    Abstract     Related articles   

  999. ZSCHABITZ S, Niegisch G
    [Second-line treatment of metastatic urothelial carcinoma : Update immuno-oncology].
    Urologe A. 2020;59:804-809.
    Abstract     Related articles   

  1000. ISHIYAMA Y, Yoshida K, Iizuka J, Unagami K, et al
    Robot-Assisted Radical Cystectomy With Orthotopic Neobladder as a Urinary Diversion for a Kidney Transplant Recipient: A Case Report.
    Transplant Proc. 2020 Feb 18. pii: S0041-1345(19)31282.
    Abstract     Related articles   

  1001. ALMASSI N, Pietzak EJ, Sarungbam J, Tickoo SK, et al
    Inverted urothelial papilloma and urothelial carcinoma with inverted growth are histologically and molecularly distinct entities.
    J Pathol. 2020;250:464-465.
    Abstract     Related articles   

  1002. ROLIM I, Henriques V, Rolim N, Blanca A, et al
    Clinicopathologic analysis of upper urinary tract carcinoma with variant histology.
    Virchows Arch. 2020;477:111-120.
    Abstract     Related articles   

  1003. BEN FRADJ MK, Bibi M, Hammami MB, Kallel A, et al
    Low Plasma 25-Hydoxyvitamin D at Diagnosis Predicts Poor Outcomes in Patients with Bladder Cancer: A Prospective Cohort Study.
    Nutr Cancer. 2020 Jul 16:1-7. doi: 10.1080/01635581.2020.1737150.
    Abstract     Related articles   

  1004. CAO R, Ma B, Yuan L, Wang G, et al
    Small nucleolar RNAs signature (SNORS) identified clinical outcome and prognosis of bladder cancer (BLCA).
    Cancer Cell Int. 2020;20:299.
    Abstract     Related articles   

  1005. JO G, Kwon MJ, Kim JN, Kim BJ, et al
    Radix Sophorae Flavescentis induces apoptosis through by Caspase, MAPK Activation and ROS Signaling Pathways in 5637 Human Bladder Cancer Cells.
    Int J Med Sci. 2020;17:1474-1481.
    Abstract     Related articles   

  1006. ZHOU Y, Zhang ZL, Luo MH, Yang H, et al
    Transurethral needle electrode resection and transurethral holmium laser resection of bladder cancer.
    World J Surg Oncol. 2020;18:166.
    Abstract     Related articles   

  1007. BURGER M
    [Clinical management of high-risk non-muscle-invasive bladder cancer during BCG shortage: what are the options, what are the risks?]
    Aktuelle Urol. 2020 Jul 15. doi: 10.1055/a-1201-2370.
    Abstract     Related articles   

  1008. CARVALHO FL, Zeymo A, Egan J, Kelly CH, et al
    Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer.
    Investig Clin Urol. 2020;61:390-396.
    Abstract     Related articles   

  1009. SCHMIDT S, Kunath F, Coles B, Draeger DL, et al
    Intravesical Bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review.
    Investig Clin Urol. 2020;61:349-354.
    Abstract     Related articles   

  1010. FUJITA N, Hatakeyama S, Okita K, Momota M, et al
    Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.
    Urol Oncol. 2020 Jul 11. pii: S1078-1439(20)30278.
    Abstract     Related articles   

  1011. ATTALLA K, Farkas AM, Anastos H, Audenet F, et al
    TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer.
    Urol Oncol. 2020 Jul 11. pii: S1078-1439(20)30275.
    Abstract     Related articles   

  1012. LOZANO F, Raventos CX, Carrion A, Trilla E, et al
    Current status of genetic urinary biomarkers for surveillance of non-muscle invasive bladder cancer: a systematic review.
    BMC Urol. 2020;20:99.
    Abstract     Related articles   

  1013. HSU CW, Cheng NC, Liao MY, Cheng TY, et al
    Development of Folic Acid-Conjugated and Methylene Blue-Adsorbed Au@TNA Nanoparticles for Enhanced Photodynamic Therapy of Bladder Cancer Cells.
    Nanomaterials (Basel). 2020;10.
    Abstract     Related articles   

  1014. LI B, Guo LH, Ban ZQ, Liu L, et al
    Upregulation of lncRNA plasmacytoma variant translocation 1 predicts poor prognosis in patients with muscle-invasive bladder cancer.
    Medicine (Baltimore). 2020;99:e21059.
    Abstract     Related articles   

  1015. SACHER AG, St Paul M, Paige CJ, Ohashi PS, et al
    Cytotoxic CD4(+) T Cells in Bladder Cancer-A New License to Kill.
    Cancer Cell. 2020;38:28-30.
    Abstract     Related articles   

  1016. SUN X, Song J, Li E, Geng H, et al
    Cigarette smoke supports stemness and epithelial-mesenchymal transition in bladder cancer stem cells through SHH signaling.
    Int J Clin Exp Pathol. 2020;13:1333-1348.
    Abstract     Related articles   

  1017. LEBLOND MM, Tille L, Nassiri S, Gilfillan CB, et al
    CD40 agonist restores the antitumor efficacy of anti-PD1 therapy in muscle-invasive bladder cancer in an IFN I/II-mediated manner.
    Cancer Immunol Res. 2020 Jul 13. pii: 2326-6066.CIR-19-0826.
    Abstract     Related articles   

  1018. CARNEY M, Quiroga M, Mounce L, Shephard E, et al
    Effect of pre-existing conditions on bladder cancer stage at diagnosis: a cohort study using electronic primary care records in the UK.
    Br J Gen Pract. 2020 Jul 13. pii: bjgp20X710921. doi: 10.3399/bjgp20X710921.
    Abstract     Related articles   

  1019. GRUNEWALD CM, Henn A, Galsky MD, Plimack ER, et al
    Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival.
    Urol Oncol. 2020 Jul 10. pii: S1078-1439(20)30276.
    Abstract     Related articles   

  1020. LI R, Li Y, Song J, Gao K, et al
    Intravesical gemcitabine versus mitomycin for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized controlled trial.
    BMC Urol. 2020;20:97.
    Abstract     Related articles   

  1021. KORAC-PRLIC J, Degoricija M, Vilovic K, Haupt B, et al
    Targeting Stat3 signaling impairs the progression of bladder cancer in a mouse model.
    Cancer Lett. 2020 Jul 10. pii: S0304-3835(20)30348.
    Abstract     Related articles   

  1022. LIU B, Zhan Y, Chen X, Hu X, et al
    Weighted gene co-expression network analysis can sort cancer-associated fibroblast-specific markers promoting bladder cancer progression.
    J Cell Physiol. 2020 Jul 13. doi: 10.1002/jcp.29939.
    Abstract     Related articles   

  1023. RUBINO S, Kim Y, Zhou J, Dhilon J, et al
    Positive Ki-67 and PD-L1 expression in post-neoadjuvant chemotherapy muscle-invasive bladder cancer is associated with shorter overall survival: a retrospective study.
    World J Urol. 2020 Jul 12. pii: 10.1007/s00345-020-03342.
    Abstract     Related articles   

  1024. ZARIFMAHMOUDI L, Ghorbani H, Sadeghi R, Sadri K, et al
    Sentinel lymph node biopsy in muscle-invasive bladder cancer: single-center experience.
    Ann Nucl Med. 2020 Jul 12. pii: 10.1007/s12149-020-01502.
    Abstract     Related articles   

  1025. HOQUE R, Mostafid H, Hughes MP
    Rapid, Low-Cost Dielectrophoretic Diagnosis of Bladder Cancer in a Clinical Setting.
    IEEE J Transl Eng Health Med. 2020;8:4300405.
    Abstract     Related articles   

  1026. KASHIWAGI E, Abe T, Kinoshita F, Ushijima M, et al
    The role of adipocytokines and their receptors in bladder cancer: expression of adiponectin or leptin is an independent prognosticator.
    Am J Transl Res. 2020;12:3033-3045.
    Abstract     Related articles   

  1027. CHEN X, Jin Y, Gong L, He D, et al
    Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer.
    Front Genet. 2020;11:607.
    Abstract     Related articles   

  1028. CHENG S, Peng T, Zhu X, Zhou F, et al
    BORA regulates cell proliferation and migration in bladder cancer.
    Cancer Cell Int. 2020;20:290.
    Abstract     Related articles   

  1029. SHARMA A, Reutter H, Ellinger J
    DNA Methylation and Bladder Cancer: Where Genotype does not Predict Phenotype.
    Curr Genomics. 2020;21:34-36.
    Abstract     Related articles   

  1030. SANTELLA C, Rouette J, Brundage MD, Filion KB, et al
    Androgen deprivation therapy for prostate cancer and the risk of bladder cancer: A systematic review of observational studies.
    Urol Oncol. 2020 Jul 9. pii: S1078-1439(20)30183.
    Abstract     Related articles   

  1031. ELSAWY AA, Harraz AM, Ghobrial FK, Abdullatef M, et al
    Diagnostic performance and predictive capacity of early urine cytology after transurethral resection of nonmuscle invasive bladder cancer: A prospective study.
    Urol Oncol. 2020 Jul 9. pii: S1078-1439(20)30279.
    Abstract     Related articles   

  1032. WHYARD T, Liu J, Darras FS, Waltzer WC, et al
    Organoid model of urothelial cancer: establishment and applications for bladder cancer research.
    Biotechniques. 2020 Jul 13. doi: 10.2144/btn-2020-0068.
    Abstract     Related articles   

  1033. PALUMBO C, Pecoraro A, Rosiello G, Luzzago S, et al
    Bladder cancer incidence rates and trends in young adults aged 20-39 years.
    Urol Oncol. 2020 Jul 8. pii: S1078-1439(20)30280.
    Abstract     Related articles   

  1034. THIBAULT C, Elaidi R, Vano YA, Rouabah M, et al
    Open-label phase II to evaluate the efficacy of NEoadjuvant dose-dense MVAC In cOmbination with durvalumab and tremelimumab in muscle-invasive urothelial carcinoma: NEMIO.
    Bull Cancer. 2020;107.
    Abstract     Related articles   

  1035. GROSS-GOUPIL M, Domblides C, Lefort F, Ravaud A, et al
    Open-label randomized multi-center phase 2 study: gemcitabine cisplatin plus avelumab or gemcitabine cisplatin as first-line treatment of patients with locally advanced or metastatic urothelial bladder carcinoma: GCisAve.
    Bull Cancer. 2020;107.
    Abstract     Related articles   

  1036. THIBAULT C, Gross-Goupil M
    [Innovations in systemic treatment of urothelial carcinoma].
    Bull Cancer. 2020;107.
    Abstract     Related articles   

  1037. LI H, Zhang Q, Shuman L, Kaag M, et al
    Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes.
    Sci Rep. 2020;10:1439.
    Abstract     Related articles   

  1038. DING D, Chen M, Xiao X, Cao P, et al
    Novel serum peptide model revealed by MALDI-TOF-MS and its diagnostic value in early bladder cancer.
    Int J Biol Markers. 2020 Jul 23:1724600820935473. doi: 10.1177/1724600820935473.
    Abstract     Related articles   

  1039. TEMIZ MZ, Colakerol A, Ulus I, Kilic E, et al
    Prediction of non-muscle-invasive bladder cancer recurrence during intravesical BCG immunotherapy by use of peripheral blood eosinophil count and percentage: a preliminary report.
    Cancer Immunol Immunother. 2020 Jul 22. pii: 10.1007/s00262-020-02673.
    Abstract     Related articles   

  1040. KITAMURA H, Hinotsu S, Tsukamoto T, Shibata T, et al
    Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.
    Jpn J Clin Oncol. 2020 Jul 23. pii: 5874842. doi: 10.1093.
    Abstract     Related articles   

  1041. NASPRO R, Finati M, Roscigno M, Pellucchi F, et al
    The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre.
    World J Urol. 2020 Jul 21. pii: 10.1007/s00345-020-03364.
    Abstract     Related articles   

  1042. WANG C, Yang Y, Yin L, Wei N, et al
    Novel Potential Biomarkers Associated With Epithelial to Mesenchymal Transition and Bladder Cancer Prognosis Identified by Integrated Bioinformatic Analysis.
    Front Oncol. 2020;10:931.
    Abstract     Related articles   

  1043. CHENG S, Jiang Z, Xiao J, Guo H, et al
    The prognostic value of six survival-related genes in bladder cancer.
    Cell Death Discov. 2020;6:58.
    Abstract     Related articles   

  1044. MOSTAFID H
    Cystoscopic surveillance for bladder cancer: Learning the lessons forced upon us by the Covid-19 pandemic.
    Scand J Urol. 2020 Jul 21:1-2. doi: 10.1080/21681805.2020.1794956.
    Abstract     Related articles   

  1045. ZHANG JJ, Cai LJ, Pang K, Dong Y, et al
    Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo.
    Clin Transl Oncol. 2020 Jul 20. pii: 10.1007/s12094-020-02455.
    Abstract     Related articles   

  1046. OGAWA K, Shimizu Y, Uketa S, Utsunomiya N, et al
    Prognosis of patients with muscle invasive bladder cancer who are intolerable to receive any anti-cancer treatment.
    Cancer Treat Res Commun. 2020;24:100195.
    Abstract     Related articles   

  1047. HUA H, Gao Y, Lin J, Hou F, et al
    Quantitative Analysis of Enhanced Computed Tomography in Differentiating Cystitis Glandularis and Bladder Cancer.
    Biomed Res Int. 2020;2020:4930621.
    Abstract     Related articles   

  1048. LIN T, Zhang Q, Yuan A, Wang B, et al
    Synergy of Tumor Microenvironment Remodeling and Autophagy Inhibition to Sensitize Radiation for Bladder Cancer Treatment.
    Theranostics. 2020;10:7683-7696.
    Abstract     Related articles   

  1049. ALFANO M, Pederzoli F, Bandini M, Necchi A, et al
    The new era of precision urobiome: RE: "Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study" by Chipollini et al.
    Urol Oncol. 2020 Jul 16. pii: S1078-1439(20)30299.
    Abstract     Related articles   

  1050. DEUKER M, Stolzenbach LF, Colla Ruvolo C, Nocera L, et al
    Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer.
    Urol Oncol. 2020 Jul 16. pii: S1078-1439(20)30291.
    Abstract     Related articles   

  1051. YIN PN, Kc K, Wei S, Yu Q, et al
    Histopathological distinction of non-invasive and invasive bladder cancers using machine learning approaches.
    BMC Med Inform Decis Mak. 2020;20:162.
    Abstract     Related articles   

  1052. LI S, Zhu H, Chen H, Xia J, et al
    Glucose promotes epithelial-mesenchymal transitions in bladder cancer by regulating the functions of YAP1 and TAZ.
    J Cell Mol Med. 2020 Jul 17. doi: 10.1111/jcmm.15653.
    Abstract     Related articles   

  1053. IDE H, Goto T, Teramoto Y, Mizushima T, et al
    FOXO1 inactivation induces cisplatin resistance in bladder cancer.
    Cancer Sci. 2020 Jul 17. doi: 10.1111/cas.14557.
    Abstract     Related articles   

  1054. VAN PUFFELEN JH, Keating ST, Oosterwijk E, van der Heijden AG, et al
    Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer.
    Nat Rev Urol. 2020 Jul 16. pii: 10.1038/s41585-020-0346.
    Abstract     Related articles   

  1055. ZHAN Y, Zhang L, Yu S, Wen J, et al
    Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/beta-catenin signaling pathway in bladder cancer.
    J Exp Clin Cancer Res. 2020;39:136.
    Abstract     Related articles   

  1056. SHEN P, He X, Lan L, Hong Y, et al
    Identification of Cell Division Cycle 20 as a Candidate Biomarker and Potential Therapeutic Target in Bladder Cancer Using Bioinformatics Analysis.
    Biosci Rep. 2020 Jul 17. pii: 225826. doi: 10.1042/BSR20194429.
    Abstract     Related articles   

  1057. LIPUNOVA N, Wesselius A, Cheng KK, van Schooten FJ, et al
    Gene-environment interaction with smoking for increased non-muscle-invasive bladder cancer tumor size.
    Transl Androl Urol. 2020;9:1329-1337.
    Abstract     Related articles   

  1058. ZHAO C, Pan Y, Wang Y, Li Y, et al
    A novel cell-free single-molecule unique primer extension resequencing (cf-SUPER) technology for bladder cancer non-invasive detection in urine.
    Transl Androl Urol. 2020;9:1222-1231.
    Abstract     Related articles   

  1059. MAO W, Xie J, Wu Y, Wu Z, et al
    Cost-effectiveness analysis of two kinds of bladder cancer urinary diversion: Studer versus Bricker.
    Transl Androl Urol. 2020;9:1113-1119.
    Abstract     Related articles   

  1060. MOGOS H, Eriksson E, Styrke J, Sherif A, et al
    Computerized tomography before the final treatment cycle of neoadjuvant chemotherapy or induction chemotherapy in muscle-invasive urinary bladder cancer, cannot predict pathoanatomical outcomes and does not reflect prognosis-results of a single centre
    Transl Androl Urol. 2020;9:1062-1072.
    Abstract     Related articles   

  1061. KOGA F
    Will chemoradiation-based bladder-sparing therapy become a standard of care for muscle-invasive bladder cancer?
    Transl Androl Urol. 2020;9:981-982.
    Abstract     Related articles   

  1062. ISMAILI N
    Editorial comment: the effect of neoadjuvant chemotherapy on tumour downstaging and outcomes in patients with muscle invasive bladder cancers.
    Transl Androl Urol. 2020;9:977-980.
    Abstract     Related articles   

  1063. GAO Q, Zheng J, Ni Z, Sun P, et al
    The m(6)A Methylation-Regulated AFF4 Promotes Self-Renewal of Bladder Cancer Stem Cells.
    Stem Cells Int. 2020;2020:8849218.
    Abstract     Related articles   

  1064. XU N, Ke ZB, Lin XD, Chen YH, et al
    Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis.
    Cancer Cell Int. 2020;20:302.
    Abstract     Related articles   

  1065. HE C, Li B, Huang L, Teng C, et al
    Gut microbial composition changes in bladder cancer patients: A case-control study in Harbin, China.
    Asia Pac J Clin Nutr. 2020;29:395-403.
    Abstract     Related articles   

  1066. WROCLAWSKI ML, Baccaglini WRC, Pazeto CL, Henriques LEB, et al
    Bladder pseudo-tumor: case report of vesical tamm-horsfall protein deposit.
    Int Braz J Urol. 2020;46:477-480.
    Abstract     Related articles   

  1067. ZHANG H, Wang H, Zhu M, Xu Z, et al
    Implementation of enhanced recovery after surgery in patients undergoing radical cystectomy: A retrospective cohort study.
    Eur J Surg Oncol. 2020;46:202-208.
    Abstract     Related articles   

  1068. QIU Y, Qiu S, Deng L, Nie L, et al
    Biomaterial 3D collagen I gel culture model: A novel approach to investigate tumorigenesis and dormancy of bladder cancer cells induced by tumor microenvironment.
    Biomaterials. 2020;256:120217.
    Abstract     Related articles   

  1069. LU N, Piao MH, Feng CS, Yuan Y, et al
    Isoflurane promotes epithelial-to-mesenchymal transition and metastasis of bladder cancer cells through HIF-1alpha-beta-catenin/Notch1 pathways.
    Life Sci. 2020 Jul 28:118154. doi: 10.1016/j.lfs.2020.118154.
    Abstract     Related articles   

  1070. SUN M, Bu R, Zhang B, Cao Y, et al
    Lentinan Inhibits Tumor Progression by Immunomodulation in a Mouse Model of Bladder Cancer.
    Integr Cancer Ther. 2020;19:1534735420946823.
    Abstract     Related articles   

  1071. KRAMER MW, Bolenz C
    [Rapid Progress in the treatment of bladder cancer: recent achievements].
    Aktuelle Urol. 2020;51:342-343.
    Abstract     Related articles   

  1072. O'MEARA S, Bhatt NR, Flynn RJ, Manecksha RP, et al
    Bladder cancer in Ireland: a 21-year review.
    Ir J Med Sci. 2020 Jul 29. pii: 10.1007/s11845-020-02318.
    Abstract     Related articles   

  1073. FULETRA JG, Watts A, Kaag MG, Lehman E, et al
    Can preoperative imaging characteristics predict pT3 bladder cancer following cystectomy?
    World J Urol. 2020 Jul 28. pii: 10.1007/s00345-020-03375.
    Abstract     Related articles   

  1074. LEI S, Xu H, Chen N, Pan H, et al
    MKP-1 overexpression is associated with chemoresistance in bladder cancer via the MAPK pathway.
    Oncol Lett. 2020;20:1743-1751.
    Abstract     Related articles   

  1075. WANG Y, Ba HJ, Liu ZC, Deng XB, et al
    Prognostic value of immune cell infiltration in bladder cancer: A gene expression-based study.
    Oncol Lett. 2020;20:1677-1684.
    Abstract     Related articles   

  1076. FRANZESE C, Francolini G, Nicosia L, Alongi F, et al
    Stereotactic Body Radiation Therapy in the Management of Oligometastatic and Oligoprogressive Bladder Cancer and Other Urothelial Malignancies.
    Clin Oncol (R Coll Radiol). 2020 Jul 25. pii: S0936-6555(20)30290.
    Abstract     Related articles   

  1077. MOSCHINI M
    From Basic Science to Clinical Research to Develop New Solutions to Improve Diagnoses and Treatment of Bladder Cancer Patients.
    J Clin Med. 2020;9.
    Abstract     Related articles   

  1078. TIAN J, Fu G, Xu Z, Chen X, et al
    Urinary exfoliated tumor single-cell metabolomics technology for establishing a drug resistance monitoring system for bladder cancer with intravesical chemotherapy.
    Med Hypotheses. 2020;143:110100.
    Abstract     Related articles   

  1079. LI Q, Huyan T, Cai S, Huang Q, et al
    The role of exosomal miR-375-3p: A potential suppressor in bladder cancer via the Wnt/beta-catenin pathway.
    FASEB J. 2020 Jul 27. doi: 10.1096/fj.202000347.
    Abstract     Related articles   

  1080. FUJITA N, Hatakeyama S, Okita K, Momota M, et al
    Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guerin therapy.
    Urol Oncol. 2020 Jul 23. pii: S1078-1439(20)30319.
    Abstract     Related articles   

  1081. AKUSHEVICH I, Yashkin AP, Inman BA, Sloan F, et al
    Partitioning of time trends in prevalence and mortality of bladder cancer in the United States.
    Ann Epidemiol. 2020;47:25-29.
    Abstract     Related articles   

  1082. ZAMBONI S, Afferi L, Soria F, Aziz A, et al
    Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent.
    World J Urol. 2020 Jul 25. pii: 10.1007/s00345-020-03362.
    Abstract     Related articles   

  1083. JUVET T, Mari A, Lajkosz K, Wallis CJ, et al
    Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure.
    Urol Oncol. 2020 Jul 22. pii: S1078-1439(20)30318.
    Abstract     Related articles   

  1084. SPEIR RW, Barboza MP, Calaway A, Masterson TA, et al
    Role of Neoadjuvant Chemotherapy in Squamous Variant Histology in Urothelial Bladder Cancer: Does Presence and Percentage Matter?
    Clin Genitourin Cancer. 2020 Jun 19. pii: S1558-7673(20)30143.
    Abstract     Related articles   

  1085. LEE CT, Mohamed NE, Pisipati S, Shah QN, et al
    Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach.
    BMC Health Serv Res. 2020;20:686.
    Abstract     Related articles   

  1086. SONG JH, Won SY, Hwang B, Jung S, et al
    In Vitro and In Vivo Antitumor Efficacy of Hizikia fusiforme Celluclast Extract against Bladder Cancer.
    Nutrients. 2020;12.
    Abstract     Related articles   

  1087. ROGERS J, Sherwood V, Wayte SC, Duffy JA, et al
    Quantification and correction of distortion in diffusion-weighted-MRI at 1.5 and 3 T in a muscle-invasive bladder cancer phantom for radiotherapy planning.
    Br J Radiol. 2020 Jul 24:20190710. doi: 10.1259/bjr.20190710.
    Abstract     Related articles   

  1088. YU X, Wang ZL, Han CL, Wang MW, et al
    LncRNA CASC15 functions as an oncogene by sponging miR-130b-3p in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2020;24:7203.
    Abstract     Related articles   

  1089. WANG F, Liu P, An H, Zhang Y, et al
    Sulforaphane suppresses the viability and metastasis, and promotes the apoptosis of bladder cancer cells by inhibiting the expression of FAT1.
    Int J Mol Med. 2020;46:1085-1095.
    Abstract     Related articles   

  1090. FRANCESCHINI T, Capizzi E, Massari F, Schiavina R, et al
    Immunohistochemical over-expression of HER2 does not always match with gene amplification in invasive bladder cancer.
    Pathol Res Pract. 2020;216:153012.
    Abstract     Related articles   

  1091. TAO TT, Chen J, Hu Q, Huang XJ, et al
    Urothelial carcinoma of the bladder with abundant myxoid stroma: A case report and literature review.
    Medicine (Baltimore). 2020;99:e21204.
    Abstract     Related articles   

  1092. XU H, Chen Z, Shen B, Wei Z, et al
    Primary bladder mucosa-associated lymphoid tissue lymphoma: A case report and literature review.
    Medicine (Baltimore). 2020;99:e20825.
    Abstract     Related articles   

  1093. NAVARRO CONDE P, Alemany Monraval P, Medina Medina C, Jimenez Sanchez A, et al
    Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain.
    Rev Esp Patol. 2020;53:188-192.
    Abstract     Related articles   

  1094. VLAD O, Catalin B, Mihai H, Adrian P, et al
    Enhanced recovery after surgery (ERAS) protocols in patients undergoing radical cystectomy with ileal urinary diversions: A randomized controlled trial.
    Medicine (Baltimore). 2020;99:e20902.
    Abstract     Related articles   

  1095. RICE-STITT T, Valencia-Guerrero A, Cornejo KM, Wu CL, et al
    Updates in Histologic Grading of Urologic Neoplasms.
    Arch Pathol Lab Med. 2020;144:335-343.
    Abstract     Related articles   

  1096. CORNEJO KM, Rice-Stitt T, Wu CL
    Updates in Staging and Reporting of Genitourinary Malignancies.
    Arch Pathol Lab Med. 2020;144:305-319.
    Abstract     Related articles   

  1097. PIERCONTI F, Raspollini MR, Martini M, Larocca LM, et al
    PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders.
    Virchows Arch. 2020;477:269-277.
    Abstract     Related articles   

  1098. WANG J, Zhao L, Peng X, Liu K, et al
    Evaluation of miR-130 family members as circulating biomarkers for the diagnosis of bladder cancer.
    J Clin Lab Anal. 2020 Aug 5:e23517. doi: 10.1002/jcla.23517.
    Abstract     Related articles   

  1099. MATULEWICZ RS, Steinberg GD
    Non-muscle-invasive Bladder Cancer: Overview and Contemporary Treatment Landscape of Neoadjuvant Chemoablative Therapies.
    Rev Urol. 2020;22:43-51.
    Abstract     Related articles   

  1100. ZHAO B, Wang K, Jiang B
    Application of clinical nursing pathway in bladder cancer patients undergoing ureteroperitoneostomy.
    Panminerva Med. 2020 Aug 5. pii: S0031-0808.20.04010.
    Abstract     Related articles   

  1101. JUSTIN S, Rutz J, Maxeiner S, Chun FK, et al
    Bladder Cancer Metastasis Induced by Chronic Everolimus Application Can Be Counteracted by Sulforaphane In Vitro.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  1102. LOBO J, Monteiro-Reis S, Guimaraes-Teixeira C, Lopes P, et al
    Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression.
    J Transl Med. 2020;18:303.
    Abstract     Related articles   

  1103. HUANG WL, Huang KH, Huang CY, Pu YS, et al
    Effect of diabetes mellitus and glycemic control on the prognosis of non-muscle invasive bladder cancer: a retrospective study.
    BMC Urol. 2020;20:117.
    Abstract     Related articles   

  1104. MOSTAFAEI S, Riahi P
    Interaction Effects of Plasma Vitamins A, E, D, B9, and B12 and Tobacco Exposure in Urothelial Bladder Cancer: A Multifactor Dimensionality Reduction Analysis.
    Nutr Cancer. 2020 Aug 6:1-2. doi: 10.1080/01635581.2020.1801776.
    Abstract     Related articles   

  1105. COSTANTINI L, Molinari R, Farinon B, Lelli V, et al
    Docosahexaenoic Acid Reverted the All-trans Retinoic Acid-Induced Cellular Proliferation of T24 Bladder Cancer Cell Line.
    J Clin Med. 2020;9.
    Abstract     Related articles   

  1106. WANG H, Niu X, Jiang H, Mao F, et al
    Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  1107. MATSUSHITA Y, Tamura K, Motoyama D, Ito T, et al
    Comprehensive assessment of oncological outcomes in 186 patients with high-risk non-muscle-invasive bladder cancer: A single institution retrospective study.
    Mol Clin Oncol. 2020;13:16.
    Abstract     Related articles   

  1108. KURODA K, Tasaki S, Sato A, Asakuma J, et al
    Effect of continuous saline bladder irrigation with concomitant single instillation of chemotherapy after transurethral resection on intravesical recurrence in patients with non-muscle-invasive bladder cancer.
    Mol Clin Oncol. 2020;13:6.
    Abstract     Related articles   

  1109. GONZALEZ-PADILLA DA, Gonzalez-Diaz A, Guerrero-Ramos F, Rodriguez-Serrano A, et al
    Quality of life and adverse events in patients with nonmuscle invasive bladder cancer receiving adjuvant treatment with BCG, MMC, or chemohyperthermia.
    Urol Oncol. 2020 Aug 1. pii: S1078-1439(20)30325.
    Abstract     Related articles   

  1110. DUBERT M, Abihssira S, Diamantis S, Guenin R, et al
    Mycobacterium bovis infection of an aortobifemoral bypass graft with Streptococcus intermedius superinfection after intravesical bacillus Calmette-Guerin immunotherapy for bladder cancer.
    Infection. 2020 Aug 4. pii: 10.1007/s15010-020-01495.
    Abstract     Related articles   

  1111. QUAN J, Zhang W, Yu C, Bai Y, et al
    Bioinformatic identification of prognostic indicators in bladder cancer.
    Biomark Med. 2020 Aug 4. doi: 10.2217/bmm-2020-0316.
    Abstract     Related articles   

  1112. LIU H, Chang JK, Hou JQ, Zhao ZH, et al
    Inhibition of miR-221 influences bladder cancer cell proliferation and apoptosis.
    Eur Rev Med Pharmacol Sci. 2020;24:7550.
    Abstract     Related articles   

  1113. KARIMI M, Heshmati M, Fattahi S, Bagheri N, et al
    The relation between the ghrelin receptor and FOXP3 in bladder cancer.
    Biotech Histochem. 2020 Aug 3:1-9. doi: 10.1080/10520295.2020.1799074.
    Abstract     Related articles   

  1114. TOMISAKI I
    Editorial Comment to Pembrolizumab-induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer.
    IJU Case Rep. 2019;3:20.
    Abstract     Related articles   

  1115. TODO M, Kaneko G, Shirotake S, Shimada Y, et al
    Pembrolizumab-induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer.
    IJU Case Rep. 2019;3:17-20.
    Abstract     Related articles   

  1116. XIE W, Bi J, Wei Q, Han P, et al
    Survival after radical cystectomy for bladder cancer: Multicenter comparison between minimally invasive and open approaches.
    Asian J Urol. 2020;7:291-300.
    Abstract     Related articles   

  1117. TRIPATHI A, Gupta S
    Androgen receptor in bladder cancer: A promising therapeutic target.
    Asian J Urol. 2020;7:284-290.
    Abstract     Related articles   

  1118. DESILETS A, Adam JP, Soulieres D
    Management of cisplatin-associated toxicities in bladder cancer patients.
    Curr Opin Support Palliat Care. 2020 Jul 23. doi: 10.1097/SPC.0000000000000505.
    Abstract     Related articles   

  1119. TULLY KH, Moschini M, von Rundstedt FE, Aziz A, et al
    Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer - examining the utility of classifying Ta bladder cancer based on size.
    Urol Oncol. 2020 Jul 29. pii: S1078-1439(20)30321.
    Abstract     Related articles   

  1120. DE LA CALLE CM, Washington SL 3rd, Lonergan PE, Meng MV, et al
    Bladder cancer in patients younger than 40 years: outcomes from the National Cancer Database.
    World J Urol. 2020 Jul 31. pii: 10.1007/s00345-020-03376.
    Abstract     Related articles   

  1121. MIZUSHIMA T, Jiang G, Kawahara T, Li P, et al
    Androgen Receptor Signaling Reduces the Efficacy of Bacillus Calmette-Guerin Therapy for Bladder Cancer via Modulating Rab27b-induced Exocytosis.
    Mol Cancer Ther. 2020 Jul 31. pii: 1535-7163.MCT-20-0050.
    Abstract     Related articles   

  1122. KIM K, Hu W, Audenet F, Almassi N, et al
    Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts.
    Nat Commun. 2020;11:1975.
    Abstract     Related articles   

  1123. MINAKATA T, Nakano Y, Tamura S, Kazuki Y, et al
    Tuberculous Spondylitis Caused by Intravesical Bacillus Calmette-Guerin Therapy.
    Intern Med. 2020;59:733-737.
    Abstract     Related articles   

  1124. TAKAHASHI K, Kimura G, Endo Y, Akatsuka J, et al
    Urothelial Carcinoma of the Bladder, Lipid Cell Variant: Case Report and Literature Review.
    J Nippon Med Sch. 2020;86:349-351.
    Abstract     Related articles   

  1125. AOE J, Ito Y, Fukui K, Nakayama M, et al
    Long-term trends in sex difference in bladder cancer survival 1975-2009: A population-based study in Osaka, Japan.
    Cancer Med. 2020 Aug 13. doi: 10.1002/cam4.3382.
    Abstract     Related articles   

  1126. YANG A, Cross CN, Townsend JP
    Non-Coding Mutations in Urothelial Bladder Cancer: Biological and Clinical Relevance and Potential Utility as Biomarkers.
    Bladder Cancer. 2020;6:211-213.
    Abstract     Related articles   

  1127. BOXLEY P, Plets M, Flaig TW
    Review of SWOG S1314: Lessons from a Randomized Phase II Study of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer.
    Bladder Cancer. 2020;6:123-129.
    Abstract     Related articles   

  1128. CLAUSEN TM, Kumar G, Ibsen EK, Orum-Madsen MS, et al
    A simple method for detecting oncofetal chondroitin sulfate glycosaminoglycans in bladder cancer urine.
    Cell Death Discov. 2020;6:65.
    Abstract     Related articles   

  1129. CHEN YT, Huang CR, Chang CL, Chiang JY, et al
    Jagged2 progressively increased expression from Stage I to III of Bladder Cancer and Melatonin-mediated downregulation of Notch/Jagged2 suppresses the Bladder Tumorigenesis via inhibiting PI3K/AKT/mTOR/MMPs signaling.
    Int J Biol Sci. 2020;16:2648-2662.
    Abstract     Related articles   

  1130. SHAHID M, Kim M, Jin P, Zhou B, et al
    S-Palmitoylation as a Functional Regulator of Proteins Associated with Cisplatin Resistance in Bladder Cancer.
    Int J Biol Sci. 2020;16:2490-2505.
    Abstract     Related articles   

  1131. ONISHI T, Sekito S, Shibahara T, Yabana T, et al
    Impact of noninvasive down-staging after transurethral resection of bladder tumor plus systemic chemotherapy on bladder-sparing strategy in patients with muscle-invasive bladder cancer.
    Urol Oncol. 2020 Aug 10. pii: S1078-1439(20)30337.
    Abstract     Related articles   

  1132. CHOI YW, Yoon HY, Yang HM, Kim CH, et al
    Current status of the development of intravesical drug delivery systems for the treatment of bladder cancer.
    Expert Opin Drug Deliv. 2020 Aug 13. doi: 10.1080/17425247.2020.1810016.
    Abstract     Related articles   

  1133. ZHANG L, Li L, Liu J, Wang J, et al
    Meta-analysis of multiple hematological biomarkers as prognostic predictors of survival in bladder cancer.
    Medicine (Baltimore). 2020;99:e20920.
    Abstract     Related articles   

  1134. JIANG P, Zhu Y, Xu Z, Chen X, et al
    Interference with circBC048201 inhibits the proliferation, migration, and invasion of bladder cancer cells through the miR-1184/ITGA3 axis.
    Mol Cell Biochem. 2020 Aug 12. pii: 10.1007/s11010-020-03835.
    Abstract     Related articles   

  1135. LIMA APB, Almeida TC, Barros TMB, Rocha LCM, et al
    Toxicogenetic and antiproliferative effects of chrysin in urinary bladder cancer cells.
    Mutagenesis. 2020 Aug 13. pii: 5892015. doi: 10.1093.
    Abstract     Related articles   

  1136. KAKIZOE T
    Orthotopic neobladder after cystectomy for bladder cancer.
    Proc Jpn Acad Ser B Phys Biol Sci. 2020;96:255-265.
    Abstract     Related articles   

  1137. LI P, Cao J, Li J, Yao Z, et al
    Identification of prognostic biomarkers associated with stromal cell infiltration in muscle-invasive bladder cancer by bioinformatics analyses.
    Cancer Med. 2020 Aug 12. doi: 10.1002/cam4.3372.
    Abstract     Related articles   

  1138. MINOLI M, Kiener M, Thalmann GN, Kruithof-de Julio M, et al
    Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  1139. ASHRAFIZADEH M, Hushmandi K, Hashemi M, Akbari ME, et al
    Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer.
    Biomolecules. 2020;10.
    Abstract     Related articles   

  1140. NUNES SP, Henrique R, Jeronimo C, Paramio JM, et al
    DNA Methylation as a Therapeutic Target for Bladder Cancer.
    Cells. 2020;9.
    Abstract     Related articles   

  1141. BLINDHEIM A, Fossa S, Babigumira R, Myklebust TA, et al
    T1 bladder cancer in Norway: treatment and survival.
    Scand J Urol. 2020 Aug 12:1-6. doi: 10.1080/21681805.2020.1803401.
    Abstract     Related articles   

  1142. MIELCZAREK L, Zapala P, Krajewski W, Nowak L, et al
    Diagnostic and treatment delays among patients with primary bladder cancer in Poland: a survey study.
    Cent European J Urol. 2020;73:152-159.
    Abstract     Related articles   

  1143. CHEN Z, Zhang F, Zhang S, Ma L, et al
    The down-regulation of SNCG inhibits the proliferation and invasiveness of human bladder cancer cell line 5637 and suppresses the expression of MMP-2/9.
    Int J Clin Exp Pathol. 2020;13:1873-1879.
    Abstract     Related articles   

  1144. NIU W, Xu L, Li J, Zhai Y, et al
    Polyphyllin II inhibits human bladder cancer migration and invasion by regulating EMT-associated factors and MMPs.
    Oncol Lett. 2020;20:2928-2936.
    Abstract     Related articles   

  1145. WANG LA, Yang B, Tang T, Yang Y, et al
    Correlation of APE1 with VEGFA and CD163(+) macrophage infiltration in bladder cancer and their prognostic significance.
    Oncol Lett. 2020;20:2881-2887.
    Abstract     Related articles   

  1146. CHENG TC, Lee YH, Chang YP, Lee DC, et al
    Improved urinary melatonin level as the perspective indicator that leads to better sleeping quality in bladder cancer patients.
    Ther Adv Urol. 2020;12:1756287220940870.
    Abstract     Related articles   

  1147. DEUKER M, Martin T, Stolzenbach F, Rosiello G, et al
    Bladder Cancer: A Comparison Between Non-urothelial Variant Histology and Urothelial Carcinoma Across All Stages and Treatment Modalities.
    Clin Genitourin Cancer. 2020 Jul 18. pii: S1558-7673(20)30171.
    Abstract     Related articles   

  1148. LEE KH, Kim BC, Jeong SH, Jeong CW, et al
    Histone Demethylase KDM7A Regulates Androgen Receptor Activity, and Its Chemical Inhibitor TC-E 5002 Overcomes Cisplatin-Resistance in Bladder Cancer Cells.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  1149. YU EYW, Wesselius A, Mehrkanoon S, Brinkman M, et al
    Grain and dietary fiber intake and bladder cancer risk: a pooled analysis of prospective cohort studies.
    Am J Clin Nutr. 2020 Aug 10. pii: 5890707. doi: 10.1093.
    Abstract     Related articles   

  1150. SEYAM RM, Zeitouni OM, Alsibai TM, AlAyoub AJ, et al
    The grasper-integrated disposable flexible cystoscope is comparable to the reusable, flexible cystoscope for the detection of bladder cancer.
    Sci Rep. 2020;10:13495.
    Abstract     Related articles   

  1151. CHANG DTS, Picardo A
    Repeat transurethral resection is still an essential tool in treating non-muscle invasive bladder cancer: the Western Australian experience.
    Bladder (San Franc). 2020;7:e42.
    Abstract     Related articles   

  1152. CHANG HC, Lin CT, Lin WY, Yu PT, et al
    Analysis of the effects of cyproheptadine on bladder cancer through big data.
    Am J Cancer Res. 2020;10:2114-2119.
    Abstract     Related articles   

  1153. SUN D, Li T, Xin H, An J, et al
    miR-489-3p inhibits proliferation and migration of bladder cancer cells through downregulation of histone deacetylase 2.
    Oncol Lett. 2020;20:8.
    Abstract     Related articles   

  1154. WAN JCM
    Survival Outcomes of Early versus Deferred Cystectomy for High-Grade Non-Muscle-Invasive Bladder Cancer: A Systematic Review.
    Curr Urol. 2020;14:66-73.
    Abstract     Related articles   

  1155. ZHAO SM, Yang TJ, Xu CM, Guo XF, et al
    [Bladder cancer local staging about muscle invasion: 3.0T MRI performance following transurethral resection].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2020;52:701-704.
    Abstract     Related articles   

  1156. QIU M, Xu CX, Wang BS, Yan Y, et al
    [Analysis of self-control trial results of narrow band imaging and white light in transurethral resection of bladder tumor].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2020;52:697-700.
    Abstract     Related articles   

  1157. WANG H, Jiang SK, Peng R, Huang Y, et al
    [Individual control of urine volume to improve stability of bladder volume in radiotherapy of urinary tumor].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2020;52:688-691.
    Abstract     Related articles   

  1158. WANG T, Hong X, Wang XF
    [Clinical application of the needle electrode in transurethral plasmakinetic resection of bladder tumor around ureteral orifice: A report of 16 cases].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2020;52:632-636.
    Abstract     Related articles   

  1159. PANARELLO D, Quaglia M, Mantica G, Cantaluppi V, et al
    Bladder cancer following renal transplantation: experiences with radical cystectomy and adjuvant radiotherapy.
    Minerva Chir. 2020 Aug 6. pii: S0026-4733.20.08377.
    Abstract     Related articles   

  1160. MAAS M, Mayer L, Hennenlotter J, Stuhler V, et al
    Prognostic impact of somatostatin receptor expression in advanced bladder cancer.
    Urol Oncol. 2020 Aug 7. pii: S1078-1439(20)30327.
    Abstract     Related articles   

  1161. LIU H, Bi J, Dong W, Yang M, et al
    Correction to: Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Mol Cancer. 2020;19:124.
    Abstract     Related articles   

  1162. MIR MC, Marchioni M, Zargar H, Zargar-Shoshtari K, et al
    Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium.
    Eur Urol Focus. 2020 Aug 5. pii: S2405-4569(20)30208.
    Abstract     Related articles   

  1163. GHASEMI H, Amini MA, Pegah A, Azizi E, et al
    Overexpression of reactive oxygen species modulator 1 is associated with advanced grades of bladder cancer.
    Mol Biol Rep. 2020 Aug 8. pii: 10.1007/s11033-020-05702.
    Abstract     Related articles   

  1164. VOSKUILEN CS, van de Kamp MW, Schuring N, Mertens LS, et al
    Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: a convenient alternative to 5-fluorouracil.
    Radiother Oncol. 2020 Aug 5. pii: S0167-8140(20)30716.
    Abstract     Related articles   

  1165. POURHANIFEH MH, Mottaghi R, Razavi ZS, Shafiee A, et al
    Therapeutic Applications of Curcumin and its Novel Formulations in the Treatment of Bladder Cancer: A Review of Current Evidence.
    Anticancer Agents Med Chem. 2020 Aug 7. pii: ACAMC-EPUB-108970.
    Abstract     Related articles   

  1166. PATEL VG, Oh WK, Galsky MD
    Treatment of muscle-invasive and advanced bladder cancer in 2020.
    CA Cancer J Clin. 2020 Aug 7. doi: 10.3322/caac.21631.
    Abstract     Related articles   

  1167. GAO ZY, Yu F, Jia HX, Ye Z, et al
    ASPM predicts poor prognosis and regulates cell proliferation in bladder cancer.
    Kaohsiung J Med Sci. 2020 Aug 6. doi: 10.1002/kjm2.12284.
    Abstract     Related articles   

  1168. Correction: Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway.
    Biosci Rep. 2020;40.
    Abstract     Related articles   

  1169. HUANG Z, Wang T, Xia W, Li Q, et al
    Oblongifolin C reverses GEM resistance via suppressing autophagy flux in bladder cancer cells.
    Exp Ther Med. 2020;20:1431-1440.
    Abstract     Related articles   

  1170. LV SW, Shi ZG, Wang XH, Zheng PY, et al
    Ribosome Binding Protein 1 Correlates with Prognosis and Cell Proliferation in Bladder Cancer.
    Onco Targets Ther. 2020;13:6699-6707.
    Abstract     Related articles   

  1171. ILIJAZI D, Pulverer W, Ertl IE, Lemberger U, et al
    Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer.
    Cells. 2020;9.
    Abstract     Related articles   

  1172. TANG Y, Hu Y, Wang J, Zeng Z, et al
    A novel risk score based on a combined signature of 10 immune system genes to predict bladder cancer prognosis.
    Int Immunopharmacol. 2020;87:106851.
    Abstract     Related articles   

  1173. HAFEEZ S, Lewis R, Griffin C, Hall E, et al
    Failing to Close the Gap Between Evidence and Clinical Practice in Radical Bladder Cancer Radiotherapy.
    Clin Oncol (R Coll Radiol). 2020 Aug 3. pii: S0936-6555(20)30283.
    Abstract     Related articles   

  1174. COOKSON E
    2020 ASCO Annual Meeting.
    Lancet Haematol. 2020;7:e507.
    Abstract     Related articles   

  1175. WANG L, Zhang Q, Wu P, Xiang W, et al
    SLC12A5 interacts and enhances SOX18 activity to promote bladder urothelial carcinoma progression via upregulating MMP7.
    Cancer Sci. 2020;111:2349-2360.
    Abstract     Related articles   

  1176. KIM DH, Park JY, Yu J, Lee SA, et al
    Intravenous Lidocaine for the Prevention of Postoperative Catheter-Related Bladder Discomfort in Male Patients Undergoing Transurethral Resection of Bladder Tumors: A Randomized, Double-Blind, Controlled Trial.
    Anesth Analg. 2020;131:220-227.
    Abstract     Related articles   

  1177. XU X, Zhang X, Tian Q, Wang H, et al
    Quantitative Identification of Nonmuscle-Invasive and Muscle-Invasive Bladder Carcinomas: A Multiparametric MRI Radiomics Analysis.
    J Magn Reson Imaging. 2018 Sep 25. doi: 10.1002/jmri.26327.
    Abstract     Related articles   

  1178. LI Y, Shi B, Dong F, Zhu X, et al
    LncRNA KCNQ1OT1 facilitates the progression of bladder cancer by targeting MiR-218-5p/HS3ST3B1.
    Cancer Gene Ther. 2020 Aug 20. pii: 10.1038/s41417-020-00211.
    Abstract     Related articles   

  1179. CHEN X, Zhang J, Ruan W, Huang M, et al
    Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer.
    J Clin Invest. 2020 Aug 20. pii: 139597. doi: 10.1172/JCI139597.
    Abstract     Related articles   

  1180. LIU Z, Zhou Q, Wang Z, Zhang H, et al
    Intratumoral TIGIT(+) CD8(+) T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer.
    J Immunother Cancer. 2020;8.
    Abstract     Related articles   

  1181. ZOU L, Li X, Zhang J, Ling L, et al
    A Highly Sensitive Catalytic Hairpin Assembly-Based Dynamic Light Scattering Biosensor for Telomerase Detection in Bladder Cancer Diagnosis.
    Anal Chem. 2020 Aug 19. doi: 10.1021/acs.analchem.0c02858.
    Abstract     Related articles   

  1182. JEE Y, Jung KJ, Back JH, Lee SM, et al
    Trajectory of smoking and early bladder cancer risk among Korean young adult men.
    Cancer Causes Control. 2020 Aug 18. pii: 10.1007/s10552-020-01335.
    Abstract     Related articles   

  1183. LAUKHTINA E, Mostafaei H, D'Andrea D, Pradere B, et al
    Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC).
    World J Urol. 2020 Aug 17. pii: 10.1007/s00345-020-03384.
    Abstract     Related articles   

  1184. CHAWLA NS, Malhotra J, Pal SK
    Switch maintenance therapy for advanced bladder cancer: A paradigm shift in 2020.
    Cancer Treat Res Commun. 2020;24:100202.
    Abstract     Related articles   

  1185. ELSAWY AA, Awadalla A, Elsayed A, Abdullateef M, et al
    Prospective Validation of Clinical Usefulness of a Novel mRNA-based Urine Test (Xpert(R) Bladder Cancer Monitor) for surveillance in Non Muscle Invasive Bladder Cancer.
    Urol Oncol. 2020 Aug 12. pii: S1078-1439(20)30335.
    Abstract     Related articles   

  1186. LEE S, Lim B, You D, Hong B, et al
    Association of Bacillus Calmette-Guerin shortages with bladder cancer recurrence: A single-center retrospective study.
    Urol Oncol. 2020 Aug 12. pii: S1078-1439(20)30338.
    Abstract     Related articles   

  1187. WANG Z, Ong WYF, Tong S, Sng JH, et al
    Beyond diabetes mellitus: role of metformin in non-muscle invasive bladder cancer.
    Singapore Med J. 2020 Aug 17. doi: 10.11622/smedj.2020121.
    Abstract     Related articles   

  1188. REN J, Yang Y, Peng T, Xu D, et al
    Predictive value of beta-catenin in bladder cancer: A Systematic Review and Meta-Analysis.
    Biosci Rep. 2020 Aug 14. pii: 226086. doi: 10.1042/BSR20202127.
    Abstract     Related articles   

  1189. ZANGOUEI AS, Barjasteh AH, Rahimi HR, Mojarrad M, et al
    Role of tyrosine kinases in bladder cancer progression: an overview.
    Cell Commun Signal. 2020;18:127.
    Abstract     Related articles   

  1190. RODLER S, Apfelbeck M, Schulz GB, Ivanova T, et al
    Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
    Eur Urol Focus. 2020;6:1097-1103.
    Abstract     Related articles   

  1191. DESOUKY E
    Impact of COVID-19 on Urologists: Learning on the Go.
    Eur Urol Focus. 2020;6:1132-1134.
    Abstract     Related articles   

  1192. JANSEN I, Lucas M, Bosschieter J, de Boer OJ, et al
    Automated Detection and Grading of Non-Muscle-Invasive Urothelial Cell Carcinoma of the Bladder.
    Am J Pathol. 2020;190:1483-1490.
    Abstract     Related articles   

  1193. KIM Y, Lee J, Kim S, Shin K, et al
    Culture, Manipulation, and Orthotopic Transplantation of Mouse Bladder Tumor Organoids.
    J Vis Exp. 2020;.
    Abstract     Related articles   

  1194. SHARMA A, Vasdev N
    Does neuroendocrine like tumor pathology impact neoadjuvant chemotherapy response precystectomy.
    Urol Oncol. 2020;38:555.
    Abstract     Related articles   

  1195. SUZUKI S, Cohen SM, Arnold LL, Pennington KL, et al
    Cotinine, a major nicotine metabolite, induces cell proliferation on urothelium in vitro and in vivo.
    Toxicology. 2020;429:152325.
    Abstract     Related articles   

  1196. GOMEZ DEL CANIZO C, Rodriguez-Izquierdo Jimenez M, Pena Vallejo E, Duarte Ojeda JM, et al
    New immunotherapies for high-risk non-muscle invasive bladder cancer: Current state and future perspectives.
    Actas Urol Esp. 2020 Aug 24. pii: S0210-4806(20)30158.
    Abstract     Related articles   

  1197. YANG F, Guo Z, He C, Qing L, et al
    Cancer-associated fibroblasts promote cell proliferation and invasion via paracrine Wnt/IL1beta signaling pathway in human bladder cancer.
    Neoplasma. 2020 Aug 28. pii: 200202N101. doi: 10.4149/neo_2020_200202.
    Abstract     Related articles   

  1198. RUSSELL B, Hemelrijck MV, Gardmark T, Holmberg L, et al
    A mediation analysis to explain socio-economic differences in bladder cancer survival.
    Cancer Med. 2020 Aug 26. doi: 10.1002/cam4.3418.
    Abstract     Related articles   

  1199. XU X
    Dairy Product Consumption and Bladder Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cohort.
    Front Nutr. 2020;7:97.
    Abstract     Related articles   

  1200. PANE K, Mirabelli P, Coppola L, Illiano E, et al
    New Roadmaps for Non-muscle-invasive Bladder Cancer With Unfavorable Prognosis.
    Front Chem. 2020;8:600.
    Abstract     Related articles   

  1201. XU C, Sun M, Zhang X, Xu Z, et al
    Activation of Glucocorticoid Receptor Inhibits the Stem-Like Properties of Bladder Cancer via Inactivating the beta-Catenin Pathway.
    Front Oncol. 2020;10:1332.
    Abstract     Related articles   

  1202. LI F, Teng H, Liu M, Liu B, et al
    Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer.
    Front Oncol. 2020;10:1302.
    Abstract     Related articles   

  1203. XIE Q, Tang T, Pang J, Xu J, et al
    LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT.
    Front Oncol. 2020;10:1234.
    Abstract     Related articles   

  1204. GLEAVE ME, Kawai Y, Imada K, Akamatsu S, et al
    Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion and Survival of Bladder Cancer.
    Mol Cancer Ther. 2020 Aug 26. pii: 1535-7163.MCT-19-1031.
    Abstract     Related articles   

  1205. PEDERZOLI F, Bandini M, Marandino L, Raggi D, et al
    Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm?
    Eur Urol Oncol. 2020 Aug 23. pii: S2588-9311(20)30121.
    Abstract     Related articles   

  1206. Aktuelle Urol. 2020;51:406-410.
    Abstract     Related articles   

  1207. ZHOU Y, Song X, Li X, Li H, et al
    Serum LUCAT1 implicates the pathogenesis of muscle-invasive bladder cancer via targeting miR-199a-5p and miR-199b-5p.
    J Mol Histol. 2020 Aug 25. pii: 10.1007/s10735-020-09907.
    Abstract     Related articles   

  1208. LIN J, Yang J, Xu X, Wang Y, et al
    A robust 11-genes prognostic model can predict overall survival in bladder cancer patients based on five cohorts.
    Cancer Cell Int. 2020;20:402.
    Abstract     Related articles   

  1209. JIANG L, Song H, Guo H, Wang C, et al
    Retraction notice to "Baicalein inhibits proliferation and migration of bladder cancer cell line T24 by down-regulation of microRNA-106" [Biomed. Pharmacother. 107 (2018) 1583-1590].
    Biomed Pharmacother. 2020 Aug 22:110634. doi: 10.1016/j.biopha.2020.110634.
    Abstract     Related articles   

  1210. HAYASHI T, Fujita K, Hayashi Y, Hatano K, et al
    Mutational Landscape and Environmental Effects in Bladder Cancer.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  1211. LEE SC, Geannette CS
    Osteomyelitis and septic arthritis after Mycobacterium Bovis BCG Therapy for Urinary Bladder Cancer.
    Clin Imaging. 2020;68:179-183.
    Abstract     Related articles   

  1212. WANG Y, Chen L, Yu M, Fang Y, et al
    Immune-related signature predicts the prognosis and immunotherapy benefit in bladder cancer.
    Cancer Med. 2020 Aug 25. doi: 10.1002/cam4.3400.
    Abstract     Related articles   

  1213. GARDE-GARCIA H, Redondo-Gonzalez E, Maestro-de Las Casas M, Fernandez-Perez C, et al
    Biomarkers and intermediate-high risk non-muscle invasive bladder cancer: a multivariate analysis of three different cellular pathways with pronostic implications.
    Clin Transl Oncol. 2020 Aug 24. pii: 10.1007/s12094-020-02476.
    Abstract     Related articles   

  1214. ZVEREVA M, Pisarev E, Hosen I, Kisil O, et al
    Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  1215. LEESON CE, Ismail A, Hashad MM, Elmansy H, et al
    Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19.
    SN Compr Clin Med. 2020 Aug 18:1-5. doi: 10.1007/s42399-020-00461.
    Abstract     Related articles   

  1216. OSAWA T, Wei JT, Abe T, Honda M, et al
    Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index.
    Int J Clin Oncol. 2020 Aug 24. pii: 10.1007/s10147-020-01770.
    Abstract     Related articles   

  1217. GUO H, Li F, Qiu H, Xu W, et al
    Synergistically Enhanced Mucoadhesive and Penetrable Polypeptide Nanogel for Efficient Drug Delivery to Orthotopic Bladder Cancer.
    Research (Wash D C). 2020;2020:8970135.
    Abstract     Related articles   

  1218. DHUNGANA S, Munjoma N, Isaac G, Gethings L, et al
    A Rapid and Comprehensive Targeted Approach for Investigating the Lipidome of Bladder Cancer Subjects.
    J Biomol Tech. 2020;31.
    Abstract     Related articles   

  1219. ARITA Y, Shigeta K, Akita H, Suzuki T, et al
    Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions.
    Eur Radiol. 2020 Aug 23. pii: 10.1007/s00330-020-07153.
    Abstract     Related articles   

  1220. CHEN JN, Li T, Cheng L, Qin TS, et al
    Synthesis and in vitro anti-bladder cancer activity evaluation of quinazolinyl-arylurea derivatives.
    Eur J Med Chem. 2020;205:112661.
    Abstract     Related articles   

  1221. GARCIA M, Arteche-Martinez U, Lertxundi U, Aguirre C, et al
    SGLT2 Inhibitors and Bladder Cancer: Analysis of Cases Reported in the European Pharmacovigilance Database.
    J Clin Pharmacol. 2020 Aug 21. doi: 10.1002/jcph.1722.
    Abstract     Related articles   

  1222. KOSLINSKI P, Pluskota R, Madra-Gackowska K, Gackowski M, et al
    Comparison of Pteridine Normalization Methods in Urine for Detection of Bladder Cancer.
    Diagnostics (Basel). 2020;10.
    Abstract     Related articles   

  1223. WANG YT, Shi T, Srivastava S, Kagan J, et al
    Proteomic Analysis of Exosomes for Discovery of Protein Biomarkers for Prostate and Bladder Cancer.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  1224. GOYAL A, O'Leary D, Goyal K, Patel K, et al
    Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer: a systematic review and meta-analysis.
    J Am Acad Dermatol. 2020 Aug 18. pii: S0190-9622(20)32444.
    Abstract     Related articles   

  1225. ANDRIANNE C, Dewandre M, El Hachem G, Burkhard F, et al
    [Metastase from lobular breast carcinoma on the ileal patch of augmentation].
    Rev Med Liege. 2020;75.
    Abstract     Related articles   

  1226. CHANAL E, Bouleftour W, Dridi M, Heritier P, et al
    [A complex case of miliary pulmonary tuberculosis following intravesical BCG therapy].
    Rev Med Liege. 2020;75.
    Abstract     Related articles   

  1227. KOUFOPOULOU M, Miranda PAP, Kazmierska P, Deshpande S, et al
    Clinical evidence for the first-line treatment of advanced urothelial carcinoma: Current paradigms and emerging treatment options.
    Cancer Treat Rev. 2020;89:102072.
    Abstract     Related articles   

  1228. ZHAO QX, Yang FY, Chen D, Wu LY, et al
    [Application of Endo-GIA stapler in laparoscopic radicalcystectomy].
    Zhonghua Yi Xue Za Zhi. 2020;100:1872-1876.
    Abstract     Related articles   

  1229. NISHIKAWA T, Sugino Y, Owa S, Kitano G, et al
    [Neoajuvant Chemotherapy with Gemcitabine and Cisplatin Plus S-1 for Primary Female Urethral Adenocarcinoma].
    Hinyokika Kiyo. 2020;66:115-119.
    Abstract     Related articles   

  1230. KAVARIC P, Eldin S, Nenad R, Dragan P, et al
    Modified wallace anastomotic technique reduces ureteroenteric stricture rates after ileal conduit urinary diversion.
    Int Braz J Urol. 2020;46:446-455.
    Abstract     Related articles   

  1231. LOPES RI, Mello MF, Lorenzo AJ
    Recent advances in pediatric bladder malignancies.
    F1000Res. 2020;9.
    Abstract     Related articles   

  1232. LI CC, Hsieh MJ, Wang SS, Hung SC, et al
    Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
    Int J Environ Res Public Health. 2020;17.
    Abstract     Related articles   

  1233. XIANG W, Lyu L, Huang T, Zheng F, et al
    The long non-coding RNA SNHG1 promotes bladder cancer progression by interacting with miR-143-3p and EZH2.
    J Cell Mol Med. 2020 Sep 4. doi: 10.1111/jcmm.15806.
    Abstract     Related articles   

  1234. AHN H, Hwang SI, Lee HJ, Choe G, et al
    Quantitation of bladder cancer for the prediction of muscle layer invasion as a complement to the vesical imaging-reporting and data system.
    Eur Radiol. 2020 Sep 4. pii: 10.1007/s00330-020-07224.
    Abstract     Related articles   

  1235. KOGA Y, Yamamoto H, Miho T, Matsuoka Y, et al
    [Rupture of Tuberculous Infective Abdominal Aortic Aneurysm after Intravesical Bacillus Calmette-Guerin Instillation Therapy].
    Kyobu Geka. 2020;73:586-589.
    Abstract     Related articles   

  1236. PAN Y, Lee CY, Lee LM, Wen YC, et al
    Incidence of Bladder Cancer in Type 2 Diabetes Mellitus Patients: A Population-Based Cohort Study.
    Medicina (Kaunas). 2020;56.
    Abstract     Related articles   

  1237. NINOMIYA S, Kawahara T, Miyoshi Y, Yao M, et al
    A retrospective study on the possible systematic inflammatory response markers to predict the prognosis of patients with bladder cancer undergoing radial cystectomy.
    Mol Clin Oncol. 2020;13:47.
    Abstract     Related articles   

  1238. OHADIAN MOGHADAM S, Mansori K, Nowroozi MR, Afshar D, et al
    Association of human papilloma virus (HPV) infection with oncological outcomes in urothelial bladder cancer.
    Infect Agent Cancer. 2020;15:52.
    Abstract     Related articles   

  1239. CHEN YC, Wang PY, Huang BM, Chen YJ, et al
    16-Hydroxycleroda-3,13-dien-15,16-olide Induces Apoptosis in Human Bladder Cancer Cells through Cell Cycle Arrest, Mitochondria ROS Overproduction, and Inactivation of EGFR-Related Signalling Pathways.
    Molecules. 2020;25.
    Abstract     Related articles   

  1240. PARDO JC, Ruiz de Porras V, Plaja A, Carrato C, et al
    Moving towards Personalized Medicine in Muscle-Invasive Bladder Cancer: Where Are We Now and Where Are We Going?
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  1241. ZHANG ZH, Yin L, Zhang LL, Song J, et al
    Efficacy and safety of Bacillus Calmette-Guerin for bladder cancer: A protocol of systematic review.
    Medicine (Baltimore). 2020;99:e21930.
    Abstract     Related articles   

  1242. SU X, Wu K, Wang S, Su W, et al
    The impact of orthotopic neobladder vs ileal conduit urinary diversion after cystectomy on the survival outcomes in patients with bladder cancer: A propensity score matched analysis.
    Cancer Med. 2020 Sep 1. doi: 10.1002/cam4.3404.
    Abstract     Related articles   

  1243. WASHINGTON SL 3RD, Gregorich SE, Meng MV, Suskind AM, et al
    Race modifies survival benefit of guideline-based treatment: Implications for reducing disparities in muscle invasive bladder cancer.
    Cancer Med. 2020 Sep 1. doi: 10.1002/cam4.3429.
    Abstract     Related articles   

  1244. JIANG T, Lu X, Yang F, Wang M, et al
    LMTK3 promotes tumorigenesis in bladder cancer via the ERK/ MAPK pathway.
    FEBS Open Bio. 2020 Aug 31. doi: 10.1002/2211-5463.12964.
    Abstract     Related articles   

  1245. BHASIN A, Sanders EC, Ziegler JM, Briggs JS, et al
    Correction to Virus Bioresistor (VBR) for the Detection of the Bladder Cancer Marker DJ-1 in Urine at 10 pM in One Minute.
    Anal Chem. 2020 Aug 31. doi: 10.1021/acs.analchem.0c03554.
    Abstract     Related articles   

  1246. LOGOTHETI S, Marquardt S, Gupta SK, Richter C, et al
    LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1.
    Theranostics. 2020;10:9620-9643.
    Abstract     Related articles   

  1247. HAMAD J, Gore J, Chisolm S, Powell M, et al
    Patient empowerment through engagement in bladder cancer research.
    Urol Oncol. 2020 Aug 27. pii: S1078-1439(20)30336.
    Abstract     Related articles   

  1248. DAI H, Liu C, Liu Y, Zhang Z, et al
    Research on mechanism of miR-130a in regulating autophagy of bladder cancer cells through CYLD.
    J BUON. 2020;25:1636-1642.
    Abstract     Related articles   

  1249. GAO Z, Li S, Zhou X, Li H, et al
    Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and ZEB1.
    Cancer Med. 2020 Aug 30. doi: 10.1002/cam4.3373.
    Abstract     Related articles   

  1250. KRANTZ D, Mints M, Winerdal M, Riklund K, et al
    IL-16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity.
    Scand J Immunol. 2020 Aug 30:e12926. doi: 10.1111/sji.12926.
    Abstract     Related articles   

  1251. LIU P, Wu L, Chand H, Li C, et al
    Silencing of miR-152 contributes to DNMT1-mediated CpG methylation of the PTEN promoter in bladder cancer.
    Life Sci. 2020 Aug 27:118311. doi: 10.1016/j.lfs.2020.118311.
    Abstract     Related articles   

  1252. HODGSON A, van Rhijn BWG, Kim SS, Ding C, et al
    Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations.
    Pathol Res Pract. 2020;216:153186.
    Abstract     Related articles   

  1253. SILVA TA, Azevedo H
    Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.
    J Proteomics. 2020 Aug 26:103951. doi: 10.1016/j.jprot.2020.103951.
    Abstract     Related articles   

  1254. WU ATH, Srivastava P, Yadav VK, Tzeng DTW, et al
    Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/beta-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages.
    Toxicol Appl Pharmacol. 2020;401:115109.
    Abstract     Related articles   

  1255. GAGLIANO TALIUN SA, VandeHaar P, Boughton AP, Welch RP, et al
    Exploring and visualizing large-scale genetic associations by using PheWeb.
    Nat Genet. 2020;52:550-552.
    Abstract     Related articles   

  1256. PORRECA A, Mineo Bianchi F, Romagnoli D, D'Agostino D, et al
    Robot-assisted radical cystectomy with totally intracorporeal urinary diversion: surgical and early functional outcomes through the learning curve in a single high-volume center.
    J Robot Surg. 2020;14:261-269.
    Abstract     Related articles   

  1257. LEE EH, Chun SY, Kim B, Yoon BH, et al
    Knockdown of TRPM7 prevents tumor growth, migration, and invasion through the Src, Akt, and JNK pathway in bladder cancer.
    BMC Urol. 2020;20:145.
    Abstract     Related articles   

  1258. ZHANG S, Song M, Zhao Y, Xu S, et al
    Radiomics nomogram for preoperative prediction of progression-free survival using diffusion-weighted imaging in patients with muscle-invasive bladder cancer.
    Eur J Radiol. 2020;131:109219.
    Abstract     Related articles   

  1259. FAN J, Zhao Y, Yuan H, Yang J, et al
    Phospholipase C-epsilon regulates bladder cancer cells via ATM/EXO1.
    Am J Cancer Res. 2020;10:2319-2336.
    Abstract     Related articles   

  1260. GOTO T, Kashiwagi E, Jiang G, Nagata Y, et al
    Estrogen receptor-beta signaling induces cisplatin resistance in bladder cancer.
    Am J Cancer Res. 2020;10:2523-2534.
    Abstract     Related articles   

  1261. PARMAR A, Richardson M, Coyte PC, Cheng S, et al
    A cost-utility analysis of atezolizumab in the second-line treatment of patients with metastatic bladder cancer.
    Curr Oncol. 2020;27:e386-e394.
    Abstract     Related articles   

  1262. OGASAWARA T, Tanaka T, Shindo T, Hashimoto K, et al
    Two cases of osteoblastic bone metastasis from muscle-invasive bladder cancer with discrepancy in response to chemotherapy: problems and limitations of bone biopsy.
    Int Cancer Conf J. 2020;9:235-239.
    Abstract     Related articles   

  1263. GHODOUSSIPOUR S, Xu W, Tran K, Atkinson R, et al
    Preoperative chemotherapy in clinically node positive muscle invasive bladder cancer: Radiologic variables can predict response.
    Urol Oncol. 2020 Sep 6. pii: S1078-1439(20)30386.
    Abstract     Related articles   

  1264. WANG W, Chen S, Song X, Gui J, et al
    ELK1/lncRNA-SNHG7/miR-2682-5p feedback loop enhances bladder cancer cell growth.
    Life Sci. 2020 Sep 5:118386. doi: 10.1016/j.lfs.2020.118386.
    Abstract     Related articles   

  1265. LORAN OB, Martov AG, Morozov AD, Ergakov DV, et al
    [Long-term results of combined treatment of patient with multiple primary cancers, including locally-advanced renal cell cancer, bladder cancer and transitional-cell cancer of the contralateral kidney].
    Urologiia. 2020;:95-99.
    Abstract     Related articles   

  1266. VAN DER HORST G, van de Merbel AF, Ruigrok E, van der Mark MH, et al
    Cationic amphiphilic drugs as potential anti-cancer therapy for bladder cancer.
    Mol Oncol. 2020 Sep 8. doi: 10.1002/1878-0261.12793.
    Abstract     Related articles   

  1267. VISWAMBARAM P, Hayne D
    Gender discrepancies in bladder cancer: potential explanations.
    Expert Rev Anticancer Ther. 2020 Sep 8. doi: 10.1080/14737140.2020.1813029.
    Abstract     Related articles   

  1268. KIMURA T, Ishikawa H, Kojima T, Kandori S, et al
    Bladder preservation therapy for muscle invasive bladder cancer: the past, present and future.
    Jpn J Clin Oncol. 2020 Sep 7. pii: 5902471. doi: 10.1093.
    Abstract     Related articles   

  1269. WANG W, Liu Z, Zhang X, Liu J, et al
    miR-211-5p is downregulated and a prognostic marker in bladder cancer.
    J Gene Med. 2020 Sep 6:e3270. doi: 10.1002/jgm.3270.
    Abstract     Related articles   

  1270. HAKOZAKI K, Kikuchi E, Ogihara K, Shigeta K, et al
    Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer.
    Jpn J Clin Oncol. 2020 Sep 7. pii: 5901982. doi: 10.1093.
    Abstract     Related articles   

  1271. BASILE G, Bandini M, Pederzoli F, Gallina A, et al
    Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639-41.
    Eur Urol Focus. 2020 Sep 2. pii: S2405-4569(20)30219.
    Abstract     Related articles   

  1272. GILD P, Vetterlein MW, Seiler R, Necchi A, et al
    The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Ur
    Surg Oncol. 2020;34:312-317.
    Abstract     Related articles   

  1273. TAHERI M, Shirvani-Farsani Z, Ghafouri-Fard S, Omrani MD, et al
    Expression profile of microRNAs in bladder cancer and their application as biomarkers.
    Biomed Pharmacother. 2020;131:110703.
    Abstract     Related articles   

  1274. ZHU G, Wang K, Qin H, Zhao X, et al
    Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer.
    J Nanobiotechnology. 2020;18:124.
    Abstract     Related articles   

  1275. RUD E, Galtung KF, Lauritzen PM, Baco E, et al
    Examining the upper urinary tract in patients with hematuria-time to revise the CT urography protocol?
    Eur Radiol. 2020;30:1664-1670.
    Abstract     Related articles   

  1276. SHEN C, Da, Wu Z, Wang Y, et al
    Expression and prognostic significance of the MMP family molecules in bladder cancer.
    Comb Chem High Throughput Screen. 2020 Sep 16. pii: CCHTS-EPUB-109981.
    Abstract     Related articles   

  1277. MIYAKE M, Nishimura N, Fujii T, Miyamoto T, et al
    Photodynamic diagnosis-assisted en bloc transurethral resection of bladder tumor for non-muscle invasive bladder cancer: short-term oncological and functional outcomes.
    J Endourol. 2020 Sep 17. doi: 10.1089/end.2020.0371.
    Abstract     Related articles   

  1278. PANEBIANCO V, Pecoraro M, Del Giudice F, Takeuchi M, et al
    VI-RADS for Bladder Cancer: Current Applications and Future Developments.
    J Magn Reson Imaging. 2020 Sep 17. doi: 10.1002/jmri.27361.
    Abstract     Related articles   

  1279. HUANG Q, Zhou Q, Zhang H, Liu Z, et al
    Identification and validation of an excellent prognosis subtype of muscle-invasive bladder cancer patients with intratumoral CXCR5(+) CD8(+) T cell abundance.
    Oncoimmunology. 2020;9:1810489.
    Abstract     Related articles   

  1280. CARUSO R, Belloni S, Albanesi B, Piredda A, et al
    Comment on "pathways to psychological wellbeing for patients with bladder cancer and their partners-in-care" and contextualization in the COVID-19 pandemic.
    Eur J Oncol Nurs. 2020;48:101821.
    Abstract     Related articles   

  1281. DALANGOOD S, Zhu Z, Ma Z, Li J, et al
    Identification of glycogene-type and validation of ST3GAL6 as a biomarker predicts clinical outcome and cancer cell invasion in urinary bladder cancer.
    Theranostics. 2020;10:10078-10091.
    Abstract     Related articles   

  1282. JIN M, Lu S, Wu Y, Yang C, et al
    Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548.
    J Exp Clin Cancer Res. 2020;39:186.
    Abstract     Related articles   

  1283. ZENG Y, Sun J, Bao J, Zhu T, et al
    BK polyomavirus infection promotes growth and aggressiveness in bladder cancer.
    Virol J. 2020;17:139.
    Abstract     Related articles   

  1284. WU Z, Liu J, Dai R, Wu S, et al
    Current status and future perspectives of immunotherapy in bladder cancer treatment.
    Sci China Life Sci. 2020 Aug 26. pii: 10.1007/s11427-020-1768.
    Abstract     Related articles   

  1285. BIALEK L, Czerwinska K, Fus L, Krajewski W, et al
    MCM5 urine expression (ADXBLADDER) is a reliable biomarker of high-risk non- muscle-invasive bladder cancer recurrence: A prospective matched case-control study.
    Cancer Biomark. 2020 Sep 4. pii: CBM200316. doi: 10.3233/CBM-200316.
    Abstract     Related articles   

  1286. CHAUDHURI AA, Pellini B, Pejovic N, Chauhan PS, et al
    Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management.
    JCO Precis Oncol. 2020;4.
    Abstract     Related articles   

  1287. XIANG Z, Zhou Q, Zeng H, Wang Z, et al
    Intratumoral CCR5(+) neutrophils identify immunogenic subtype muscle-invasive bladder cancer with favorable prognosis and therapeutic responses.
    Oncoimmunology. 2020;9:1802176.
    Abstract     Related articles   

  1288. ZHONG W, Wang B, Yu H, Lin J, et al
    Serum CCL27 predicts the response to Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer.
    Oncoimmunology. 2020;9:1776060.
    Abstract     Related articles   

  1289. YI R, Lin A, Cao M, Xu A, et al
    ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment.
    Front Genet. 2020;11:933.
    Abstract     Related articles   

  1290. LIANG X, Gao J, Wang Q, Hou S, et al
    ECRG4 Represses Cell Proliferation and Invasiveness via NFIC/OGN/NF-kappaB Signaling Pathway in Bladder Cancer.
    Front Genet. 2020;11:846.
    Abstract     Related articles   

  1291. LIU Z, Zhang X, Wu B, Zhao Y, et al
    Development and Validation of a Model for Predicting Urethral Recurrence in Male Patients with Muscular Invasive Bladder Cancer After Radical Cystectomy Combined with Urinary Diversion.
    Cancer Manag Res. 2020;12:7649-7657.
    Abstract     Related articles   

  1292. HUANG W, Lu Y, Wang F, Huang X, et al
    Circular RNA circRNA_103809 Accelerates Bladder Cancer Progression and Enhances Chemo-Resistance by Activation of miR-516a-5p/FBXL18 Axis.
    Cancer Manag Res. 2020;12:7561-7568.
    Abstract     Related articles   

  1293. YAMAMOTO S, Fukuhara H, Karashima T, Inoue K, et al
    Real-world experience with 5-aminolevulinic acid for the photodynamic diagnosis of bladder cancer: Diagnostic accuracy and safety.
    Photodiagnosis Photodyn Ther. 2020 Sep 10:101999.
    Abstract     Related articles   

  1294. CHEN D, Chen T, Guo Y, Wang C, et al
    Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
    Exp Cell Res. 2020 Sep 10:112281. doi: 10.1016/j.yexcr.2020.112281.
    Abstract     Related articles   

  1295. NG K, Stenzl A, Sharma A, Vasdev N, et al
    Urinary biomarkers in bladder cancer: A review of the current landscape and future directions.
    Urol Oncol. 2020 Sep 9. pii: S1078-1439(20)30368.
    Abstract     Related articles   

  1296. RIPPING TM, Witjes JA, Meijer RP, van Rhijn BWG, et al
    Hospital-specific probability of cystectomy affects survival from muscle-invasive bladder cancer.
    Urol Oncol. 2020 Sep 8. pii: S1078-1439(20)30381.
    Abstract     Related articles   

  1297. MOUSSA M, Papatsoris AG, Dellis A, Abou Chakra M, et al
    Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer.
    Expert Rev Anticancer Ther. 2020 Sep 11. doi: 10.1080/14737140.2020.1822743.
    Abstract     Related articles   

  1298. DARO-FAYE M, Kassouf W, Souhami L, Marcq G, et al
    Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response.
    World J Urol. 2020 Sep 11. pii: 10.1007/s00345-020-03440.
    Abstract     Related articles   

  1299. HAYASHI T, Teishima J
    Editorial Comment to Progressive plasmacytoid variant bladder cancer with retroperitoneal dissemination: An autopsy case report.
    IJU Case Rep. 2020;3:169-170.
    Abstract     Related articles   

  1300. KOHADA Y, Kaiho Y, Ito J, Mikami J, et al
    Progressive plasmacytoid variant bladder cancer with retroperitoneal dissemination: An autopsy case report.
    IJU Case Rep. 2020;3:166-169.
    Abstract     Related articles   

  1301. YANG Y, Liu C, Yang X
    Endoscopic Molecular Imaging plus Photoimmunotherapy: A New Strategy for Monitoring and Treatment of Bladder Cancer.
    Mol Ther Oncolytics. 2020;18:409-418.
    Abstract     Related articles   

  1302. VOLOVAT SR, Ciuleanu TE, Koralewski P, Olson JEG, et al
    A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer.
    Oncotarget. 2020;11:3105-3117.
    Abstract     Related articles   

  1303. GU C, Zhao K, Zhou N, Liu F, et al
    UBAC2 promotes bladder cancer proliferation through BCRC-3/miRNA-182-5p/p27 axis.
    Cell Death Dis. 2020;11:733.
    Abstract     Related articles   

  1304. MANCINI M, Righetto M, Zumerle S, Montopoli M, et al
    The Bladder EpiCheck Test as a Non-Invasive Tool Based on the Identification of DNA Methylation in Bladder Cancer Cells in the Urine: A Review of Published Evidence.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  1305. SHEN J, Song ZQ, Shen HS, Li CF, et al
    [Transplantation of Autologous Peritoneum Using Ileal Seromuscular Flaps for Orthotopic Neobladder Reconstruction].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2020;42:497-503.
    Abstract     Related articles   

  1306. WANG H, Zou YW, Liu HY, Li YJ, et al
    [Pure small cell carcinoma of the urinary bladder: a clinicopathologic and prognostic study].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:928-930.
    Abstract     Related articles   

  1307. XU J, Zheng J, Ma Y
    Monopolar versus bipolar transurethral resection of bladder tumors: An updated systematic review and meta-analysis of existing studies.
    Medicine (Baltimore). 2020;99:e21768.
    Abstract     Related articles   

  1308. LIU B, Qi DJ, Zhang QF
    Primary adult primitive neuroectodermal tumor of the bladder: A case report and literature review.
    Medicine (Baltimore). 2020;99:e21740.
    Abstract     Related articles   

  1309. NAIKI T, Sugiyama Y, Tasaki Y, Iida K, et al
    Efficacy of a Newly Modified Short Hydration Method for Gemcitabine and Cisplatin Combination Chemotherapy in Patients with Urothelial Carcinoma.
    Oncology. 2020;98:612-620.
    Abstract     Related articles   

  1310. KUBOTA M, Kokubun H, Yamaguchi R, Murata S, et al
    Atypical oncologic failure after laparoscopic and robot-assisted radical cystectomy at a single institution.
    Int J Clin Oncol. 2020;25:1385-1392.
    Abstract     Related articles   

  1311. MAURER A, Ortiz-Bruechle N, Guricova K, Rose M, et al
    Comparative genomic profiling of glandular bladder tumours.
    Virchows Arch. 2020;477:445-454.
    Abstract     Related articles   

  1312. BRODERICK C, Mahon CE, Sterling J
    Urothelial carcinoma initially presenting as vulvodynia.
    Clin Exp Dermatol. 2020;45:667-668.
    Abstract     Related articles   

  1313. MILOVANCEV M, Scharf VF, Townsend KL, Singh A, et al
    Partial cystectomy with a bipolar sealing device in seven dogs with naturally occurring bladder tumors.
    Vet Surg. 2020;49:794-799.
    Abstract     Related articles   

  1314. KIDA T, Kobashi T, Usuda Y, Kobayashi K, et al
    Severe and Prolonged Hypotension After Oral 5-Aminolevulinic Acid Administration in a Patient With End-Stage Renal Disease Undergoing Transurethral Resection of a Bladder Tumor: A Case Report.
    A A Pract. 2020;14:12-14.
    Abstract     Related articles   

  1315. SKINNER OT, Boston SE, Maxwell PL
    Interventions and experience after complicated total cystectomy in a dog with transitional cell carcinoma.
    Vet Surg. 2020;49:811-817.
    Abstract     Related articles   

  1316. XIA W, Li Y, Wu Z, Wang Y, et al
    Transcription factor YY1 mediates epithelial-mesenchymal transition through the TGFbeta signaling pathway in bladder cancer.
    Med Oncol. 2020;37:93.
    Abstract     Related articles   

  1317. SEKAR D
    miRNA 21: a novel biomarker in the treatment of bladder cancer.
    Biomark Med. 2020;14:1065-1067.
    Abstract     Related articles   

  1318. KOTI M, Ingersoll MA, Gupta S, Lam CM, et al
    Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment.
    Eur Urol Oncol. 2020 Sep 20. pii: S2588-9311(20)30140.
    Abstract     Related articles   

  1319. OMORPHOS NP, Piedad JCP, Vasdev N
    Guideline of guidelines: Muscle-invasive bladder cancer.
    Turk J Urol. 2020 Sep 21. pii: tud.2020.20337. doi: 10.5152/tud.2020.20337.
    Abstract     Related articles   

  1320. GUI JQ, Zhang C, Yang HB, Yu YW, et al
    LncRNA AFAP1-AS1 promotes proliferation ability and invasiveness of bladder cancer cells.
    Eur Rev Med Pharmacol Sci. 2020;24:8747-8755.
    Abstract     Related articles   

  1321. HE YC, Bi YG, Jiang L
    LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2020;24:8740-8746.
    Abstract     Related articles   

  1322. LIU H, Gu J, Jin Y, Yuan Q, et al
    Genetic variants in N6-methyladenosine are associated with bladder cancer risk in the Chinese population.
    Arch Toxicol. 2020 Sep 22. pii: 10.1007/s00204-020-02911.
    Abstract     Related articles   

  1323. WANG M, Liu S, Zhou B, Wang J, et al
    RRBP1 is highly expressed in bladder cancer and is associated with migration and invasion.
    Oncol Lett. 2020;20:203.
    Abstract     Related articles   

  1324. GOFRIT ON, Meirovitz A, Frank S, Rabinovich I, et al
    Trimodal therapy in T2-4aN0M0 bladder cancer--How to select the best candidate?
    Cancer Med. 2020 Sep 22. doi: 10.1002/cam4.3478.
    Abstract     Related articles   

  1325. RUTHERFORD C, Patel MI, Tait MA, Smith DP, et al
    Patient-reported outcomes in non-muscle invasive bladder cancer: a mixed-methods systematic review.
    Qual Life Res. 2020 Sep 22. pii: 10.1007/s11136-020-02637.
    Abstract     Related articles   

  1326. DEFANT J, Huff S, Henningsen J, Krishnamurthy A, et al
    Long-Term Survival of Metastatic Bladder Cancer Treated With Chemotherapy, Radiation, and Arthroplasty: A Case Report.
    JBJS Case Connect. 2020;10:e2000098.
    Abstract     Related articles   

  1327. WANG Z, Zhou Y, Guan C, Ding Y, et al
    The impact of previous cancer on overall survival of bladder cancer patients and the establishment of nomogram for overall survival prediction.
    Medicine (Baltimore). 2020;99:e22191.
    Abstract     Related articles   

  1328. BELGOROSKY D, Girouard J, Langle YV, Hamelin-Morrissete J, et al
    Relevance of iNOS expression in tumor growth and maintenance of cancer stem cells in a bladder cancer model.
    J Mol Med (Berl). 2020 Sep 16. pii: 10.1007/s00109-020-01973.
    Abstract     Related articles   

  1329. GHOSH A, Roy R, Chatterjee E, Bankura B, et al
    Induction of apoptosis in human bladder cancer cells by triterpenoids isolated from Holarrhena antidysenterica through differential reactive oxygen species generation.
    Nat Prod Res. 2020 Sep 21:1-8. doi: 10.1080/14786419.2020.1819272.
    Abstract     Related articles   

  1330. KONAC E, Kurman Y, Baltaci S
    Contrast effects of autophagy in the treatment of bladder cancer.
    Exp Biol Med (Maywood). 2020 Sep 20:1535370220959336.
    Abstract     Related articles   

  1331. WANG Y, Yang T, Han Y, Ren Z, et al
    lncRNA OTUD6B-AS1 Exacerbates As2O3-Induced Oxidative Damage in Bladder Cancer via miR-6734-5p-Mediated Functional Inhibition of IDH2.
    Oxid Med Cell Longev. 2020;2020:3035624.
    Abstract     Related articles   

  1332. SU H, Li T, Li C, Liu X, et al
    Expression of Rab1A in bladder cancer and its clinical implications.
    Exp Ther Med. 2020;20:44.
    Abstract     Related articles   

  1333. PFAIL JL, Katims AB, Gul Z, Rosenzweig SJ, et al
    Can anesthetics affect bladder cancer recurrence? Total intravenous versus volatile anesthesia in patients undergoing robot-assisted radical cystectomy: A single institution retrospective analysis.
    Urol Oncol. 2020 Sep 17. pii: S1078-1439(20)30393.
    Abstract     Related articles   

  1334. XIE R, Chen X, Cheng L, Huang M, et al
    NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMAR.
    Mol Ther. 2020 Sep 5. pii: S1525-0016(20)30428.
    Abstract     Related articles   

  1335. MENDELAAR PAJ, Kraan J, Van M, Zeune LL, et al
    Defining the dimensions of Circulating Tumor Cells in a large series of breast, prostate, colon, and bladder cancer patients.
    Mol Oncol. 2020 Sep 18. doi: 10.1002/1878-0261.12802.
    Abstract     Related articles   

  1336. DEGER MD, Celik S, Yildiz A, Sari H, et al
    Can we perform frozen section instead of repeat transurethral resection in bladder cancer?
    Urol Oncol. 2020 Sep 16. pii: S1078-1439(20)30400.
    Abstract     Related articles   

  1337. GALGANO SJ, Porter KK, Burgan C, Rais-Bahrami S, et al
    The Role of Imaging in Bladder Cancer Diagnosis and Staging.
    Diagnostics (Basel). 2020;10.
    Abstract     Related articles   

  1338. ZHAI B, Chen P, Wang W, Liu S, et al
    An ATF24 peptide-functionalized beta-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment.
    Cancer Biol Med. 2020;17:676-692.
    Abstract     Related articles   

  1339. WANG G, Cao R, Qian K, Peng T, et al
    TRPM8 Inhibition Regulates the Proliferation, Migration and ROS Metabolism of Bladder Cancer Cells.
    Onco Targets Ther. 2020;13:8825-8835.
    Abstract     Related articles   

  1340. FUJITA N, Hatakeyama S, Momota M, Tobisawa Y, et al
    Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer.
    Urol Oncol. 2020 Sep 14. pii: S1078-1439(20)30395.
    Abstract     Related articles   

  1341. SANTOYO VARGAS J, Castillo-Cobaleda DF, Garcia-Perdomo HA
    [Applying the ERAS (Enhanced Recovery After Surgery) protocol in radical cystectomy.]
    Arch Esp Urol. 2020;73:600-610.
    Abstract     Related articles   

  1342. ZHANG Y, Birmann BM, Han J, Giovannucci EL, et al
    Personal use of permanent hair dyes and cancer risk and mortality in US women: prospective cohort study.
    BMJ. 2020;370:m2942.
    Abstract     Related articles   

  1343. POON DM
    Immunotherapy for urothelial carcinoma: Metastatic disease and beyond.
    Asia Pac J Clin Oncol. 2020;16 Suppl 3:18-23.
    Abstract     Related articles   

  1344. ADWAN R
    Upper urinary tract urothelial carcinomas - our experience.
    Rozhl Chir. 2020;99:219-225.
    Abstract     Related articles   

  1345. PARK JY, Hong JH, Kim DH, Yu J, et al
    Magnesium and Bladder Discomfort after Transurethral Resection of Bladder Tumor: A Randomized, Double-blind, Placebo-controlled Study.
    Anesthesiology. 2020;133:64-77.
    Abstract     Related articles   

  1346. ALHALABI O, Campbell M, Shah A, Siefker-Radtke A, et al
    Emerging treatments in advanced urothelial cancer.
    Curr Opin Oncol. 2020;32:232-239.
    Abstract     Related articles   

  1347. MELILLI A
    Uncommon skeletal metastasis secondary to transitional cell carcinoma.
    Open Vet J. 2020;9:313-316.
    Abstract     Related articles   

  1348. TERAGAKI M, Yamamoto T, Hosomi K, Tada Y, et al
    Miction-induced Hypertension Disclosed by Home Blood Pressure Measurement in a Patient with Small Paraganglioma.
    Intern Med. 2020;59:793-797.
    Abstract     Related articles   

  1349. DYER T, Siemens DR, Nippak P, Meyer J, et al
    Histology at transurethral resection of bladder tumor and radical cystectomy for bladder cancer: Insights from population-based data.
    Can Urol Assoc J. 2020 Sep 28. pii: cuaj.6856. doi: 10.5489/cuaj.6856.
    Abstract     Related articles   

  1350. SOMUNCU B, Keskin S, Antmen FM, Saglican Y, et al
    Non-muscle invasive bladder cancer tissues have increased base excision repair capacity.
    Sci Rep. 2020;10:16371.
    Abstract     Related articles   

  1351. VALENBERG FJPV, Hiar AM, Wallace E, Bridge JA, et al
    Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria.
    Eur Urol Oncol. 2020 Sep 28. pii: S2588-9311(20)30141.
    Abstract     Related articles   

  1352. KUBON J, Sikic D, Eckstein M, Weyerer V, et al
    Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  1353. ZHOU X, Chen Y, Wang F, Wu H, et al
    Artesunate induces autophagy dependent apoptosis through upregulating ROS and activating AMPK-mTOR-ULK1 axis in human bladder cancer cells.
    Chem Biol Interact. 2020 Sep 28:109273. doi: 10.1016/j.cbi.2020.109273.
    Abstract     Related articles   

  1354. LYU ZJ, Wang Y, Huang JL, Chen M, et al
    Recurrent ZNF83-E293V Mutation Promotes Bladder Cancer Progression through the NF-kappaB Pathway via Transcriptional Dysregulation of S100A8.
    Mol Ther. 2020 Sep 5. pii: S1525-0016(20)30461.
    Abstract     Related articles   

  1355. HE H, Wu S, Ai K, Xu R, et al
    LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca(2+) concentration via transcription factor GATA6.
    Cell Oncol (Dordr). 2020 Oct 1. pii: 10.1007/s13402-020-00563.
    Abstract     Related articles   

  1356. LI S, Jia Y, Yu C, Xiao H, et al
    Influences of Different Operative Methods on the Recurrence Rate of Non-Muscle-Invasive Bladder Cancer.
    Urol J. 2020 Oct 1:5965. doi: 10.22037/uj.v16i7.5965.
    Abstract     Related articles   

  1357. XU Z, Gan G, Chen G, Wu G, et al
    A Systematic Review and Meta- Analysis of Green-Light Laser Vaporization for Superficial Bladder Cancer.
    Urol J. 2020 Sep 30. pii: 5854. doi: 10.22037/uj.v16i7.5854.
    Abstract     Related articles   

  1358. XU G, Yang H, Liu M, Niu J, et al
    lncRNA TINCR facilities bladder cancer progression via regulating miR7 and mTOR.
    Mol Med Rep. 2020;22:4243-4253.
    Abstract     Related articles   

  1359. FIAZ S, Ali A, Adnan S, Khalil MAI, et al
    Comparison of Outcomes Between Radical Radiotherapy and Radical Cystectomy in Muscle Invasive Bladder Cancer in a Cancer Specialized Unit of a Developing Country.
    Cureus. 2020;12:e10057.
    Abstract     Related articles   

  1360. ROUANNE M, Gaillard F, Meunier M, Soorojebally Y, et al
    Measured glomerular filtration rate (GFR) significantly and rapidly decreases after radical cystectomy for bladder cancer.
    Sci Rep. 2020;10:16145.
    Abstract     Related articles   

  1361. CHEN M, Xu Y, Xu J, Chancoco H, et al
    Leukocyte telomere length and bladder cancer risk: a large case control study and Mendelian randomization analysis.
    Cancer Epidemiol Biomarkers Prev. 2020 Sep 30. pii: 1055-9965.EPI-20-0351.
    Abstract     Related articles   

  1362. SCHUETTFORT VM, Pradere B, Quhal F, Mostafaei H, et al
    Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis.
    World J Urol. 2020 Sep 29. pii: 10.1007/s00345-020-03436.
    Abstract     Related articles   

  1363. LIANG Y, Wang Y, Wang L, Liang Z, et al
    Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer.
    Bioact Mater. 2020;6:433-446.
    Abstract     Related articles   

  1364. BATUR AF, Aydogan MF, Kilic O, Korez MK, et al
    Comparison of De Ritis Ratio and Other Systemic Inflammatory Parameters for the Prediction of Prognosis of Patients with Transitional Cell Bladder Cancer.
    Int J Clin Pract. 2020 Sep 29:e13743. doi: 10.1111/ijcp.13743.
    Abstract     Related articles   

  1365. YU G, Zhou H, Xu K, Meng L, et al
    [Mir-29c-3p targeting TUG1 affects migration and invasion of bladder cancer cells by regulating CAPN7 expression].
    Nan Fang Yi Ke Da Xue Xue Bao. 2020;40:1325-1331.
    Abstract     Related articles   

  1366. CAO Y, Xu K, Chen B, Wang Y, et al
    [Expression of DNMT3b in human bladder cancer tissue and its correlation with clinical prognosis].
    Nan Fang Yi Ke Da Xue Xue Bao. 2020;40:1295-1300.
    Abstract     Related articles   

  1367. AYYILDIZ V, Aydin F, Baspinar S, Ogul H, et al
    Massive penile metastasis of bladder cancer.
    Br J Hosp Med (Lond). 2020;81:1.
    Abstract     Related articles   

  1368. DU Q, Chen J
    SNHG1 promotes proliferation, migration and invasion of bladder cancer cells via the PI3K/AKT signaling pathway.
    Exp Ther Med. 2020;20:110.
    Abstract     Related articles   

  1369. SHI MJ, Meng XY, Fontugne J, Chen CL, et al
    Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
    Genome Med. 2020;12:85.
    Abstract     Related articles   

  1370. SUGIYAMA K, Imamura M, Fujimoto T, Chihara I, et al
    [A Case of Bladder Cancer Treated with Arterial Stent-Grafting to Prevent Uretero-Arterial Fistula Due to Radiation Therapy for Metastasis].
    Hinyokika Kiyo. 2020;66:319-321.
    Abstract     Related articles   

  1371. OTA H, Yamaguchi T, Tsuruta M, Fuchigami Y, et al
    [A Case of Small Cell Carcinoma of the Bladder].
    Hinyokika Kiyo. 2020;66:313-317.
    Abstract     Related articles   

  1372. SIEVERINK CA, Batista RPM, Prazeres HJM, Vinagre J, et al
    Clinical Validation of a Urine Test (Uromonitor-V2((R))) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients.
    Diagnostics (Basel). 2020;10.
    Abstract     Related articles   

  1373. HAN L, Gallan AJ, Steinberg GD, Sweis RF, et al
    Morphological Correlation of Urinary Bladder Cancer Molecular Subtypes in Radical Cystectomies.
    Hum Pathol. 2020 Sep 25. pii: S0046-8177(20)30182.
    Abstract     Related articles   

  1374. MCFERRIN C, Davaro F, May A, Raza S, et al
    Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer.
    Investig Clin Urol. 2020 Sep 8. pii: 61.e60. doi: 10.4111/icu.20200132.
    Abstract     Related articles   

  1375. ALSHYARBA MH, Alamri A, Assiri AA
    Economic impacts of the Bacillus Calmette-Guerin (BCG) therapy shortage and the proposed solutions for patients with non-muscle invasive bladder Cancer in Aseer Province, Saudi Arabia.
    J Family Med Prim Care. 2020;9:2758-2762.
    Abstract     Related articles   

  1376. HIROTSU Y, Yokoyama H, Amemiya K, Hagimoto T, et al
    Genomic Profiling Identified ERCC2 E606Q Mutation in Helicase Domain Respond to Platinum-Based Neoadjuvant Therapy in Urothelial Bladder Cancer.
    Front Oncol. 2020;10:1643.
    Abstract     Related articles   

  1377. ADNAN S, Khalil MAI, Fiaz S, Abu Bakar M, et al
    Oncological Outcomes of Non-Urothelial Bladder Cancers in a Specialized Cancer Hospital of a Developing Country.
    Cureus. 2020;12:e9957.
    Abstract     Related articles   

  1378. OSTERMAN CK, Milowsky MI
    New and Emerging Therapies in the Management of Bladder Cancer.
    F1000Res. 2020;9.
    Abstract     Related articles   

  1379. WU Y, Liu Y, He A, Guan B, et al
    Identification of the Six-RNA-Binding Protein Signature for Prognosis Prediction in Bladder Cancer.
    Front Genet. 2020;11:992.
    Abstract     Related articles   

  1380. JIAO F, Sun H, Yang Q, Sun H, et al
    Identification of FADS1 Through Common Gene Expression Profiles for Predicting Survival in Patients with Bladder Cancer.
    Cancer Manag Res. 2020;12:8325-8339.
    Abstract     Related articles   

  1381. YUAN B, Sun R, Du Y, Jia Z, et al
    STAT3-Induced Upregulation of lncRNA CASC9 Promotes the Progression of Bladder Cancer by Interacting with EZH2 and Affecting the Expression of PTEN.
    Onco Targets Ther. 2020;13:9147-9157.
    Abstract     Related articles   

  1382. CHEN C, Liu X, Jiang J, Li S, et al
    Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis.
    Onco Targets Ther. 2020;13:9059-9069.
    Abstract     Related articles   

  1383. LU Y, Shao J, Shu X, Jiang Y, et al
    FADS1 is a Prognostic Biomarker in Bladder Cancer: A Study Based on TCGA Data.
    Comb Chem High Throughput Screen. 2020 Sep 24. pii: CCHTS-EPUB-110227.
    Abstract     Related articles   

  1384. HO CY, Chang AC, Hsu CH, Tsai TF, et al
    Miconazole induces protective autophagy in bladder cancer cells.
    Environ Toxicol. 2020 Sep 27. doi: 10.1002/tox.23024.
    Abstract     Related articles   

  1385. REESINK DJ, van de Garde EMW, Peters BJM, van der Nat PB, et al
    Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands.
    Sci Rep. 2020;10:15822.
    Abstract     Related articles   

  1386. TABER A, Christensen E, Lamy P, Nordentoft I, et al
    Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis.
    Nat Commun. 2020;11:4858.
    Abstract     Related articles   

  1387. ZHOU X, Qiu S, Nie L, Jin D, et al
    Classification of Muscle-Invasive Bladder Cancer Based on Immunogenomic Profiling.
    Front Oncol. 2020;10:1429.
    Abstract     Related articles   

  1388. SARKIS J, Samaha R, Kattan J, Sarkis P, et al
    Bladder cancer during the COVID-19 pandemic: the calm before the storm?
    Future Sci OA. 2020;6:FSO615.
    Abstract     Related articles   

  1389. ZENG M, Su Y, Li K, Jin D, et al
    Gallic Acid Inhibits Bladder Cancer T24 Cell Progression Through Mitochondrial Dysfunction and PI3K/Akt/NF-kappaB Signaling Suppression.
    Front Pharmacol. 2020;11:1222.
    Abstract     Related articles   

  1390. LI WX, Zhang YL
    Novel Long Non-coding RNA Markers for Prognostic Prediction of Patients with Bladder Cancer.
    Chin Med Sci J. 2020;35:239-247.
    Abstract     Related articles   

  1391. PARK BS, Cho SH, Kim SJ, Kim TU, et al
    Synchronous quadruple colon cancer with two lesions previously obscured by ischemic colitis, plus bladder cancer and thymoma: a case report.
    Ann Coloproctol. 2020 Sep 18. pii: ac.2020.06.18. doi: 10.3393/ac.2020.
    Abstract     Related articles   

  1392. MORI K, Miura N, Mostafaei H, Quhal F, et al
    Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis.
    Int J Clin Oncol. 2020;25:1459-1474.
    Abstract     Related articles   

  1393. CURLEY M, Bhardwaj H
    Disseminated Bacillus Calmette-Guerin Infection Detected on FDG PET/CT Following Intravesical Bacillus Calmette-Guerin Therapy.
    Clin Nucl Med. 2020 May 19. doi: 10.1097/RLU.0000000000003046.
    Abstract     Related articles   

  1394. CHAWLA J, Selhi PK, Narang V, Sood N, et al
    Synchronous high-grade bladder carcinoma associated with chronic lymphocytic leukemia: A rare entity in Indian literature.
    J Cancer Res Ther. 2020;16:180-182.
    Abstract     Related articles   

  1395. BANKHEAD A 3RD, McMaster T, Wang Y, Boonstra PS, et al
    TP63 isoform expression is linked with distinct clinical outcomes in cancer.
    EBioMedicine. 2020;51:102561.
    Abstract     Related articles   

  1396. SCHERZER ND, Greenberg JW, Shaw EJ, Silberstein JL, et al
    Robotic vs. open surgical management of ureteroenteric anastomotic strictures: technical modifications to enhance success.
    J Robot Surg. 2020;14:615-619.
    Abstract     Related articles   

  1397. MIGUEL CM, Kosinski KE, Fazzari MJ, Kongnyuy M, et al
    Pathologic measures of quality compare favorably in patients undergoing robot-assisted radical cystectomy to open cystectomy cohorts: a National Cancer Database analysis.
    J Robot Surg. 2020;14:609-614.
    Abstract     Related articles   

  1398. SIDDEEK RAT, Gupta A, Gupta S, Goyal B, et al
    Evaluation of platelet distribution width as novel biomarker in gall bladder cancer.
    J Carcinog. 2020;19:5.
    Abstract     Related articles   

  1399. SRI D, Lee HJ, El-Gemmal S, Backhouse C, et al
    Cystectomy outcomes in patients who have failed Radiofrequency-induced Thermo-chemotherapeutic Effect Mitomycin-C (RITE-MMC) treatment for high-risk non-muscle invasive bladder cancer (HRNMIBC)-Does it complicate surgery and adversely impact oncologic
    Urol Oncol. 2020 Oct 5. pii: S1078-1439(20)30438.
    Abstract     Related articles   

  1400. CARANDO R, Afferi L, Marra G, Krajewski W, et al
    The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review.
    Arab J Urol. 2020;18:67-71.
    Abstract     Related articles   

  1401. HURLE R, Maccagnano C
    Active surveillance for recurrent low-grade non-muscle-invasive bladder cancer: Can we take any advantage from the COVID-19 crisis?
    Arab J Urol. 2020;18:65-66.
    Abstract     Related articles   

  1402. WANG Z, Tang H, Xue Y, Xue L, et al
    Clinical application of drug sensitive gene detection in postoperative instillation for non-muscle invasive bladder cancer.
    BMC Nephrol. 2020;21:426.
    Abstract     Related articles   

  1403. LE GOUX C, Vacher S, Schnitzler A, Barry Delongchamps N, et al
    Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer.
    Sci Rep. 2020;10:16641.
    Abstract     Related articles   

  1404. OLKHOV-MITSEL E, Hodgson A, Liu SK, Vesprini D, et al
    Can immune markers help identify fast relapse in patients with muscle invasive bladder cancer?
    Pathol Res Pract. 2020;216:153200.
    Abstract     Related articles   

  1405. MOSCHINI M, Afferi L, Gandaglia G, D'Andrea D, et al
    Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer.
    Eur Urol Focus. 2020 Oct 2. pii: S2405-4569(20)30268.
    Abstract     Related articles   

  1406. BEDNOVA O, Leyton JV
    Targeted Molecular Therapeutics for Bladder Cancer-A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors?
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  1407. DU L, Zhang L, Sun F
    Puerarin Inhibits the Progression of Bladder Cancer by Regulating circ_0020394/miR-328-3p/NRBP1 Axis.
    Cancer Biother Radiopharm. 2020 Oct 5. doi: 10.1089/cbr.2019.3382.
    Abstract     Related articles   

  1408. LI R, Zheng JZ, Huang X
    Suppression of HAX-1 induced by miR-325 resensitizes bladder cancer cells to cisplatin-induced apoptosis.
    Eur Rev Med Pharmacol Sci. 2020;24:9303-9314.
    Abstract     Related articles   

  1409. HUNT A, Hanson I, Dunlop A, Barnes H, et al
    Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer.
    Clin Transl Radiat Oncol. 2020;25:46-51.
    Abstract     Related articles   

  1410. VAN HEMELRIJCK M, Patel P, Mouw KW
    Editorial: Bladder Cancer - A Cinderella Cancer: Advances and Remaining Research Questions.
    Front Oncol. 2020;10:1749.
    Abstract     Related articles   

  1411. LIU X, Zhou Z, Wang Y, Zhu K, et al
    Corrigendum: Downregulation of HMGA1 Mediates Autophagy and Inhibits Migration and Invasion in Bladder Cancer via miRNA-221/TP53INP1/p-ERK Axis.
    Front Oncol. 2020;10:1735.
    Abstract     Related articles   

  1412. FANG M, Liu F, Huang L, Wu L, et al
    A Urine Metabonomics Study of Rat Bladder Cancer by Combining Gas Chromatography-Mass Spectrometry with Random Forest Algorithm.
    Int J Anal Chem. 2020;2020:8839215.
    Abstract     Related articles   

  1413. NICOLAZZO C, de Berardinis E, Gazzaniga P
    Liquid Biopsy for Predicting Bacillus Calmette-Guerin Unresponsiveness in Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2020 Oct 1. pii: S2588-9311(20)30145.
    Abstract     Related articles   

  1414. ALVAREZ-MAESTRO M, Guerrero-Ramos F, Rodriguez-Faba O, Dominguez-Escrig JL, et al
    Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC).
    Actas Urol Esp. 2020 Oct 1. pii: S0210-4806(20)30186.
    Abstract     Related articles   

  1415. NAHON I, Paterson C, Sayner A
    The Impact of Exercise and Nutrition as Part of a Person-Centered Approach to Prehabilitation in Patients with Bladder Cancer.
    Semin Oncol Nurs. 2020 Sep 30:151072. doi: 10.1016/j.soncn.2020.151072.
    Abstract     Related articles   

  1416. CAO Y
    [Diagnostic experience of urinary non-invasive papillary urothelial neoplasms].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:1093-1096.
    Abstract     Related articles   

  1417. YAZAWA Y, Ikarashi N, Hoshino M, Kikkawa H, et al
    Inhibitory effect of ergosterol on bladder carcinogenesis is due to androgen signaling inhibition by brassicasterol, a metabolite of ergosterol.
    J Nat Med. 2020;74:680-688.
    Abstract     Related articles   

  1418. NAGUMO Y, Kawai K, Kojima T, Shiga M, et al
    Prognostic significance of non-urothelial carcinoma of bladder: analysis of nationwide hospital-based cancer registry data in Japan.
    Jpn J Clin Oncol. 2020;50:1068-1075.
    Abstract     Related articles   

  1419. NOUHAUD FX, Williams M, Yaxley W, Cho J, et al
    Robot-assisted orthotopic "W" ileal neobladder in male patients: step-by-step video-illustrated technique and preliminary outcomes.
    J Robot Surg. 2020;14:739-744.
    Abstract     Related articles   

  1420. MOSCHOVAS MC, Chade DC, Arap MA, Sarkis AS, et al
    Robotic-assisted radical cystectomy: the first multicentric Brazilian experience.
    J Robot Surg. 2020;14:703-708.
    Abstract     Related articles   

  1421. PAILLAS S, Then CK, Kilgas S, Ruan JL, et al
    The Histone Deacetylase Inhibitor Romidepsin Spares Normal Tissues While Acting as an Effective Radiosensitizer in Bladder Tumors in Vivo.
    Int J Radiat Oncol Biol Phys. 2020;107:212-221.
    Abstract     Related articles   

  1422. GHAFERI M, Asadollahzadeh MJ, Akbarzadeh A, Ebrahimi Shahmabadi H, et al
    Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  1423. REZAEE ME, Goldwag JL, Goddard B, Bihrle Iii W, et al
    Parastomal hernia development after cystectomy and ileal conduit for bladder cancer: results from the Dartmouth ileal conduit enhancement (DICE) project.
    Can J Urol. 2020;27:10369-10377.
    Abstract     Related articles   

  1424. LUO Y, Chen L, Zhou Q, Xiong Y, et al
    Identification of a prognostic gene signature based on an immunogenomic landscape analysis of bladder cancer.
    J Cell Mol Med. 2020 Oct 13. doi: 10.1111/jcmm.15960.
    Abstract     Related articles   

  1425. XU N, Lin W, Sun J, Sadahira T, et al
    Nitroxoline inhibits bladder cancer progression by reversing EMT process and enhancing anti-tumor immunity.
    J Cancer. 2020;11:6633-6641.
    Abstract     Related articles   

  1426. HAAS M, Huber T, Pickl C, van Rhijn BWG, et al
    The comprehensive complication index is associated with a significant increase in complication severity between 30 and 90 days after radical cystectomy for bladder cancer.
    Eur J Surg Oncol. 2020 Oct 5. pii: S0748-7983(20)30831.
    Abstract     Related articles   

  1427. BI J, Liu H, Dong W, Xie W, et al
    Correction to: Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence.
    Mol Cancer. 2020;19:148.
    Abstract     Related articles   

  1428. CARVALHO S, Abreu CM, Ferreira D, Lima L, et al
    Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies.
    Front Oncol. 2020;10:1774.
    Abstract     Related articles   

  1429. ANDERSSON N, Ohlsson J, Wahlin S, Nodin B, et al
    Lymphocyte antigen 6 superfamily member D is a marker of urothelial and squamous differentiation: implications for risk stratification of bladder cancer.
    Biomark Res. 2020;8:51.
    Abstract     Related articles   

  1430. TIAN Z, Meng L, Long X, Diao T, et al
    Identification and validation of an immune-related gene-based prognostic index for bladder cancer.
    Am J Transl Res. 2020;12:5188-5204.
    Abstract     Related articles   

  1431. ZHU H, Wang Y, Wei T, Zhao X, et al
    KAT8/MOF-Mediated Anti-Cancer Mechanism of Gemcitabine in Human Bladder Cancer Cells.
    Biomol Ther (Seoul). 2020 Oct 12. pii: biomolther.2020.
    Abstract     Related articles   

  1432. SUN X, Hu X, Wang X, Jiang X, et al
    MiR-381-3p/RAB2A axis activates cell proliferation and inhibits cell apoptosis in bladder cancer.
    Cell Mol Biol (Noisy-le-grand). 2020;66:117-120.
    Abstract     Related articles   

  1433. LU JL, Xia QD, Lu YH, Liu Z, et al
    Efficacy of intravesical therapies on the prevention of recurrence and progression of non-muscle-invasive bladder cancer: A systematic review and network meta-analysis.
    Cancer Med. 2020 Oct 11. doi: 10.1002/cam4.3513.
    Abstract     Related articles   

  1434. CHEN YT, Huang ZY, Tang HH, Kuo WT, et al
    Pterostilbene Sensitizes Cisplatin-Resistant Human Bladder Cancer Cells with Oncogenic HRAS.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  1435. BHARDWAJ N, Farkas AM, Gul Z, Sfakianos JP, et al
    Harnessing Natural Killer Cell Function for Genitourinary Cancers.
    Urol Clin North Am. 2020;47:433-442.
    Abstract     Related articles   

  1436. FARIA EF
    Editorial Comment: Does the Use of a Robot Decrease the Complication Rate Adherent to Radical Cystectomy? A Systematic Review and Meta-Analysis of Studies Comparing Open with Robotic Counterparts.
    Int Braz J Urol. 2020;46:657-658.
    Abstract     Related articles   

  1437. LIU Z, Sun T, Zhang Z, Bi J, et al
    An 18-gene signature based on glucose metabolism and DNA methylation improves prognostic prediction for urinary bladder cancer.
    Genomics. 2020 Oct 20. pii: S0888-7543(20)31981.
    Abstract     Related articles   

  1438. HUANG W, Li Y, Zhang C, Zha H, et al
    IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer.
    J Cell Mol Med. 2020 Oct 22. doi: 10.1111/jcmm.16003.
    Abstract     Related articles   

  1439. ABD-EL-RAOUF R, Ouf SA, Gabr MM, Zakaria MM, et al
    Escherichia coli foster bladder cancer cell line progression via epithelial mesenchymal transition, stemness and metabolic reprogramming.
    Sci Rep. 2020;10:18024.
    Abstract     Related articles   

  1440. KAMOUN W, Swindell E, Pien C, Luus L, et al
    Targeting EphA2 in Bladder Cancer Using a Novel Antibody-Directed Nanotherapeutic.
    Pharmaceutics. 2020;12.
    Abstract     Related articles   

  1441. LUO Q, Vogeli TA
    A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  1442. SHARIFUZZAMAN M, Barman SC, Zahed MA, Sharma S, et al
    An Electrodeposited MXene-Ti3C2Tx Nanosheets Functionalized by Task-Specific Ionic Liquid for Simultaneous and Multiplexed Detection of Bladder Cancer Biomarkers.
    Small. 2020 Oct 8:e2002517. doi: 10.1002/smll.202002517.
    Abstract     Related articles   

  1443. IZOL V, Deger M, Baltaci S, Akgul M, et al
    The Effect of Body Mass Index on Oncological and Surgical Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Multicenter Study of the Association of Urooncology, Turkey.
    Int J Clin Pract. 2020 Oct 8:e13750. doi: 10.1111/ijcp.13750.
    Abstract     Related articles   

  1444. XIA W, Chen C, Zhang MR, Zhu LN, et al
    LncRNA PCAT6 aggravates the progression of bladder cancer cells by targeting miR-513a-5p.
    Eur Rev Med Pharmacol Sci. 2020;24:9908-9914.
    Abstract     Related articles   

  1445. MORTADA WI, Awadalla A, Khater SM, Barakat NM, et al
    Preventive effect of pomegranate juice against chemically induced bladder cancer: An experimental study.
    Heliyon. 2020;6:e05192.
    Abstract     Related articles   

  1446. KADOURI Y, Lachkar S, Dergamoun H, El Sayegh H, et al
    Management of the Uncommon Bladder Cancers: A Single-Center Experience over 10 Years.
    Adv Urol. 2020;2020:7563703.
    Abstract     Related articles   

  1447. NGUYEN OTD, Sundstrom SH, Westvik GS, Rottereng AKS, et al
    Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case Report.
    Case Rep Oncol. 2020;13:1059-1066.
    Abstract     Related articles   

  1448. MOORTHY HK, Prabhu GGL, Venugopal P
    Clinical and therapeutic implications of sex steroid hormone receptor status in urothelial bladder cancer.
    Indian J Urol. 2020;36:171-178.
    Abstract     Related articles   

  1449. FAN Z, Huang Z, Hu C, Tong Y, et al
    Risk factors and nomogram for newly diagnosis of bone metastasis in bladder cancer: A SEER-based study.
    Medicine (Baltimore). 2020;99:e22675.
    Abstract     Related articles   

  1450. HALABI IE, Husseini ZE, Haibe Y, Charafeddine M, et al
    Cystectomy vs. bladder preservation after neoadjuvant chemotherapy in muscle-invasive bladder cancer: A tertiary medical center experience.
    Cancer Treat Res Commun. 2020;25:100222.
    Abstract     Related articles   

  1451. DEL GIUDICE F, Pecoraro M, Vargas HA, Cipollari S, et al
    Systematic Review and Meta-Analysis of Vesical Imaging-Reporting and Data System (VI-RADS) Inter-Observer Reliability: An Added Value for Muscle Invasive Bladder Cancer Detection.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  1452. KRAJEWSKI W, Moschini M, Nowak L, Poletajew S, et al
    Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit.
    J Clin Med. 2020;9.
    Abstract     Related articles   

  1453. KACEM BEN FRADJ M, Ouanes Y, Hadj-Taeib S, Mrad Dali K, et al
    Prognostic significance of plasma folate and cobalamin concentrations in non-muscle-invasive bladder cancer: A Prospective Cohort Study.
    Cancer Invest. 2020 Oct 19:1-18. doi: 10.1080/07357907.2020.1839760.
    Abstract     Related articles   

  1454. ZHU H, Mo Q, Shen H, Wang S, et al
    Carbohydrates, Glycemic Index, and Glycemic Load in Relation to Bladder Cancer Risk.
    Front Oncol. 2020;10:530382.
    Abstract     Related articles   

  1455. MURAKAMI Y, Matsumoto K, Shimizu Y, Ikeda M, et al
    PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy.
    Urol Oncol. 2020 Oct 15. pii: S1078-1439(20)30470.
    Abstract     Related articles   

  1456. MARANDINO L, Capozza A, Bandini M, Raggi D, et al
    [18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab.
    Urol Oncol. 2020 Oct 15. pii: S1078-1439(20)30472.
    Abstract     Related articles   

  1457. GULINAC M, Dikov D, Velikova T, Belovezhdov V, et al
    Increased PD-L1 expression in high-grade bladder cancer with squamous cell differentiation in Bulgarian and French patients' samples.
    Ann Diagn Pathol. 2020;49:151640.
    Abstract     Related articles   

  1458. MACGREGOR M, Safizadeh Shirazi H, Chan KM, Ostrikov K, et al
    Cancer cell detection device for the diagnosis of bladder cancer from urine.
    Biosens Bioelectron. 2020;171:112699.
    Abstract     Related articles   

  1459. TOSTIVINT V, Verhoest G, Cabarrou B, Gas J, et al
    Quality of life and functional outcomes after radical cystectomy with ileal orthotopic neobladder replacement for bladder cancer: a multicentre observational study.
    World J Urol. 2020 Oct 16. pii: 10.1007/s00345-020-03484.
    Abstract     Related articles   

  1460. AMBROSIO L, Argenziano M, Cucci MA, Grattarola M, et al
    Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells.
    Antioxidants (Basel). 2020;9.
    Abstract     Related articles   

  1461. OTT PA, Hu-Lieskovan S, Chmielowski B, Govindan R, et al
    A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.
    Cell. 2020;183:347-362.
    Abstract     Related articles   

  1462. AKAN S, Ediz C, Kizilkan YE, Alcin A, et al
    Covid-19 Threat in Patients with High-Risk Non-Muscle Invasive Bladder Cancer Receiving Intravesical BCG Therapy.
    Int J Clin Pract. 2020 Oct 16:e13752. doi: 10.1111/ijcp.13752.
    Abstract     Related articles   

  1463. YANG Z, Bai Y, Liu M, Hu X, et al
    Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
    Cancer Med. 2020 Oct 16. doi: 10.1002/cam4.3535.
    Abstract     Related articles   

  1464. CHENG C, Song D, Wu Y, Liu B, et al
    RAC3 Promotes Proliferation, Migration and Invasion via PYCR1/JAK/STAT Signaling in Bladder Cancer.
    Front Mol Biosci. 2020;7:218.
    Abstract     Related articles   

  1465. BI H, Shang Z, Jia C, Wu J, et al
    Predictive Values of Preoperative Prognostic Nutritional Index and Systemic Immune-Inflammation Index for Long-Term Survival in High-Risk Non-Muscle-Invasive Bladder Cancer Patients: A Single-Centre Retrospective Study.
    Cancer Manag Res. 2020;12:9471-9483.
    Abstract     Related articles   

  1466. YANG S, Guan H, Wang S, Wu H, et al
    Plasma Fibrinogen Predicts the Prognosis of Bladder Cancer Patients After Radical Cystectomy.
    Cancer Manag Res. 2020;12:9303-9314.
    Abstract     Related articles   

  1467. ZHOU Z, Liu X, Li Y, Li J, et al
    TP53INP2 Modulates Epithelial-to-Mesenchymal Transition via the GSK-3beta/beta-Catenin/Snail1 Pathway in Bladder Cancer Cells.
    Onco Targets Ther. 2020;13:9587-9597.
    Abstract     Related articles   

  1468. CAI Z, Li H
    Circular RNAs and Bladder Cancer.
    Onco Targets Ther. 2020;13:9573-9586.
    Abstract     Related articles   

  1469. YUK HD, Jeong CW, Kwak C, Kim H, et al
    Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial.
    BMJ Open. 2020;10:e035530.
    Abstract     Related articles   

  1470. FURRER MA, Grueter T, Bosshard P, Vartolomei MD, et al
    Routine Preoperative Bone Scintigraphy Has Limited Impact on the Management of Patients with Invasive Bladder Cancer.
    Eur Urol Focus. 2020 Oct 12. pii: S2405-4569(20)30275.
    Abstract     Related articles   

  1471. RODUIT A, Pouget R, Defabiani N, Troillet N, et al
    [BCGitis following intravesical administration of bacillus Calmette-Guerin].
    Rev Med Suisse. 2020;16:1920-1923.
    Abstract     Related articles   

  1472. PFAIL JL, Katims AB, Alerasool P, Sfakianos JP, et al
    Immunotherapy in non-muscle-invasive bladder cancer: current status and future directions.
    World J Urol. 2020 Oct 15. pii: 10.1007/s00345-020-03474.
    Abstract     Related articles   

  1473. LI X, Shang D, Shen H, Song J, et al
    Corrigendum to "ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes" [Biomed. Pharmacother. 126 (2020) 110066].
    Biomed Pharmacother. 2020 Oct 11:110858. doi: 10.1016/j.biopha.2020.110858.
    Abstract     Related articles   

  1474. HAMID ARAH, Ridwan FR, Parikesit D, Widia F, et al
    Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients.
    BMC Urol. 2020;20:158.
    Abstract     Related articles   

  1475. MULLER J, Kalbermatten Magaya N, Traichel B, Taverna C, et al
    [Unusual Cause of Acute Kidney Failure in a Patient with Metastatic Bladder Carcinoma Undergoing Palliative Chemotherapy].
    Praxis (Bern 1994). 2020;109:1070-1073.
    Abstract     Related articles   

  1476. ECKE TH, Kiani A, Schlomm T, Friedersdorff F, et al
    Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  1477. VACHER S, Suybeng V, Girard E, Masliah Planchon J, et al
    Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  1478. OH JY
    Autoimmune Keratitis after Atezolizumab Treatment.
    N Engl J Med. 2020;383:1468.
    Abstract     Related articles   

  1479. LI R, Chen H, Gong G, Wang L, et al
    Bladder Wall Segmentation in MRI Images via Deep Learning and Anatomical Constraints.
    Annu Int Conf IEEE Eng Med Biol Soc. 2020;2020:1629-1632.
    Abstract     Related articles   

  1480. SHIMIZU G, Amano R, Nakamura I, Wada A, et al
    Disseminated Bacillus Calmette-Guerin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review.
    BMC Infect Dis. 2020;20:708.
    Abstract     Related articles   

  1481. RENZI C, Lyratzopoulos G
    Comorbidity and the diagnosis of symptomatic-but-as-yet-undiagnosed cancer.
    Br J Gen Pract. 2020;70:e598-e599.
    Abstract     Related articles   

  1482. ASHOUR DS, Othman AA
    Parasite-bacteria interrelationship.
    Parasitol Res. 2020;119:3145-3164.
    Abstract     Related articles   

  1483. MAZDAK H, Gholampour M, Tolou Ghamri Z
    A Quick Review of Redox State in Cancer: Focus to Bladder.
    Gulf J Oncolog. 2020;1:59-62.
    Abstract     Related articles   

  1484. YU Y, Zhang W, Li A, Chen Y, et al
    Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.
    JAMA Netw Open. 2020;3:e202149.
    Abstract     Related articles   

  1485. ABRANTES AM, Pires AS, Monteiro L, Teixo R, et al
    Tumour functional imaging by PET.
    Biochim Biophys Acta Mol Basis Dis. 2020;1866:165717.
    Abstract     Related articles   

  1486. SUNDARAM A, Gupta K, Singla S, Singh SK, et al
    Glandular-type inverted papilloma of urinary bladder - Report of a unique case with immunohistochemistry.
    Indian J Pathol Microbiol. 2020;63:96-97.
    Abstract     Related articles   

  1487. ROMAGNOLI D, Schiavina R, Bianchi L, Borghesi M, et al
    Is Fast Track protocol a safe tool to reduce hospitalization time after radical cystectomy with ileal urinary diversion? Initial results from a single high-volume centre.
    Arch Ital Urol Androl. 2020;91:230-236.
    Abstract     Related articles   

  1488. GRIFFIN MA, Culp WTN, Giuffrida MA, Ellis P, et al
    Lower urinary tract transitional cell carcinoma in cats: Clinical findings, treatments, and outcomes in 118 cases.
    J Vet Intern Med. 2020;34:274-282.
    Abstract     Related articles   

  1489. VIVIANI E, Bracale UM
    Re: "Ruptured Mycotic Aneurysm After Intravesical Instillation for Bladder Tumor".
    Ann Vasc Surg. 2020;65:e299.
    Abstract     Related articles   

  1490. ZHU X, Tong H, Gao S, Yin H, et al
    C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients.
    Biomed Res Int. 2020;2020:7139721.
    Abstract     Related articles   

  1491. ZHANG R, Xia J, Wang Y, Cao M, et al
    Co-Expression of Stem Cell and Epithelial Mesenchymal Transition Markers in Circulating Tumor Cells of Bladder Cancer Patients.
    Onco Targets Ther. 2020;13:10739-10748.
    Abstract     Related articles   

  1492. ERAY A, Guneri PY, Yilmaz GO, Karakulah G, et al
    Analysis of open chromatin regions in bladder cancer links beta-catenin mutations and Wnt signaling with neuronal subtype of bladder cancer.
    Sci Rep. 2020;10:18667.
    Abstract     Related articles   

  1493. WANG Q, Hu L, Ma W, Meng Z, et al
    UriBLAD - a urine-based gene expression assay for non-invasive detection of bladder cancer.
    J Mol Diagn. 2020 Oct 26. pii: S1525-1578(20)30519.
    Abstract     Related articles   

  1494. LIU J, Wu P, Lai S, Song X, et al
    Preoperative Monocyte-to-lymphocyte Ratio Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Clin Genitourin Cancer. 2020 Sep 18. pii: S1558-7673(20)30220.
    Abstract     Related articles   

  1495. HUANG X, Yan Y, Wei R, Liu H, et al
    Centrosome Protein 78 Is Overexpressed in Muscle-Invasive Bladder Cancer and Is Associated with Tumor Molecular Subtypes and Mutation Signatures.
    Med Sci Monit. 2020;26:e925197.
    Abstract     Related articles   

  1496. HOWARD JM, Margulis V, Woldu SL
    Clinical outcomes of a cohort of patients with bulky, clinically node-positive bladder cancer undergoing radical cystectomy in the contemporary era.
    Can Urol Assoc J. 2020 Oct 27. pii: cuaj.6966. doi: 10.5489/cuaj.6966.
    Abstract     Related articles   

  1497. JENSEN BT, Lauridsen SV, Jensen JB
    Optimal Delivery of Follow-Up Care After Radical Cystectomy for Bladder Cancer.
    Res Rep Urol. 2020;12:471-486.
    Abstract     Related articles   

  1498. HOCKMAN L, Bailey J, Sanders J, Muzzey C, et al
    A Qualitative Assessment of Patient Satisfaction with Radical Cystectomy for Bladder Cancer at a Single Institution: How Can We Improve?
    Res Rep Urol. 2020;12:447-453.
    Abstract     Related articles   

  1499. LONG Q, An X, Chen M, Wang N, et al
    PUF60/AURKA Axis Contributes to Tumor Progression and Malignant Phenotypes in Bladder Cancer.
    Front Oncol. 2020;10:568015.
    Abstract     Related articles   

  1500. TANG C, Ma J, Liu X, Liu Z, et al
    Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene Sets.
    Front Oncol. 2020;10:544610.
    Abstract     Related articles   

  1501. ZHANG R, Wang Z, You W, Zhou F, et al
    Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT.
    Cancer Cell Int. 2020;20:520.
    Abstract     Related articles   

  1502. LI D, Li A, Yang Y, Feng D, et al
    Clinical Characteristics and Prognosis of Rare Histological Variants of Bladder Cancer: A Single-Center Retrospective Study from China.
    Cancer Manag Res. 2020;12:9635-9641.
    Abstract     Related articles   

  1503. Erratum: GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process [Erratum].
    Onco Targets Ther. 2020;13:10759.
    Abstract     Related articles   

  1504. ZHANG L, Liang J, Liu X, Wu J, et al
    Aloperine Exerts Antitumor Effects on Bladder Cancer in vitro.
    Onco Targets Ther. 2020;13:10351-10360.
    Abstract     Related articles   

  1505. TANG C, Ma J, Liu X, Liu Z, et al
    Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling.
    Stem Cell Res Ther. 2020;11:457.
    Abstract     Related articles   

  1506. CAVALLARI I, Grassi A, Del Bianco P, Aceti A, et al
    Prognostic Stratification of Bladder Cancer Patients with a MicroRNA-based Approach.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  1507. OLAH C, Tschirdewahn S, Hoffmann MJ, Krafft U, et al
    Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients.
    Diagnostics (Basel). 2020;10.
    Abstract     Related articles   

  1508. LIU J, Zhang Y, Yu C, Zhang P, et al
    Bergenin inhibits bladder cancer progression via activating the PPARgamma/PTEN/Akt signal pathway.
    Drug Dev Res. 2020 Oct 28. doi: 10.1002/ddr.21751.
    Abstract     Related articles   

  1509. WANG P, Zang S, Li G, Qu W, et al
    The role of surgery on the primary tumor site in bladder cancer with distant metastasis: significance of histology type and metastatic pattern.
    Cancer Med. 2020 Oct 27. doi: 10.1002/cam4.3560.
    Abstract     Related articles   

  1510. OTO J, Plana E, Fernandez-Pardo A, Cana F, et al
    Identification of miR-29c-3p as a Robust Normalizer for Urine microRNA Studies in Bladder Cancer.
    Biomedicines. 2020;8.
    Abstract     Related articles   

  1511. SHEN D, Xu J, Cao X, Cao X, et al
    Long noncoding RNA MAGI2-AS3 inhibits bladder cancer progression through MAGI2/PTEN/epithelial-mesenchymal transition (EMT) axis.
    Cancer Biomark. 2020 Oct 13. pii: CBM201421. doi: 10.3233/CBM-201421.
    Abstract     Related articles   

  1512. MASSAFRA M, Passalacqua MI, Lupo G, Altavilla G, et al
    Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer.
    Urol Case Rep. 2020 Oct 21:101461. doi: 10.1016/j.eucr.2020.101461.
    Abstract     Related articles   

  1513. MBANEFO EC, Agbo CT, Zhao Y, Lamanna OK, et al
    IPSE, an abundant egg-secreted protein of the carcinogenic helminth Schistosoma haematobium, promotes proliferation of bladder cancer cells and angiogenesis.
    Infect Agent Cancer. 2020;15:63.
    Abstract     Related articles   

  1514. CORAGGIO G, Husheng S, Loganadane G, Ghith S, et al
    Hemostatic radiotherapy for bladder cancer-related hematuria in patients unfit for surgery: is there any impact of fractionation schedule?
    J BUON. 2020;25:2092-2096.
    Abstract     Related articles   

  1515. WAHBY S, Jarczyk J, Fierek A, Heinkele J, et al
    POFUT1 mRNA expression as an independent prognostic parameter in muscle-invasive bladder cancer.
    Transl Oncol. 2020;14:100900.
    Abstract     Related articles   

  1516. WANG Y, Chen J, Wang X, Wang K, et al
    miR-140-3p inhibits bladder cancer cell proliferation and invasion by targeting FOXQ1.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  1517. SAHATSAPAN N, Ngawhirunpat T, Rojanarata T, Opanasopit P, et al
    Catechol-Functionalized Alginate Nanoparticles as Mucoadhesive Carriers for Intravesical Chemotherapy.
    AAPS PharmSciTech. 2020;21:212.
    Abstract     Related articles   

  1518. LUZZAGO S, Palumbo C, Rosiello G, Pecoraro A, et al
    The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder.
    Am J Clin Oncol. 2020;43:567-574.
    Abstract     Related articles   

  1519. TANG Y, Chen J, Dai M, Li L, et al
    Imaging features of inflammatory myofibroblastic tumour in the urinary bladder.
    Br J Hosp Med (Lond). 2020;81:1-2.
    Abstract     Related articles   

  1520. JANARDANAN S, Rifat M, Patil K
    Zero clamping technique during radical cystectomy.
    Ann R Coll Surg Engl. 2020;102:545-546.
    Abstract     Related articles   

  1521. NGUYEN JK, Przybycin CG, McKenney JK, Magi-Galluzzi C, et al
    Immunohistochemical staining patterns of Ki-67 and p53 in florid reactive urothelial atypia and urothelial carcinoma in situ demonstrate significant overlap.
    Hum Pathol. 2020;98:81-88.
    Abstract     Related articles   

  1522. AKGUL M, MacLennan GT, Cheng L
    The applicability and utility of immunohistochemical biomarkers in bladder pathology.
    Hum Pathol. 2020;98:32-55.
    Abstract     Related articles   

  1523. PALUMBO C, Knipper S, Pecoraro A, Rosiello G, et al
    Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy.
    Surg Oncol. 2020;32:8-13.
    Abstract     Related articles   

  1524. AKAN S, Ediz C, Sahin A, Tavukcu HH, et al
    Can the systemic immune inflammation index be a predictor of bcg response in patients with high-risk non-muscle invasive bladder cancer?
    Int J Clin Pract. 2020 Nov 5. doi: 10.1111/ijcp.13813.
    Abstract     Related articles   

  1525. YILMAZ M, Sahin Y, Ates HA, Hacibey I, et al
    De Ritis ratio: how effectively we can use in bladder cancer management?
    Biomark Med. 2020 Nov 5. doi: 10.2217/bmm-2020-0212.
    Abstract     Related articles   

  1526. NING XH, Qi YY, Wang FX, Li SC, et al
    A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
    Biomed Res Int. 2020;2020:7272960.
    Abstract     Related articles   

  1527. WANG H, Niu X, Mao F, Liu X, et al
    Hsa_circRNA_100146 Acts as a Sponge of miR-149-5p in Promoting Bladder Cancer Progression via Regulating RNF2.
    Onco Targets Ther. 2020;13:11007-11017.
    Abstract     Related articles   

  1528. YANG J, Chen J, Wu S, Fei X, et al
    Microarray Expression Profiles and Bioinformatics Analyses Reveal Aberrant Circular RNAs Expression in Bladder Cancer.
    Onco Targets Ther. 2020;13:10889-10899.
    Abstract     Related articles   

  1529. RIVANO M, Cancanelli L, Spazio LD, Chiumente M, et al
    Restricted mean survival time as outcome measure in advanced urothelial bladder cancer: analysis of 4 clinical studies.
    Immunotherapy. 2020 Nov 5. doi: 10.2217/imt-2020-0160.
    Abstract     Related articles   

  1530. IKEDA A, Nosato H, Kochi Y, Negoro H, et al
    Cystoscopic imaging for bladder cancer detection based on stepwise organic transfer learning with a pre-trained convolutional neural network.
    J Endourol. 2020 Nov 4. doi: 10.1089/end.2020.0919.
    Abstract     Related articles   

  1531. LEI T, Gong B, Meng Q, Zhang M, et al
    Transthyretin in bladder cancer.
    J Biol Regul Homeost Agents. 2020;34.
    Abstract     Related articles   

  1532. SUN YU, Nishino H, Zhao M, Miyake K, et al
    A Non-invasive Imageable GFP-expressing Mouse Model of Orthotopic Human Bladder Cancer.
    In Vivo. 2020;34:3225-3231.
    Abstract     Related articles   

  1533. PETRELLA G, Ciufolini G, Vago R, Cicero DO, et al
    The Interplay between Oxidative Phosphorylation and Glycolysis as a Potential Marker of Bladder Cancer Progression.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  1534. ZHU J, Zhu Z, Cai P, Gu Z, et al
    Bladder cancer-associated transcript 2 contributes to nephroblastoma progression.
    J Gene Med. 2020 Nov 3:e3292. doi: 10.1002/jgm.3292.
    Abstract     Related articles   

  1535. ZHANG D, Du D, Yi S, Li X, et al
    LncRNA PCAT6: A potential biomarker for diagnosis and prognosis of bladder cancer.
    Ann Diagn Pathol. 2020;49:151642.
    Abstract     Related articles   

  1536. ROUANNE M, Radulescu C, Adam J, Allory Y, et al
    PD-L1 testing in urothelial bladder cancer: essentials of clinical practice.
    World J Urol. 2020 Nov 3. pii: 10.1007/s00345-020-03498.
    Abstract     Related articles   

  1537. GABER DA, Wassef RM, El-Ayat WM, El-Moazen MI, et al
    Role of a schistosoma haematobium specific microRNA as a predictive and prognostic tool for bilharzial bladder cancer in Egypt.
    Sci Rep. 2020;10:18844.
    Abstract     Related articles   

  1538. KIM J, Jin P, Yang W, Kim WJ, et al
    Proteomic profiling of bladder cancer for precision medicine in the clinical setting: A review for the busy urologist.
    Investig Clin Urol. 2020;61:539-554.
    Abstract     Related articles   

  1539. CHIANCONE F, Fabiano M, Fedelini M, Meccariello C, et al
    Outcomes and complications of Hyperthermic IntraVesical Chemotherapy using mitomycin C or epirubicin for patients with non-muscle invasive bladder cancer after bacillus Calmette-Guerin treatment failure.
    Cent European J Urol. 2020;73:287-294.
    Abstract     Related articles   

  1540. KOURBANHOUSSEN K, McMartin C, Lodde M, Zlotta A, et al
    Switching Cancers: A Systematic Review Assessing the Role of Androgen Suppressive Therapy in Bladder Cancer.
    Eur Urol Focus. 2020 Oct 29. pii: S2405-4569(20)30286.
    Abstract     Related articles   

  1541. SAVCHUK R, Kostyev F, Dekhtiar Y
    Georgian Med News. 2020;:7-10.
    Abstract     Related articles   

  1542. SETTI BOUBAKER N, Gurtner A, Trabelsi N, Manni I, et al
    Uncovering the expression patterns and the clinical significance of miR-182, miR-205, miR-27a and miR-369 in patients with urinary bladder cancer.
    Mol Biol Rep. 2020 Oct 31. pii: 10.1007/s11033-020-05932.
    Abstract     Related articles   

  1543. LIU Y, Huang W, Cai Z
    Synthesizing AND gate minigene circuits based on CRISPReader for identification of bladder cancer cells.
    Nat Commun. 2020;11:5486.
    Abstract     Related articles   

  1544. DINH TT, Mitin T, Bagshaw HP, Hoffman KE, et al
    Executive Summary of the American Radium Society Appropriate Use Criteria for Radiation Treatment of Node-Negative Muscle Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Oct 27. pii: S0360-3016(20)34448.
    Abstract     Related articles   

  1545. RINK M, Riethdorf S, Yu H, Kolker M, et al
    The Impact of Circulating Tumor Cells on Venous Thromboembolism and Cardiovascular Events in Bladder Cancer Patients Treated with Radical Cystectomy.
    J Clin Med. 2020;9.
    Abstract     Related articles   

  1546. BRAVETTI C, Le Garff-Tavernier M, De Septenville A, Maloum K, et al
    Watch out for a second train.
    Ann Biol Clin (Paris). 2020;78:527-536.
    Abstract     Related articles   

  1547. LI R, Du Y, Chen Z, Xu D, et al
    Macroscopic somatic clonal expansion in morphologically normal human urothelium.
    Science. 2020;370:82-89.
    Abstract     Related articles   

  1548. LAWSON ARJ, Abascal F, Coorens THH, Hooks Y, et al
    Extensive heterogeneity in somatic mutation and selection in the human bladder.
    Science. 2020;370:75-82.
    Abstract     Related articles   

  1549. JUSZCZAK K, Gastecka A, Adamowicz J, Adamczyk P, et al
    Health-related quality of life is not related to laparoscopic or robotic technique in radical cystectomy.
    Adv Clin Exp Med. 2020;29:857-863.
    Abstract     Related articles   

  1550. EL KAWAK M, Dhaini HR, Jabbour ME, Moussa MA, et al
    Slow N-acetylation as a possible contributor to bladder carcinogenesis.
    Mol Carcinog. 2020;59:1017-1027.
    Abstract     Related articles   

  1551. ZHU J, Zheng G, Xu H, Jin X, et al
    Expression and prognostic significance of pyruvate dehydrogenase kinase 1 in bladder urothelial carcinoma.
    Virchows Arch. 2020;477:637-649.
    Abstract     Related articles   

  1552. ZHOU Y, Abel GA, Hamilton W, Singh H, et al
    Imaging activity possibly signalling missed diagnostic opportunities in bladder and kidney cancer: A longitudinal data-linkage study using primary care electronic health records.
    Cancer Epidemiol. 2020;66:101703.
    Abstract     Related articles   

  1553. ANAND K, Ensor J, Pingali SR, Hwu P, et al
    T-cell lymphoma secondary to checkpoint inhibitor therapy.
    J Immunother Cancer. 2020;8.
    Abstract     Related articles   

  1554. GHOSH M, Gauger M, Marcu A, Nelde A, et al
    Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies.
    Mol Cell Proteomics. 2020;19:432-443.
    Abstract     Related articles   

  1555. SOLOWAY M, Matulay JT, Kamat AM
    A Case for Risk-adapted Management of Low-grade Bladder Tumors.
    Eur Urol Oncol. 2020;3:128-129.
    Abstract     Related articles   

  1556. ZHAO M, Sun Y, Gao Z, Cui H, et al
    Gigantol Attenuates the Metastasis of Human Bladder Cancer Cells, Possibly Through Wnt/EMT Signaling.
    Onco Targets Ther. 2020;13:11337-11346.
    Abstract     Related articles   

  1557. BI H, Shang Z, Jia C, Wu J, et al
    LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis.
    Onco Targets Ther. 2020;13:11277-11288.
    Abstract     Related articles   

  1558. HE H, Xie H, Chen Y, Li C, et al
    Global, regional, and national burdens of bladder cancer in 2017: estimates from the 2017 global burden of disease study.
    BMC Public Health. 2020;20:1693.
    Abstract     Related articles   

  1559. HOWARD JM, Woldu S, Daneshmand S, Lotan Y, et al
    Enhanced endoscopy with IMAGE1 S CHROMA improves detection of non-muscle invasive bladder cancer during transurethral resection.
    J Endourol. 2020 Nov 11. doi: 10.1089/end.2020.0821.
    Abstract     Related articles   

  1560. WANG L, Li H, Qiao Q, Ge Y, et al
    Circular RNA circSEMA5A promotes bladder cancer progression by upregulating ENO1 and SEMA5A expression.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  1561. LAI C, Wu Z, Shi J, Li K, et al
    Autophagy-related long noncoding RNAs can predict prognosis in patients with bladder cancer.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  1562. IINUMA K, Yuhara K, Kotaka H, Ozawa K, et al
    Preoperative predictive factors of carcinoma in situ in the normal-appearing mucosa in patients who underwent an initial transurethral resection for non-muscle-invasive bladder cancer under white light cystoscopy.
    Cancer Rep (Hoboken). 2020 Nov 11:e1321. doi: 10.1002/cnr2.1321.
    Abstract     Related articles   

  1563. SHAHID M, Yeon A, Kim J
    Metabolomic and lipidomic approaches to identify biomarkers for bladder cancer and interstitial cystitis (Review).
    Mol Med Rep. 2020;22:5003-5011.
    Abstract     Related articles   

  1564. RODRIGUES D, Teixeira L, Garcia S, Pinto MG, et al
    Outcome of radiotherapy for invasive bladder cancer in older patients - not candidates for or decline cystectomy.
    Cancer Radiother. 2020 Nov 7. pii: S1278-3218(20)30296.
    Abstract     Related articles   

  1565. MARANDINO L, Capozza A, Bandini M, Raggi D, et al
    Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy.
    Eur Urol Focus. 2020 Nov 7. pii: S2405-4569(20)30287.
    Abstract     Related articles   

  1566. LI F, Guo H, Liu B, Liu N, et al
    Explore prognostic biomarker of bladder cancer based on competing endogenous network.
    Biosci Rep. 2020 Nov 10. pii: 226921. doi: 10.1042/BSR20202463.
    Abstract     Related articles   

  1567. ALJABERY F, Jancke G, Skoglund P, Hallbook O, et al
    Stapled versus robot-sewn ileo-ileal anastomosis during robot-assisted radical cystectomy: a review of outcomes in urinary bladder cancer patients.
    Scand J Urol. 2020 Nov 10:1-5. doi: 10.1080/21681805.2020.1843534.
    Abstract     Related articles   

  1568. ZAREINEJAD M, Faghih Z, Ariafar A, Safaei A, et al
    Establishment of a bladder cancer cell line expressing both mesenchymal and epithelial lineage-associated markers.
    Hum Cell. 2020 Nov 9. pii: 10.1007/s13577-020-00456.
    Abstract     Related articles   

  1569. DATE AA, Kates M, Yoshida T, Babu T, et al
    Preclinical evaluation of a hypotonic docetaxel nanosuspension formulation for intravesical treatment of non-muscle-invasive bladder cancer.
    Drug Deliv Transl Res. 2020 Nov 8. pii: 10.1007/s13346-020-00870.
    Abstract     Related articles   

  1570. ZHENG Y, Pei Y, Yang L, Zeng Z, et al
    Upregulated GRB7 promotes proliferation and tumorigenesis of Bladder Cancer via Phospho-AKT Pathway.
    Int J Biol Sci. 2020;16:3221-3230.
    Abstract     Related articles   

  1571. HU D, Xu X, Zhao Z, Li C, et al
    Detecting urine metabolites of bladder cancer by surface-enhanced Raman spectroscopy.
    Spectrochim Acta A Mol Biomol Spectrosc. 2020;247:119108.
    Abstract     Related articles   

  1572. TELLINI R, Mari A, Muto G, Cacciamani GE, et al
    Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis.
    Eur Urol Oncol. 2020 Nov 4. pii: S2588-9311(20)30171.
    Abstract     Related articles   

  1573. ZHANG S, Shi Z, Pang K, He H, et al
    MAP30 Inhibits Bladder Cancer Cell Migration and Invasion In Vitro Through Suppressing Akt Pathway and the Epithelial/Mesenchymal Transition Process.
    DNA Cell Biol. 2020;39:1948-1960.
    Abstract     Related articles   

  1574. DONG ZC, Zhang D, Wang SB, Lin ZQ, et al
    Target inhibition on GSK-3beta by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
    Eur Rev Med Pharmacol Sci. 2020;24:10301.
    Abstract     Related articles   

  1575. DING H, Fan N, Ning Z, Ma D, et al
    Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis.
    Front Oncol. 2020;10:564779.
    Abstract     Related articles   

  1576. ALFANO M, Salonia A, Necchi A
    Re: Madhuri Koti, Molly A. Ingersoll, Shilpa Gupta, et al. Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. Eur Urol Oncol 2020;3:622-30.
    Eur Urol Oncol. 2020 Nov 3. pii: S2588-9311(20)30172.
    Abstract     Related articles   

  1577. BALLAS L, Singh P, Lerner SP
    Targeting barriers to wider use of trimodality therapy in localized muscle invasive bladder cancer.
    Urol Oncol. 2020 Nov 2. pii: S1078-1439(20)30478.
    Abstract     Related articles   

  1578. LOPEZ-BELTRAN A, Cheng L
    Stage T1 bladder cancer: diagnostic criteria and pitfalls.
    Pathology. 2020 Nov 3. pii: S0031-3025(20)30943.
    Abstract     Related articles   

  1579. [Consensus on immunohistochemical detection of PD-L1 (SP263) in bladder invasive urothelial carcinoma].
    Zhonghua Bing Li Xue Za Zhi. 2020;49:1102-1107.
    Abstract     Related articles   

  1580. YU J, Lim B, Lee Y, Park JY, et al
    Risk factors and outcomes of myocardial injury after non-cardiac surgery in high-risk patients who underwent radical cystectomy.
    Medicine (Baltimore). 2020;99:e22893.
    Abstract     Related articles   

  1581. PIVOVARCIKOVA K, Svajdler M, Hes O
    Immunohistochemistry in hollow urinary tract.
    Cesk Patol. 2020;56:140-152.
    Abstract     Related articles   

  1582. GROSS AJ, Netsch C, Stolzenburg JU, Becker B, et al
    [Upper urinary tract urothelial cell carcinoma].
    Urologe A. 2020;59:1265-1274.
    Abstract     Related articles   

  1583. GRULLICH C, Kubler H
    [Urothelial carcinoma: immuno-oncology on all fronts].
    Urologe A. 2020;59:783.
    Abstract     Related articles   

  1584. BARIZZI J, Freguia S, Sarro R, Venzi G, et al
    Prostatic Ductal Adenocarcinoma with Papillary Features in a Bladder Washing: A Possible Pitfall in Urinary Cytology - Report of One Case.
    Acta Cytol. 2020;64:607-611.
    Abstract     Related articles   

  1585. DE FALCO F, Urraro C, Cutarelli A, Roperto S, et al
    Bovine papillomavirus E5 oncoprotein upregulates parkin-dependent mitophagy in urothelial cells of cattle with spontaneous papillomavirus infection: A mechanistic study.
    Comp Immunol Microbiol Infect Dis. 2020;70:101463.
    Abstract     Related articles   

  1586. ROUBAL K, Myint ZW, Kolesar JM
    Erdafitinib: A novel therapy for FGFR-mutated urothelial cancer.
    Am J Health Syst Pharm. 2020;77:346-351.
    Abstract     Related articles   

  1587. DELANGHE SE, Speeckaert MM, Delanghe JR
    How to assess renal function in patients with a neobladder.
    Clin Chim Acta. 2020;504:154.
    Abstract     Related articles   

  1588. ELMETWALI T, Salman A, Wei W, Hussain SA, et al
    CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation.
    Sci Rep. 2020;10:342.
    Abstract     Related articles   

  1589. YASUTOMI E, Yano Y, Kodama Y
    Urinary bladder metastasis of hepatocellular carcinoma incidentally revealed by hematuria.
    Dig Liver Dis. 2020;52:115.
    Abstract     Related articles   

  1590. D'ANDREA D, Abufaraj M, Soria F, Gust K, et al
    Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization.
    World J Urol. 2020;38:121-128.
    Abstract     Related articles   

  1591. BABOUDJIAN M, Al-Balushi K, Michel F, Lannes F, et al
    Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.
    World J Urol. 2020;38:159-165.
    Abstract     Related articles   

  1592. WANG X, Chen F, Gou S
    Anti-tumor effects and cell motility inhibition of the DN604-gemcitabine combined treatment in human bladder cancer models.
    Bioorg Med Chem. 2020 Nov 7:115858. doi: 10.1016/j.bmc.2020.115858.
    Abstract     Related articles   

  1593. CAI PY, Khan AI, Scherr DS, Shoag JE, et al
    Robotic Radical Cystectomy in the Contemporary Management of Bladder Cancer.
    Urol Clin North Am. 2021;48:45-50.
    Abstract     Related articles   

  1594. SANTHA S, Ling X, Aljahdali IAM, Rasam SS, et al
    Mutant Kras as a Biomarker Plays a Favorable Role in FL118-Induced Apoptosis, Reactive Oxygen Species (ROS) Production and Modulation of Survivin, Mcl-1 and XIAP in Human Bladder Cancer.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  1595. PENG X, Wang J, Li D, Chen X, et al
    Identification of grade-related genes and construction of a robust genomic-clinicopathologic nomogram for predicting recurrence of bladder cancer.
    Medicine (Baltimore). 2020;99:e23179.
    Abstract     Related articles   

  1596. MEI Y, Zheng J, Xiang P, Liu C, et al
    Prognostic value of the miR-200 family in bladder cancer: A systematic review and meta-analysis.
    Medicine (Baltimore). 2020;99:e22891.
    Abstract     Related articles   

  1597. MERRILL NM, Vandecan NM, Day KC, Palmbos PL, et al
    MEK is a promising target in the basal subtype of bladder cancer.
    Oncotarget. 2020;11:3921-3932.
    Abstract     Related articles   

  1598. DEL GIUDICE F, Campa R, Bicchetti M, De Berardinis E, et al
    Vesical Imaging-Reporting and Data System (VI-RADS) incorporated into bladder cancer clinical practice: what's the perspectives beyond diagnostic accuracy?
    Transl Androl Urol. 2020;9:2320-2322.
    Abstract     Related articles   

  1599. KRIEGMAIR MC, Bolenz C
    Re: "Multiparametric cystoscopy: opportunities to enhance bladder cancer detection".
    Transl Androl Urol. 2020;9:2318-2319.
    Abstract     Related articles   

  1600. PARIZI PK, Yarahmadi F, Tabar HM, Hosseini Z, et al
    MicroRNAs and target molecules in bladder cancer.
    Med Oncol. 2020;37:118.
    Abstract     Related articles   

  1601. NOUHAUD FX, Chakroun M, Lenormand C, Ouzaid I, et al
    Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study.
    Urol Oncol. 2020 Nov 16. pii: S1078-1439(20)30424.
    Abstract     Related articles   

  1602. JORDAHL KM, Phipps AI, Randolph TW, Tinker LF, et al
    Mediation by differential DNA methylation of known associations between single nucleotide polymorphisms and bladder cancer risk.
    BMC Med Genet. 2020;21:228.
    Abstract     Related articles   

  1603. YING H, Fengying S, Feng H, Yanhong W, et al
    Diagnostic value of quantification of circulating free DNA for gall bladder cancer using a chemiluminescence DNA biosensor system based on DNA G-quadruplex/ hemin enzyme.
    Transl Oncol. 2020;14:100928.
    Abstract     Related articles   

  1604. DELLI PIZZI A, Mastrodicasa D, Marchioni M, Primiceri G, et al
    Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach.
    Eur Radiol. 2020 Nov 19. pii: 10.1007/s00330-020-07473.
    Abstract     Related articles   

  1605. POUDEL R, Shah A
    Incidence of Incidental Gall Bladder Cancer and Role of Routine Histopathological Examination in Cholecystectomies Specimens for Benign Disease.
    J Nepal Health Res Counc. 2020;18:547-550.
    Abstract     Related articles   

  1606. TAYLOR J, Matulewicz RS
    Multiparametric cystoscopy: opportunities to enhance bladder cancer detection.
    Transl Androl Urol. 2020;9:2302-2304.
    Abstract     Related articles   

  1607. HUANG H, Fan X, Zhang X, Xie Y, et al
    LncRNA CARLo-7 facilitates proliferation, migration, invasion, and EMT of bladder cancer cells by regulating Wnt/beta-catenin and JAK2/STAT3 signaling pathways.
    Transl Androl Urol. 2020;9:2251-2261.
    Abstract     Related articles   

  1608. BOWDEN M, Nadal R, Zhou CW, Werner L, et al
    Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer.
    Sci Rep. 2020;10:20135.
    Abstract     Related articles   

  1609. RAMMANT E, Deforche B, Van Hecke A, Verhaeghe S, et al
    Development of a pre- and postoperative physical activity promotion program integrated in the electronic health system of patients with bladder cancer (The POPEYE study): An intervention mapping approach.
    Eur J Cancer Care (Engl). 2020 Nov 17:e13363. doi: 10.1111/ecc.13363.
    Abstract     Related articles   

  1610. NADLER N, Kvich L, Bjarnsholt T, Bjerggaard Jensen J, et al
    The discovery of bacterial biofilm in patients with muscle invasive bladder cancer.
    APMIS. 2020 Nov 18. doi: 10.1111/apm.13097.
    Abstract     Related articles   

  1611. YAN Y, Zhang H, Jiang C, Ma X, et al
    Human papillomavirus prevalence and integration status in tissue samples of bladder cancer in Chinese population.
    J Infect Dis. 2020 Nov 18. pii: 5986718. doi: 10.1093.
    Abstract     Related articles   

  1612. ZHAO X, Tang Y, Ren H, Lei Y, et al
    Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database.
    Biomed Res Int. 2020;2020:9143695.
    Abstract     Related articles   

  1613. YANG J, Jian Z, Shen P, Bai Y, et al
    Associations between Interleukin-32 Gene Polymorphisms rs12934561 and rs28372698 and Susceptibilities to Bladder Cancer and the Prognosis in Chinese Han Population.
    Dis Markers. 2020;2020:8860445.
    Abstract     Related articles   

  1614. CAO R, Ma B, Wang G, Xiong Y, et al
    An Epithelial-Mesenchymal Transition (EMT) Preoperative Nomogram for Prediction of Lymph Node Metastasis in Bladder Cancer (BLCA).
    Dis Markers. 2020;2020:8833972.
    Abstract     Related articles   

  1615. LIU J, Yu X, Liu B, Yu H, et al
    Phosphorylated MAPK14 Promotes the Proliferation and Migration of Bladder Cancer Cells by Maintaining RUNX2 Protein Abundance.
    Cancer Manag Res. 2020;12:11371-11382.
    Abstract     Related articles   

  1616. LAI CH, Xu K, Zhou J, Wang M, et al
    DEPDC1B is a tumor promotor in development of bladder cancer through targeting SHC1.
    Cell Death Dis. 2020;11:986.
    Abstract     Related articles   

  1617. PAPADAKI V, Asada K, Watson JK, Tamura T, et al
    Two Secreted Proteoglycans, Activators of Urothelial Cell-Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression.
    Cancers (Basel). 2020;12.
    Abstract     Related articles   

  1618. LENIS AT, Lec PM, Chamie K, Mshs MD, et al
    Bladder Cancer: A Review.
    JAMA. 2020;324:1980-1991.
    Abstract     Related articles   

  1619. LENIS AT, Lec PM, Chamie K
    Bladder Cancer.
    JAMA. 2020;324:2006.
    Abstract     Related articles   

  1620. ANDOLFI C, Bloodworth JC, Papachristos A, Sweis RF, et al
    The Urinary Microbiome and Bladder Cancer: Susceptibility and Immune Responsiveness.
    Bladder Cancer. 2020;6:225-235.
    Abstract     Related articles   

  1621. TAO L, Pan X, Zhang L, Wang J, et al
    Marital Status and Prognostic Nomogram for Bladder Cancer With Distant Metastasis: A SEER-Based Study.
    Front Oncol. 2020;10:586458.
    Abstract     Related articles   

  1622. ZUCALI PA, Cordua N, D'Antonio F, Borea F, et al
    Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer.
    Front Oncol. 2020;10:568279.
    Abstract     Related articles   

  1623. PENG YL, Wu ZS, Lu HM, Wei WS, et al
    Prognostic significance of tumor-infiltrating immune cells in muscle-invasive bladder cancer.
    Am J Transl Res. 2020;12:6524-6536.
    Abstract     Related articles   

  1624. YAN L, Li Q, Sun K, Jiang F, et al
    MiR-4644 is upregulated in plasma exosomes of bladder cancer patients and promotes bladder cancer progression by targeting UBIAD1.
    Am J Transl Res. 2020;12:6277-6289.
    Abstract     Related articles   

  1625. DOSHI GK, Bhanegaonkar A, Kearney M, Bharmal M, et al
    Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR).
    Clinicoecon Outcomes Res. 2020;12:645-656.
    Abstract     Related articles   

  1626. WANG H, Wu JX, Chen XP, Zhang Q, et al
    Expression and Clinical Significance of MMP-28 in Bladder Cancer.
    Technol Cancer Res Treat. 2020;19:1533033820974017.
    Abstract     Related articles   

  1627. WANG T, Zhang D, Sun K, Wu G, et al
    The second to fourth digit ratio (2D:4D): A risk factor of bladder cancer in men.
    Early Hum Dev. 2020;152:105247.
    Abstract     Related articles   

  1628. WANG J, Shen C, Dong D, Zhong X, et al
    Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
    Int Immunopharmacol. 2020 Nov 11:107146. doi: 10.1016/j.intimp.2020.107146.
    Abstract     Related articles   

  1629. HURMUZ P, Ozyigit G, Kilickap S, Esen CSB, et al
    Gemcitabine based trimodality treatment in patients with muscle invasive bladder cancer: May neutrophil lymphocyte and platelet lymphocyte ratios predict outcomes?
    Urol Oncol. 2020 Nov 11. pii: S1078-1439(20)30575.
    Abstract     Related articles   

  1630. CHEN M, Zhang R, Lu L, Du J, et al
    LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
    Aging (Albany NY). 2020;12:22291-22312.
    Abstract     Related articles   

  1631. FISCHER-VALUCK BW, Michalski JM, Harton JG, Birtle A, et al
    Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy.
    Clin Genitourin Cancer. 2020 Jun 22. pii: S1558-7673(20)30144.
    Abstract     Related articles   

  1632. ZHU C, Zuo W, Yuan L, Su J, et al
    Comparison of Laparoendoscopic Single-Site and Laparoscopic Radical Cystectomy for Male Patients with Bladder Cancer: Perioperative and Oncologic Outcomes.
    J Laparoendosc Adv Surg Tech A. 2020 Nov 13. doi: 10.1089/lap.2020.0611.
    Abstract     Related articles   

  1633. KARPOV VK, Kapranov SA, Sharapov BM, Kamalov AA, et al
    [Super-selective embolisation of bladder arteries for treatment of patients with bladder tumors complicated by recurrent macrohematuria].
    Urologiia. 2020;:133-138.
    Abstract     Related articles   

  1634. GULIEV BG, Komyakov BK, Bolokotov RR, Al-Attar TK, et al
    [Robot-assisted radical cystectomy with neobladder formation].
    Urologiia. 2020;:54-60.
    Abstract     Related articles   

  1635. ZHU J, Wang H, Ma T, He Y, et al
    Identification of immune-related genes as prognostic factors in bladder cancer.
    Sci Rep. 2020;10:19695.
    Abstract     Related articles   

  1636. PHILYPPOV IB, Sotkis GV, Rock A, Roudbaraki M, et al
    Alterations in detrusor contractility in rat model of bladder cancer.
    Sci Rep. 2020;10:19651.
    Abstract     Related articles   

  1637. LIN Y, Shen Z, Tao T, Xu C, et al
    Study on the Effect of Polymer Nano-Loaded Drug System on Bladder Cancer Perfusion.
    J Nanosci Nanotechnol. 2021;21:955-961.
    Abstract     Related articles   

  1638. LIU B, Gao X, Han B, Chen G, et al
    Mouse Model to Explore the Therapeutic Effect of Nano-Doxorubicin Drug Delivery System on Bladder Cancer.
    J Nanosci Nanotechnol. 2021;21:914-920.
    Abstract     Related articles   

  1639. RABY SEM, Hoskin P, Choudhury A
    The role of palliative radiotherapy in bladder cancer: a narrative review.
    Ann Palliat Med. 2020 Nov 10. pii: apm-20-1347. doi: 10.21037/apm-20-1347.
    Abstract     Related articles   

  1640. HULSEN S, Lippolis E, Ferrazzi F, Otto W, et al
    High Stroma T-Cell Infiltration is Associated with Better Survival in Stage pT1 Bladder Cancer.
    Int J Mol Sci. 2020;21.
    Abstract     Related articles   

  1641. KIM SH, Ryu E, Kim EJ
    A Narrative Inquiry into the Adjustment Experiences of Male Bladder Cancer Survivors with a Neobladder.
    Int J Environ Res Public Health. 2020;17.
    Abstract     Related articles   

  1642. GAO L, Xie W, Li K, Huang G, et al
    Primitive neuroectodermal tumor of urinary bladder: A case report and literature review.
    Medicine (Baltimore). 2020;99:e23032.
    Abstract     Related articles   

  1643. KONG J, Lee H, Kim D, Han SK, et al
    Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients.
    Nat Commun. 2020;11:5485.
    Abstract     Related articles   

  1644. VUILLERMET C, Meillat H, Manceau G, Creavin B, et al
    Advanced colonic cancer with clinically suspected bladder invasion: Outcomes and prognosis from a multicentric study of 117 patients from the FRENCH research group.
    Surgery. 2020;168:786-792.
    Abstract     Related articles   

  1645. BABJUK M
    Unanswered Questions for Bladder Tumours Unresponsive to Bacillus Calmette-Guerin.
    Eur Urol Oncol. 2020;3:341-342.
    Abstract     Related articles   

  1646. JHANG S, Chen M, Chen LC
    Concurrent mullerianosis of the urinary bladder and the umbilicus presenting with umbilical bleeding: a rare case report and review of the literature.
    BMC Womens Health. 2020;20:66.
    Abstract     Related articles   

  1647. ZUPPONE S, Assalini C, Minici C, Bertagnoli S, et al
    The anti-tumoral potential of the saporin-based uPAR-targeting chimera ATF-SAP.
    Sci Rep. 2020;10:2521.
    Abstract     Related articles   

  1648. KAPLAN TM, Milman T, Shields CL
    Atypical Conjunctival Lesion Associated With a Bladder Problem.
    JAMA Ophthalmol. 2020;138:204-205.
    Abstract     Related articles   

  1649. WILSON C, Moseshvili E, Tacey M, Quin I, et al
    Assessment of Intrafraction Motion of the Urinary Bladder Using Magnetic Resonance Imaging (cineMRI).
    Clin Oncol (R Coll Radiol). 2020;32:101-109.
    Abstract     Related articles   

  1650. UCER O, Temeltas G, Gumus B, Muezzinoglu T, et al
    Comparison of pain, quality of life, lower urinary tract symptoms and sexual function between flexible and rigid cystoscopy in follow-up male patients with non muscle invasive bladder cancer: a randomized controlled cross section single blind study.
    Int J Clin Pract. 2020 Nov 27:e13853. doi: 10.1111/ijcp.13853.
    Abstract     Related articles   

  1651. YUAN L, Li D, Mu D, Zhang X, et al
    Combined T2 SPAIR, Dynamic Enhancement and DW Imaging Reliably Detect T Staging and Grading of Bladder Cancer With 3.0T MRI.
    Front Oncol. 2020;10:582532.
    Abstract     Related articles   

  1652. TIAN Y, Guan Y, Su Y, Luo W, et al
    MiR-582-5p Inhibits Bladder Cancer-Genesis by Suppressing TTK Expression.
    Cancer Manag Res. 2020;12:11933-11944.
    Abstract     Related articles   

  1653. HUANG X, Tao Y, Gao J, Zhou X, et al
    UBC9 coordinates inflammation affecting development of bladder cancer.
    Sci Rep. 2020;10:20670.
    Abstract     Related articles   

  1654. HAN Y, Liu X, Ye H, Tian Y, et al
    Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis.
    World J Surg Oncol. 2020;18:310.
    Abstract     Related articles   

  1655. ZHU S, Xu Z, Zeng Y, Long Y, et al
    ADNP Upregulation Promotes Bladder Cancer Cell Proliferation via the AKT Pathway.
    Front Oncol. 2020;10:491129.
    Abstract     Related articles   

  1656. WANG HH, Chen Y, Changchien CY, Chang HH, et al
    Pharmaceutical Evaluation of Honokiol and Magnolol on Apoptosis and Migration Inhibition in Human Bladder Cancer Cells.
    Front Pharmacol. 2020;11:549338.
    Abstract     Related articles   

  1657. ELLA-TONGWIIS P, Lamb RM, Makanga A, Shergill I, et al
    The role of antibody expression and their association with bladder cancer recurrence: a single-centre prospective clinical-pilot study in 35 patients.
    BMC Urol. 2020;20:187.
    Abstract     Related articles   

  1658. PEREIRA DI, Amparo TR, Almeida TC, Costa FSF, et al
    Cytotoxic activity of butanolic extract from Sambucus nigra L. flowers in natura and vehiculated in micelles in bladder cancer cells and fibroblasts.
    Nat Prod Res. 2020 Nov 25:1-9. doi: 10.1080/14786419.2020.1851220.
    Abstract     Related articles   

  1659. LI D, Zhong S, Zhu Z, Jiang X, et al
    LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
    Pathobiology. 2020 Nov 25:1-11. doi: 10.1159/000509957.
    Abstract     Related articles   

  1660. GUO P, Wang L, Shang W, Chen J, et al
    Intravesical In Situ Immunostimulatory Gel for Triple Therapy of Bladder Cancer.
    ACS Appl Mater Interfaces. 2020 Nov 25. doi: 10.1021/acsami.0c15176.
    Abstract     Related articles   

  1661. WANG F, Ma X, Mao G, Zhang X, et al
    STAT3 enhances radiation-induced tumor migration, invasion and stem-like properties of bladder cancer.
    Mol Med Rep. 2021;23.
    Abstract     Related articles   

  1662. ZHAO C, Li Y, Hu X, Wang R, et al
    LncRNA HCP5 Promotes Cell Invasion and Migration by Sponging miR-29b-3p in Human Bladder Cancer.
    Onco Targets Ther. 2020;13:11827-11838.
    Abstract     Related articles   

  1663. RINALDETTI S, Worst TS, Rempel E, Kriegmair MC, et al
    Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer.
    Sci Rep. 2020;10:20472.
    Abstract     Related articles   

  1664. WU S, Xu R, Zhu X, He H, et al
    The long noncoding RNA LINC01140/miR-140-5p/FGF9 axis modulates bladder cancer cell aggressiveness and macrophage M2 polarization.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  1665. TANG C, Cai Y, Jiang H, Lv Z, et al
    LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis.
    Aging (Albany NY). 2020;12.
    Abstract     Related articles   

  1666. YAO DW, Song Q, He XZ
    Kinesin family member 23 (KIF23) contributes to the progression of bladder cancer cells in vitro and in vivo.
    Neoplasma. 2020 Nov 25. pii: 200803N808. doi: 10.4149/neo_2020_200803.
    Abstract     Related articles   

  1667. WANG W, Ding Y, Lu Q, Qi J, et al
    The development of a behaviour questionnaire for stoma self-management for persons with bladder cancer and an ileal conduit.
    J Adv Nurs. 2020 Nov 24. doi: 10.1111/jan.14662.
    Abstract     Related articles   

  1668. DEUKER M, Stolzenbach LF, Colla Ruvolo C, Nocera L, et al
    Bladder cancer stage and mortality: urban vs. rural residency.
    Cancer Causes Control. 2020 Nov 23. pii: 10.1007/s10552-020-01366.
    Abstract     Related articles   

  1669. BROUGHMAN JR, Vuong W, Mian OY
    Current Landscape and Future Directions on Bladder Sparing Approaches to Muscle-Invasive Bladder Cancer.
    Curr Treat Options Oncol. 2020;22:3.
    Abstract     Related articles   

  1670. KRAJEWSKI W, Moschini M, Chorbinska J, Nowak L, et al
    Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes.
    World J Urol. 2020 Nov 23. pii: 10.1007/s00345-020-03522.
    Abstract     Related articles   

  1671. WANG F, Fan M, Cai Y, Zhou X, et al
    Circular RNA circRIMS1 Acts as a Sponge of miR-433-3p to Promote Bladder Cancer Progression by Regulating CCAR1 Expression.
    Mol Ther Nucleic Acids. 2020;22:815-831.
    Abstract     Related articles   

  1672. XIE F, Xiao X, Tao D, Huang C, et al
    circNR3C1 Suppresses Bladder Cancer Progression through Acting as an Endogenous Blocker of BRD4/C-myc Complex.
    Mol Ther Nucleic Acids. 2020;22:510-519.
    Abstract     Related articles   

  1673. ACHENBACH F, Rose M, Ortiz-Bruchle N, Seillier L, et al
    SWI/SNF Alterations in Squamous Bladder Cancers.
    Genes (Basel). 2020;11.
    Abstract     Related articles   

  1674. BANGASH M, Ather MH, Khan N, Mohammad S, et al
    Comparison Of Recurrence Rate Between "EN BLOC" Resection Of Bladder Tumour And Conventional Technique For Non-Muscle Invasive Bladder Cancer.
    J Ayub Med Coll Abbottabad. 2020;32:435-440.
    Abstract     Related articles   

  1675. LANDAAS EJ, Eckel AM, Wright JL, Baird GS, et al
    Application of Health Technology Assessment (HTA) to Evaluate New Laboratory Tests in a Health System: A Case Study of Bladder Cancer Testing.
    Acad Pathol. 2020;7:2374289520968225.
    Abstract     Related articles   

  1676. BARNETT J, Bruha M, Ozay F, Hyacinthe L, et al
    Muscle-invasive bladder cancer following radiotherapy for prostate adenocarcinoma.
    Urol Case Rep. 2020;34:101485.
    Abstract     Related articles   

  1677. KACEW A, Sweis RF
    FGFR3 Alterations in the Era of Immunotherapy for Urothelial Bladder Cancer.
    Front Immunol. 2020;11:575258.
    Abstract     Related articles   

  1678. CARVALHO J, Lopes V, Travasso R
    Tumor Cell Invasiveness in the Initial Stages of Bladder Cancer Development - a computational study.
    Int J Numer Method Biomed Eng. 2020 Nov 22:e3417. doi: 10.1002/cnm.3417.
    Abstract     Related articles   

  1679. HUANG B, Huang G, Li W, Chen L, et al
    Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral resection of the bladder tumor.
    J Cancer Res Clin Oncol. 2020 Nov 22. pii: 10.1007/s00432-020-03453.
    Abstract     Related articles   

  1680. WU Y, Zhang L, He S, Guan B, et al
    Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
    Aging (Albany NY). 2020;12.